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Abstract 
Self-medication of plant based foods and food extracts which have ostensible 
therapeutic benefits has considerably increased within non-clinical populations over the 
last two decades. The overarching reason for this rise in consumption is to improve 
health and cognitive performance. One such group of foods are flavonoid-rich berry 
fruits. In the literature, there has been a recent rise in evidence showing that the 
consumption of flavonoid-rich berries can modulate aspects of behaviour, especially 
memory, in animal models and in aged humans. Physiological parameters such as 
blood-flow and glucose levels; and biological mechanisms such as monoamine oxidase 
(MAO) activity and nitric oxide (NO) synthesis, which have the potential to impact 
human behaviour, are also shown to be manipulated by flavonoid compounds. The 
dark purple fruits of the blackcurrant (Ribes nigrum) are naturally high in flavonoids, 
however no literature assessing cognitive effects of their consumption is available. The 
main focus of this thesis was to assess the impact of standardised flavonoid-rich 
blackcurrant extracts upon cognitive performance and mood in healthy human 
participants. Two extracts were examined within the thesis, a freeze dried powder 
extract fortified to contain 30% anthocyanins (DelcyanTM) and a fresh from frozen cold 
pressed juice extract (Blackadder cultivar, Plant and Food Research Ltd). Utilising a 
series of randomised, between subjects, double bind studies, measures of memory, 
attention, executive function and psychomotor performance were implemented during 
the course of the thesis at various post-dose time points. Throughout the 
investigational chapters of the thesis, physiological parameters and potential 
mechanisms driving any behavioural changes were measured. Such measures 
included measures of central and peripheral haemodynamics, MAO inhibition, 
monoaminergic tone, prolactin secretion and post-prandial glucose profiles.  
Single doses of each of the blackcurrant extracts used in this thesis yielded 
positive results with effects of post-harvest extraction technique evident. Although no 
clear pattern of behavioural modulation was found after consumption of the 
blackcurrant extracts, there was some evidence to show increases in attention 
processes during cognitively demanding paradigms in young participants. No positive 
effects were evident upon any other cognitive paradigm. Physiological effects of acute 
blackcurrant supplementation included a modulation of post-prandial glucose profile 
and hemispheric dependent modulations of cerebral blood flow. Most strikingly, a 
pharmaceutical level inhibition of both monoamine oxidase isoforms and reductions in 
blood plasma prolactin were found. The findings of this thesis may have implications for 
enhancement of cognitive performance, attenuation in natural cognitive decline over 
the lifespan, and potentially, clinical applications in the treatment of neurological 
diseases. 
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CHAPTER 1. INTRODUCTION 
1.1 General introduction 
Food is essential for everyday life, providing nutrients to maintain homeostasis. Certain 
foods also contain bioactive compounds, which can be advantageous for health 
promotion and disease prevention. Foods that are high in these bioactive compounds 
have been termed “functional foods” or “super foods”. Plant based functional foods 
comprise phytochemicals that have the potential to exert a psychological or 
physiological effect beyond their nutritional capacity. The purported biological effects 
caused by the consumption of some phytochemicals found in functional foods are 
wide-ranging and include, but are not restricted to; stimulant properties (Haskell et al., 
2007), alleviation from stress (Brattstram, 2009), protection from cardiovascular 
disease (Francis et al., 2006), cognitive enhancement (Kennedy et al., 2007), neuro-
protection (Kim et al., 2010) and protection from carcinogenesis (Bishayee et al., 
2011). These effects differ greatly depending upon the compounds present within the 
foods, their chemical structures and their post-harvest processing. Although many 
compounds found in functional foods have shown promising results in vitro, definitive in 
vivo effects, especially in humans, are lacking. Therefore, a growing discussion 
regarding potential in vivo mechanisms driving purported health promoting properties is 
emerging in the literature.  
 
Self-medication in healthy non-clinical populations through products derived from 
functional foods, has significantly increased in popularity over the last decade; to such 
a level that approximately 20% of the North American population use them daily (Bent, 
2008). This is despite a lack of data to support the efficacy of the majority of these 
products’ purported in vivo effects. This increase in consumer demand is driving the 
search for definitive functional foods with quantifiable, in vivo effects upon human 
health maintenance, disease prevention and behaviour modulation. Berries are such a 
functional food, which have a growing convergence of scientific evidence suggesting a 
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modulation of both animal model and human behaviour. These effects are particularly 
evident in memory and attention paradigms (see section 1.4.1). When compared to 
other commonly eaten berries, such as raspberries (30mg of flavonoids per 100g of 
dried berry) and strawberries (10mg/100g dried berry), blackcurrants have especially 
high levels of the class of phytochemical, flavonoids (80mg/100g dried berry)  
(Kähkönen et al., 2001). 
 
Given the growing popularity of “super foods”; the emerging research surrounding the 
potential behavioural enhancing effects of flavonoid-rich foods; and the lack of 
controlled human trials investigating blackcurrants and their impact upon cognitive 
performance; the first question that this thesis will attempt to address is whether the 
consumption of standardised blackcurrant extracts can have a beneficial effect upon 
human behaviour. The second question is whether the underlying physiological 
mechanisms of action driving any behavioural effects can be elucidated. The studies 
that make up this thesis will include investigations of the cognitive enhancement 
properties of a commercially available powdered blackcurrant extract and a cold 
pressed blackcurrant juice. 
 
The remainder of this chapter includes a review of the literature across a number of 
disciplines and, in addition to blackcurrants, encompasses other functional foods that 
are flavonoid-rich. The inclusion of these foods is necessary due to a lack of research 
into the effects of blackcurrants, as they provide peer-reviewed evidence from well 
conducted nutritional intervention trials for an augmentation of psychological and 
physiological parameters in healthy human participants after the consumption of 
flavonoid-rich food extracts. The review will begin with a discussion of the potential 
bioactive compounds in blackcurrants, incorporating their structure and 
pharmacokinetics. The effect of post-harvest processing upon the levels and structures 
of phytochemicals in flavonoid-rich foods will also be discussed to outline the impact of 
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food preparation upon potentially bioactive compounds. The review will then give a 
synopsis of the modulating effect flavonoid-rich foods upon biological and physiological 
parameters which could impact human cognitive performance and health. Finally, the 
impact of foods, rich in flavonoids, upon the cognitive ability of animal models and 
humans will be discussed. 
 
1.2. Phytochemicals in blackcurrants 
Phytochemicals are chemical plant compounds that naturally occur in all plants and 
plant-based foods. A large selection of these phytochemicals consumed in the human 
diet may have the potential to influence human well-being through a variety of 
mechanisms. Based upon their chemical structure, there are several major subclasses 
of phytochemicals including terpenes, thiols, alkaloids, isoprenoids and phenols, with 
phenols being the largest group. The following section will focus upon polyphenols and 
phenolic acids, which are abundant in blackcurrants and are theorised to be the 
compounds behind physiological and psychological modulations discussed in sections 
1.4 to 1.5 of this thesis. 
 
1.2.1 (Poly)phenols 
Polyphenols are organic compounds, of plant origin, which have more than one phenol 
group. There are thousands of molecules in plants that have a polyphenolic structure 
(Manach et al., 2005). The structure of natural polyphenols range from simple 
molecules such as phenolic acids, to large polymerised compounds such as tannins 
(Bravo, 1998). Polyphenols can be separated into four main sub categories; flavonoids, 
phenolic acids, lignans and stilbenes. In terms of blackcurrants, flavonoids and 
phenolic acids make up the majority of the phenolic profile (figure 1.1). Within these 
sub divisions sit the flavonoids: anthocyanins, proanthocyanidins, flavonols, flavones, 
flavanones isoflavones and flavanols (Beecher, 2003); and the phenolic acids: 
hydroxycinnamic acids and hydroxybenzoic acids. These ‘secondary metabolites’ occur 
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ubiquitously in all plants to varying degrees. They play endogenous roles that can 
encompass the provision of colour (Koes et al., 1994), protective actions (Kootstra, 
1994), and deterrence and attraction of insects and herbivores, including symbiotic 
hormonal and central nervous system interactions with insects (Wink, 2003). With this 
in mind, the potential health benefits of polyphenol consumption within mammalian 
biological systems may be related to their bioactive roles within plants; these have 
been shown to include antioxidant, anti-allergic, anti-inflammatory and antiviral 
properties (see Kennedy & Wightman 2011 for a full review). The absorption and, 
therefore, bioactivity of a polyphenol is dependent upon its molecular size and 
configuration. The following sub-sections will focus primarily upon the structure of 
flavonoids and phenolic acids because of their abundance in blackcurrants. 
 
Figure 1.1 Classifications of the major polyphenols found in blackcurrants. 
 
1.2.1.1 Flavonoids 
Flavonoids are organic plant secondary metabolites with a low molecular weight. They 
are almost universally expressed in plants and include the pigments responsible for the 
colours in some plants. Derived from 2-phenylchromen-4-one (Mcnaught et al., 1997), 
flavonoids are an assortment of phenylbenzopyrone structures based on a common 
three-ring nucleus which can be seen below in figure 1.2. The major subclasses of 
flavonoids include, flavonols, flavanols, flavones, chalcones and anthocyanidins 
(Mcnaught et al., 1997). The structural differences of the most common flavonoids can 
also be seen in figure 1.2. 
  
Phenolic Acids Flavonoids
Anthocyanins
LignansStilbenes
Polyphenols
Flavonols ChalconesFlavanols Flavanones
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Figure 1.2 Chemical structures of the most common flavonoid subclasses. (Picture modified with permission from 
Middleton et al., 2000). 
 
Anthocyanins 
Anthocyanins are the most abundant flavonoid found in the fresh blackcurrant fruit. 
They are derivatives of the three ring anthocyanidin structure shown in figure 1.2; 
however, they include pendant sugars, which, as discussed in section 1.3 of this 
chapter, could greatly increase the bioavailability of the flavonoid. Anthocyanins are 
responsible for the red, violet, and blue colour of most berries and fruits. Seventeen 
different anthocyanins exist, each differing in chemical structure to one another (Kong 
et al., 2003). Below are the structures of the two most abundant anthocyanins in 
blackcurrants; cyanidin-3-0-glucoside and delphinidin-3-0-glucoside along with their 
aglycone molecules, cyanidin and delphinidin (figure 1.3). 
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Figure 1.3 Chemical structure of anthocyanidins cyanidin (a) and delphinidin (b) and their anthocyanin glucoside 
derivatives cyanidin-3-0-glucoside (c) and delphinidin-3-0-glucoside (d) which are the major phenolic constituents of 
blackcurrants. Marvin was used for drawing, displaying and characterizing chemical structures. Marvin sketch (version 
6.0), 201n (2013), ChemAxon (http://www.chemaxon.com) 
 
1.2.1.2 Phenolic acids 
The two major subclasses of phenolic acids, detectable in processed blackcurrants to 
varying degrees, are hydroxycinnamic acids and hydroxybenzoic acids. The most 
common hydroxycinnamic acids are ferulic, p-coumaric, sinapic and caffeic acids; while 
the corresponding hydroxybenzoic acids are p-hydroxybenzoic, protocatechuic, vanillic, 
and syringic acids (Mattila et al., 2006), with the structural difference between the two 
subgroups being a differentiation in the hydroxylations and methoxylations of their 
aromatic rings (Mattila et al., 2006). Figure 1.4 below provides an example of this, 
showing the structural differences of the compounds p-coumaric acid and vanillic acid, 
which belong to each of the sub groups.   
a. Cyanidin b. Delphinidin 
c. Cyanidin-3-0-glucoside d. Delphinidin-3-0-glucoside 
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             a. p-Coumaric acid         b. Vanillic acid 
Figure 1.4 Phenolic acid subgroups (a). an example of a hydroxycinnamic acid (b). an example of a hydroxybenzoic 
acid. Marvin was used for drawing, displaying and characterizing chemical structures,, Marvin sketch (version 6.0), 201n 
(2013), ChemAxon (http://www.chemaxon.com) 
 
1.2.2 Foods rich in flavonoids  
As discussed in section 1.1, there is evidence to support an augmentation of human 
behaviour after the consumption of flavonoid-rich foods. However, there are no peer 
reviewed publications assessing the consumption of blackcurrants upon the cognitive 
performance of humans. This thesis will, therefore, look at the evidence from cocoa 
and berries, two flavonoid-rich foods which, in the literature, have evidence to support 
modulations of cognitive function and physiological parameters that could benefit 
health, well-being and cognitive performance. The section below outlines these 
flavonoid-rich foods and their flavonoid constituents. Moreover, this section will also 
discuss the impact post-harvest processing has upon the quantity and structure of 
potentially bioactive compounds within these foods; two factors which could affect their 
ability to impact human behaviour.  
 
1.2.2.1 Cocoa 
When ripe, the cocoa pod of the Theobroma cacoa plant weighs around 500g and 
contains approximately 20-60 seeds, known as cocoa beans. The cocoa bean contains 
around 40% to 60% fat and is rich in polyphenols. Cocoa beans contain high levels of 
flavan-3-ols, a sub class of flavonoids, which are now widely accepted to be the main 
active component responsible for the health benefits observed following cocoa 
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consumption. As with all polyphenols, there is large variability in content of flavan-3-ols 
as a consequence of cultivar, growing conditions, harvesting and processing; however, 
flavan-3-ols tend to make up at least 10% of cocoa powder (Hammerstone et al., 
2000). Of the flavan-3-ols, the monomers (+)-catechin and (-)-epicatechin are of 
particular interest. These monomers, along with their enantiomeric forms (-)-catechin 
and (+)-epicatechin, are often present in nature as subunits of the oligomers 
(procyanidins). Monomers have been shown to make up around 12% of the total 
procyanidin content of cocoa based products irrespective of whether measured in 
unsweetened or dark chocolate, whereas large polymers range from ~28% in dark 
chocolate to ~34% in unsweetened chocolate (Gu et al., 2004).  
 
1.2.2.2 Berries 
Berries are many seeded fleshy fruits (Allaby, 1996). Amongst others, this fruit genus 
contains grape, blueberry, cranberry, redcurrant and blackcurrant.  Berries are 
polyphenol-rich foods containing up to 5240mg/100g of fruit (crowberry). However, the 
amount and type of polyphenols depends upon berry species, growing conditions and 
geological location of cultivation (Kähkönen et al., 2001). The major polyphenols in 
berries are the flavonoid anthocyanins with up to 3090mg/100g of fruit (Kähkönen et 
al., 2001) and phenolic acids (Mattila et al., 2006). 
 
Blueberry 
The blueberry plant [Cyanococcus vaccinium] is an erect or bushlike plant found in 
central America, Europe, Asia and Africa. The fruit is a small berry with a flared crown 
at the end. When ripe the berries are a purple in colour and are coated in a white 
bloom “epicuticular wax”. Blueberries contain from 400 to 600mg of total phenolics per 
100g (chlorogenic acid equivalents) of fresh fruit, dependent upon cultivar and growing 
location (Connor et al., 2002). The dark purple colour of the berries is owed to the 
anthocyanin content which range from 110 to 260 mg/100g of fresh berries dependent 
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upon the cultivar (Gao & Mazza, 1994). However, processing and storage of 
blueberries greatly changes the anthocyanin and phenolic acid yield, with a reduction 
of up to 68% and 47% respectively after the juicing process (Skrede et al., 2000). 
Cooking of the berries further changes the phenolic content of the berries with 
reductions of anthocyanins of 20% after the cooking process and an increase in 
phenolic acids of 15% (Rodriguez-Mateos et al., 2013). 
 
Blackcurrant 
The blackcurrant [Ribes nigrum] is a temperate fruit native to Europe and northern 
Asia. It is now widely cultivated both commercially and domestically for its abundant 
berries. Blackcurrant berries are widely commercially available and are consumed in 
their raw state, cooked, juiced and used as concentrated extracts. The berries of the 
blackcurrant are dark purple with a glossy skin and contain several small seeds. 
Blackcurrant berries are known to be naturally high in polyphenols (Hollands et al., 
2008). The major anthocyanin constituents of blackcurrants are delphinidin 3-O-
glucoside (D3G) (14%), delphinidin 3-O-rutinoside (D3R) (36.59%) cyanidin 3-O-
glucoside (C3G) (7.08%) and cyanidin 3-O-rutinoside (C3R) (40.15%) (Slimestad & 
Solheim, 2002). Other anthocyanins such as petunidin, pelargonidin, peonidin and 
malvidin glucosides and rutinosides are also found in blackcurrants, but at much lower 
quantities (Slimestad & Solheim, 2002). Although anthocyanins, their derivatives and 
conjugates are the main polyphenols found in blackcurrants, accounting for over 90% 
of their phenolic makeup (Anttonen & Karjalainen, 2006), conjugates of other 
flavonoids such as myricetin glucoside (22mg/kg), quercetin glucoside (17.8mg/kg) and 
kaempferol glucoside (4.65 mg/kg); as well as phenolic acids such as p-coumaric acid 
(2.32mg/kg), 3-caffeoylquinic acid (3.37mg/kg) and ferulic acid (4.09mg/kg), can also 
be found (Anttonen & Karjalainen, 2006). Quantities of these polyphenols are greatly 
influenced by specifics of cultivar, cultivation techniques, geographical location and 
post-harvest preparation (Anttonen & Karjalainen, 2006; Hollands et al., 2008). For 
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example, European cultivars of blackcurrants contain on average 500mg of 
polyphenols per 100g of fruit, whereas cultivars grown in New Zealand can yield up to 
700mg of polyphenols. Further to this, the anthocyanin content of fresh blackcurrants 
has been shown to be as high as 900mg/100g of fresh fruit as measured by HPLC, 
whereas ready to drink blackcurrant juice can contain as little as 0.5mg/100g (Hollands 
et al., 2008).  
 
1.3 Pharmacokinetics of flavonoids and phenolic acids 
The release of phytochemicals from the food matrix depends upon the plant food 
source, its processing conditions and the presence of other dietary components. 
Thereafter, the absorption of the phytochemical separated from the food matrix is 
dependent upon its molecular size and configuration, lipophilicity, solubility, stability at 
low pH and the effect of phase one, two and three metabolising enzymes/systems. The 
available literature on the effect of the plant food matrix on absorption is limited, with 
very little potential for intra-study comparisons. 
 
In regards to anthocyanins, the bioavailability in humans is extremely low after oral 
ingestion of berries with less than 0.1% of intact glucoside, rutinoside and acylated 
forms being found in plasma after oral consumption (Matsumoto et al., 2001; Mazza et 
al., 2002; Nielsen et al., 2003). Intact glucosides, galactosides and arbinosides of 
cyanidin, delphinidin, petunidin, pelargonidin, peonidin and malvidin, have been found 
in the blood and urine of humans after oral ingestion of flavonoid-rich berries, such as 
blueberries and boysenberries (Kay et al., 2004). However, studies investigating 
blackcurrants have measured only D3G, D3R, C3G and C3R (Matsumoto et al., 2001; 
Nielsen et al., 2003; Matsumoto et al., 2005b). The absorption after oral ingestion and 
subsequent maximal concentrations (Cmax) and time to maximal concentration (tmax) of 
anthocyanins quantified in the blood, have been shown to be dependent upon the form 
of food ingested. For example, Matsumoto et al., (2005) supplemented healthy 
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participants with 33mg (combined total) of isolated D3G, D3R, C3G and C3R 
compounds per kilo of body weight. D3G, D3R, C3G and C3R were found intact in both 
plasma and urine with total blood plasma tmax at one to two hours post-
supplementation, dependent on the anthocyanin, with a gradual decline in plasma 
concentration to half of Cmax over the subsequent four hours of measurement. The Cmax 
of the total ingested anthocyanins found in blood plasma was less than 1% at ~40 
ng/ml. In a study using a whole food matrix, Mazza et al., (2002) supplemented five 
adult males with 100g of freeze dried blueberries containing 2.79g of polyphenols, of 
which 1.2g were anthocyanins. Maximum concentrations of anthocyanins (combined 
total) were found in plasma four hours after consumption with Cmax of 13ng/ml. 
Differences in time to maximum blood plasma concentrations of anthocyanins between 
these two studies suggest that the absorption rate of anthocyanins and other flavonoids 
in humans may be affected by not only the chemical structure of the compound, but 
other factors including chemical interactions within food matrices and intestinal 
components, as well as structural and compositional characteristics of the source of the 
flavonoid being studied.  
 
As with circulatory blood levels, urinary excretion of anthocyanins is also low after oral 
ingestion with between 0.016 and 0.22% of that ingested being excreted (Netzel et al., 
2001; Nielsen et al., 2003; Hollands et al., 2008). Animal models have also shown that 
there is limited excretion of intact anthocyanins in faeces. This poor bioavailability of 
intact anthocyanins suggests a comprehensive bio-transformation after oral ingestion. 
Along with pH, metabolism of anthocyanins by microflora may contribute to the 
bioavailability of anthocyanins. Keppler & Humpf (2005) utilised pig microflora as a 
model of anthocyanin degradation in the human digestive tract. It was found that 
anthocyanidin glycosides are hydrolysed extensively by intestinal microflora depending 
on the sugar moiety. After cleavage of the protective 3-glycosidic linkage, the released 
aglycones are very unstable under physiological conditions in the intestine at neutral 
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pH and degrade spontaneously into phenolic acids and aldehydes. A graphical 
representation of this can be seen in figure 1.5. This would, therefore, reduce the 
possibility for anthocyanins or anthocyanidins to act locally or systemically in their 
polymer state because of their deglycosylation and degradation into monomeric 
phenolic molecules, which is dependent on both pH and microbial metabolism. This 
was demonstrated in a human in vivo study whereby benzoic, hippuric, salicylic and 
phenylacetic acid were detectable in blood plasma of 20 healthy adults post 
supplementation of a 20% blackcurrant juice drink containing 31mg of polyphenols 
(30.4mg of anthocyanins and 616µM phenolic acids), despite not being present in the 
juice administered. Plasma concentrations of benzoic, hippuric, salicylic and 
phenylacetic acid peaked 30 minutes after consumption of the drink, levels then 
diminished after 80 minutes, remerging at 120 minutes and peaking for a second time 
180 minutes after ingestion (Jin et al., 2011). This metabolic transformation could 
indicate quick metabolism of flavonoids in the colon (Kim et al., 1998) then further 
biochemical or microbial degradation of the phenolic compounds, as suggested by 
Keppler & Humpf (2005) (figure 1.5). However, anthocyanins have been shown to be 
quickly absorbed through the stomach, potentially through interactions with gut efflux 
transporters (Dreiseitel et al., 2009b), and, as discussed above, are detectable in the 
blood and urine of humans. This outlines absorption of anthocyanins from the stomach 
into the blood stream, then further transformation of the anthocyanins through a 
complex stage of events in the gut to smaller phenolic compounds, which are later 
absorbed and reappear in the blood in a biphasic manner. These multiple peaks in 
blood plasma phenolics potentially outline several therapeutic windows after the 
consumption of flavonoid-rich foods and also the potential for a pro-drug effect, where 
compounds present in the foods are not biologically active per se, but are metabolised 
into an active compound in vivo. 
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Figure 1.5 Degradation of an anthocyanidin into an α-diketone and monomeric phenolic compounds (modified with 
permission from Keppler & Humpf, 2005). 
 
  
Despite an increase in evidence regarding the ability of anthocyanins to reach the 
periphery, a lot less is known about their ability to gain access to the central nervous 
system; a crucial factor if they are to have a direct effect upon the brain. In order to 
reach the central nervous system, molecules must cross the blood brain barrier, a 
selectively permeable endothelial cell layer that actively isolates molecules in the 
peripheral vasculature from the central nervous system. A recent review by Stevenson 
et al., (2010) describes how flavonoids have the correct hydrophobicity to cross the 
blood brain barrier. Although glucoronidation and sulphation restrict their permeability 
by greatly reducing their hydrophobicity; intact galactoside, glucoside and arabinose 
forms of anthocyanins have been quantified at femtomolar levels in the cerebellum, 
cortex, hippocampus and striatum of blueberry fed rats, but not control animals, after 
eight weeks supplementation of a 2% blueberry diet (Andres-Lacueva et al., 2005). 
However, blood contamination of the tissue or the possibility of polyphenols sticking to 
blood vessel walls cannot be ruled out as an explanation for these extraordinarily small 
amounts being detectable. 
 
The rate of absorption and bioavailability discussed above and the in vivo site of 
availability of potentially psychoactive compounds, has a fundamental effect on their 
physiological function (Keppler & Humpf, 2005) and, therefore, their ability to modulate 
human behaviour. If a compound is potent in vitro but the in vivo bioavailability is low, 
the direct behaviour modulating effects may be extremely modest or absent. For this 
reason, research focusing upon the intact compounds found in fruit and vegetables 
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directly acting upon cells must be treated with caution in terms of its applicability in 
vivo.  
 
1.4 Mechanisms of action of flavonoids and phenolic acids 
A number of the biological effects of flavonoids could play a key role in the modulation 
of both acute and chronic human cognitive performance. These include antioxidant and 
anti-inflammatory properties, modulation of nitric oxide synthesis, enzyme modulation, 
regulation of cell signalling cascades, gene expression and neurotransmitter 
modulation. These may facilitate observed physiological effects reported after the 
consumption of flavonoid-rich foods which, as discussed in section 1.5 of this chapter, 
include neuro-protection, regulation of haemodynamics and neurotransmitter 
modulation. 
 
1.4.1 Neuro-protection and neuro-signalling 
Oxidative stress describes a disparity amongst the accumulation of systemic reactive 
oxygen species and the body’s natural capacity to detoxify the facilitating structures 
and repair any damage caused. Historically, it has been assumed that the foundations 
of the neuro-protective actions of flavonoids are based on their ability to scavenge 
reactive oxygen species or influence intracellular redox species and, therefore, protect 
against damage associated with oxidative stress. It is now becoming common theory 
that the effects of flavonoids on the brain are mediated by their capacity to; enhance 
existing neuronal function, enhance synaptic transmission, stimulate neurogenesis, and 
protect vulnerable neurons via various mechanisms. As discussed earlier, flavonoids 
have been found intact in the brains of rodents, so a direct effect upon the brain is not 
an unreasonable assumption. The ability of flavonoids to affect the memory of humans, 
discussed later in section 1.6, could be in part related to interactions, on a physiological 
level, with cells and neurons responsible for normal memory function.  
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1.4.1.1 Neuro-protection 
In the presence of extracellular events, cells send an intracellular response to initiate 
an appropriate action. The mitogen activated protein kinase (MAPK) pathway is a chain 
of proteins found in all eukaryotic cells (Robinson & Cobb, 1997). Playing a major role 
in physiological and pathological cell proliferation, the MAPK pathway transmits a 
signal from a receptor on the outer surface of the cell to DNA in the nucleus of the cell; 
directing cellular responses to a diverse array of stimuli, such as mitogens, heat 
stress, osmotic stress and pro-inflammatory cytokines  (for a comprehensive review 
see Zhang & Liu, 2002). Therefore, MAPK pathways are an ideal therapeutic target for 
cell survival. A contributing factor to disintegration of neuronal cells is neuronal 
inflammation. Processes surrounding neuro-inflammation are believed to be heavily 
implicated in neurodegenerative diseases (Hunot & Hirsch, 2003), as well as in 
neuronal injury associated with ischemia (Zheng et al., 2003). Increases in interleukin-
1β, tumour necrosis factor-alpha (Holmin & Mathiesen, 2000), inducible nitric oxide 
synthase (iNOS) and nitric oxide (Bal-Price & Brown, 2001) and NADPH oxidase 
activation (Sun et al., 2008), all contribute to this neuro-inflammation in activated 
central nervous system cells such as astrocytes and microglia, causing glial-induced 
neuronal death. Many of these signalling cascades are regulated by MAPK signalling 
(Bhat et al., 1998), a key mediator of cytokines and iNOS (Marcus et al., 2003). 
Therefore, regulating upstream MAPK could reduce glial inflammation and associated 
cell damage, protecting against progressive neuronal loss (Casper et al., 2000) and 
amyloidogenesis associated with neurodegenerative diseases (Heneka et al., 2005).  
 
The literature demonstrates that phytochemicals found in fruits can regulate MAPK and 
other signalling pathways. For example, blueberries have been shown to up regulate 
the expression of protective MAPK/cAMP response element binding (CREB), (Joseph 
et al., 2003), and to increase neuronal MAPK signalling and extracellular signal-
regulated kinases (ERK) and insulin-like growth factor 1 (IGF-1) expression associated 
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with hippocampal plasticity, learning and memory (Casadesus et al., 2004). 
Furthermore, naringenin, a citrus fruit flavonoid, has been shown to protect against 
inflammatory-induced neuronal death in a primary neuronal–glial co-culture system via 
inhibition of p38/c-Jun N-terminal kinases (JNK) signalling cascades, and also reduced 
iNOS expression and nitric oxide production in glial cells (Vafeiadou et al., 2009). 
Flavonoid-rich blueberry extracts have also been shown to attenuate inflammatory 
responses of brain microglia in animal models via inhibition of nitric oxide, as well as 
the pro-inflammatory cytokines interleukin-1 β and tumour necrosis factor-alpha (TNFα) 
(Lau et al., 2007).  
 
Hippocampal plasticity and signal transduction 
As discussed in section 1.6 of this thesis, the modulation of cognitive performance of 
research animals after the introduction of flavonoid-rich diets, centres on improvements 
in memory and learning. This process of learning and memory involves changes in 
hippocampal synaptic transmission, most pertinently, long term potentiation (LTP) as 
the mechanism by which memories are stored (Bliss & Collingridge, 1993). This 
storage of memory primarily depends upon the protein synthesis driven formation of, 
and changes in, neuronal connections (Rendeiro et al., 2012), such protein synthesis 
as cAMP response element binding (CREB), which is a key factor in the molecular 
switch that transforms short-term memory into long-term memory (Brightwell et al., 
2007). A recent study (Rendeiro et al., 2013) indicates that flavonoid-rich diets can both 
promote CREB activation and increase levels of brain-derived neurotrophic factor 
(BDNF), a neurotrophin responsible for neuronal survival in the hippocampus. This 
increase in levels of neurotrophins was coupled with improvements in cognitive 
performance in aged rats. These interactions between flavonoids and the above 
discussed signalling cascades and protein transcription could, therefore, play a neuro-
protective role and lay the basis for an attenuation of cognitive decline found in 
epidemiological studies and rat models discussed later in this chapter.  
 
 
31 
 
1.4.2 Haemodynamic modulation 
During natural ageing, cerebral blood flow reduces by up to 0.5% per year (Leenders et 
al., 1990). Preservation of blood flow, including the maintenance of endothelial function 
and large artery elasticity are inversely associated with the incidence of cardiovascular 
disease (CVD), dementia and stroke. Furthermore, epidemiological observations 
demonstrate that diets high in phytochemicals, such as anthocyanins, can significantly 
reduce incidence of CVD risk factors, dementia and stroke (Curin et al., 2006; He et al., 
2006).  
 
In vitro, anthocyanins have been shown to induce endothelial dependent relaxation, 
facilitated by up-regulation of endothelial nitric oxide synthesis (eNOS) 
(Andriambeloson et al., 1998), inhibition of inducible nitric oxide synthase (iNOS) 
(Pergola et al., 2006), reduction of adhesion of inflammatory monocytes to endothelial 
cells (Nizamutdinova et al., 2009) and reduction of oxidative stress in endothelial cells 
via direct penetration of cell membrane and cytosol (Youdim et al., 2000). In humans, 
there is a growing body of intervention studies exhibiting the ability of fruit 
phytochemicals to modulate haemodynamics in the brain (Francis et al., 2006; 
Kennedy et al., 2010; Wightman et al., 2012) and in the periphery (Grassi et al., 2005b; 
Matsumoto et al., 2005b; Heiss et al., 2007). The regulation of neuronal blood flow is 
innately complex with multiple overlapping regulatory systems and key structural 
components existing, such as auto and neurogenic regulation, flow metabolism 
coupling and endothelial dependent regulation (see Peterson et al., 2011 for a recent 
review). Recent human intervention studies focusing upon cerebral blood flow and 
cognitive activities, relate purported increases or decreases in blood flow to 
intervention-dependent modulations of ratios in nitric oxide (Kennedy et al., 2010; 
Wightman et al., 2012). Nitric oxide is a critical regulator of vascular homeostasis. 
Berry constituents have been shown to up-regulate eNOS in vitro (Andriambeloson et 
al., 1998) and inhibit in vitro iNOS (Chen et al., 2001). However, there is no data 
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published on their effects upon neuronal nitric oxide synthase (nNOS), manipulation of 
which is essential if changes in neuronal blood flow post-intervention are to been seen 
(Santizo et al., 2000; Kitaura et al., 2007). Neurotransmitters, and therefore their 
modulation, play a major role in the regulation of cerebral blood flow. For example, the 
increase in extracellular levels of adenosine due to neuronal activity are implicated in 
vasodilation (Blackwell et al., 1967), and noradrenalin, a key neurotransmitter in terms 
of haemodynamics, causes heart rate to increase and vasoconstriction to occur when 
released into the bloodstream (Mckim, 2003). Neurotransmitters will be discussed 
further in the following section. 
 
1.4.3 Neurotransmitter modulation  
Neurotransmitters are chemicals within the central nervous system and the periphery, 
which transmit signals from a neuron to a specific cell across a synapse (Mckim, 2003). 
Since the first neurotransmitter was discovered in 1921, there has been a great deal of 
research conducted on their structure and function. Over 60 neurotransmitters have 
been discovered, some directly influencing human behaviour and others protecting the 
integrity of cell structure (Mckim, 2003). Monoamines are a sub class of 
neurotransmitters derived from dietary and endogenous amino acids, such as 
tryptophan, tyramine and phenylalanine (Mckim, 2003). The sub-category of 
monoamines encompasses a multitude of neuro-modulating chemicals such as the 
catecholamines: dopamine, noradrenaline and adrenaline; and the tryptamines: 
serotonin and melatonin (Mckim, 2003).  Any abnormalities in monoaminergic tone can 
cause severe implications to health and well-being, including clinical implications in 
pathological disorders such as depression (Murphy et al., 2013) and Parkinson’s 
disease (Chaudhuri & Schapira, 2009). The modulation of these neurotransmitters is 
inherently complex; however, their modulation via pharmaceuticals can be used to 
alleviate symptoms of clinical conditions such as depression and anxiety (Kopin, 1985), 
but also pathological diseases such as Parkinson`s (Riederer & Youdim, 1986)  and 
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Alzheimer’s disease (Donnelly & Murphy, 1977). More pertinent to this thesis, there is 
the potential to attenuate age-related cognitive decline by modulation of 
neurotransmitters via the inhibition of the enzyme monoamine oxidase (MAO) (Alper et 
al., 1999). MAO are insoluble mitochondrial enzymes (Pombo et al., 2008) that can be 
found in both peripheral and central tissue. Their main role is to deaminate dietary 
amines and terminate actions of monoaminergic neurotransmitters, including 
dopamine, serotonin, adrenaline and noradrenaline. This deamination of 
neurotransmitters creates amongst other things hydrogen peroxide and ammonia, both 
of which are highly toxic to cells. Two isoforms of MAO exist: MAO-A and MAO-B, 
these isoforms differ in substrate preference, tissue distribution and inhibitor specificity. 
MAO-A preferably catalyses the oxidation of serotonin, and MAO-B is more active 
towards 2-phenylethilamine and benzylamine. Dopamine, adrenaline, noradrenaline, 
tryptamine and tyramine are oxidised by both isoforms (Youdim et al., 1988). The ratio 
of distribution of MAO isoforms in brain tissue is not equal, with approximately three 
quarters of the enzyme being MAO-B and one quarter MAO-A (Saura Marti et al., 
1990). An understanding of the localization of MAO-A and MAO-B is important since 
tissue and cellular compartmentalization of these enzymes determines, to some 
degree, the substrates to which they are exposed; and therefore, their action in vivo. 
Inhibition of MAO allows endogenous monoamines and monoamines from the diet to 
accumulate both centrally and in the periphery and may, therefore, alter the dynamics 
of regular monoamine transmitters, such as noradrenaline, serotonin, or dopamine 
(Yamada & Yasuhara, 2004). Anthocyanins and, to a lesser degree, phenolic acids 
have been shown to be inhibitors of both MAO isoforms in vitro at IC50 concentrations 
of 36.9±5.8µM for MAO-A and 36.8±5.2µM for MAO-B  (Dreiseitel et al., 2009a). 
However, these levels are 1000 fold higher than quantities normally found in human 
plasma following the consumption of an anthocyanin-rich meal (Mazza et al., 2002). 
For example, concentrations of 34.3µMof cyanidin-3-glucoside are need to 
competitively inhibit half of the enzyme activity (IC50) of MAO-Ain vitro, whereas 
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cyanidin-3-glucoside is reported in blood plasma at around 5nMol after oral 
consumption (Matsumoto et al., 2001). The mean IC50 value of phenolic acids was 
11.5±7mM for MAO-A with no inhibition discovered for MAO-B. Plasma levels of 
phenolic acids after blackcurrant consumption have been reported by Jin et al., (2011), 
however from a highly processed drink. Plasma levels of phenolic acids were shown to 
increase by 40% after consumption of the blackcurrant extract. No units other than 
percentage were provided. 
 
In regards to blackcurrant extracts in vivo,  Borman and Schatton., (1996) filed a 
European patent detailing the inhibitory effect of a single serve undefined blackcurrant 
drink on human MAO-B activity. They discovered that supplementation of 50g of 
blackcurrant extract can inhibit peripheral MAO-B activity by up to 92%, one hour post-
supplementation. They also recorded inhibition of MAO-A in vitro by the same 
blackcurrant extract. However, it must be noted that this finding was only substantiated 
in an experiment with one participant. 
 
The manipulation of neurotransmitters via inhibition of MAO isoforms by anthocyanins 
found in blackcurrants could, in theory, positively affect cognitive ability of not only 
clinical populations, but also healthy adults. A wide range of pharmaceutical MAO 
inhibitors are currently available which encompass reversible and irreversible inhibition 
of MAO-A and MAO-B, or both isoforms. For many decades, these drugs have been 
providing pharmacological therapy for depressive disorders and neurological diseases. 
However, Youdim et al., (2006) discuss in a recent review that there are still many 
questions to be answered regarding the actions of MAO and what regulates its activity 
in the brain. Differing active sites between human and rat brains exist, raising questions 
about the use of animal models for human MAO trials, a factor which is possibly 
confounded by arbitrary dosage selection and defects in trial designs. 
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1.5 Physiological effects  
The literature outlines several physiological parameters that could be impacted by 
consumption of flavonoid-rich foods. These include modulations of peripheral and 
central haemodynamics and peripheral glucose regulation; physiological parameters, 
which may have the potential to acutely and chronically impact health and behaviour. 
 
1.5.1. Glucose regulation 
Glucose is the primary source of energy in the brain. After a glucose load, brain 
extracellular glucose levels increase in a similar pattern to that of blood glucose 
(Harada et al., 1993).There has, therefore, been considerable interest over the past 30 
years regarding glucose and cognition, especially surrounding a possible enhancement 
in cognitive function after a glucose load. On the most basic level, some of this 
research has shown glucose to be a modulator of cognitive performance when high 
demand is placed on the brain (Donohoe & Benton, 2000; Kennedy & Scholey, 2000; 
Scholey et al.2001; Riby et al., 2004; Scholey & Kennedy, 2004). Glucose regulation is 
the mechanism whereby blood glucose levels rise sharply immediately after glucose 
intake, then return to baseline as a consequence of increased insulin secretion, usually 
within 30 minutes of consumption. In healthy young humans, poor glucose regulation, 
as defined by glucose levels above normal values after a glucose load, has been 
shown to be associated with impairments in cognition (Craft et al., 1994; Messier, 
1998; Awad et al., 2002). For example, Messier et al., (1999) highlighted that young 
healthy adult participant with poor glucose regulation show improvements in word 
recall, paragraph recall or word order recall after a 50g glucose load. However, 
participants with good glucose regulation showed no cognitive improvement. Donohoe 
& Benton (2000) report that the quicker blood glucose returned to baseline the better 
was the performance on paragraph recall. There was, however, no correlation between 
any other task (vigilance and reaction time) and glucose regulation. Craft et al., (1994) 
compared the effects of 50g of glucose or 2mg saccharin upon cognitive performance 
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In young adults (19-28) or older adults (58-77). Measures of declarative memory, 
working memory, procedural learning and response inhibition were taken 15 minutes 
after consumption of the study drink. The glucose load was found to enhance memory 
in young poorer glucoregulators. However, younger males whose blood glucose levels 
were lowest 60 minutes post glucose ingestion showed reductions in memory 
outcomes. This glucoregluatory effect upon cognitive performance is more apparent in 
healthy older adults, especially in aspects of verbal memory executive functioning 
(Kaplan et al., 2000; Convit et al., 2003; Greenwood et al., 2003; Messier et al., 2003) 
and in older adults with type two diabetes (Kanaya et al., 2004). Further to this, 
improving glycaemic control for six months via an oral hypoglycaemic agent in elderly 
diabetes patients, can improve aspects of dexterity (grooved pegboard), visual 
attention and task switching (stroop-word naming and trail making-part a) and retrieval 
memory (cued recall) (Meneilly et al., 1993). It has been suggested that these glucose 
effects are more readily available in younger adults with poor glucose regulation 
because of the increased amount of time glucose is raised in the blood stream, 
therefore, available for utilisation (Craft et al., 1994).  
 
Nakazawa first showed a reduction in glucose transportation as a consequence of 
exposure to phenolic compounds in 1922 (Nakazawa, 1922). Since then, there has 
been an increase in evidence to show that flavonoid-rich foods can modulate the profile 
of post-prandial blood glucose levels. Johnston et al., (2002) supplemented nine 
healthy adult participants with 25g of glucose naturally occurring in commercial clear 
apple juice or commercially available cloudy apple juice, and compared their effects to 
25g of glucose consumed in water. The authors reported that intestinal glucose uptake, 
as measured by intravenous cannula, was significantly reduced 15 and 30 minutes, 
and increased 45 to 120 minutes, after consumption of both apple juice treatments 
compared to the control. They also found a reduced level of plasma insulin and 
glucose-dependent insulinotropic polypeptide (GIP) 90 minutes after supplementation 
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of both apple juice treatments when compared to control, together with higher 
glucagon-like peptide-1 (GLP-1) plasma concentrations after 90 minutes; but only after 
supplementation of the cloudy apple treatment. This increase in GLP-1 is likely to be 
brought about by reduced gastric emptying, facilitated by the inhibition of sodium 
glucose transporters by phenolic compounds (Manzano & Williamson, 2010). Further to 
these findings, Bassoli et al., (2008) found that oral supplementation of chlorogenic 
acid (CA), when combined with a glucose tolerance test, reduces blood glycaemic peak 
in male albino Wistar rats. Interestingly CA supplemented intravenously did not have 
any impact upon post- prandial blood glucose levels after a glucose tolerance test in 
male albino Wistar rats. This finding would suggest that there is an effect of CA in the 
gut, reducing the uptake of glucose.  
 
A similar blunted post-prandial glucose peak has also been seen after consumption of 
berries. In a study investigating the effect of cranberry juice, participants received one 
of five intervention treatments (all 480mls): low calorie cranberry drink (38kcal), normal 
calorie cranberry drink (280kcal), an isocalorific low calorie corn syrup drink, an 
isocalorific normal calorie corn syrup drink, or a water control. Consumption of the 
normal calorie cranberry juice resulted in significantly higher blood glucose 
concentrations 30 minutes post-prandially. These differences were no longer significant 
180 minutes post-supplementation. Plasma insulin was also significantly higher 60 
minutes post-prandially after consumption of the normal calorie cranberry juice, but not 
significantly different 120 minutes post-prandially when compared to control. 
Interestingly, no effects were found after the consumption of any of the other 
beverages, indicating a glucose load must be consumed in conjunction with the 
cranberry phytochemicals for this glucose effect to be observable (Wilson et al., 
2008b). The same authors found the same pattern of results in a cohort with type two 
diabetes (Wilson et al., 2008a). Törrönen et al., (2012) supplemented 12 healthy 
subjects aged 25-69 years with 150g mixed berry purée consisting of equal amounts 
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(37·5g) of blackcurrants, bilberries and cranberries with 35g sucrose or a control 35g 
sucrose load in a randomised, controlled cross-over design. Compared to control, the 
consumption of the mixed berry meals signiﬁcantly lowered post-prandial blood glucose 
at 15 and 30 minutes post consumption. Blood glucose levels were then signiﬁcantly 
higher at 150 minutes post consumption of the mixed berry meal compared with the 
control meal. Peak glucose concentrations were reached at 30 minutes after the control 
meal and 15 minutes later at 45 minutes after consumption of the berry meal. The peak 
increase from baseline was also 1mmol/l smaller after ingestion of the berry meal. This 
highlights a slower uptake of glucose into the blood after the consumption of berry 
purée, suggesting that, the glycaemic response to sucrose consumption can be 
modulation via co-consumption of a berry purée. As a follow on to this, in the same 
paper the author supplemented 12 healthy participants with the same berry purée meal 
(150 g made of bilberries, blackcurrants, cranberries and strawberries) as well as 35g 
sucrose or a sucrose matched control. This time, fingertip capillary and venous blood 
samples were taken at baseline and at 15, 30, 45, 60, 90 and 120 min after starting to 
eat the meal. Compared to the control meal, ingestion of the berry meal resulted in 
lower capillary and venous plasma glucose and serum insulin concentrations at 
15 minutes and higher concentrations at 90 minutes. Post-prandial capillary and 
venous glucose and insulin concentrations were also reduced, improving the glycaemic 
response and increasing GLP-1. This suggests that glycaemic control after ingestion of 
sucrose can be modulated by simultaneous consumption of berries.   
 
The findings above demonstrate a reduction in post-prandial blood glucose levels after 
consumption of phenolic compounds and phenolic-rich foods for the initial 30 to 45 
minutes, with an increased level thereafter. In light of findings by Bassoli et al., (2008) it 
seems that this modulation of blood glucose profile is due to interactions between 
phenolic compounds and glucose transport systems in the gut. Indeed, the 
mechanisms driving this modulation of glucose transport are known, and are believed 
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to be centralised around direct interactions with the gut endothelial glucose 
transporters, sodium dependent glucose transporter 1 and glucose transporter 2 in the 
small intestine (Manzano & Williamson, 2010). Although it is unlikely that modulating 
the pattern of glucose absorption in young healthy adults will impact memory and 
central executive functioning as seen in older cohorts, as glucose is the primary fuel of 
the brain, it is hypothesised that by controlling glucose uptake by phenolic compounds, 
allowing glucose to be available systemically for longer, a direct modulation of cognitive 
performance may be attainable during bouts of high cognitive demand. 
 
1.5.2 Haemodynamics 
1.5.2.1 Peripheral haemodynamics 
As discussed in section 1.4.2, there are biological mechanisms controlling blood flow, 
which can be manipulated after exposure to berry phytochemicals. Epidemiological 
observations demonstrate that incidence of CVD risk factors, dementia and stroke, can 
be significantly reduced by long-term diets rich in berry polyphenols (Curin et al., 2006; 
He et al., 2006). Shorter term intervention studies have reported similar findings after 
the consumption of flavonoid-rich foods, the findings of which are discussed below. 
 
Cocoa and peripheral blood flow 
Amongst fruits, cocoa has been the most prolifically investigated for its ability to 
modulate peripheral blood flow. This body of research highlights a significant impact of 
flavonoid-rich foods upon human blood flow. Whether investigated acutely two hours 
post-dose (Heiss et al., 2005; Vlachopoulos et al., 2006; Davison et al., 2008; Faridi et 
al., 2008b; Berry et al., 2010; Njike et al., 2011) or over periods of eight days to 12 
weeks (Engler et al., 2004; Heiss et al., 2007; Davison et al., 2008; Grassi et al., 2008), 
studies utilising flow-mediated dilation have reported increases in peripheral blood flow 
following cocoa consumption. There are also demonstrations of an acute increase in 
peripheral blood flow after consumption of cocoa products, which are superimposed 
 
 
40 
 
upon effects of chronic cocoa intake. These benefits are apparent after 30 days of 
intake, potentially suggesting that the long-term benefit of cocoa consumption may 
peak beyond 30 days (Heiss et al., 2007; Balzer et al., 2008). 
 
Berries peripheral blood flow 
Over the last decade, berries have received attention in terms of their modulating 
effects upon blood flow. For example, grapes and grape extracts have been shown to 
modulate peripheral blood flow in both clinical and non-clinical populations. In a study 
of coronary artery disease patients, 15 adults were supplemented with 4ml/kg of body 
weight of purple grape juice twice daily for 14 days. Flow-mediated vasodilation was 
measured using high-resolution brachial artery ultrasonography at baseline, and after 
the 14 day purple grape juice intervention. Compared to baseline, the authors reported 
an increase in flow-mediated dilation of 6.4%, indicating an improvement in 
endothelium dependent vasodilation (Stein et al., 1999). Further to this, Coimbra et al., 
(2005) reported similar results in hypercholesterolemic patients. Sixteen participants 
received either 250ml of red wine or 500ml of red grape juice per day for 14 days (no 
phenolic constituent data reported) in a parallel study design (N=8 in each arm), with 
24 healthy participants used as baseline controls for vascular reactivity. At baseline, 
brachial artery flow-mediated dilation was significantly decreased in the patients 
compared to healthy controls (9.0% in the clinical population vs. 12.1% in the healthy 
control). After the 14 day intervention, hypercholesterolemic patients showed an 
increase in brachial artery flow-mediated dilation of 7% after grape juice intervention 
and 5% after the red wine intervention. The red wine but not the red grape intervention 
also significantly increased endothelium dependent vasodilation by 5% as measured by 
nitro-glycerine-mediated dilation. This effect is not only observable in participants with 
endothelial dysfunction. In an acute study, Agewall et al., (2000) observed an 
improvement in brachial artery flow-mediated dilation one hour after supplementing 
healthy volunteers with 250ml red wine. Twelve healthy adults were randomly assigned 
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to either the red wine group (Merlot red wine containing 12% alcohol) or a 
dealcoholized red wine (containing less than 0.5% alcohol). Brachial artery diameter 
and flow mediation were measured at baseline and one hour post-drink consumption. 
Compared to baseline, brachial artery diameter and blood flow were both increased 
after consumption of both intervention drinks. However, flow-mediated dilatation was 
significantly higher after drinking dealcoholized red wine (5·6%) than after drinking red 
wine (3·9%). 
 
With reference to blackcurrant extracts and peripheral haemodynamics, significant 
increases in the skin blood circulation have been observed one hour after 
supplementing eight healthy females with 140mg of blackcurrant polyphenols, 
containing 50mg of blackcurrant anthocyanins (Matsumoto et al., 2005a). In a later 
study, the same authors also reported that supplementing 17mg/kg of body weight of 
pure blackcurrant anthocyanins increased peripheral blood flow, as measured by near 
infrared spectroscopy, and reduced shoulder stiffness during typing (Matsumoto et al., 
2005b). In contrast, no effect was found using flow-mediated dilation on peripheral 
blood flow after supplementation of a 20% blackcurrant drink when measured supine, 
one hour and several further time points post-dose (Jin et al., 2011). Although there are 
methodological differences in measurement techniques in the above mentioned 
studies, there are also differences between extract types and, therefore, the phenolic 
profiles of the intervention drinks, most noticeably the amount and type of 
anthocyanins. Jin et al., (2011) supplemented participants with a cordial-like extract 
containing 31mg of polyphenols in total (30.4mg of anthocyanins and 616µM phenolic 
acids) whereas Matsumoto used doses of 33mg of anthocyanins per kg. It is, therefore, 
likely that the lack of effects presented by Jin et al., (2011) were due to low polyphenol 
content. 
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The impact of cocoa and berries upon blood pressure and heart rate 
As with peripheral blood flow, cocoa consumption has been shown to acutely modulate 
blood pressure in healthy populations (Grassi et al., 2005a; Grassi et al., 2005b). For 
example, a recent meta-analysis of 42 acute or short-term chronic studies (under 18 
weeks) concluded that consistent acute and chronic benefits of chocolate or cocoa 
consumption on flow-mediated dilation and blood pressure can be seen. However, the 
literature reports no acute effects of other fruit extract intake upon blood pressure and 
heart rate in either healthy or clinical populations (Hooper et al., 2012). Jin et al., (2011) 
found no effect upon blood pressure or heart rate after acute supplementation of a 20% 
blackcurrant drink, nor did Matsumoto et al., (2005b) after supplementing nine healthy 
young adults with 17mg/kg of body weight of blackcurrant polyphenols in the form of a 
juice drink. Wilson et al., (2008b) also failed to find effects after acutely supplementing 
187 healthy young participants with either a control drink or a cranberry juice drink 
containing 480ml of cranberry juice. In a parallel design, heart rate and blood pressure 
measurements were taken at baseline and 30, 60,120 and 180 minutes post-
supplementation.  
 
In contrast, longer studies have revealed positive effects in clinical populations. For 
example, un-medicated middle-aged subjects with cardiovascular risk showed a 
decrease in systolic and diastolic blood pressure after eight weeks supplementation 
with 150mg of anthocyanins per day for eight weeks (from a bilberry, lingenberry, 
blackcurrant, strawberry, chokeberry and raspberry purée), when compared to a 
control group. As might be expected, it was the participants with the highest baseline 
blood pressure that showed the greatest response to the intervention (Erlund et al., 
2008). Further to this, intervention studies supplementing 50ml of pomegranate juice, a 
fruit containing high levels of anthocyanins and tannins, per day for 14 days to 
hypertensive participants induced a 5% reduction in systolic blood pressure when 
compared to placebo (Aviram & Dornfeld, 2001) and a 21% reduction in systolic blood 
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pressure after supplementing patients with asymptomatic severe carotid artery stenosis 
for one year. Three years of supplementation did not yield any further changes (Aviram 
et al., 2004). However, supplementation of 240ml of pomegranate juice for 90 days did 
not affect systolic blood pressure in ischaemic coronary disease and myocardial 
ischaemic patients (Sumner et al., 2005). The reasons for the discrepancies between 
findings is not clear; however, the juices were differentially sourced and Sumner et al., 
(Sumner et al., 2005) did not report the phytochemical breakdown of the juice, so the 
interventions are not completely comparable, masking any discrepancies in 
phytochemical makeup. Naruszewicz et al., (2007) also found reductions in systolic 
and diastolic blood pressure after supplementing 44 myocardial infarction sufferers with 
255mg of chokeberry extract per day for 42 days. The literature would suggest that 
effects of a fruit intervention, other than cocoa, upon blood pressure and heart rate are 
unlikely to be seen in healthy participants. This is a cohort where blood pressure and 
heart rate are tightly regulated by the autonomic nervous system 
 
The literature above shows that peripheral blood flow can be acutely modulated by the 
consumption of flavonoid-rich cocoa and berries. When FMD is utilised as a measure 
of endothelial function, the consumption of cocoa has been shown to increase 
peripheral blood flow and modulate endothelium dependent vasodilatation in healthy 
populations (Heiss et al., 2005; Vlachopoulos et al., 2006; Davison et al., 2008;). In 
relation to berry supplementation, studies show a chronic increase in peripheral blood 
flow after 14 days supplementation of grape extracts in clinical populations (Stein et al., 
1999; Coimbra et al., 2005) and one hour post-dose in a healthy cohort (Agewall et al., 
2000). There is also evidence to suggest an acute increase in peripheral blood flow 
following the consumption of a blackcurrant extract when measured using NIRS. 
However, no effects were observed when peripheral blood flow is assessed via FMD. 
This null finding is more than likely due to the low dose of polyphenols in the extract 
used by Jin et al., (2011). Although acute improvements in peripheral endothelial 
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function are not associated with an acute modulation of cognitive performance, the 
preservation of large artery elasticity and the preservation of endothelial function are 
inversely associated with cardiovascular disease (Targonski et al., 2003; Dede et al., 
2007). Modulations in blood flow via flavonoid-rich foods could, therefore, potentially 
impact long term cognitive performance by maintaining healthy blood flow throughout 
life, attenuating symptoms associated with vascular dementia (Dede et al., 2007). 
 
1.5.2.2 Cerebral haemodynamics 
Cocoa 
An initial pilot study by Francis et al., (2006), utilising fMRI, explored the acute effects 
of flavan-3-ols on cerebral blood flow following either a flavan-3-ol rich cocoa drink 
(516mg) or matched control (39mg) in healthy young adults. Significant increases in 
grey matter cerebral blood flow were observed two hours post-consumption using 
arterial spin labelling, with a return to baseline by six hours post-consumption. Francis 
et al., (2006) then examined effects of five days’ consumption of flavan-3-ol-rich cocoa 
(172mg) or a matched control (13mg) in healthy young females. fMRI scanning took 
place during completion of a letter-pair switching task at approximately 90 minutes 
post-consumption on the fifth day of consumption in each condition. BOLD signal 
intensity was shown to be significantly increased by flavan-3-ol rich cocoa as compared 
to control. No significant effects were evident in behavioural paradigms. It must be 
noted that methylxanthines such as caffeine were not matched between the control and 
active treatments. As caffeine is known to increase BOLD signal intensity (Chen & 
Parrish, 2009), this, therefore, cannot be ruled out as the compound driving the 
reported CNS effects. In a later study, Sorond et al., (2008) assessed the impact, in 
elderly adults, of short-term flavan-3-ol-rich cocoa consumption on cerebral blood flow 
velocity and vaso-reactivity as assessed by transcranial doppler. Beat-to-beat arterial 
pressure and cerebrovascular conductance were also assessed. Seven days’ 
consumption of either flavan-3-ol-rich cocoa (900mg) or flavan-3-ol-poor control 
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(36mg), matched for calories, macronutrients, micronutrients and the methylxanthines 
caffeine and theobromine, produced no significant effects on the outcomes measured. 
When compared to data described by Francis et al., (2006) these results highlight the 
need for a methylxanthine-matched control for definitive cerebral haemodynamic 
effects of flavan-3-ols in cocoa products to be quantified. 
 
Non-flavonoid polyphenol interventions 
Wightman et al., (2012) assessed the impact of the tea polyphenol epigallocatechin 
gallate (EGCG) on cerebral haemodynamics in healthy young adults. In the crossover 
intervention study utilising near infrared spectroscopy (NIRS), participants received 
either 135mg of EGCG, 270mg of EGCG or placebo. After a 45 minute resting 
absorption period, participants completed a 43 minute cognitive assessment designed 
to stimulate the pre-frontal cortex. The 135mg intervention caused a reduction in total 
haemoglobin, a proxy for cerebral blood flow, during cognitive tasks with no differences 
in hemispheric activity or effect of task cognitive difficulty. No effects were reported 
after the consumption of the 270mg intervention. The authors attribute this to 
vasoconstriction properties potentially attributed to inhibition of nNOS. Further to this 
Kennedy et al., (2010) supplemented 22 healthy adults with 250mg or 500mg of trans-
resveratrol, a red grape polyphenol which has been shown to up-regulate levels of both 
eNOS and nNOS (Tsai et al., 2007). NIRS measurements were recorded during a 45 
minute absorption period and during completion of a selection of cognitive tasks that 
activate the frontal cortex. This within subject’s trial showed that supplementation of 
trans-resveratrol increased pre-frontal cerebral blood flow during cognitive demand in a 
dose-dependent manner, as compared to placebo. Results also indicated a similar 
increase in deoxyhaemoglobin towards the end of the 45 minute absorption period and 
throughout cognitive demand. This decrease in deoxyhaemoglobin during task 
performance following the resveratrol treatment is not what would be expected during 
cognitive demand. Neurovascular coupling is a phenomenon which is utilised in 
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neuroimaging techniques such as BOLD fMRI to assess neuronal activity. It refers to 
the relationship between active neuronal cells and related changes in cerebral blood 
flow. Whereby, both oxyhaemoglobin and deoxyhaemoglobing increase in response to 
cognitive demand. Therefore, it would have been expected that as oxyhaemoglobin 
increased during cognitive demand after the consumption of resveratrol, 
deoxyhaemoglobin would also increase due to neurovascular coupling. The authors 
explained that reductions in deoxyhaemoglobin could be indicative enhanced oxygen 
extraction (Kennedy et al., 2010).  
 
Berries 
There are no studies which assess the impact of blackcurrants upon central 
haemodynamics and only one intervention study has assessed the impact of berries 
upon cerebral blood flow. Krikorian et al., (2012) supplemented 16 adults aged  68 
years and older with mild age-related memory decline with either a grape juice 
determined by body weight (444ml average) containing, on average, 209mg of 
polyphenols (96.2mg anthocyanins, 60.61mg phenolic acids, 20.9mg procyanidins), or 
a sugar matched placebo drink for 16 weeks (N=8 in each arm). Neurological activation 
was assessed with the use of functional magnetic resolution imaging (fMRI) whilst 
completing the n-back working memory task. Increased activation on fMRI in the right 
anterior and posterior cortical regions during cognitive performance was observed. No 
impact of the intervention was seen on n-back task performance. Increased regional 
fMRI activation represents greater haemodynamic response, which is associated with 
increased neuronal activity.  
 
1.5.2.3 Summary of haemodynamic effects of polyphenol rich foods 
The foregoing literature outlines that polyphenol-rich foods and their isolated 
components have the ability to modulate blood flow in the brain after acute 
interventions. These modulations are more pronounced during cognitive demand with 
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modulations engendering both reduced and increased blood flow. In addition, 
enhanced oxygen utilisation and potential improvements in neuronal efficiency have 
been reported, however, these modulations do not manifest into improved cognitive 
performance. Cerebral blood flow has been reported to reduce by up to 5% per decade 
during natural ageing (Leenders et al., 1990). Therefore, the chronic modulation of 
blood flow through nutritional interventions, could potentially aid the preservation of 
blood flow throughout life, attenuating reductions in blood flow associated with the 
natural ageing process. On an acute level, increases in cerebral blood flow via a 
nutritional intervention could be beneficial to acute cognitive performance; increasing 
the transport of blood borne metabolic substances to the brain and the transportation of 
waste products from the brain, both of which are necessary for natural brain function 
(Attwell et al., 2010).  
 
1.6 Behavioural effects of flavonoid-rich foods 
There is a growing body of literature highlighting cognitive paradigms which are 
sensitive to berry fruit interventions in animal models. However, evidence regarding 
their cognitive modulating properties in humans, especially after acute 
supplementation, is lacking. The following section describes a brief synopsis of the 
impact of berries upon cognitive abilities in animal models and then reviews the in vivo 
impact of flavonoid-rich food supplementation upon human behaviour. This section 
provides epidemiological evidence of the impact of flavonoid consumption upon 
cognitive performance in humans and then goes on to address peer reviewed evidence 
from well conducted nutritional interventions of the impact of flavonoid-rich food upon 
cognitive performance. 
 
1.6.1 In vivo animal models 
In a relatively short-term study, Ramirez et al., (2005) supplemented 20 male Wistar 
rats (12 months old) with a dried blueberry extract-supplemented diet containing 3.2mg 
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of anthocyanins per kilogram of body weight per day, or a non-supplemented diet for 
30 days (N=10 in each group). Increases in short-term, but not long-term, memory on 
inhibitory avoidance tasks; reduced anxiety as measured using the open field maze; 
and improvements in working memory as measured by the radial maze were found, 
with results most pronounced for short-term memory outcomes (Ramirez et al., 2005). 
Further to this, a longer term study supplemented eight, young (six month old) male 
Lister-hooded rats with a control diet and  sixteen aged (eighteen months old) male 
Lister-hooded rats with either a blueberry supplemented diet or a control diet (N=8 in 
each condition). Animals in the aged plus blueberry group had their diet supplemented 
with dried blueberry extract containing 10.5mg of flavonoids per day for 12 weeks. The 
remaining two groups were fed an iso-calorific diet for 12 weeks. Reversals in age 
related deficits in spatial working memory (as measured by the cross maze) were found 
after three weeks of supplementation of the blueberry extract when compared to the 
control aged group. This improvement continued until the last measurement at 12 
weeks where the deficit was reduced to a level similar to the young control animal 
model. The authors attributed these changes in behaviour to correlations between ex-
vivo anthocyanin levels in the rat brains and levels of ERK- cyclic AMP-response 
element binding protein (CREB) and brain-derived neurotrophic factor (Williams et al., 
2008), which when up regulated, have been shown to promote cognitive plasticity and 
positively impact memory (Tully et al., 2003). Strikingly, potentially via ERK and 
alterations in neutral sphingomyelin-specific phospholipase C activity, Joseph et al., 
(2003) showed that supplementing the diet of APP+PS1 transgenic mice (Alzheimer’s 
model which show visible amyloid plaque deposition after 6 months of age) with a 2% 
blueberry diet, eradicated deficits in Y-maze performance at 12 months of age when 
compared to non-blueberry supplemented controls; suggesting that symptoms of 
Alzheimer’s could be alleviated through diet. 
 
 
 
49 
 
Supplementation of blueberry extracts has also been shown to augment psychomotor 
performance. Forty, nineteen month old rats were randomly assigned to one of four diet 
groups; a control diet containing only the base diet, a base diet containing 1.48% 
strawberry, a base diet containing 0.91% spinach, or base diet containing 1.86% 
blueberry. Rats were fed the intervention diets for eight weeks. Results showed that the 
blueberry-supplemented group exhibited increases in psychomotor performance as 
measured by latency to fall on the rod walk and rotarod. Unlike other similar studies 
discussed below, no statistically significant effect was found after supplementation of 
any active treatment on the Morris water maze (Joseph et al., 1999), indicating no 
impact of the intervention upon spatial memory.  
 
Although blueberries have received the most attention, other flavonoid-rich berries 
such as blackberries have been shown to augment behaviour in animal models. In a 
chronic study, 19 month old male Fischer 344 rats were fed either a base diet or a base 
diet containing 2% blackberry. After eight weeks of supplementation, the 2% blackberry 
supplemented diet improved motor performance on the wire suspension, the small 
plank walk and the accelerating rotarod when compared to control diet fed rats; tasks 
which rely on balance and co-ordination. Further to this, rats in the 2% blackberry-
supplemented diet group had significantly better short-term working memory 
performance, as measured by the Morris water maze, when compared to control fed 
rats (Shukitt-Hale et al., 2009a). Concord grapes have also been shown to increase 
psychomotor performance in aged rats (Shukitt-Hale et al., 2006). In addition to these 
berry studies, Shukitt-Hale et al., (2009b) conducted two intervention studies assessing 
the effect of two plum extracts upon working memory of aged rats. In the first study, 
thirty, 19 month old Fischer 344 rats were assigned to a dried plum powder group or a 
control group. Rats in the dried plum group were supplemented 20g of dried plum 
extract per kg of body weight, containing approximately 3.30mg of gallic equivalents 
per day, the powder contained no anthocyanins. Rats were supplemented for eight 
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weeks before cognitive testing at 21 months of age. In the second study, twenty-eight, 
19 month old rats were supplemented with either a reconstituted plum juice drink 
containing 30.3mg of gallic equivalents, including 0.043mg of anthocyanins per day, or 
water for eight weeks before cognitive testing at 21 months of age. Testing procedures 
were the same in both studies. After the eight weeks, increases in spatial working 
memory, in the Morris water maze were reported after supplementation of the juice 
extract but not the powder extract when compared to the control group. Although this 
initially looks like an effect of extraction technique, the total polyphenol content 
consumed per day was ten times higher in the juice group, instead suggesting an effect 
of dose upon behaviour. In the most recent study Rendeiro et al., (2013) supplemented 
four groups of eight male 18 month old Wistar rats with one of four diets for six weeks. 
The diets were a control diet, a 2% blueberry diet, an anthocyanin diet and a flavanol-
enriched diet. Results showed that rats in the supplemented diet groups had increased 
spatial working memory scores on the cross maze when compared to control. These 
improvements in cognitive performance were coupled with increased levels of BDNF 
mRNA expression in the hippocampus when compared to the control group. This 
elevation was the greatest in the pure anthocyanin fed group.  
 
Research using animal models has, therefore, shown that supplementation of 
flavonoids, as well as dried fruit or fruit juices can positively impact several aspects of 
memory. These include spatial and short-term working memory (Ramirez et al., 2005; 
Williams et al., 2008; Rendeiro et al., 2013), reversal learning and rapid memory 
acquisition (Wang et al., 2006), long-term reference memory (Casadesus et al., 2004), 
slow memory acquisition (Joseph et al., 1999) and memory retrieval (Van Praag et al., 
2007). The overarching nature of this research is the augmentation of natural cognitive 
decline in aged animal models. Furthermore, the consumption of polyphenol-rich 
extracts has been shown to protect rodent cognitive function from a range of neuronal 
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insults and natural ageing (Bastianetto et al., 2007), as well as to reduce the onset of 
symptoms of Alzheimer`s disease (Joseph et al., 2003). 
 
1.6.2 In vivo human studies 
1.6.2.1 Epidemiological observations 
Epidemiological studies have shown that diets high in polyphenols are linked with an 
attenuation of cognitive decline associated with natural ageing in humans, when 
compared to diets lower in polyphenols (Letenneur et al., 2007; Nurk et al., 2009; 
Devore et al., 2012; Kesse-Guyot et al., 2012). For example, diets high in flavonoid-rich 
wine (up to 100ml/day), tea (up to 200ml/day) and chocolate (up to 10g/day) were 
associated with a dose-dependent decrease in cognitive decline in participants aged 
over 70 years; particularly episodic memory, recall memory, visual attention, visuo-
spatial and motor skills, verbal memory and overall memory (Mini Mental State Exam - 
MMSE) (Nurk et al., 2009). Greater long-term consumption of berries, anthocyanidins, 
and total dietary flavonoids are also reportedly related to significantly slower rates of 
cognitive decline, in particular verbal memory and memory span in women aged over 
70 years (Devore et al., 2012). Kesse et al., (2012) displayed similar findings reporting 
that an increased intake of catechins, theaflavins, flavonols and phenolic acids were 
associated with better verbal memory in a 13 year assessment of middle aged adults. 
Although numerous other factors such as recall bias and other lifestyle factors could be 
responsible for the preservation of cognitive function shown in epidemiological studies, 
shorter chronic laboratory controlled studies, which are detailed overleaf, have also 
highlighted similar findings. Although there are no published peer-reviewed studies 
investigating the direct effect of blackcurrant supplementation upon human behaviour, 
information can be drawn from nutritional interventions investigating foods with high 
polyphenol content.  
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1.6.2.2 Cocoa 
Several peer reviewed intervention studies have assessed the efficacy of cocoa`s 
purported cognitive enhancing properties, with differing and, at times, conflicting results 
being discussed. In a randomised, controlled, double-blinded, balanced, crossover trial, 
30 healthy young adults consumed drinks containing 520mg, 994mg cocoa flavanols or 
a matched control. Increases in working memory and/or psychomotor performance (as 
assessed by the serial threes subtractions task) were reported after both active drinks 
when compared to placebo and improvements in sustained attention (seen as 
decreased reaction times during the rapid information processing task) were found 
after the 994mg drink only, when compared to control. The 994mg drink, however, 
resulted in more errors during the serial sevens subtractions task. Increases in self-
reported mental fatigue were also significantly attenuated but only by consumption of 
the 520mg drink (Scholey et al., 2010). Interestingly, findings are more pronounced 
after consumption of the lower flavanol dose, potentially outlining a ceiling effect, or an 
“inverted u” shaped effect curve if the dosage is too high. Francis et al., (2006) 
examined the effects of five days consumption of flavan-3-ol-rich cocoa (172mg) or a 
matched control (13mg) in healthy young females. Despite significant increases in fMRI  
BOLD signal intensity when compared to control, completion of a letter-pair switching 
task at approximately 90 minutes post-consumption on the fifth day of consumption in 
each condition elicited no significant differences in attention switching performance 
between conditions. More recently, Field et al., (2011) demonstrated improvements to 
visual contrast sensitivity (as assessed by reading numbers that became progressively 
more similar in luminance to their background) and the time to detect motion direction, 
90 minutes following acute consumption of dark chocolate (720mg cocoa flavan-3-ols, 
38mg caffeine) as compared to white chocolate. This study also demonstrated 
improvements to a visual spatial memory task following dark chocolate. However, given 
that a crossover design was utilised, the use of a placebo which was not sensorally 
matched could have inadvertently un-blinded participants, therefore, potentially 
 
 
53 
 
impacting the data of this study. In a longer term study, Crews et al., (2008) 
supplemented 101 healthy adult participants with either 754mg of cocoa 
proanthocyanins (one dark chocolate bar and one cocoa drink) per day or similar 
control products matched for appearance taste and energy, but not caffeine content, for 
six weeks in a parallel fixed dose design. No significant effects were found after six 
weeks consumption of the cocoa based products in any cognitive paradigms (after an 
acute load).  
 
Camfield et al., (2012) conducted the only study to measure the cognitive effects of 
chronic cocoa supplementation in the absence of an acute load, allowing accumulative 
effects to be measured. Forty to sixty-five year old adults were supplemented with 
cocoa at low (~0mg), medium (~250mg) and high (~500mg) flavan-3-ol levels for 30 
days. At baseline and after 30 days supplementation, participants completed a spatial 
working memory task whilst Steady State Visually Evoked Potentials (SSVEPs) were 
recorded with the use of Steady State probe Topography (SST – (Silberstein et al., 
1990), a form of electrophysiological brain imaging. After consumption of the medium 
flavan-3-ol dose, the pattern of posterior-parietal SSVEP amplitude was significantly 
lower when compared to control. Whereas, latency was decreased in the same region 
following both the medium and high flavan-3-ol doses. This decrease in latency 
suggests an increase in neural processing speed. No effects of the intervention upon 
working memory were seen. The authors suggest that this reduction in latency, but lack 
of effects upon cognitive performance are indicative of increased neuronal efficiency, 
allowing the participants to perform at a similar level to baseline, with reduced neuronal 
activation.  
 
One suggestion for the lack of definitive behavioural effects in the cocoa literature is 
that the healthy young participants were performing close to ceiling and benefits were, 
therefore, unlikely to be observed. Further to this, neuropsychological tasks used in the 
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literature may not be sensitive enough to detect small changes in cognition as a 
consequence of a nutritional intervention over the time-frame employed. This point is 
supported by findings from one of only three studies to date to detect an effect of cocoa 
flavan-3-ols on cognition. Scholey et al., (2010) demonstrated significant improvements 
to performance and fatigue during an intense 60-minute Cognitive Demand Battery in 
healthy young adults at 90 minutes post-administration of 520 and 994mg flavan-3-ols 
compared to matched control (46mg). Therefore, it may be possible that cognitive 
enhancement after the consumption of flavan-3-ols are only evident during prolonged 
cognitive demand. It must also be noted that although intervention treatments in the 
literature are controlled for flavonoid intake, methylxanthines such as caffeine and 
theobromine, which are known to be cognitively enhancing (Smit et al., 2004), are not 
consistently matched between treatment groups. Although this give a more ecological 
outlook on the impact of cocoa upon cognitive performance, these fluctuating levels of 
methylxanthines could, therefore, be responsible for conflicting findings in the literature. 
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1.6.2.3 Berries 
Only five studies investigating the effect of berry supplementation upon human 
behaviour have been published, none of which examine blackcurrants. Krikorian et al., 
(2010a) reported positive effects upon verbal learning, spatial memory and delayed 
verbal recall after supplementing 12 adults aged 78.2 ± 5 years exhibiting symptoms of 
age related memory decline with 532ml of concord grape juice per day (phytochemical 
composition was not disclosed), over a 12 week period; however, effects on spatial and 
retrieval memory outcomes were not statistically significant. As an addition to this study 
Krikorian et al., (2010b) supplemented nine adults aged 76.2 ± 5.2 years with age 
related memory decline, a blueberry juice drink standardised to contain on average 
1.26g of polyphenols per day for 12 weeks. Accuracy in the Californian verbal learning 
task in the blueberry juice group increased compared to baseline after the 12 week 
intervention. Although indicative of a positive effect of berry consumption upon human 
memory, it must be noted that the sample size was small and age differences between 
groups were large. The blueberry study was also an add-on to the earlier grape study, 
using the initial study’s placebo arm, thereby lacking a proper control treatment. 
Results should, therefore, be interpreted with caution. In a more recent study by the 
same author, 21 healthy adults aged 68 years and older with mild age related memory 
decline were supplemented either a grape juice determined by body weight (444ml 
average) containing, on average, 209mg of polyphenols (96.2mg anthocyanins, 
60.61mg phenolic acids, 20.9mg procyanidins) or a sugar matched placebo drink for 16 
weeks. After the 16 week supplementation, interference during the recognition memory 
task was reduced in the concord grape juice arm when compared to control, indicating 
that participants were better able to discriminate previously learned material from 
decoy stimuli after consuming the grape juice. The acute effect of the intervention was 
not assessed. In contrast, a shorter study investigated the effect of six weeks’ 
cranberry juice supplementation in cognitively intact older adults (50-60 years of age). 
Participants were required to drink two 8oz cranberry drinks per day containing 27% 
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cranberry juice, no phytochemical data was reported. The study investigated various 
memory and central executive tasks. No significant effects of the cranberry juice were 
reported after the six week intervention (Crews et al., 2005).   
 
 In terms of intervention studies assessing the effect of berry supplementation on 
behaviour in a healthy young cohort, the only published study reported no significant 
positive or negative effects of acute grape juice supplementation upon implicit memory 
or mood (Hendrickson & Mattes, 1998). It is, however, possible that concomitant 
consumption of lunch could have obscured an effect of the intervention potentially 
altering the food matrix, altering the pharmacodynamics of the potentially active 
compounds. It must also be noted that the memory task employed was implicit and it is, 
therefore, difficult to compare the findings from this study to others that have explored 
explicit memory measures. Although no peer reviewed studies of the cognitive effects 
of blackcurrant in humans have been published, a patent filed in 1992 by Bormann & 
Shatton (Bormann & Schatton, 1996) examined the effects of blackcurrant on vigilance, 
tracking and mood. Twenty-four participants (N=8 in each arm) were supplemented 
with either placebo or 3.4g or 10.2g of blackcurrant extract in a between subjects 
design. The results highlighted an increase in attention after supplementation. This was 
evinced as an increase in vigilance as assessed using a modified version of a vigilance 
task (Miner, 1971) after supplementation with 10.2g extract when compared to placebo. 
No effects upon mood or tracking performance were observed. However, the authors 
do not state how the task was modified. The blackcurrant extract employed was also 
undisclosed and phytochemically un-quantified. In addition, each intervention treatment 
was supplemented at 13:30, with no information regarding restriction of food intake 
prior to supplementation or absorption period between consumption of the intervention 
and commencing of cognitive assessment made available in the patent.  
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One important factor surrounding the human berry literature cited above is the lack of 
control for vitamins and minerals such as vitamin-C between intervention treatments. 
Although no modulations of cognitive performance have been reported in humans after 
acute consumption of vitamins, chronic supplementation has been shown to improve 
mood in humans (Brody, 2002; Smith et al., 1999). Further to this, a recent review of 
the evidence of the cognitive benefits of vitamin-C upon human cognitive performance 
concluded that there is evidence that maintaining vitamin-C levels throughout life can 
have a protective effect against age related cognitive decline (Harrison, 2012). Vitamin-
C can, therefore, not be ruled out as the compound driving the subtle cognitive effects 
of berries in aged adults. 
 
1.6.2.4 Summary of the behavioural effects of flavonoid-rich foods 
In regards to berry supplementation, the literature outlines some positive benefits of 
short-term chronic supplementation (six weeks and over), with no acute effects being 
reported in any population. In humans, these chronic effects include improvements in 
spatial memory and verbal learning. It must, however, be noted that these nutritional 
interventions studies contain several methodological issues, such as, small sample 
sizes and poorly matched control arms. Likewise, acute effects of the intervention are 
only assessed in one published study, making it impossible to ascertain if the reported 
effects are due to an accumulative chronic effect, or an acute effect of the intervention 
on the day of cognitive testing. In animal models, improvements in cognitive 
performance encompass modulations of; spatial and short-term working memory, 
reversal learning and rapid memory acquisition, long-term reference memory, slow 
memory acquisition and memory retrieval, as well as improvements in psychomotor 
control. Limited acute effects of berry consumption (positive or otherwise) have been 
reported in the literature to date. The exact reasons are unclear; however, publication 
bias towards positive findings could be a limiting factor. Although no acute effects of 
berry consumption upon human performance have been reported, information can be 
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drawn from controlled trials using nutritional interventions from other flavonoid-rich 
foods. In the case of this thesis, effects of consumption of cocoa have been drawn 
upon. In regards to cocoa, acute supplementation of flavan-3-ol-rich cocoa foods in 
young healthy adults has been shown to increase visuo-spatial attention and 
attenuation of self-reported fatigue after cognitively fatiguing cognitive tasks. Although 
there are some positive effects reported, conflicting results are seen in the literature 
which could be due to methodological limitations such as; varying doses and dosing 
length, extract types, differing cohorts and varying platforms used to deliver cognitive 
paradigms. Factors which greatly hinder inter study comparisons. 
 
Given the previously demonstrated modulations of grey matter cerebral blood flow after 
nutritional interventions outlined in section 1.5.2, it is apparent that blood flow may be 
modulated by nutritional interventions in areas of the brain where demand is placed 
during the completion of the specific cognitive task being undertaken. It, therefore, 
seems surprising that no positive effects upon cognitive performance were identified. 
One suggestion for the lack of behavioural effects is that the healthy young participants 
were performing close to ceiling and benefits were therefore unlikely to be observed. A 
more overarching observation is the choice of cognitive tasks known to activate brain 
regions being investigated, rather than because task performance outcomes are 
theorised to be sensitive to the study intervention. 
 
1.7 General conclusion and summary of the objectives of the thesis 
The foregoing literature review has concentrated on the two main areas of this thesis, 
the behavioural and physiological impacts of phytochemical compounds found in 
blackcurrants and other flavonoid-rich fruits. Reference has been made to a number of 
other dietary manipulations which fall outside of the remit of the experimental focus of 
the thesis but which may owe demonstration of cognitive enhancing properties to 
similar mechanisms as blackcurrants. 
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The evidence in respect to the augmentation or reversal of cognitive decline by 
flavonoid-rich foods in rodent models is overwhelmingly positive and there is a growing 
body of literature supporting a similar effect in aged humans. Animal models in 
particular have highlighted that the cognitive paradigms sensitive to berry fruit 
interventions are psychomotor performance, short-term memory, spatial memory, 
working memory and verbal memory; as well as reductions in anxiety with similar 
findings evident in young human populations after supplementation of other flavonoid-
rich foods, such as cocoa. 
 
There is a convergence of research suggesting that foods rich in flavonoids, especially 
those flavonoids present in berries, exert a number of behavioural effects both in 
animal models and aged humans. It is, therefore, entirely plausible that blackcurrant 
extracts that contain high levels of phytochemicals, which potentially have the ability to 
exert physiological effects great enough to affect human behaviour, could modulate 
acute cognitive performance and potentially provide novel treatments for pathological 
diseases and attenuate cognitive decline associated with natural ageing.  
 
It seems from the above that an appropriate starting point for moving forward the 
research in this domain would ideally incorporate three specific criteria; well-defined 
extracts with emphasis based on their post-harvest preparation and their 
phytochemical composition; objective computer-based measures of cognitive 
functioning and; rigorous methodological design incorporating paradigms shown to be 
sensitive to similar nutritional interventions in animal models and human trials as well 
as to changes in monoaminergic tone. 
 
In regards to the first of these criteria, two extracts will be utilised. The first is a 
commercially available standardised, freeze-dried, anthocyanin-enriched powdered 
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blackcurrant extract ((DelcyanTM), Just The Berries, Palmerston North. New Zealand)) 
and the second will be a fresh from frozen, cold-pressed crude blackcurrant juice 
extract created from the Blackadder cultivar (Plant & Food Ltd. New Zealand). When 
used alongside each other in an intervention study, extracts will be standardised for 
total polyphenol level only, therefore, they will differ in phenolic profiles, allowing for a 
direct comparison between different extract types and placebo.   
 
With regards to the psychometric instruments, the Computerised Mental Performance 
Assessment System (COMPASS) will be utilised throughout the thesis. This is a 
purpose designed software application for the flexible delivery of randomly generated 
parallel versions of standard and novel cognitive assessment tasks, which has 
previously been shown to be sensitive to a range of nutritional interventions (e.g. 
Haskell et al., 2008; Kennedy et al., 2010; Kennedy & Haskell, 2011; Moss & Oliver, 
2012; Asamoah et al., 2013; Stonehouse et al., 2013). 
 
In relation to rigorous methodological design, studies will be designed to incorporate 
paradigms which have been shown previously to be sensitive to flavonoid intake in 
animal models and humans, and to modulations in monoaminergic tone. These will 
include attention, several aspects of memory, psychomotor performance, mood and 
central executive tasks. Cognitive measurements will be observed during times when 
the purported active constituents and associated metabolites of the berry juice are 
available in the peripheral circulatory system, with multiple time point experiments 
being used to accommodate the biphasic nature of flavonoid and phenolic acid 
absorption. 
 
Finally, the thesis will examine the dose effect and time course of the purported 
monoamine oxidase inhibiting effect, and the effect upon circulating monoamines, 
associated metabolites and hormones. 
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It is necessary to acknowledge that the double-blind placebo-controlled, randomised 
intervention studies that will make up the majority of this thesis, are not intended to 
answer all of the fundamental questions pertaining to the consumption of blackcurrants 
and their effects upon human behaviour. The chronic and accumulative effects of the 
consumption of blackcurrant extracts will not be assessed. Whilst this is a major factor 
surrounding the augmentations of flavonoids in animal models and in the long-term, 
questions of this nature are of upmost importance, it is necessary to start with the basic 
acute effects, and provide a foundation for future scientific research which will be 
required to assess more long-term questions. 
 
The objective of the studies making up this thesis is to investigate the potentially 
beneficial behavioural effects of acute supplementation of standardised blackcurrant 
extracts, and the mechanisms underlying such effects. The main aims of the thesis are: 
1) To assess the effect of standardised blackcurrant extracts upon cognitive 
performance in healthy adults 
2) To examine the physiological and haemodynamic effects of blackcurrant 
extracts 
3) To examine underlying mechanisms of any effects, in particular the potential in 
vivo monoamine oxidase inhibitory properties of blackcurrants and other 
associated biomarkers 
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CHAPTER 2. ACUTE SUPPLEMENTATION WITH BLACKCURRANT 
EXTRACTS MODULATES COGNITIVE FUNCTIONING AND INHIBITS 
MONOAMINE OXIDASE-B IN HEALTHY YOUNG ADULTS 
 
2.1 Introduction 
 
There is a growing body of evidence supporting modulation of mammalian behaviour, 
in particular an improvement in cognitive ability of research animals following the 
ingestion of flavonoid-rich berries (Casadesus et al., 2004; Williams et al., 2008). This 
literature surrounding berries and mammalian behaviour has mainly focused upon the 
slowing or reversal of natural cognitive decline (Joseph et al., 1999; Casadesus et al., 
2004; Williams et al., 2008). As discussed in section 1.4, several mechanisms of action 
have been proposed and investigated in an attempt to underpin and explore 
improvements to memory in animal models, ranging from anti-inflammatory and 
antioxidant responses, to improvements in neural signalling.  
 
Peer-reviewed intervention studies have highlighted positive effects of short-term 
chronic berry consumption upon cognitive functions of aged adults. Most notably, 
improvements in verbal learning, spatial memory and delayed verbal recall after 
supplementation of concord grape juice (Krikorian et al., 2010a); and increased verbal 
memory after supplementation of blueberry (Krikorian et al., 2010b) have been 
observed. Increases in recalled words in the paired learning task have also been 
reported by the same author after supplementation of concord grape juice (Krikorian et 
al., 2012). In contrast, a shorter study investigating the effect of six weeks cranberry 
juice supplementation found no significant effects upon various memory and central 
executive tasks (Crews et al., 2005). The only published intervention study focusing 
upon the effects of berries upon cognitive processing in healthy young adults reported 
that an acute intervention assessing the effect of grape juice consumed with a 
standardised lunch did not have a significant effect on cognitive function or mood 
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(Hendrickson & Mattes, 1998). Conversely, the few reported studies that have 
investigated the impact of berry extracts in vivo (Bormann & Schatton, 1996; 
Matsumoto et al., 2005b) and in vitro (Dreiseitel et al., 2009a) upon biological 
mechanisms with potential to affect the behaviour of healthy young adult human 
participants, have revealed promising results. Most prominently, anthocyanins, their 
aglycones, and phenolic acids, have been shown to have monoamine oxidase 
inhibiting properties. The average IC50 effects in vitro were shown to be 36.9±5.8µM for 
MAO-A and 36.8±5.2µM for MAO-B  (Dreiseitel et al., 2009a). However, these 
quantities were much greater than normally found in human plasma following the 
consumption of an anthocyanin rich meal (Mazza et al., 2002).  
 
In 1992, Borman & Schatton filed a European patent detailing the inhibitory effect of a 
single serve of undefined blackcurrant drink on human monoamine oxidase-B (MAO-B) 
activity (Bormann & Schatton, 1996). They also record inhibition of MAO-A in vitro. 
Although the in vivo findings of the patent are demonstrated in only one human subject 
and are not peer-reviewed to scrutinise their scientific integrity, these “pilot” findings are 
of great interest in terms of the potential of a berry extract to modulate human 
behaviour. In the same patent, Bormann and Schatton also discussed improvements to 
attention and mood state. In a parallel study 24 (n=8 in each study arm) healthy human 
participants were supplemented with 3.2g or 10.2g of an unnamed blackcurrant extract 
or an inert placebo. The 10.2g dose was reported to engender improvements in 
vigilance and mood. However, no absorption period or fasting regime were reported. 
As discussed in section 1.4, MAO inhibitors have been used for several decades for 
the treatment of mood disorders and amelioration of neurodegenerative disease 
symptoms, including those of Parkinson’s disease (Youdim & Bakhle, 2006). MAO-B 
constitutes about 80% of total MAO activity in the brain (Johnston, 1968) and unlike 
most neuronal cells and their associated neurotransmitters and enzymes, MAO-B does 
not exhibit age-related reductions in activity or presence. In fact, brain MAO-B activity 
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has been shown to increase with natural ageing (Sparks, 1991) and during 
neurodegenerative disease, specifically in areas of cell loss in Parkinson’s disease. A 
major by-product of monoamine degradation is hydrogen peroxide (H2O2). H2O2 is the 
major source of central nervous system oxidative stress and is, therefore, implicated in 
reductions in cell function and cell death via oxidative stress and the pathogenesis of 
neurodegenerative diseases (Ciccone, 1998). Inhibiting this degradation of central 
monoamines through inhibition of central MAO could, therefore, reduce the oxidative 
stress caused by the oxidative metabolism of monoamines (Aluf et al., 2013) and allow 
monoamines, and their precursors, to accumulate and potentially alter the dynamics of 
regular monoamine transmitters (Youdim & Bakhle, 2006). 
 
As outlined in chapter one, the major anthocyanin constituents of blackcurrants are 
D3G, D3R, C3G and C3R. There is also an abundance of other less prolific phenolic 
structures present in smaller quantities. These have the potential to exert physiological 
changes capable of modulating human behaviour, such as the rate and pattern of 
glucose uptake from the small intestine (Bassoli et al., 2008; Manzano & Williamson, 
2010; Cropley et al., 2012) 
 
It must also be noted that blackcurrants contain up to 175mg of vitamin-C per 100g of 
fruit (Hägg et al., 1995) which, following chronic supplementation, has been shown to 
improve mood in humans (Smith et al., 1999; Brody, 2002) and cognition in mice (Arzi 
et al., 2004). Extracts used in the intervention chapters of this thesis were not matched 
for vitamin-C, however, there are no reports of acute behavioural effects in humans or 
any data relating to its impact upon MAO activity. 
 
The primary outcome in published flavonoid intervention studies has been an 
improvement in memory performance after chronic supplementation of aged cohorts. 
Data depicting the impact of flavonoid supplementation upon cognitive outcomes in 
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young healthy participants is lacking. With reference to the above literature, the 
flavonoid-rich berries of the blackcurrant plant could potentially modulate behaviour 
through various mechanisms, particularly via inhibition of central monoamine oxidase, 
which could modulate the levels of neurotransmitters such as serotonin and dopamine 
that are responsible for the regulation of attention and cognitive flexibility. Patent data 
can also be drawn upon, outlining improvements in attention processing after acute 
blackcurrant supplementation. The primary objective of the current study will therefore 
focus upon the impact of two standardised blackcurrant extracts upon attention 
functioning and mood. The extracts to be used will be a crude, cold pressed 
blackcurrant juice and an anthocyanin-enriched, commercially available blackcurrant 
powder. The two blackcurrant extracts were matched for quantities of polyphenols and 
sugars but have differing phenolic profiles. As anthocyanins are hypothesised to be 
one of the major active compounds in blackcurrants, cognitive assessments will be 
administered whilst anthocyanin levels are at maximal concentration (Cmax), between 
60 and 120 minutes post-supplementation. 
 
The second aim of the current study is to ascertain if the extracts employed inhibit the 
activity of platelet MAO-B and blood parameters associated with peripheral MAO-A 
inhibition, as well as establishing whether any inhibition is affected by the differing 
phenolic profiles of the blackcurrant extracts. As the MAO activity in human blood 
platelets has been shown to be primarily MAO-B (Donnelly & Murphy, 1977) and has a 
high correlation with brain MAO-B activity (Benchet al., 1991), platelets will be isolated 
so peripheral MAO-B can be quantified. As MAO-A is mostly active in the digestive 
system and the CNS, it is difficult to directly measure MAO-A activity in humans without 
tissue biopsy. Instead 3,4-Dihydroxyphe-nylglycol (DHPG), the major MAO-A-mediated 
deaminated metabolite of noradrenaline (Kopin, 1985), will be used as an indirect 
measurement. This method has been used in a plethora of pharmacological MAO 
inhibitor studies (Koulu et al., 1989; Zimmer, 1990; Dingemanse et al., 1992). 
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Monoaminergic tone will also be measured through blood plasma monoamine content 
and associated metabolites, general dopaminergic tone will be assessed through the 
measurement of plasma prolactin levels. Prolactin is a polypeptide hormone 
predominantly secreted from lactotroph cells of the anterior pituitary gland (Fitzgerald & 
Dinan, 2008). The predominant control of prolactin secretion into plasma is via 
hypothalamic inhibition of lactotroph activity (Ben-Jonathan & Hnasko, 2001). The most 
important hypothalamic prolactin inhibiting factor is dopamine, where it is secreted into 
the portal vessels of the hypothalamus in high enough quantities to inhibit lactotroph 
prolactin secretion (Fitzgerald & Dinan, 2008). However, it must be noted that because 
the pituitary gland is placed both within and outside of the blood brain barrier it is 
readily exposed to circulating hormones (Ho et al., 1985). Although the majority of 
circulating dopamine is biologically inactive conjugate dopamine sulphate (Claustre et 
al., 1990), this placing of the pituitary makes it difficult to demonstrate a direct increase 
in central dopaminergic activity through the measurement of peripheral prolactin 
activity. However, it indicates the effect of the study treatment on general dopaminergic 
tone and potentially modulations of cerebral MAO activity. Finally, the study will assess 
the effect of the extracts, with differing phenolic profiles on post-prandial blood glucose 
levels, heart rate and blood pressure.  
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2.2 Materials and methods 
2.2.1 Design 
The study investigated the effects of two blackcurrant drinks, with balanced polyphenol 
content, on human cognitive function, mood and defined biochemical parameters. The 
study followed a double-blind, counterbalanced, placebo controlled, repeated 
measures design. Participants were randomly allocated to treatment orders as selected 
through a Williams Latin Square (Williams, 1949). 
 
2.2.2 Participants 
Thirty six participants were recruited, of which thirty-five participants (17 male, 18 
female) aged 24 years ± 3.9, with a mean body mass index of 24 ± 4.7 kg/m2 
completed the study. Full demographics can be seen in table 2.1.  
 
 
 
 
Participants were recruited from Auckland, New Zealand using opportunity sampling 
and received $120NZ to recompense them for any expense they may have incurred to 
participate in the trial. Before participants were enrolled in the study they attended a 90 
minute training session. During this training session participants gave their signed 
consent to participate in the study and were screened for any contraindications to the 
study with the use of an exclusion questionnaire (see appendix I for an example) and a 
case report form (see appendix II for an example). In brief, all participants reported 
themselves to be healthy, not pregnant, non-tobacco users. Participants were not using 
dietary supplements or over the counter or recreational drugs (excluding the 
contraceptive pill), did not have any sensitivities to any of the study treatments and had 
a body mass index below 35kg/m2. Participants then completed three repetitions of the 
study day tasks to ensure they met the required minimum standards (internally set) to 
Table 2.1 Mean participant characteristics   
Measure 
Average 
measurement 
SD Range 
Age (years) 24.8 3.93 18-34 
Height (m) 1.72 0.12 1.52-1.97 
Mass (kg) 70.93 17.82 44-116 
BMI (m
2
) 23.67 3.96 17-34 
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participate in the study and to minimise practice effects. The study received ethical 
approval from the New Zealand Regional Northern X Ethics board. (Application number 
NTX/10/07/066) and was conducted according to the Declaration of Helsinki (1964). All 
participants gave their written informed consent before their inclusion in the study. 
 
2.2.3 Treatments 
Participants received three treatment drinks in an order dictated by random allocation 
to a counterbalancing (Williams Latin Square) order with at least one week washout 
between visits. Extracts were assessed for the phytochemical constituents by Dr David 
Stevenson at Plant and Food Research Ltd using the method described by Schrage et 
al., (2010). The phytochemical content of each treatment can be seen in table 2.2 ans 
2.3. Anthocyanin stability of the Blackadder juice extract at -20 degrees was confirmed 
via HPLC. Over the eight week period no significant loss due to storage was seen. 
Drinks were standardised at ~500mg of polyphenols per 60kg individual as this is the 
average world weight of an adult (Walpole et al., 2012).  Intervention drinks contained 
either 0mg of polyphenols (control) or 525±5mg of polyphenols per 60kg of bodyweight 
from an anthocyanin enriched blackcurrant extract, (1.66g of Just the Berries, New 
Zealand (DelcyanTM)) or from 142ml of a cold pressed blackcurrant fruit juice, 
(Blackadder cultivar, cultivated and processed in 2010 by Plant and Food Research 
Ltd, New Zealand (Blackadder Juice)). The Blackadder juice was frozen in 50ml 
aliquots at -20°C until the day of use. The naturally occurring sugars in the Blackadder 
juice were quantified by Helen Boldingh, Plant and Food Research Ltd. The same 
levels were supplemented to the control and DelcyanTM treatments to ensure caloric 
equality. In each case all drinks contained; 0.78g of glucose, 0.13g of fructose, 0.09g of 
Splenda® sweetener and 3.34µl blackcurrant flavouring (NI #12220, Formula foods 
NZ) per kilogram of bodyweight. The total volume of the drink was then made up to 
200ml (for a 60kg person) with cold drinking water. All drinks quantities were calculated 
per kilo of body weight resulting in differing volumes. Drinks were coded and prepared 
 
 
69 
 
fresh each morning by a third party who had no further part in the running of the study. 
No member of the investigation team was aware of the coding of the drinks until a 
blind-data review was completed.  
Table 2.2 Phytochemical constituents of Blackadder juice and Delcyan
TM
 extracts (mg/100ml of raw juice and mg/g of  
raw powder) and the constituents supplemented per kilo of bodyweight (mg/kg). 
Compound 
Blackadder juice 
mg/100ml 
Blackadder juice mg/kg 
Delcyan
TM
 extract 
mg/g 
Delcyan
TM
 extract mg/kg 
body weight 
Caffeoyl quinate 6.3 0.15 0.1 0.002 
Caffeic acid glucoside 1.9 0.04 0.2 0.005 
pCoumaroyl quinate 3.6 0.09 0.4 0.011 
EGC 8.6 0.20 0 0 
Delphinidin glucoside 24.1 0.57 44.6 1.23 
Delphinidin rutinoside 115.9 2.74 107.4 2.97 
Cyanidin glucoside 13.6 0.32 28.8 0.79 
Cyanidin rutinoside 150.9 3.57 149 4.12 
Myricetin rutinoside 15.6 0.37 4.5 0.12 
Myricetin glucoside 2.1 0.05 0 0 
Quercetin rutinoside 3.4 0.08 1.2 0.03 
Quercetin glucoside 1.9 0.04 2.3 0.06 
Quercetin pentoside 1.4 0.03 5.5 0.15 
Myricetin 0.2 0.00 0.6 0.01 
Vitamin C 168 3.97 0 0 
 
Table 2.3 Anthocyanins and other phenolic compounds in each of the treatment conditions. (mg per kilo of body weight, average dose used in 
the intervention and dose range)  
Treatment 
Anthocyanins 
(mg/kg) 
Anthocyanin 
average dose 
(mg) 
Dose 
range 
Other 
polyphenols 
(mg/kg) 
Other 
polyphenols 
average dose 
(mg) 
Dose 
range 
total 
polyphenols 
(mg/kg) 
Total 
polyphenols 
average dose 
Dose 
range 
Placebo 0 0 
 
0 0 
 
0 0 
 
Blackadder 7.786333 552.3336 344-906 0.66 46.93 29-77 8.44 599.3 373-983 
Delcyan
TM
 8.05 571.03 356-937 0.28 19.86 12-32 8.32 590 368-968 
 
2.2.4 Cognitive and mood measures 
All cognitive measures and mood scales were delivered using the Computerised 
Mental Performance Assessment System ((COMPASS) as developed by Northumbria 
University), a purpose designed software application for the flexible delivery of 
randomly generated parallel versions of standard and novel cognitive assessment 
tasks, which has previously been shown to be sensitive to a range of nutritional 
interventions (Haskell et al., 2010; Kennedy et al., 2010; Kennedy & Haskell, 2011). 
For the purpose of behavioural analysis, three tasks were selected with the intention 
that attention performance and cognitive flexibility could be assessed. Seven 
repetitions of the digit vigilance task, Stroop task and rapid visual information task were 
completed in a fashion similar to that of the cognitive demand battery (Kennedy & 
Scholey, 2004) where subsequent repetitions of a ten minute battery are shown to 
incrementally induce mental fatigue. 
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2.2.4.1 Digit vigilance: The digit vigilance task is a measure of vigilance involving 
accurate selection of target stimuli. It focuses on alertness and vigilance while placing 
minimal demands on two other components of attention: selectivity and capacity. A 
single target digit was randomly selected and constantly displayed to the right of the 
screen. A series of single digits were presented in the left of the screen at the rate of 80 
per minute. The participant was required to press the target button on the computer 
keyboard as quickly as possible every time the digit in the series matched the target 
digit. The task lasted two minutes and there were 30 stimulus-target matches. Task 
outcomes were accuracy (%) and reaction time for overall responses (msec). 
 
2.2.4.2 Stroop: The Stroop test is a measure of attention, inhibition and cognitive 
flexibility. Participants were presented with a colour name. The colour name presented 
was written in a coloured ink which could be the same as the colour name or different. 
Participants had to respond to the colour of the ink using the peripheral mouse and 
corresponding colour response buttons. Participants were presented with 60 stimuli. 
Task measures were accuracy (percent correct), incorrect responses and reaction time 
(msec).  
 
2.2.4.3 Rapid visual information processing (RVIP): The RVIP task is a measure of 
sustained attention and working memory. The participant was required to monitor a 
continuous series of digits for targets of three consecutive odd or three consecutive 
even single digits. The single digits were presented at the rate of 100 per minute and 
the participant responded to the detection of a target string by pressing the space bar 
on the computer keyboard as quickly as possible. The task was continuous and lasted 
for 5 minutes, with 8 correct target strings being presented in each minute. The task 
was scored for percentage of target strings correctly detected, average reaction time 
for correct detections (msec), and number of incorrect responses (false alarms). 
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2.2.4.4 Logical reasoning: The logical reasoning test requires the participant to think 
logically and analytically and is a measure of cognitive flexibility. A series of statements 
referring to the relationships between two letters appeared on the screen one at a time 
(e.g. “a precedes b: ba”). Participants were required to decide if each statement 
correctly described the order of the 2 letters that followed it by pressing the designated 
‘YES’ or ‘NO’ button on the computer keyboard. There were 24 stimuli. Mean reaction 
times were measured in msec, and accuracy of responses were recorded as 
percentages. 
 
2.2.4.6 Bond-Lader visual analogue scales: Bond-Lader visual analogue mood 
scales (Bond & Lader, 1974) as used in a number of nutritional intervention studies 
(Kennedy et al., 2006; Haskell et al., 2008; Haskell et al., 2010) were employed. The 
reliability and validity of these visual analogue scales has been demonstrated (Ahearn, 
1997). The scales comprise a total of sixteen 100mm lines anchored at either end by 
antonyms (e.g. alert-drowsy, calm-excited) on which participants mark their current 
subjective position. Scores from the 16 Bond-Lader visual analogue scales were 
combined as recommended by the authors to form three mood factors: ‘alert’, ‘calm’ 
and ‘content’ (Bond & Lader, 1974). 
 
2.2.4.7 Visual analogue scales: Following each repetition of the attentional demand 
battery, participants were asked to subjectively rate how mentally fatigued they felt and 
how difficult they found the cognitive tasks. The electronic visual analogue scales were 
anchored “Not at all” on the left hand side of the scale and “extremely” on the right, with 
higher scores representing more mental fatigue/higher difficulty. 
 
 
 
 
 
72 
 
2.2.5 Blood analysis 
Venous blood samples (2x5ml) were collected by a qualified phlebotomist at baseline 
and 150 minutes after supplementation of the intervention treatments. Samples were 
collected in 5ml BD vacutainers© (Becton, Dickinson and company, Plymouth, New 
Zealand). Both receptacles were treated with anticoagulants, one with lithium heparin 
(LH) and one with ethylenediaminetetraacetic acid (EDTA). Whole blood samples 
treated with LH were immediately centrifuged at 5000rpm for 10 minutes at 4ºC. 
Plasma was then extracted and aliquoted into 1ml eppendorf© tubes. One aliquot was 
spiked with 5% triflorocetic acid for the purpose of measuring plasma anthocyanin 
content. Plasma samples were stored at -80°C until analysis was performed. 
 
Whole blood samples treated with EDTA were used to isolate blood platelets using the 
method reported by Corash et al., (1980) as modified by Snell et al., (2002). Three and 
a half millilitres of whole blood and 2ml of phosphate buffered saline solution (PBS) 
containing 2g of glucose per litre of solution (PBS solution) were added to a 25ml 
Falcon tube (Becton and Dickinson, AU) and gently inverted to mix the blood and buffer 
solution. The solution was then centrifuged at 600g at 22ºC for three minutes without 
the use of a centrifuge brake. The supernatant was then removed from the red cell 
pellet with the use of a pipette and placed on ice. The volume of the residual red cell 
pellet was restored to 7ml with PBS solution, gently mixed and centrifuged again at 
600g at 22°C for three minutes without the use of a centrifuge brake, the supernatant 
portion was again removed and pooled with the first supernatant fraction. This 
procedure was performed five times. The pooled supernatant fraction was then 
centrifuged at 2000g at 4°C for 10 minutes. The supernatant fraction was then poured 
off to leave a platelet pellet. The pellet was stored at -80ºC until the MAO-B analysis 
was performed. 
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2.2.5.1 Platelet monoamine oxidase-B (MAO-B) activity analysis 
Due to technical difficulties, only 8 of the 35 participants provided sufficient blood 
samples for all the study time points for MAO-B analysis to be conducted. 
 
The isolated platelet pellet was slowly thawed on ice, re-suspended in 1ml of PBS 
solution, sonicated with a probe sonicator (Microson ultrasonic cell disruptor, model 
XL2005) for 15 seconds on ice and centrifuged (Hitachi Himac preparative 
ultracentrifuge model CP100MX) for 10 minutes at 36,000g at 4 °C. Sonication and 
centrifugation were then repeated after which the supernatant was removed and the 
pellet consisting of lysed platelets was re-suspended in sodium phosphate buffer 
(reaction buffer) (as supplied in the Amplex® Red Monoamine oxidase-B Assay Kit 
(A12214 Invitrogen). The protein concentration of the lysed platelet solution was 
determined against a bicinchoninic acid standard curve by using the Pierce BCA 
protein assay (ThermoFischer Scientific New Zealand Ltd) as per manufacturer’s 
instructions. Each sample was measured in triplicate and the average protein 
concentration was used. The lysed platelet solution was re-suspended in PBS to a final 
concentration of 150µg/ml of protein.  
 
Determination of MAO-B activity was conducted using the Amplex® Red monoamine 
oxidase-B assay kit (A12214 Invitrogen), as per manufacturer’s instructions. One 
hundred microlitres of the diluted lysed platelet solution was added to a black flat 
bottom 96 well plate (Greiner bio-one, REF 655101) in triplicates. Two microlitres of the 
MAO-A inhibitor clorgyline were then added to each well that contained platelet 
membranes and incubated for 30 min at room temperature. During the incubation, 
100µl of H2O2 standards and the negative control were then added to the micro-plate in 
triplicate. After the 30 minute incubation, 100µl of the Amplex® Red working solution 
were added to each well. The microplate was immediately placed into the microplate 
reader (FLUOstar Omega Plate reader, BMG labtech), and set to incubate at 37°C with 
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an excitation wavelength of 530-560nm and an emission wavelength of 590nm. The 
micro-plate reader was programmed to take a reading every 5 min for one hour (13 
readings in total). The 30 minute reading was used to compare platelet MAO-B activity 
between treatments. A full methodology can be found in appendix III. 
 
2.2.5.2 Glucose 
Blood glucose was measured from a finger prick puncture with the use of an Accu-
Check (Roche Healthcare, NZ) blood glucose monitor at baseline, 60 minutes and 150 
minutes post-supplementation. The Accu-Check reader has a reported coefficient of 
variance (CV) of less than 5%. 
 
2.2.5.3 Anthocyanin analysis 
Blood plasma anthocyanin analysis was conducted by Dr Janine Cooney at Plant and 
Food Research Ltd. Anthocyanins; D3G, D3R, C3G and C3R were identified by LC-MS 
using a 5500 QTrap triple quadrupole/linear ion trap (QqLIT) mass spectrometer 
equipped with a TurboIon-SprayTM interface (AB Sciex, Concord, ON, Canada) coupled 
to an Ultimate 3000 UHPLC (Dionex, Sunnyvale, CA, USA). Compound separation was 
achieved on a Zorbax SB-C18 Rapid Resolution HD 2.1x100mm ID 1.8 micron column 
(Agilent Technologies, Santa Clara, CA, USA) maintained at 70ºC. Solvents were (A) 
5:3:92 acetonitrile/formic acid:water v/v/v and (B) 99.9:0.1 acetonitrile/formic acid v/v 
and the flow rate was 600μL/min. During the initial mobile phase, 100% A was held 
isocratically for 0.5 min, then ramped linearly to 10% B at 5 min, followed by another 
linear ramp to 90% B at 5.1 min and held for 1.9 min before resetting to the original 
conditions. Sample injection volume was 20μL.  MS data was acquired in the positive 
mode using a multiple reaction monitoring (MRM) method in order to maximise 
sensitivity by screening out any chemical noise from other compounds present. This 
method monitors the distinctive daughter ions formed by fragmenting the targeted 
precursor ions (M)+ for the 4 major blackcurrant anthocyanins, D3G, D3R, C3G and 
C3R;  D3G: MRM m/z 465 > m/z 303; D3R: MRM m/z 611 > m/z 303; C3G: MRM m/z 
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449 > m/z 287 and C3R: MRM m/z 595 > m/z 287 in addition to malvidin-3-O-
galactoside (Mv-gal: MRM m/z 493 > m/z 331), the internal standard. The turbo spray 
voltage, temperature, gas one, gas two and curtain gas pressure were set at 5500V, 
700º C, 20 psi, 20 psi and 20 psi, respectively. 
2.2.5.4 Catecholamine Analysis 
Eight catecholamines were analysed from blood plasma using LCMS. These were; 
serotonin, dopamine, phenylethylamine, adrenalin, noradrenalin, normetanephrine, 3,4-
dihydroxyphenylglycol (DHPG) and homovanillic acid (HMV). 
Materials 
Formic acid (Riedel-de Haën), ammonium formate and acetic anhydride (Fluka), and 
Hunig’s base were purchased from Sigma Aldrich (Auckland, New Zealand). Optima 
LC/MS grade acetonitrile (Fisher Scientific) was purchased from ThermoFisher 
(Auckland, New Zealand). Water was of Milli-Q grade. Analytical standards, dopamine, 
normetanephrine, noradrenalin, adrenalin, 3,4-dihydroxyphenylglycol (DHPG), 
serotonin and homovanillic acid (HMV) were purchased from Sigma-Aldrich and 
phenylethylamine (PEA) from Acros Organics (Geel, Belgium). Deuterated acetic 
anhydride [d6] was purchased from Sigma-Aldrich and deuterated dopamine [d4] from 
CDN Isotopes (Quebec, Canada). Phree ™ Phospholipid removal plates were 
purchased from Phenomenex (Torrance, CA, USA). 
Standard Preparation 
normetanephrine, 
noradrenalin, adrenalin, DHPG and HMV) were prepared in 0.1% formic acidaq, and 
separate labelled internal standard for spiking and recovery was also prepared [(IS) 
 
separately, as described for the samples, to prepare a derivatised mixed standard, and 
a derivatised (IS). The derivatised mixed standard was used to prepare calibration 
standards in the range 0.02 ng/mL to 1 ng/mL.   
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To facilitate quantitation and correct for matrix effects during analysis, labelled internal 
standards for each analyte were prepared (d-
escribed for the samples, with the exception 
that deuterated acetic anhydride [d6] was used in place of unlabelled acetic anhydride. 
100 ng/mL; final concentration 1 ng/mL] and 100 µL of the derivatized labelled internal 
standard catecholamine mixture [(d-IS) 10 ng/mL; final concentration 1 ng/mL] and 
prepared at a final volume of 1 mL. 
Sample Preparation 
Plasma samples were treated to remove proteins and phospholipids and derivatised in 
two stages to acetylate alcohol and amine functional groups and alkylate free 
carboxylic acids with hunig’s base prior to LC-MS analysis. A double derivatization was 
found to be necessary to acetylate the less reactive alkyl hydroxyl groups. Briefly, each 
plasma sample (200 µL) was added to an individual well of a Phree ™ Phospholipid 
removal plate already containing cold 600 µL acetonitrile, 100 µL acetic anhydride and 
10 µL 100 ng/mL dopamine-d4 [internal standard (IS); final concentration 1 ng/mL]. The 
Phree ™ plate was centrifuged at 500 g for 30 min, a further 200 µL acetonitrile added 
to each well, and the plate centrifuged at 500 g for a further 10 min. The filtrate was 
transferred to a 2 mL micro tube, 100 µL acetic anhydride added and heated at 50 oC. 
After 30 min 20 µL Hunig’s base was added to each sample, vortexed then heated for 
a further 60 min. Samples were then evaporated to near dryness with nitrogen at 40 oC. 
Samples were re-derivatised; 100 µL acetonitrile, 100 µL acetic anhydride and 10 µL 
Hunig’s base heated for 40 min at 50 oC. Finally, to each sample 100 µL of the 
derivatized labelled internal standard catecholamine mixture [(d-IS) 10 ng/mL; final 
concentration 1 ng/mL] was added, and the sample made up to 1 mL with water and  
transferred to an autosampler vial ready for analysis. 
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LC-MS Analysis 
Analysis of Catecholamines was performed using an AB Sciex Qtrap 5500 equipped 
with a Turbo V electrospray source (ESI) (AB Sciex, Foster City, California, USA), 
coupled to a Dionex UltiMate 3000 HPLC system, which consisted of two UltiMate 
3000 RS pumps, an UltiMate 3000 RS autosampler and an UltiMate 3000 RS column 
compartment (Dionex, Olten/Switzerland) and controlled with Analyst 1.5.2 software.  
The analytical column used was a 150 by 2.1 mm Atlantis® T3 column, (3 µm particle 
size; Waters Corp., Milford, MA, USA), maintained at 40 oC. Solvents were (A) MilliQ 
water +0.03 % ammonium formate + 0.1 % formic acid and (B) acetonitrile + 0.1 % 
formic acid and the flow rate was 0.6 mL/min. The initial mobile phase, 98% A, was 
held for 4 min then ramped linearly to 70 % A at 11 min, 20 % A at 14 min, and 0 % A 
at 14.5 min and held for 5 min before resetting to the original conditions. Sample 
injection volume was 100 µL.  
 
The ESI conditions were: gas 1, nitrogen (40 psi); gas 2, nitrogen (50 psi); ion spray 
voltage, 2500 V; ion source temperature, 700 oC; curtain gas, nitrogen (50 psi).  
MS/MS data was acquired in the positive mode using the most intense selected 
reaction monitoring (SRM) transition of each compound. In some cases the ammonium 
adduct was the most abundant ion observed for Q1. Scheduled SRM mode was used 
with a 2 minute window.  A detailed description of analyte specific MS parameters is 
given in the table below.  Quantitation was performed using the internal standard ratio 
method using MultiQuant software.  
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Table 2.4: MRM Transitions used for Catecholamines and their Isotopically Labelled Internal Standard Analogues 
Q1 Q3 Time Name DP EP CE CXP 
164 105 10.6 PEA 105 30 10 25 10 
167 105 10.6 PEA [d3] 30 10 25 10 
280 137 11.1 Dopamine  70 6.14 35 15 
289 139 11.1 Dopamine [d9] 70 6.14 35 15 
284 141 11.1 Dopamine [d4] 70 10 37 15 
293 143 11.1 Dopamine [d4] [d9] 70 10 37 15 
261 160 11.1 Serotonin  10 5 25 1 
267 161 11.1 Serotonin [d6] 10 5 25 1 
250 166 11.6 Normetanephrine 50 9 25 15 
256 168 11.5 Normetanephrine [d9] 50 9 25 15 
355 194 11.6 Noradrenalin 10 10 30 1 
367 199 11.5 Noradenalin [d12] 10 10 30 1 
292 250 12.5 Adrenalin  170 10 20 1 
301 257 12.5 Adrenalin [d12] 170 10 20 1 
356. 237 13.4 DHPG  90 13 20 20 
368 244 13.3 DHPG [d12] 90 13 20 20 
308 224 13.9 HMV  110 10 25 20 
311 225 13.9 HMV [d3] 110 10 25 20 
 
2.2.5.5 Prolactin analysis 
Prolactin was measured by diagnostic Medlab, Auckland, New Zealand. Prolactin was 
analysed in 300µL of blood plasma collected in LH treated vacutainers. Due to 
technical issues, only 20 sets of blood samples were available for prolactin analysis (8 
control, 7 DelcyanTM, 5 Blackadder juice). For the above reasons, prolactin analysis 
was between subjects. 
 
2.2.6 Study day testing procedures 
Each participant was required to attend a total of three study days which were 
conducted at least seven days apart to ensure a sufficient wash out between 
conditions. During the week before, and throughout their participation in the study, 
participants were asked to abstain from berry consumption. Cognitive testing took 
place in a laboratory with participants visually and auditorily isolated from each other. 
On arrival at their first session, participants were randomly allocated to a treatment 
regime using a Latin square design that counterbalanced the order of treatments 
across the three active days of the study. On all three study days participants arrived at 
the lab in the morning (8:30 am), after an overnight fast, and firstly gave a 10ml venous 
blood sample. Heart rate, blood pressure and blood glucose were then measured. 
Participants then completed one repetition of the ten minute baseline cognitive 
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assessment battery comprising of the digit vigilance task, the Stroop task, the RVIP 
task, mood scales and the logical reasoning task. This constituted the baseline 
measure for that day. Participants were then supplemented with one of the study 
treatments in the form of a drink, which they were given five minutes to consume. 
Drinks were served chilled and in a dark brown 300ml plastic bottle with a straw to 
minimise the possibility of the participant recognising subtle differences in taste, look 
and mouth-feel between the treatments. After a 60 minute resting absorption period, in 
which participants read in a waiting area, participants’ blood pressure and heart rate 
were measured again and a second blood glucose reading was taken by finger prick. 
Participants then completed the post-dose cognitive assessment. This paradigm 
consisted of seven repetitions of the attention tasks (digit vigilance, Stroop RVIP) and 
mood scales. This lasted 70 minutes and was followed by the logical reasoning central 
executive task. Participants then gave a third blood pressure reading and a third blood 
glucose reading before providing a second and final venous blood sample. A diagram 
of the study visit running order can be seen in figure 2.1 
 
Figure 2.1 Study day running order. Scale depicts minutes post-supplementation. CRF=Case report form, HR=heart rate 
,BP=blood pressure, BG=blood glucose. 
 
2.3 Statistics 
Mood, cognitive scores and the physiological measures were analysed as ‘change from 
baseline’ using the SPSS 18 statistics package. The null hypothesis was rejected with 
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a p value <0.05. Baseline differences were calculated for all measures using a one way 
(treatment) ANOVA. 
 
Two way repeated measures ANOVAs (General linear model) (Treatment [placebo, 
DelcyanTM, juice] X completion [1 to 7] for cognitive battery and visual analogue scale 
outcomes OR Treatment [placebo, DelcyanTM, Juice] X completion [1 to 2] for blood 
glucose and Bond-Lader) were conducted. Logical reasoning performance, platelet 
Monoamine Oxidase B activity and plasma anthocyanins levels were analysed by one-
way (treatment) repeated measures ANOVA. Blood plasma prolactin was analysed 
using a one way (treatment) between subjects ANOVA. In all instances Mauchly`s test 
of sphericity was used to assess equality of the variances of the differences between 
factors. Where sphericity had been violated, Huynh-Feldt corrections for non-sphericity 
were implemented. Pairwise comparisons were conducted on all outcomes with a p 
value <0.5 on the initial ANOVA to ascertain any differences between treatments for 
the whole session and at each task repetition. Partial Bonferroni corrections were 
applied to protect for error against multiple comparisons, therefore, the p value was 
multiplied by the number of treatments being compared to control. All post hoc p values 
are reported after corrections for multiple comparisons have been applied. 
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2.4 Results 
Prior to analysis of change from baseline data, mean pre-dose scores for each 
outcome were subjected to a one way repeated measures ANOVA to assess on-day 
differences. The only significant baseline difference found between treatments was for 
homovanillic acid [F (1.622,25.95)=4.768. p=0.025] with higher levels of homovanilic 
acid in the baseline Blackadder juice group when compared to control (p=0.026). 
Therefore, results for this variable should be interpreted with caution. 
 
A one way ANOVA was conducted on control change from baseline scores for the 
outcome fatigue to ensure the sustained attention cognitive paradigm was indeed 
mentally fatiguing. A significant effect of repetition was observed [F(6,192)=16.436. 
p<0.0001] with each subsequent repetition of the tasks causing an increased rating of 
self-reported mental fatigue. A graphical representation can be seen in figure 2.2. 
 
Figure 2.2 Mean change from baseline scores for the visual analogue outcome fatigue post supplementation of the 
control treatment, depicting increasing self-reported fatigue with each repetition of the cognitive battery. 
 
 
2.4.1 Cognitive performance 
Mean pre-dose baseline and change from baseline scores for each behavioural 
condition are presented in tables 2.5 and 2.6 and significant differences are presented 
in figure 2.3. Unchanged “raw” data tables can be found in appendix x .Only ANOVA 
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results for behavioural measures which generated significant effects are reported 
below. 
Table 2.5 Mean pre-dose baseline and change from baseline scores, standard deviations and ANOVA outcomes for Bond-
Lader mood scales following supplementation of the control, Delcyan
TM
 and Blackadder juice drinks. 
Measure N Treatment 
Baseline Repetition 1 Repetition 2 Effect of 
Treatment 
Treatment*repetition 
interaction Mean SD Mean SD Mean SD 
Bond-
Lader 
calm 
33 
Control 58.71 15.05 -0.65 11.02 4.52 20.13 
F=1.15 p>0.1 F=0.71 p>0.1 DelcyanTM 61.06 16.35 -3.23 11.31 2.45 14.53 
Juice 60.11 15.08 2.24 14.32 4.44 18.43 
Bond-
Lader 
content 
33 
Control 69.33 10.20 -1.93 10.08 -10.38 13.78 
F=1.51 p>0.1 F=0.98 p>0.1 DelcyanTM 70.16 11.41 -0.40 5.58 -6.42 10.13 
Juice 69.01 11.09 0.08 5.79 -6.25 12.99 
Bond-
Lader 
alert 
33 
Control 61.31 12.60 -1.81 10.83 -22.49 15.95 
F=2.61 p>0.1 F=2.60 p=0.082 DelcyanTM 62.99 15.32 -0.62 6.51 -14.16 13.99 
Juice 62.83 13.15 -0.76 11.45 -18.37 18.54 
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Table 2.6 Mean pre-dose baseline and change from baseline scores, standard deviations and main ANOVA outcomes for each cognitive condition following supplementation of the 
control, Delcyan
TM
 and Blackadder juice drinks. 
 
Measure N Treatment 
Baseline Repetition 1 Repetition 2 Repetition 3 Repetition 4 Repetition 5 Repetition 6 Repetition 7 Effect of 
treatment 
Treatment*repetition 
interaction Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Digit vigilance accuracy (%) 33 
Control 97.03 4.30 -0.82 4.75 -2.55 6.32 -4.85 9.69 -6.89 6.49 -7.34 9.36 -8.99 8.00 -7.35 7.14 
 F=1.03 p>0.1 F=0.95 p=0.1 DelcyanTM  97.50 3.22 -2.63 6.38 -4.69 8.61 -4.59 7.74 -5.84 8.85 -5.99 8.68 -5.89 7.54 -6.84 9.24 
Juice 96.45 3.83 0.02 3.78 -2.54 5.21 -3.84 8.39 -5.94 9.55 -4.99 5.57 -6.27 8.21 -4.52 6.63 
Digit vigilance false alarms 
(Number) 
33 
Control 0.91 1.34 0.42 1.68 0.36 1.58 0.94 1.39 1.58 1.89 1.61 1.84 1.94 1.90 1.61 1.92 
F=0.32 p>0.1 F=0.98 p>0.1 DelcyanTM  0.80 0.80 0.33 1.27 0.70 1.45 1.12 1.95 1.00 1.90 1.55 1.79 1.12 1.56 1.30 2.01 
Juice 0.86 1.14 0.24 1.37 0.88 1.67 1.15 2.31 1.55 1.82 1.39 1.50 1.73 2.18 1.36 1.83 
Digit vigilance reaction time 
(msec) 
33 
Control 414.1 29.28 20.41 24.68 28.34 22.78 31.30 25.15 45.13 25.95 38.98 26.07 47.04 27.50 45.04 24.73  F=3.48 
p=0.037 
 
F1.82 p>0.043 DelcyanTM  413.5 28.64 15.70 19.23 19.11 25.51 36.27 30.17 31.88 25.62 34.79 24.12 32.85 23.30 39.97 24.72 
Juice 422.1 31.03 4.43 28.43 16.01 31.00 25.34 34.69 24.73 29.66 28.96 34.31 32.58 35.92 28.62 29.62 
RVIP accuracy (%) 32 
Control 65.86 15.26 -1.25 11.47 -6.72 11.84 -3.59 12.76 -7.58 12.32 -8.59 16.82 -8.13 11.55 -10.63 14.84  F=5.88 
p=0.005 
 
F=1.07 p>0.1 DelcyanTM  64.53 17.59 -0.23 9.38 -1.56 10.04 1.95 10.79 -1.72 11.80 -1.72 10.73 -1.56 10.79 -2.03 16.08 
Juice 70.47 14.60 -5.31 12.08 -6.56 12.84 -7.58 14.11 -10.70 13.17 -10.55 13.81 -9.84 13.51 -8.83 14.31 
RVIP false alarms 32 
Control 4.00 4.70 -1.03 3.76 -0.94 3.43 -1.28 3.21 -0.25 3.56 -0.75 4.13 -0.97 3.36 -0.72 3.39 
F=0.57 p>0.1 F=1.10 p>0.1 DelcyanTM  2.88 4.88 -0.25 3.41 -0.19 3.76 -0.25 4.44 -0.38 4.29 0.03 3.95 -0.25 4.54 0.28 5.29 
Juice 2.81 3.35 -0.88 2.55 -0.41 2.87 0.38 2.09 0.66 3.74 -0.13 2.78 -0.72 3.20 -0.25 2.86 
RVIP reaction time (msec) 32 
Control 484.4 43.93 -0.87 29.83 7.16 31.80 12.71 31.23 9.43 32.70 10.89 35.65 8.75 40.32 19.71 44.98 
F=0.04 p>0.1 F=1.01 p>0.1 DelcyanTM  479.8 35.20 7.71 34.25 14.39 37.04 8.41 31.31 10.65 35.15 14.34 37.62 4.54 37.58 12.49 35.15 
Juice 484.6 40.58 -1.38 26.74 15.88 32.19 11.08 34.31 14.36 40.99 11.96 35.43 7.52 35.99 10.27 43.18 
Stroop accuracy (%) 35 
Control 98.88 2.14 -0.16 2.28 0.14 1.61 0.15 2.43 -0.73 2.86 -0.67 2.73 -0.51 2.53 -0.29 2.29 
F=0.014 p>0.1 F=0.94 p>0.1 DelcyanTM  99.14 1.61 -0.31 1.91 -0.31 2.05 0.07 1.90 0.04 1.59 -0.42 1.83 0.09 1.69 -0.72 2.27 
Juice 98.90 2.77 -0.57 2.97 -0.26 2.11 0.03 2.06 0.00 2.49 -0.27 2.51 -0.28 2.29 -0.50 3.01 
Stroop reaction time (msec) 35 
Control 797.4 105.9 -9.03 51.78 -4.23 49.64 -11.26 54.52 14.94 60.77 10.51 59.67 53.80 174.7 18.60 64.57 
F=0.33 p>0.1 F=0.57 p>0.1 DelcyanTM  801.5 124.4 -15.86 49.59 -2.31 57.42 26.43 157.3 -1.57 57.53 -11.39 120.66 6.00 60.99 -3.26 72.49 
Juice 788.5 115.1 -15.69 70.97 -7.91 81.20 5.31 102.1 25.00 121.7 -2.43 70.25 19.66 95.64 7.77 79.30 
VAS fatigue 
(mm) 
33 
Control 35.06 19.23 3.55 13.13 10.03 17.41 12.73 16.19 15.39 18.22 20.58 19.31 21.94 17.08 23.33 18.22 
F=1.27 p>0.1 F=1.70 p=0.063 DelcyanTM  34.42 19.97 3.15 10.48 7.03 12.57 8.30 12.93 10.64 13.55 14.39 14.88 15.03 15.68 15.30 16.53 
Juice 32.61 17.69 5.18 15.47 7.52 15.99 14.03 17.30 14.91 17.48 18.91 15.99 18.97 16.70 20.97 16.54 
VAS difficulty 
(mm) 
33 
Control 48.97 15.48 2.94 14.29 10.97 20.25 17.24 14.14 20.76 18.76 25.03 17.67 25.55 18.86 29.24 17.73 
F=0.51 p>0.1 F=1.46 p>0.1 DelcyanTM  40.12 18.97 4.91 10.85 12.88 14.57 15.00 12.78 17.61 14.83 21.24 15.25 22.45 15.95 23.12 16.04 
Juice 39.85 20.63 7.70 18.05 15.67 21.86 17.79 18.51 20.58 17.26 24.82 19.43 26.73 21.01 27.48 20.04 
Logical reasoning reaction 
time 
33 
Control 3977 1330 -136.7 797.52 
 
F=0.35 p>0.1 
 
DelcyanTM  3834 1132 -108.9 964.06 
Juice 3963 1266 -257.7 750.06 
Logical reasoning accuracy 
(%) 
33 
Control 86.48 15.88 1.39 22.97 
 
F=0.07 p>0.1 
 
DelcyanTM  86.48 15.85 0.18 8.34 
Juice 86.30 16.93 1.52 11.25 
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2.4.1.1 Digit vigilance  
There was a significant treatment × repetition interaction on digit vigilance reaction time 
[F (12,384)=1.82 p=0.04] without any effect upon accuracy. Pairwise comparisons 
revealed a positive modulation of reaction time after supplementation of the juice 
treatment at repetition 1 (p=0.03), 4 (p=0.01) and 7 (p=0.04). See Figure 2.3a. There 
were no effects on any digit vigilance outcomes after supplementation with DelcyanTM. 
 
2.4.1.2 RVIP 
There was a significant main effect of treatment on RVIP accuracy [F (2,62)=5.87, 
p=0.005]. Pairwise comparisons showed an attenuation in the reduction of RVIP 
accuracy after supplementation of the DelcyanTM extract treatment when compared to 
control (p=0.01), without any significant effect on reaction time or false alarms. See 
Figure 2.3b. There were no effects on any RVIP outcomes after supplementation with 
juice.  
   
Figure 2.3 Mean change from baseline scores following Control, Delcyan
TM
 and Juice treatments for digit vigilance 
reaction time (millisecond  (msec)) and RVIP accuracy (% correct). Significant differences compared to control are 
indicated (*p<0.05).  
 
2.4.2 Physiological parameters 
Mean pre-dose baseline and change from baseline scores for each physiological 
measure are presented in table 2.7 and significant differences are presented in figure 
2.4. Unchanged “raw” data tables can be found in appendix X. Only ANOVA results for 
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physiological measures which generated significant treatment related effects are 
reported below. 
 
2.4.2.1 Blood glucose  
There was a significant main effect of treatment on blood glucose [F(2,68)=8.89, 
p<0.001]. Pairwise comparisons showed significantly higher blood glucose levels 
following supplementation of the juice treatment when compared to control (p=0.002). 
See figure 2.4a. There were no significant effects following supplementation of 
DelcyanTM. 
Table 2.7 Mean pre-dose baseline and change from baseline scores, standard deviations and ANOVA outcomes for 
each physiological parameter following supplementation of the control, Delcyan
TM
 and Blackadder juice drinks. 
Measure N Treatment 
Baseline Repetition 1 Repetition 2 
Effect of 
Treatment 
Treatment* 
repetition 
interaction 
Mean SD Mean SD Mean SD 
Heart rate (BPM) 35 
Control 69.6 11.76 -2.26 9.12 -7.46 10.12 
F=1.00 p>0.1 F=0.72 p>0.1 Delcyan
TM
 72.14 12.07 -4.2 7.26 -8.14 7.87 
Juice 72.46 11.89 -4.09 9.81 -10.2 11.2 
Diastolic blood 
pressure (mmHg) 
35 
Control 76.83 7.64 -2.17 6.88 0.71 10.6 
F=0.04 p>0.1 F=1.64 p>0.1 Delcyan
TM
 76.89 8.31 -1.91 6.22 -0.11 6.76 
Juice 74.63 7.32 0.54 6.13 0 8.32 
Systolic blood 
pressure (mmHg) 
35 
Control 121.3 12.62 -3.09 9.3 -0.29 10.7 
F=0.16 p>0.1 F=1.53 p>0.1 Delcyan
TM
 122.7 13.65 -2.2 9.77 -0.6 11.37 
Juice 122.9 11.74 -1.86 11.77 -3.51 14.41 
Glucose (mmoL) 35 
Control 4.71 1.22 -0.2 0.8 -0.43 0.42 
F=8.89 
p<0.001 
F=2.45 
p=0.09 
Delcyan
TM
 4.68 1.13 0.02 0.62 -0.39 0.39 
Juice 4.71 1.15 0.33 0.82 -0.21 0.47 
Prolactin (IU/L) 
8 Control 271.6 70.52 -103.2 79.85 
 
F=1.6 p>0.1  7 Delcyan
TM
 315.4 135.9 -121.3 116.36 
5 Juice 353.4 105.3 -196.2 77.42 
MAO-B 
(nmol H
2
O
2
) 
8 
Control 258 112.3 11.32 68.28 
 
F=15.22 
p<0.001 
 Delcyan
TM
 220.6 131.2 -78.06 131.88 
Juice 273.1 114.1 -267.4 109.82 
Total 
anthocyanins 
(nM/L) 
17 
Control 0 0 -0.02 0.35 
 
F=105.54 
p<0.001 
 Delcyan
TM
 0 0 22.03 7.62 
Juice 0 0 15.16 4.6 
Phenylethylamine 
(ng/ml) 
17 
Control 0.05 0.18 0.01 0.04 
 
F=0.96 p>0.1  Delcyan
TM
 0.04 0.14 0.02 0.08 
Juice 0.09 0.35 0.01 0.02 
Dopamine 
(ng/ml) 
17 
Control 0.02 0.02 0 0.02 
 
F=0.39 p>0.1  Delcyan
TM
 0.02 0.01 0 0.01 
Juice 0.02 0.01 0 0.01 
Serotonin 
(ng/ml) 
17 
Control 1.9 1.34 -0.15 2.25 
 
F=0.75 p>0.1  Delcyan
TM
 2.37 2.06 -0.73 1.26 
Juice 2.23 2.3 -0.62 2.03 
Normetanephrine 
(ng/ml) 
17 
Control 0.05 0.02 0 0.02 
 
F=12.19 
p<0.001 
 Delcyan
TM
 0.06 0.03 0 0.02 
Juice 0.05 0.02 0.03 0.02 
Noradrenaline 
(ng/ml) 
17 
Control 0.3 0.1 0.15 0.16 
 
F=0.97 p<0.1  Delcyan
TM
 0.35 0.1 0.11 0.15 
Juice 0.33 0.11 0.09 0.17 
Adrenaline 
(ng/ml) 
17 
Control 0.02 0.02 0.01 0.03 
 
F=2.189 p>0.1  Delcyan
TM
 0.02 0.03 0 0.01 
Juice 0.02 0.02 -0.01 0.02 
DHPG 
(ng/ml) 
17 
Control 1.61 0.36 0.2 0.41 
 
F=21.30 
p=0.001 
 Delcyan
TM
 1.6 0.34 0.2 0.51 
Juice 1.63 0.37 -0.58 0.34 
Homovanillic acid 
(ng/ml) 
17 
Control 21.42 12.21 -4 14.9 
 
F=0.55 p>0.1  Delcyan
TM
 27.45 16.7 -7.67 10.34 
Juice 17.12 8.01 -5.31 7.63 
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2.4.2.2 Platelet MAO-B  
There was a significant main effect of treatment on blood platelet MAO-B activity [F 
(2,16)=15.2 p<0.001]. Pairwise comparisons showed a decrease in platelet MAO-B 
activity after supplementation with the juice treatment when compared to control 
(p<0.001). See figure 2.4b. There were no significant differences between active 
treatment groups. There was no effect of the DelcyanTM treatment on blood platelet 
MAO-B. 
 
2.4.2.3 Monoamines 
The repeated measures ANOVA revealed a significant main effect of treatment [F 
(2,32)=12.18 p<0.001] on plasma levels of normetanephrine. Pairwise comparisons 
showed levels of normetanephrine were significantly higher after supplementation of 
the juice treatment when compared to the control (p<0.001) and DelcyanTM (p<0.001). 
There were no effects of DelcyanTM. See figure 2.4c. 
 
The repeated measures ANOVA revealed a significant main effect of treatment [F 
(2,32)=21.296 p<0.001] on plasma levels of DHPG. Pairwise comparisons revealed 
levels of DHPG were significantly higher after supplementation of the juice treatment 
when compared to the control (p<0.001) and DelcyanTM (p<0.001). There were no 
effects of DelcyanTM. See figure 2.4d. 
 
 
87 
 
 
Figure 2.4 Mean change from baseline scores following control, Delcyan
TM
 and juice treatments. Significant differences 
compared to control (a,b) are indicated and compared to control and Delcyan
TM
 (c,d) (*p<0.05 **p<0.01 ***p<0.001). 
 
2.4.2.4 Blood plasma anthocyanin levels 
The repeated measures ANOVA revealed a significant effect of treatment on plasma 
levels of C3G, C3R, D3G and D3R [F(2,34)=27.5 (p<0.001)], [F(2,34)=33.7 (p<0.001)], 
[F(2,34)=112.51 p<0.001), [F(1.45,25.25)=96.26 p<0.001) respectively. 
 
Plasma C3G, C3R, D3G and D3R levels were significantly higher after 
supplementation with the DelcyanTM treatment when compared to control p<0.001, 
p=0.001, p<0.001, p<0.001 and the Blackadder juice treatment p<0.001, p<0.001, 
p<0.003, p<0.001 respectively. 
 
Plasma C3G, C3R, D3G and D3R levels were also significantly higher after 
supplementation of the Blackadder juice treatment when compared to control 
(p<0.001), (p<0.001), (p=0.003) and (p<0.001) respectively. A graphical representation 
of anthocyanin levels in blood plasma can be seen in figure 2.5a. 
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Following supplementation, the repeated measures ANOVA revealed a significant 
effect of the treatment on combined levels of C3G, C3R, D3G and D3R in blood 
plasma (combined anthocyanin level is the total amount of anthocyanins measured in 
blood plasma after supplementation of the study treatment) after consumption of the 
study treatments, [F (2,32)=105.34, p<0.0001]. Pairwise comparisons revealed that 
combined anthocyanin levels were significantly higher after consumption of the 
DelcyanTM (p<0.001) and juice (p<0.001) treatment when compared to control. Levels 
were also significantly after supplementation of the DelcyanTM extract when compared 
to the Blackadder juice extract (p<0.001). A graphical representation of combined 
anthocyanin levels in blood plasma can be seen in figure 2.5b. 
 
 
 
 
 
 
Figure 2.5 Grouped mean blood plasma anthocyanins for each anthocyanin (a) and combined plasma anthocyanins (b) 
(combined anthocyanin is the sum of measured anthocyanins for each condition). Means with a different letter are 
significantly different to each other. 
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Table 2.8  Means and SD for the amount of measured anthocyanins given to the participants and the amount found in 
blood plasma (change from baseline) 150 minutes post supplementation of the Delcyan
TM
 and Blackadder juice 
treatments 
Treatment Anthocyanin 
Amount supplemented mg/kilo body 
weight 
Average amount in 
plasma (nM) 
DelcyanTM 
Cyanidin glucoside 0.80 0.41 ± 0.31 
Delphinidin glucoside 1.23 1.31 ± 0.91 
Cyanidin rutinoside 4.12 8.57 ± 2.89 
Delphinidin rutinoside 2.97 11.74 ± 4.51 
Blackadder juice 
Cyanidin glucoside 0.32 0.19 ± 0.15 
Delphinidin glucoside 0.57 0.77 ± 0.61 
Cyanidin rutinoside 3.57 6.36 ± 2.26 
Delphinidin rutinoside 2.74 7.85 ± 2.50 
Control 
Cyanidin glucoside 0 -0.02 ± 0.12 
Delphinidin glucoside 0 0.00 ± 0.012 
Cyanidin rutinoside 0 -0.03 ± 0.09 
Delphinidin rutinoside 0 0.03 ± 0.19 
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2.5 Discussion and conclusion 
The current study has outlined evidence of positive modulation of behaviour following 
administration of two blackcurrant extracts when compared to control, with no negative 
effects of either active treatment found. Improvements in RVIP accuracy were found 
after supplementation of the DelcyanTM extract and improvements in reaction time on 
the digit vigilance task were found after supplementation of the Blackadder juice 
extract. Although there were no other significant effects on behaviour, the juice 
treatment demonstrated a number of physiological effects not present following 
DelcyanTM. These comprised of an extremely powerful inhibition of platelet MAO-B 
activity (96%) and a significant reduction in plasma normetanephrine (60%) and DHPG 
(~35.5%) when measured 2.5 hours after supplementation. The blackcurrant juice 
treatment also showed a significantly sustained (over both time points) increase in 
blood glucose when compared to control despite being sugar matched.  
 
An increase in accuracy was shown during the RVIP task after supplementation with 
the DelcyanTM treatment, irrespective of task repetition, with no evidence of slowed 
reaction times. In regards to the juice treatment, there was evidence of an attenuation 
of the increase of digit vigilance reaction times seen with repeated testing, with no 
evidence of decreased accuracy. This improvement was seen during repetitions one, 
four and seven (70, 100 and 140 minutes post-supplementation, respectively). Further 
evidence for a modulation of behaviour following the blackcurrant extracts comes from 
non-significant trends observed on the treatment*repetition ANOVAs for Bond-Lader 
alertness ratings and mental fatigue visual analogue scales showed. These indicated a 
pattern of  attenuation in decreased self-reported alertness and increased ratings of 
fatigue following supplementation of the DelcyanTM treatment but only reached 
significance after the final repetition of the 70 minute attentionally demanding cognitive 
battery. A graphical representation can be seen in appendix IV.a and IV.b. 
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There is evidence of direct cellular and molecular interactions of flavonoids on rodent 
brains (Spencer et al., 2009) and changes in central (Francis et al., 2006) and 
peripheral (Matsumoto et al., 2005b) vascular function in humans after consumption of 
flavonoid-rich fruits. However, definitive mechanisms driving the behavioural effects in 
the present study are currently unknown, especially after supplementation of the 
DelcyanTM treatment, which had no significant effect upon any of the physiological 
measures. 
 
As expected, blood plasma anthocyanins D3G, D3R, C3G and C3R were significantly 
increased 2.5 hours after supplementation of both blackcurrant treatments when 
compared to control. Measured blood plasma anthocyanins were also greater after 
supplementation of the DelcyanTM treatment when compared to the juice treatment. 
When all four measured anthocyanins were combined there was a 30% increase in 
plasma concentration following DelcyanTM when compared to the juice treatment. 
However, this extract contained 20% more of the measured anthocyanins than the 
juice drink. Although there was a significant difference in blood plasma anthocyanins 
between the two blackcurrant treatments, in line with past published research (Mazza 
et al., 2002; Nielsen et al., 2003; Matsumoto et al., 2005b), anthocyanin quantities 
found in blood plasma were less than one percent of that ingested. It must be noted 
that vitamins and minerals, other than L-ascorbic acid, were not quantified in any of the 
study treatments. However, to my knowledge there are no reported cognitive or 
behavioural effects of acute vitamin or mineral supplementation. Given that the major 
phenolic constituents of each treatment were anthocyanins and both extracts affected 
attention based tasks, this may indicate that the effects of blackcurrant upon attention 
processing are directly related to their anthocyanin content; an acute effect which has 
previously been shown in children aged 7-9 years (Whyte & Williams, 2012). The 
specific demands of the two attention tasks are, however, not equal, with a higher 
demand both in processing, and duration of the RVIP task when compared to the digit 
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vigilance task. The RVIP contains a higher working memory element than the digit 
vigilance task, potentially indicating changes in numeric working memory processing as 
well attention, a cognitive outcome which has previously been shown to be sensitive to 
flavonoid-rich cocoa (Scholey et al., 2010) and ginkgo biloba (Rigney et al., 1999). 
However, until replication of the behavioural effects presented in the current has been 
achieved, it is difficult to elaborate further at this point 
 
In terms of MAO-B activity, this is the first demonstration of a clinically significant 
inhibition of platelet MAO-B following blackcurrant supplementation. Central MAO-B 
inhibitors have been used for several decades for the treatment of depressive disorders 
and neurodegenerative diseases (Youdim & Bakhle, 2006) and have also been shown 
to improve cognitive processing when given to non-demented Parkinson patients 
(Hanagasi et al., 2011). Most importantly MAO-B inhibitors have the potential to 
attenuate the breakdown of endogenous neurotransmitters, reducing levels of H2O2
 
associated with deamination of dopamine (Pizzinat et al., 1999). Although the current 
study only measured MAO-B inhibition in peripheral tissue, if the inhibition can be 
shown to be centrally active, the clinical applications of a MAO inhibitor from a 
commonly consumed fruit could be vast. Potential applications include attenuating 
cognitive decline associated with natural ageing, as well as in clinical populations, 
including those suffering from early stage Parkinson’s disease, whom are known to 
respond favourably to MAO inhibitors (Hanagasi et al., 2011). DHPG, a metabolite 
largely determined by MAO-A dependent metabolism of noradrenalin (Scheinin et al., 
1991), which is a marker for reduced MAO-A activity after administration of 
pharmacological MAO-A inhibitors (Zimmer, 1990), was also found to be reduced after 
consumption of the Blackadder blackcurrant juice extract in the current study. This 
effect was not seen after consumption of the DelcyanTM extract, highlighting that, in 
addition to MAO-B inhibition, the Blackadder juice treatment possesses MAO-A 
inhibitory properties.  
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The observed reduction in DHPG is approximately two thirds of the reduction found 
after administration of 100mg of the selective MAO-A inhibitor drug moclobemide 
(Koulu et al., 1989). These changes in DHPG did not coincide with an accumulation of 
adrenalin or noradrenalin in the current study, which is in line with previous research 
investigating acute supplementation of MAO-A inhibitors in humans (Illi et al., 1996). In 
addition to decreased levels of DHPG, indicating MAO-A inhibition, we also see an 
increase in normetanephrine, a metabolite of noradrenalin via catechol-O-methyl 
transferase (COMT). This increase is potentially indicative of increased noradrenalin 
breakdown through COMT as a result of inhibition of the MAO-A enzyme. The ability of 
a MAO inhibitor to exert mood altering properties relies on its ability to inhibit MAO in 
the central nervous system, modulating the breakdown of dopamine, noradrenalin and 
serotonin in the brain. Serotonin is predominantly deaminated by the MAO-A isoform 
and is related to the aetiology of depression, for this reason, reversible MAO-A 
inhibitors yield the best therapeutic results in depressive patients (Gareri et al., 2000). 
Although MAO-B inhibitors do not possess anti-depressive properties on their own, 
MAO-B inhibition is useful for alleviating early symptoms associated with Parkinsonism, 
elevating dopamine and phenylethylamine in the brain (Riederer & Youdim, 1986). As 
MAO-B expression in the brain increases with age (Fowler et al., 1997), and as a 
consequence of neurological diseases, the effectiveness of a MAO-B inhibitor in the 
brain where the ratio of MAO-B much outweighs that of MAO-A is increased in 
conjunction with supplementation of the dopamine precursor L-DOPA, at least in early 
stages of disease (Cools, 2006). Therefore, supplementation of a dopamine pre-curser 
with the MAO-B inhibiting Blackadder juice extract could yield greater results. Also 
related to this MAO inhibitory effect is a non-significant modulation of plasma prolactin 
observed in the current study where post-dose prolactin is lower after consumption of 
the Blackadder juice extract when compared to control. Although gamma-aminobutyric 
acid (GABA), serotonin, adrenalin and noradrenalin are slight rate limiting factors of 
prolactin secretion, dopamine is the most important hypothalamic prolactin inhibiting 
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factor, (Fitzgerald & Dinan, 2008) indicating that general and potentially central 
dopaminergic tone could have been affected by supplementation of the Blackadder 
juice drink. Although these prolactin findings are hindered by a small sample size and 
between subjects design, they illuminate the need for further research. 
 
The blackcurrant juice treatment also showed a significantly sustained (over both time 
points) increase in blood glucose when compared to control, despite being sugar 
matched; an effect not seen with supplementation of the DelcyanTM treatment. Blood 
glucose was elevated by 0.53mmo/L 60 minutes and 0.23mmol/L 150 minutes post 
supplementation of the juice treatment. Although these results must be interpreted with 
caution as there were only two post-dose blood glucose measurements, this result 
shows a clear effect of the juice treatment on blood glucose. Therefore, a more 
thorough investigation needs to be completed to ascertain a full post supplementation 
blood glucose profile. Based upon the current findings, the effect on glucose appears to 
resemble the pattern after supplementation of apple juice where the post-prandial peak 
in blood glucose level is reduced resulting in a higher blood glucose reading one hour 
after supplementation (Johnston et al., 2002). The main difference between the study 
treatments was phenolic acids at 0mg in the DelcyanTM treatment and 61mg in the juice 
treatment per 60kg of bodyweight, which could provide further evidence of the slowing 
of glucose transport from the gut via direct inhibition of intestinal epithelial glucose 
transporters by phenolic acids as described by Manzano and Williamson (2010). The 
study also showed no effect of acute blackcurrant supplementation on blood pressure 
or heart rate, which is consistent with the findings by Jin et al., (2011).  
 
The findings of the present study demonstrate, for the first time, a positive modulation 
of behaviour in a “young and healthy” adult cohort after supplementation of a 
blackcurrant extract. This is also the first evidence of a clinically significant reduction in 
MAO activity following ingestion of a commonly consumed fruit. The results suggest 
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that the MAO-B inhibition found in this study cannot be wholly responsible for the 
behavioural effects observed as both active conditions positively influenced attention 
based cognitive tasks, whereas only the juice treatment inhibited MAO-A and MAO-B. 
The finding of more robust effects on attention following DelcyanTM, containing higher 
levels of anthocyanins, may indicate that these effects are attributable to the 
anthocyanin content and that any effects on MAO are independent of these. The 
possibility that a MAO-A and MAO-B inhibiting blackcurrant drink will exert favourable 
effects on cognitive modulation of non-clinical populations deserves further 
investigation. More exploration therefore needs to be undertaken to ascertain if other 
cognitive paradigms, especially those which have previously been shown to be 
sensitive to flavonoid-rich nutritional interventions in rats and humans, specifically 
memory tasks and paradigms sensitive to changes in levels of dopamine, are 
modulated after supplementation of a MAO inhibiting blackcurrant juice.
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CHAPTER 3. DOSE-RESPONSE EFFECTS OF THE BLACKADDER 
BLACKCURRANT JUICE EXTRACT ON MOOD, COGNITION AND 
NEUROENDOCRINOLOGY IN HEALTHY ADULTS 
 
3.1 Introduction 
Chapter two of this thesis presented data in support of patent findings (Bormann & 
Schatton, 1996) showing improvements to attention following acute supplementation of 
a blackcurrant extract to young healthy participants. The results from the previous 
chapter also suggested that different post-harvest preparation techniques applied to 
blackcurrant berries can yield different physiological responses. Previous findings, both 
in animal models (Joseph et al., 1999; Casadesus et al., 2004; Ramirez et al., 2005; 
Wang et al., 2006; Van Praag et al., 2007; Williams et al., 2008) and in the limited 
published human studies (Krikorian et al., 2010a; Krikorian et al., 2010b; Krikorian et 
al., 2012), show positive effects of berries and their constituents upon several aspects 
of memory; a cognitive process which was not investigated in the first intervention 
study of this thesis. The nature of this published research is the attenuation of natural 
cognitive decline in aged animal models after the ingestion of flavonoid-rich foods. 
There is a similar focus in human intervention studies and, as discussed in chapter one 
and two of this thesis, positive effects upon spatial and verbal memory after 12 weeks 
supplementation of cranberry juice (Krikorian et al., 2010a) or blueberry juice (Krikorian 
et al., 2010b) have been reported in elderly adults with age related memory decline.  
 
Although the above literature focuses upon cognitive performance in aged adults after 
consumption of flavonoid-rich berries, supplementation with other flavonoid-rich foods 
has been shown to elicit improvements to memory in younger participants. This 
research has highlighted that dose selection and time of post-dose cognitive 
assessments have an impact on the findings in flavonoid based intervention studies 
(Kennedy et al., 2000; Scholey et al., 2010). It must also be noted that Shukitt-Hale et 
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al., (2006) have demonstrated differential neurocognitive responses at different doses 
within the same time frame in animal models after supplementation with grape juice. 
Further to this, Willis et al., (2009) demonstrated dose-related effects in terms of motor 
and cognitive improvements in rats after supplementation with low and moderate doses 
of walnut, but impairment of both motor function and cognition with higher doses. 
Different findings shown at different time points and different doses (Kennedy et al., 
2000) may be due to the biphasic nature of flavonoid pharmacokinetics, where 
metabolites of flavonoid compounds re-emerge in the blood stream at a later time point 
(Jin et al., 2011). In terms of intervention studies assessing the effect of berry 
supplementation on behaviour in a healthy young cohort, the only published study to 
date reported no significant positive or negative effects of acute supplementation of 
10ml/kg of body weight (21mg/kg polyphenols) with 100% concord grape juice upon 
implicit memory or mood, as measured by a modified version of the word fragment 
completion task (Hendrickson & Mattes, 1998). The lack of effects in this study may be 
indicative of the implicit memory measure used, or other specifics of the study, such as, 
measuring effects post-prandially. The above evidence and data presented in chapter 
two, however, suggest that further exploration of acute effects of berries on memory 
performance in young adults is warranted.   
 
Although in vitro data demonstrates the MAO inhibitory effects of anthocyanins 
(Dreiseitel et al., 2009b), data from chapter two of this thesis highlighted that they are 
unlikely to be the sole compound driving the inhibition of MAO-A and MAO-B. The 
anthocyanin enriched DelcyanTM treatment elicited no significant effect on either MAO 
isoform, whereas, the Blackadder juice treatment with the full blackcurrant profile of 
polyphenols (standardised at 500mg of polyphenols per 60kg of body weight) inhibited 
both MAO subtypes. In addition to MAO-inhibition, there was also indication of 
modulation of prolactin following the Blackadder juice extract in the previous chapter. 
Interpretation of these findings was hindered by poor sample size, however, the effects 
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warrant further investigation as the hormone prolactin may be regulated by central 
dopaminergic tone. The relevance of this to behaviour is demonstrated by a plethora of 
scientific papers and review articles exploring the effects of dopamine on behaviour. 
For example, the lesioning of dopaminergic terminals or neurons (Viallet et al., 1983; 
Amalric & Koob, 1987) and administration of D2 dopaminergic receptor antagonists 
(Amalric et al., 1993; Marrow et al., 1993) decrease movement time and increase 
reaction times in animal models. The opposite is true after administration of dopamine 
receptor agonists, with decreased reaction times in animal models (Smith & Kieval, 
2000). Reductions in CNS dopamine activity are purported to be associated with 
deficits in attention in clinical populations, such as, sufferers of attention deficit 
disorders (Lahoste et al., 1996) and executive dysfunction (Levy et al., 2002). In 
addition, reductions in motor control (Cooper et al., 1991) and increases in 
impulsiveness (O’sullivan et al., 2011) in sufferers of Parkinson’s disease have been 
observed.  
 
Oxidative stress occurs when levels of reactive oxygen species are greater than the 
capacity of the antioxidant defence system (Halliwell, 2008). Studies have shown that 
maintaining this equilibrium in the brain is of particular importance during ageing                                                                                                                             
(see Floyd & Hensley, 2002 for a full review). Along with oxidative stress, increases in 
hydrogen peroxide (H2O2) occur in the brain during ageing, playing a significant role in 
cell death (Cavazzoni et al., 1999). Although anthocyanins have been shown to be 
powerful antioxidants in vitro, the levels found in plasma are not great enough to cause 
an antioxidative effect in vivo, which could explain null effects found by Jin et al., 
(2011). It would, therefore, be beneficial to quantify plasma ferric reducing/antioxidant 
power (FRAP) activity after consumption of the Blackadder blackcurrant extracts. This 
would  not only  assess the extracts direct potential to protect against reactive oxygen 
species and reduce oxidative stress, but additionally, assess whether the reduction in 
MAO-B activity, which is associated with deamination of amines producing H2O2 
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(Pizzinat et al., 1999), could potentially cause an indirect effect upon FRAP. The FRAP 
assay is a direct measure of the total antioxidant potential of a sample (Benzie & 
Strain, 1996). FRAP results are only based on the antioxidant reducing potential of the 
ferric ion, and not the antioxidant preventative effect. In a recent study comparing the 
antioxidant potential of a guava extract (Thaipong et al., 2006), FRAP analysis was 
shown to best correlate to polyphenol and ascorbic acid levels when compared to other 
measures such as 1,1-Diphenyl-2-picryl-hydrazyl (DPPH) and oxygen radical 
absorbance capacity (ORAC) antioxidant assays. 
 
In light of the research outlined above, and the effects described in chapter two, which 
saw the Blackadder juice extract impact attention processes and MAO; the aim of the 
current study is to ascertain if the positive behavioural and physiological effects of the 
Blackadder juice extract gathered can be replicated, and if they are dose and time 
dependent. A dose of the Blackadder juice extract standardised at 500mg of total 
polyphenols, which was shown to be effective at modulating both psychological and 
physiological parameters in chapter two, will again be used. Sequentially, reduced 
doses of the extract standardised at 250mg of total polyphenols and 125mg of total 
polyphenols will also be assessed. The first cognitive assessment will begin 60 minutes 
post-dose, the same time point as chapter one. A second cognitive assessment will 
then be implemented 150 minutes post-dose. One hundred and fifty minutes is a time 
point where MAO was shown to be inhibited by 96% in chapter two, and a time point 
where a secondary peak of potentially bioactive metabolites of flavonoid compounds 
re-emerge in the blood stream (Jin et al., 2011). Secondly, the results from study one 
will be expanded by exploring memory paradigms shown to be sensitive to flavonoid 
supplementation in animal models and aged human trials as discussed in this section. 
Specifically these will include verbal, spatial and working memory, memory span and 
psychomotor performance. A final aim is to ascertain if supplementation of levels of 
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flavonoids from a blackcurrant extract, with levels of anthocyanins high enough to be 
quantified in plasma, can have an effect upon blood plasma FRAP. 
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3.2 Materials and methods 
3.2.2 Design 
The project investigated the acute effects on cognitive function, neuroendocrinology 
and mood of a single consumption of three blackcurrant drinks with varying levels of 
berry polyphenols versus a sugar, flavour, volume and appearance matched control. 
The study followed a double-blind, counterbalanced, placebo controlled, repeated 
measures design. Participants were randomly allocated to treatment orders as selected 
through a Williams Latin Square (Williams, 1949). 
 
3.2.3 Participants 
Forty healthy adults were recruited for the study, of these, 32 completed all study days 
(14 male, 18 female). Demographical information for the 32 participants who completed 
all study days can be found in table 3.1 
 
 
 
 
Participants were recruited using opportunity sampling from Northumbria University. 
Participants received £80 to recompense them for any expense they may have 
incurred during participation in the trial. Before potential participants were enrolled in 
the study, they attended a 90 minute training session. During this training session, 
participants gave their signed consent to participate in the study and were screened for 
any contraindications to the study, with the use of an exclusion questionnaire (see 
appendix I). In brief, all participants reported themselves to be healthy, not pregnant, 
non-tobacco users. Participants were not using dietary supplements or over the 
counter or recreational drugs (excluding the contrac eptive pill), did not have any 
sensitivities to any of the study treatments and had a body mass index below 35kg/m2. 
Participants then completed three repetitions of the study day tasks to ensure they met 
Table 3.1 Mean participant characteristics   
Measure 
Average 
measurement 
SD Range 
Age (Years) 21 3.61 18-35 
Height (m) 1.7 0.09 1.53-1.89 
Mass (kg) 67.37 9.72 50.4-90 
BMI (m
2
) 23.05 2.37 18-35 
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the required minimum standards on cognitive tasks to participate in the study and to 
reduce the likelihood of practice effects. 
 
The study received ethical approval from the Northumbria University School of Life 
Sciences Ethics Committee and was conducted according to the Declaration of 
Helsinki (1964).  
 
3.2.4 Treatments 
The Blackadder juice which was given to participants in chapter two was again used in 
this present study. This juice was processed from the same cultivar of berry, but from a 
different year (one year later) (Blackadder cultivar, cultivated and processed in 2011 by 
Plant and Food Research Ltd, New Zealand). The crude Blackadder juice extract is a 
cold pressed crude juiced extract yielding approximately 100ml of juice containing 
~500mg of polyphenols per 135g of fresh fruit. The Blackadder cultivar was juiced at 
Massey University, Palmerston North, New Zealand by the food solution team at PFR. 
The juice extract was then sent to Assure Quality Ltd, Auckland, New Zealand to be 
microbiologically tested. The juice extract was declared fit for human consumption. 
 
Participants received four drinks with a one week washout period in between 
treatments. These drinks contained either; 0mg of polyphenols (control), 125mg, 
250mg or 500mg of total polyphenols in the form of a cold pressed blackcurrant juice 
drink. In each case, drinks were comprised of 3.44g of glucose, 4.63g of fructose, 0.8g 
of sucrose, 6g of Splenda® and 50ml of an inert synthetic blackcurrant flavouring 
(blackcurrant flavour cordial, Schweppes, UK). The total volume of the drink was made 
up to 200ml with water. All quantities discussed are based on a 60kg person, drink 
quantities were calculated per kilo of body weight. The phytochemical breakdown of 
study drinks can be found in tables 3.2 and 3.3.  
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Table 3.2 Anthocyanins and other phenolic compounds in each of the treatment 
conditions (mg per 60kg of bodyweight) 
Treatment 
Anthocyanins 
mg/60kg b.w 
Other phenolics 
mg/60kg b.w 
Total phenolics 
mg/60kg b.w 
Control 0 0 0 
125mg 92.96 32.03 125 
250mg 184.04 65.95 250 
500mg 372.80 127.19 500 
 
Table 3.3 Anthocyanins and other phenolic compounds in each of the treatment conditions.(mg per kilo of body weight, average dose 
given (mg) and dose range (mg))  
Treatment 
Anthocyanins 
(mg/kg) 
Anthocyanin 
average dose 
(mg) 
Dose 
Range (mg) 
Other 
polyphenols 
(mg/kg) 
Other 
polyphenols 
average dose 
(mg) 
Dose 
range 
(mg) 
total 
polyphenols 
(mg/kg) 
Total 
polyphenols 
average 
dose (mg) 
Dose 
range 
(mg) 
Control 0 0 0 0 0 0 0 0 0 
125mg 1.54 103.74 77-138 0.53 35.71 26-47 2.08 140.1 105-187 
250mg 3.06 206.15 154-275 1.09 73.43 54-98 4.16 280.2 209-374 
500mg 6.21 418.36 312-558 2.11 142.1 106-189 8.33 561.1 419-749 
 
3.2.5 Cognitive tasks 
All cognitive measures and mood scales were delivered using the Computerised 
Mental Performance Assessment System (COMPASS) described in chapter two. Task 
stimuli were responded to using a peripheral response box (Cedrus RB-530) as shown 
below in figure 3.1. In order to assess the robustness of the effects of the Blackadder 
juice extract upon digit vigilance as outlined in chapter two, the digit vigilance task was 
combined with several cognitive tasks and repeated in a fashion similar to that of 
chapter two. Differences in the speed of the stimuli in the digit vigilance task were also 
investigated to assess whether increases in cognitive demand affect task performance. 
Other cognitive tasks focused upon paradigms shown to be sensitive to flavonoid 
supplementation in animal models and aged human trials discussed in section 3.1. 
Specifically, verbal, spatial and working memory, memory span and psychomotor 
performance. 
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Figure 3.1 Peripheral response box configuration used by participants to respond to stimuli during computerised 
cognitive tasks. 
 
3.2.5.1 Dual task: A dual task was used to incite a performance deficit in individuals 
who otherwise may be performing at levels near to their peak. This creates the 
opportunity for any facilitation by the intervention drinks to become apparent. Motor 
movement and verbal learning memory were assessed with the use of the dual task. 
Participants were played 20 words through a set of headphones whilst tracking an * 
around the computer screen with an optical mouse. Participants were asked to 
memorise as many of the words as possible whist keeping the mouse cursor as close 
to the tracking stimulus as they could. The task lasted for 60 seconds. Participants 
were advised to complete both tasks to the best of their ability with no advice given to 
prioritise one task over the other. 
 
3.2.5.2 Immediate word recall: The participant was given 60 seconds to write down 
as many of the words presented during the dual task as possible. The number of words 
correctly recalled was recorded as a percentage of the total possible. 
YESNo
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3.2.5.3 Digit vigilance slow: A target digit was randomly selected and constantly 
displayed to the right of the screen. A series of digits were presented in the left of the 
screen at the rate of 80/ per minute and the participant was required to press the centre 
button on the peripheral response box as quickly as possible every time the digit in the 
series matched the target digit. The task lasted two minutes and there were 30 
stimulus-target matches. Task measures were accuracy (%), reaction time (msec) and 
number of incorrect responses (False Alarms). 
 
3.2.5.4 Digit vigilance fast: The task is the same as digit vigilance slow task outlined 
above and used in chapter two, however, digits were presented in the left of the screen 
at the rate of 150/ per minute. This increase in the speed of  the stimulus increases the 
cognitive demand of the task, therefore,  placing a greater demand upon the attention 
of the participant. Task measures were accuracy (%), reaction time (msec) and number 
of incorrect responses. 
 
3.2.5.5 Corsi blocks: A computerised adaptation of the Corsi blocks (Miner, 1971) 
task was used to assess visuo-spatial working memory. Nine blue squares were 
presented on a black background screen. The blue squares then changed to red and 
back to blue in a random sequence. Participants were asked to follow the sequence 
and respond via a mouse click. The task began at level four with four of the nine blue 
squares lighting up in sequence, and was repeated five times at each level. Task 
difficulty increased in increments with the number of blue squares lighting up as the 
levels increased. The task ended if the participant did not correctly recall 3 or more 
sequences on a level. The task was scored as span score derived from the average of 
the last 3 correctly completed trials. 
 
3.2.5.6 Telephone number task: The telephone number task assesses working 
memory using an array of digits. The participant was shown a random 9 digit number 
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on the computer screen for 10 seconds. This number then disappeared from the 
screen for 5 seconds before a key pad appeared on the screen for the participant to 
type in the number which was previously presented, using the mouse. There were 10 
presentations of numbers. The task was scored as average time to complete a 
sequence and the number of correct nine digit number entries presented as a 
percentage of the total possible correct recalls.   
 
3.2.5.7 Three back: The N-Back task is one of the most popular working memory 
tasked used to invoke brain activation in fMRI studies (Owen et al., 2005). The N-back 
task is a useful tool for assessing inter-individual differences in working memory 
(Jaeggi et al., 2010). Participants were presented with a series of letters appearing on 
the computer screen one at a time. Participants were asked to respond using the “yes” 
or “no” button on the response pad if the letter on the screen was presented 3 letters 
previously. There were 45 letter presentations with 15 target stimuli. The task was 
scored as a percentage number of correct responses and overall reaction time (msec). 
 
3.2.5.8 Simple reaction time: The participant was instructed to press the response 
button as quickly as possible every time an arrow was presented on the screen. Fifty 
stimuli were presented with an inter-stimulus interval that varied randomly between 1 
and 3.5 seconds. Reaction times were recorded in msec. 
 
3.2.5.9 Delayed word recall: The participant was given 60 seconds to write down as 
many of the words presented during the dual task as possible. The number of words 
correctly recalled was recorded as a percentage of the total possible.  
 
3.2.5.10 Word recognition: The 20 words which were presented during the dual task 
and 20 unique distracter words were presented on the computer monitor. Words were 
presented individually and randomly. The participant was asked to respond using the 
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“yes” button on the computer keyboard if the word had been presented during the dual 
task and the “no” button if it had not. The word remained on the screen until the 
participant responded. The number of words correctly recalled was recorded as a 
percentage of the total possible and incorrect responses were recorded as the error. 
Overall reaction time was also recorded. 
 
3.2.6 Mood 
3.2.6.1 Bond-Lader visual analogue scales: The scales comprise of a total of sixteen 
100mm lines anchored at either end by antonyms (e.g. alert-drowsy, calm-excited, etc.) 
on which participants mark their current subjective position. Scores from the 16 Bond-
Lader visual analogue scales were combined as recommended by the authors to form 
three mood factors: ‘alert’, ‘calm’ and ‘content’ (Bond & Lader. 1974). 
 
3.2.6.2 Visual analogue scales: Participants were asked to subjectively rate how 
difficult they perceived the tasks and how mentally energised, physically energised and 
motivated they felt. Visual analogue scales were displayed electronically at the end of 
every set of tasks. The scale was anchored “Not at all” on the left of the scale and 
“extremely” on the right. 
 
3.2.6.3 State anxiety questionnaire The State-Trait Anxiety Inventory (STAI) is a 
commonly used measure of trait and state anxiety (Spielberger Cd, 1970). It is a 40 
item scale which indicates the intensity of feelings of anxiety, distinguishing between 
state anxiety and trait anxiety. In the case of the present study, only the state (Y1) 
section of the inventory was used to assess changes in mood state.  
 
The order of tasks in the baseline and post-dose cognitive assessments can be seen in 
figure 3.2a and 3.2b.  
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                Figure 3.2b 
 
Figure 3.2 The order of tasks in the baseline cognitive assessment (3.2a) and the post-dose cognitive assessment 
(3.2b). VAS=Visual analogue scale  
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3.2.6 Blood analysis 
Venous blood samples (2x5ml) were collected at baseline and 120 minutes after 
supplementation of treatments. Samples were collected in 5ml BD vacutainers© 
(Becton, Dickinson and company). Both receptacles were treated with anticoagulants, 
one with lithium heparin (LH) and one with ethylenediaminetetraacetic acid (EDTA). 
 
Whole blood samples treated with LH and EDTA were prepared for storage using the 
methods described in section 2.2.5 Prepared samples were stored at -80ºC until 
analysis was performed.  
 
3.2.6.1 Monoamine oxidase-B activity 
A subsection of eight participants were analysed for MAO-B activity. Isolated platelet 
pellets were tested for MAO-B activity using the same methods as described in section 
2.2.5.1.  
 
3.2.6.2 Prolactin analysis 
A subsection of nine participants were analysed for prolactin analysis. Analysis was 
conducted as described in section 2.2.5.4. 
 
3.2.6.3 Ferric reducing antioxidant power assay 
The ferric reducing/antioxidant power (FRAP) assay is a direct measure of the total 
antioxidant potential of a sample (Benzie & Strain, 1996). At low pH, ferric iron (Fe3+) is 
converted to its ferrous form (Fe2+); this chemical reaction results in the formation of a 
blue colour to the solution. (Benzie & Strain, 1996). The intensity of this blue colour is 
proportional to the antioxidant capacity of the sample. The method measures 
absorbance at 593nm. FRAP results are only based on the antioxidant reducing 
potential of the ferric ion, and not the antioxidant preventative effect. Full methods can 
be seen in appendix VI. 
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3.2.7 Procedures 
Each participant was required to attend a total of four study days conducted at least 7 
days apart, to ensure a sufficient wash out between conditions. Cognitive testing took 
place in a laboratory with participants visually and auditorally isolated from each other. 
On arrival at their first session, participants were randomly allocated to a treatment 
regime using a Latin square design that counterbalanced the order of treatments 
across the three active days of the study. On all 4 testing days participants arrived at 
the lab in the morning (8:00am), after a 12 hour overnight fast, and firstly completed 
one repetition of the baseline COMPASS computerised cognitive assessment (figure 
3.2a). Participants then gave a 10mL baseline venous blood sample taken by a trained 
phlebotomist. They were then orally supplemented with treatment in the form of a 
single serve juice drink (200ml per 60kg weight) and asked to sit and watch TV or read 
quietly in a designated waiting room during a 60 minute resting absorption period. Sixty 
minutes after supplementation, the first post-dose state anxiety questionnaire was 
completed followed by the first post-dose COMPASS assessment (figure 3.2b). After 
completion of the assessment (120 minutes post-dose), participants immediately gave 
a second 10 ml venous blood sample. The blood sample was taken 120 minutes post-
dose and not 150 minutes post-dose as in chapter two of this thesis to limit any impact 
of venepuncture upon the second cognitive assessment. Participants were then given a 
30 minute break before completing a final post-dose state anxiety questionnaire and 
the second post-dose COMPASS assessment. Participants were then free to leave. A 
diagram of the study visit running order can be seen in figure 3.3.  
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Figure 3.3 Study day running order (minutes). CRF=Case report form. 
 
3.4 Statistical analysis  
Mood, cognitive scores and the physiological measures were analysed as ‘change from 
baseline’ using the SPSS statistics package. The null hypothesis was rejected with a p 
value <0.05. Baseline differences were calculated for all measures using a one way 
(treatment) ANOVA. 
 
Repeated measures ANOVAs (General linear model) (Treatment [control, 125mg, 
250mg and 500mg] × assessment [1 to 2] × completion [1 to 4] for digit vigilance and 
VAS OR treatment [control, 125mg, 250mg and 500mg] × assessment [1 to 2] for 
Bond-Lader and all other cognitive assessments conducted). Plasma FRAP levels, 
platelet MAO-B and prolactin were analysed by one-way (treatment) repeated 
measures ANOVA. Mauchly`s test of sphericity was used to assess equality of 
the variances of the differences between factors. Where sphericity had been violated, 
Huynh-Feldt corrections for non-sphericity were implemented. Post hoc comparisons 
(pairwise) were used where the initial ANOVA revealed a p value <0.05 to ascertain 
any differences between treatments for the whole session, at each assessment and at 
each task repetition. Partial Bonferroni corrections were used to protect for error 
against multiple comparisons and, therefore, the p value was multiplied by the number 
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of treatments being compared to control (5 for MAO, PRL and FRAP, 3 for all other 
outcomes). Adjusted p values are reported. 
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3.5 Results 
Prior to analysis of change from baseline data, mean pre-dose scores for all four 
treatments (control, 125mg, 250mg and 500mg) for each outcome were subjected to a 
one way repeated measures ANOVA. There were no significant differences found 
between any variables at baseline. 
 
3.5.1 Cognitive performance  
Mean pre-dose baseline and change from baseline scores for each behavioural 
condition and all ANOVA outcomes are presented in tables 3.4a, 34b, 3.5a, 3.6a and 
3.6b. Significant differences are presented in figure 3.3. Unchanged “raw” data tables 
can be found in appendix X. Only ANOVA results for behavioural measures which 
generated significant effects are reported below. 
 
 
113 
 
Table 3.4a  Mean pre-dose baseline and change from baseline scores, standard deviations for the digit vigilance physiological parameter over the two measured assessments 
Measure N Treatment 
Baseline 
Session 1 (60 minutes) Session 2 (150 minutes) 
Repetition 1 Repetition 2 Repetition 3 Repetition 4 Repetition 1 Repetition 2 Repetition 3 Repetition 3 
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Digit vigilance accuracy (%) 28 
Control 97.48 2.78 -0.24 3.05 -0.16 5.09 -3.89 8.37 -4.45 8.99 -4.29 11.91 -2.55 8.36 -1.59 4.23 -2.54 5.53 
125mg 97.11 3.46 -0.08 4.55 -2.06 4.23 -4.52 7.25 -3.10 6.91 -2.70 6.12 -5.24 8.93 -5.40 7.24 -6.67 10.37 
250mg 97.63 2.40 -1.27 4.12 -3.25 6.44 -2.70 5.07 -5.00 7.97 -1.91 4.94 -3.25 6.15 -4.76 8.74 -3.57 7.87 
500mg 96.37 5.99 -0.24 7.01 -2.78 7.83 -5.08 7.95 -2.78 5.53 0.00 7.11 -1.19 9.04 -3.73 8.55 -2.38 7.13 
Digit vigilance false alarms (Number) 28 
Control 0.03 0.18 0.00 0.27 -0.04 0.19 -0.04 0.19 -0.04 0.19 -0.04 0.19 -0.04 0.19 -0.04 0.19 0.07 0.38 
125mg 0.00 0.00 0.04 0.19 0.07 0.38 0.00 0.00 0.00 0.00 0.04 0.19 0.04 0.19 0.00 0.00 0.04 0.19 
250mg 0.03 0.18 -0.04 0.19 0.00 0.27 -0.04 0.19 0.00 0.27 0.00 0.27 0.00 0.27 -0.04 0.19 0.00 0.27 
500mg 0.00 0.00 0.04 0.19 0.04 0.19 0.04 0.19 0.00 0.00 0.00 0.00 0.07 0.38 0.14 0.45 0.04 0.19 
Digit vigilance reaction time (msec) 28 
Control 397.2 33.65 7.67 22.01 26.52 31.20 30.16 25.66 35.97 33.23 15.18 28.17 24.07 34.77 29.13 31.86 24.87 31.05 
125mg 404.9 33.11 3.23 32.94 25.05 32.13 33.94 33.17 35.55 36.84 9.25 32.37 18.91 33.29 32.43 31.99 39.32 42.77 
250mg 397.2 29.80 8.04 22.46 21.39 27.26 26.51 31.35 31.83 32.85 14.58 27.93 22.08 29.42 29.62 33.61 31.03 38.21 
500mg 405. 7 38.13 13.84 21.44 26.67 24.40 29.64 30.64 40.39 36.12 21.39 28.42 29.07 32.01 34.88 26.37 35.10 31.32 
Digit vigilance fast accuracy (%) 29 
Control 93.19 7.14 0.23 7.26 -2.22 7.70 -4.14 8.81 -4.21 8.59 0.31 7.02 0.54 6.99 -2.99 11.75 -2.68 10.05 
125mg 92.69 6.72 -1.53 4.57 -3.30 7.02 -8.05 12.03 -8.97 12.76 -2.68 5.89 -4.06 5.82 -3.99 7.69 -5.52 8.20 
250mg 93.84 6.51 -3.14 10.47 -5.90 6.27 -7.66 10.83 -7.66 10.93 -4.67 5.61 -4.67 6.99 -6.36 11.54 -5.75 8.56 
500mg 91.83 7.96 -1.61 9.14 -2.99 10.59 -5.36 11.13 -4.67 14.17 -0.31 7.10 -1.99 8.64 -4.60 9.12 -2.45 10.17 
Digit vigilance fast false alarms (Number) 29 
Control 1.71 1.99 0.00 1.73 0.07 2.45 0.41 2.13 0.62 2.23 0.07 2.39 0.17 1.83 1.10 2.64 0.86 2.50 
125mg 3.19 8.78 0.00 1.79 -0.24 1.77 1.10 2.35 0.34 2.06 0.62 2.19 0.45 2.47 -0.03 1.92 0.10 1.97 
250mg 1.84 1.93 -0.03 2.35 0.17 2.21 0.62 2.44 0.34 2.04 -0.17 2.04 0.31 1.81 0.69 2.65 0.48 2.59 
500mg 1.71 1.60 -0.28 1.85 0.41 2.16 0.69 2.12 0.28 1.94 -0.24 2.15 0.28 1.94 0.69 2.42 1.07 1.98 
Digit vigilance fast reaction time (msec) 29 
Control 427.6 33.61 1.77 26.36 15.36 29.37 22.84 33.88 30.47 36.78 -0.68 31.53 9.77 32.53 15.87 33.48 13.55 29.45 
125mg 428.2 34.52 5.10 25.34 22.90 41.06 28.09 40.88 33.31 40.21 11.16 34.57 12.38 39.16 25.66 41.63 28.99 35.26 
250mg 422.7 31.95 10.16 29.80 30.37 34.64 28.03 28.01 32.08 38.91 15.09 28.57 22.09 31.35 22.95 32.13 22.46 31.78 
500mg 425.0 33.97 11.61 35.98 28.02 32.33 37.27 37.97 35.82 39.01 16.80 26.23 29.44 32.72 28.75 26.26 31.72 33.88 
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Table 3.4b Main ANOVA and ANOVA interaction outcomes for the digit vigilance physiological parameter over the two 
measured assessments 
Measure Effect of treatment 
Treatment*repetition 
interaction 
Treatment*session 
interaction 
Digit vigilance accuracy 
 (%) 
F=1.05 p>0.1 F=0.40 p>0.1 F=2.40 p=0.09 
Digit vigilance false alarms 
(Number) 
F=1.04 p>0.1 F=1.84 p>0.1 F=0.77 p>0.1 
Digit vigilance reaction time 
(msec) 
F=0.52 p>0.1 F=0.67 p>0.1 F=0.83 p>0.1 
Digit vigilance fast accuracy 
(%) 
F=2.84 p=0.043 F=0.51 p>0.1 F=0.80 p>0.1 
Digit vigilance fast false alarms 
(Number) 
F=0.03 p>0.1 F=1.08 p>0.1 F=1.70 p>0.1 
Digit vigilance fast reaction 
time (msec) 
F=1.62 p>0.1 F=1.04 p>0.1 F=0.75 p>0.1 
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Table 3.5 Mean pre-dose baseline and change from baseline scores, standard deviations and ANOVA 
outcomes for cognitive paradigms over both measured epochs 
 
Measure N Treatment 
Baseline 
Session 1  
(60 minutes) 
Session 2 
(150 minutes) Effect of 
Treatment 
Treatment * 
session 
interaction Mean SD Mean SD Mean SD 
Simple RT 30 
Control 293.5 36.69 21.17 58.19 30.09 113.7 
F=0.90 p>0.1 F=1.27p>0.1 
125mg 301.8 52.58 46.15 154.0 1.77 58.18 
250mg 282.9 32.40 50.15 122.9 61.12 147.7 
500mg 297.2 50.67 58.25 167.4 16.92 40.98 
Corsi blocks 
span 
30 
Control 6.61 0.61 -0.19 0.66 -0.18 0.74 
F=0.50 p>0.1 F=0.79 p>0.1 
125mg 6.37 0.76 -0.04 0.88 0.01 0.91 
250mg 6.38 0.70 -0.29 0.94 -0.24 0.85 
500mg 6.29 0.76 -0.07 0.99 -0.21 0.92 
3-back % correct 30 
Control 89.93 7.69 -1.41 6.92 2.07 8.13 
F=0.25 p>0.1 F=0.92 p>0.1 
125mg 89.19 7.78 -0.22 6.61 0.52 5.91 
250mg 90.22 7.84 -0.96 7.71 -0.52 7.69 
500mg 89.71 6.64 -1.71 8.33 0.07 7.14 
3-back missed 
sequences 
30 
Control 0.43 0.94 0.13 0.57 -0.03 0.56 
F=0.67 p>0.1 F=0.40 p>0.1 
125mg 0.70 1.58 -0.23 1.17 -0.20 1.42 
250mg 0.50 1.04 0.10 0.66 0.00 0.53 
500mg 0.53 1.20 0.30 2.42 -0.03 1.13 
3-back reaction 
time 
30 
Control 652.7 189.1 -31.12 119.9 -57.41 126.8 
F=0.40 p>0.1 F=0.28 p>0.1 
125mg 612.7 195.7 -16.07 82.90 -30.29 98.08 
250mg 642.7 193.3 -56.07 90.78 -29.14 92.78 
500mg 630.3 177.7 -35.42 111.9 -39.49 92.81 
Telephone % 
correct 
31 
Control 38.33 26.25 6.67 26.82 12.50 22.50 
F2.09 p>0.1 F=0.21 p>0.1 
125mg 42.92 27.01 2.08 24.80 4.17 22.58 
250mg 42.50 27.97 0.00 28.99 0.00 27.27 
500mg 42.92 23.37 -0.42 24.45 -6.67 19.35 
Telephone 
reaction time 
32 
Control 6397 1087 -74.99 1061 -394.4 998.6 
F=1.30 p>0.1 F=0.04 p>0.1 
125mg 6471 1484 -183.5 1046 -504.4 1133 
250mg 6434 1177 -52.84 1194 -419.2 698.1 
500mg 6776 1165 -451.2 882.1 -728.3 674.7 
Tracking 
accuracy (twips) 
30 
Control 4110 408.2 -412.6 210.7 -31.43 269.7 
F=1.43 p>0.1 F=0.46 p>0.1 
125mg 4218 421.1 -304.4 340.1 -9.38 223.5 
250mg 4169 425.1 -351.0 216.3 -62.57 216.7 
500mg 4209 448.2 -337.9 335.1 5.05 245.4 
Word recognition 
% correct 
30 
Control 74.41 11.17 -7.25 11.95 -10.17 11.39 
F=0.65 p>0.1 F=1.17 p>0.1 
125mg 74.42 8.35 -4.08 11.27 -6.17 9.49 
250mg 72.92 9.89 -4.25 15.24 -3.83 16.48 
500mg 73.58 8.63 -3.67 9.23 -9.50 10.31 
Word recognition 
reaction time 
30 
Control 1.31 0.205 0.00 0.18 -2.57 0.28 
F=0.83 p>0.1 F=1.06 p>0.1 
125mg 1.30 0.14 0.01 0.22 -2.57 0.25 
250mg 1.29 0.16 0.05 0.27 -2.52 0.33 
500mg 1.35 0.19 -0.03 0.14 -2.60 0.24 
Immediate word 
recall % correct 
32 
Control 37.73 14.10 -4.30 12.89 -3.13 13.91 
F=0.68 p>0.1 F=1.89 p>0.1 
125mg 40.78 12.69 -1.33 11.36 -8.20 11.66 
250mg 36.41 9.69 -2.97 9.01 -5.23 12.29 
500mg 35.47 12.02 -0.23 11.51 -2.73 12.37 
Immediate word 
recall error 
32 
Control 0.69 0.93 0.20 1.20 0.28 1.44 
F=1.36 p>0.1 F=1.06 p>0.1 
125mg 0.56 0.716 0.28 0.92 0.25 1.19 
250mg 0.53 0.718 0.16 0.92 0.59 1.74 
500mg 0.91 1.03 -0.34 0.97 0.03 1.38 
Delayed word 
recall % correct 
32 
Control 28.05 14.71 -11.17 12.31 -11.33 14.23 
F=1.22 p>0.1 F=1.07 p>0.1 
125mg 28.82 12.08 -6.56 12.73 -11.88 9.88 
250mg 28.05 9.22 -11.17 9.22 -14.06 14.41 
500mg 26.56 12.45 -7.42 12.39 -8.52 13.81 
Delayed word 
recall error 
32 
Control 0.687 0.78 1.05 1.50 0.88 1.26 
F=1.83 p>0.1 F=1.12 p>0.1 
125mg 0.875 1.40 0.63 1.76 0.47 1.39 
250mg 0.625 0.71 0.72 1.08 1.44 1.72 
500mg 1.00 1.41 0.31 1.71 0.50 1.65 
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Table 3.6a  Mean pre-dose baseline and change from baseline scores, standard deviations for each mood parameter over both measured assessments  
Measure N Treatment 
Baseline Session 1 (60 minutes) Session 2 (150 minutes) 
 
Repetition 1 Repetition 2 Repetition 3 Repetition 4 Repetition 1 Repetition 2 Repetition 3 Repetition 4 
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
VAS mentally energised 32 
Control 45.06 11.93 0.03 12.52 -3.84 12.06 -6.47 12.86 -6.34 12.75 2.75 10.36 -3.28 13.11 -3.09 13.81 -4.69 12.13 
125mg 46.91 11.47 1.84 13.42 -5.31 17.29 -3.75 17.12 -7.63 16.48 2.44 11.32 -1.09 13.65 0.09 14.10 -1.03 15.47 
250mg 46.13 15.55 4.75 13.04 -0.84 14.65 -1.03 11.72 -1.59 11.66 2.47 12.31 -2.25 13.51 -1.97 12.42 -2.72 10.29 
500mg 44.63 12.47 -1.44 13.84 -6.81 14.81 -7.25 16.07 -7.88 15.68 0.47 12.09 -1.34 15.09 -1.47 13.57 -2.16 16.75 
VAS motivation 32 
Control 47.88 14.66 -0.72 16.17 -4.63 13.47 -6.72 16.59 -9.03 15.85 -0.16 14.64 -3.75 16.51 -7.13 14.76 -4.94 17.44 
125mg 49.78 10.25 0.87 17.40 -4.00 13.28 -6.34 19.04 -6.03 18.85 1.53 15.91 -4.19 18.81 -3.75 18.60 -2.16 20.08 
250mg 47.56 15.96 1.69 12.45 -3.13 13.44 -6.88 11.02 -8.22 11.68 -2.47 14.49 -6.81 15.00 -9.47 13.53 -8.41 14.47 
500mg 49.50 12.56 -1.88 12.40 -5.44 12.44 -5.28 11.51 -7.22 12.68 0.16 12.11 -0.47 13.04 -1.63 14.22 -1.81 14.25 
VAS physically energised 32 
Control 48.97 13.05 -0.59 11.44 -3.78 12.70 -7.19 13.24 -7.13 13.34 1.03 11.10 -2.94 12.50 -3.69 12.29 -4.13 13.41 
125mg 49.31 11.03 1.25 11.39 -3.66 12.61 -3.09 15.33 -5.56 13.77 1.41 11.72 -1.56 11.77 0.16 15.20 1.34 16.89 
250mg 45.47 13.35 1.44 14.97 -0.38 12.36 -1.16 15.38 -4.22 14.14 -0.34 11.24 -2.09 12.83 -2.63 14.52 -5.00 12.70 
500mg 46.81 11.80 -1.59 8.84 -6.72 12.61 -5.75 12.35 -7.69 13.13 -1.44 9.98 -1.00 10.90 -0.66 13.29 -3.69 11.87 
STA-I 32 
Control 31.31 1.32 -0.13 0.47 2.09 0.85 0.06 0.72 2.09 1.00 
 
125mg 32.10 1.23 -0.10 0.77 1.52 0.70 -0.07 0.84 0.80 0.93 
250mg 31.53 1.13 -0.53 0.74 1.66 0.90 0.00 0.97 1.09 1.15 
500mg 31.31 1.32 -1.27 0.59 1.97 0.87 -0.55 0.73 .900 1.06 
Bond-Lader calm 32 
Control 62.84 11.71 -4.95 9.26 -3.91 9.08 -2.86 10.24 -4.25 13.70 
125mg 62.97 11.44 -1.47 8.73 -0.55 8.73 -1.48 11.08 -3.39 7.98 
250mg 64.23 10.80 -5.89 7.45 -2.89 9.16 -4.75 10.55 -2.89 9.76 
500mg 63.34 11.69 -1.39 9.47 -0.67 9.01 -1.61 11.04 -3.02 9.41 
Bond-Lader content 32 
Control 61.99 13.51 -0.73 6.37 -3.86 8.75 -0.03 7.72 -0.84 7.72 
125mg 62.41 12.73 0.20 7.36 -1.75 8.42 1.08 10.44 1.11 9.68 
250mg 63.54 12.73 -1.99 6.16 -3.04 5.96 -1.84 7.24 -2.37 7.47 
500mg 63.15 11.37 1.09 7.45 -1.48 7.67 0.82 6.73 -0.78 7.97 
Bond-Lader alert 32 
Control 52.89 13.57 1.73 8.98 -6.92 13.61 0.49 9.81 -4.53 10.36 
125mg 55.73 12.32 1.63 9.82 -7.94 14.07 -0.06 12.60 -3.16 13.81 
250mg 53.53 14.71 1.11 9.21 -6.96 9.43 -1.29 8.76 -8.62 11.02 
500mg 51.63 11.24 1.03 9.10 -6.93 12.65 0.85 8.67 -1.57 12.98 
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Table 3.6b Main ANOVA and ANOVA interaction outcomes for each mood parameter over both measured treatments 
Measure 
Effect of 
treatment 
Treatment*repetition interaction Treatment*session interaction 
VAS mentally energised F=0.61 p>0.1 F=1.43 p>0.1 F=1.57 p>0.05 
VAS motivation F=0.51 p>0.1 F=1.34 p>0.1 F=0.29 p>0.05 
VAS physically energised F=0.69 p>0.1 F=1.29 p>0.1 F=1.573 p>0.05 
Bond-Lader calm F=1.24 p>0.1 F=1.56 p>0.1 F=0.92 p>0.05 
Bond-Lader content F=1.10 p>0.1 F=0.87 p>0.1 F=0.81 p>0.05 
Bond-Lader alert F=0.50 p>0.1 F=0.80 p>0.1 F=1.38 p>0.05 
STAI F=0.252 p>0.1 
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3.5.1.1 Digit vigilance fast 
The repeated measures ANOVA revealed an overall treatment effect on digit vigilance 
accuracy [F (3,28)=2.843, p=0.04]. Post hoc comparisons revealed a significant 
reduction (p=0.04) in accuracy after supplementation of the 250mg treatment when 
compared to control. A graphical representation can be seen in figure 3.4. 
 
Figure 3.4. Change from baseline scores for digit vigilance accuracy during cognitive testing sessions 1 (1-4) and 2 (5-
8). There was a main effect of treatment, therefore no individual repetitions are highlighted. 
 
 
3.5.2 Physiological parameters 
Mean pre-dose baseline and change from baseline scores for each physiological 
condition are presented in table 3.5 and significant differences are presented in figure 
3.4. Unchanged “raw” data tables can be found in appendix X. Only ANOVA results for 
physiological measures which generated significant effects, are reported below. 
Table 3.5 Mean pre-dose baseline and change from baseline scores, standard deviations and main ANOVA outcomes 
for each physiological parameter over both measured epochs  
Measure N Treatment 
Baseline Post Dose 
Effect of treatment 
Mean SD Mean SD 
Platelet MAO-B 8 
Control 2517 1556 -532.1 856.1 
F=5.63 p=0.005 
125mg 2391 1600 -1323 1219 
250mg 2366 1897 -1502 905.4 
500mg 2276 1319 -1369 1053 
FRAP 10 
Control 859.9 110.7 72.98 73.78 
F=0.91 p>0.1 
125mg 917.7 113.1 -13.17 26.45 
250mg 843.5 124.9 -20.84 23.50 
500mg 873.2 105.7 3.48 18.68 
Prolactin 9 
Control 340.4 187.1 -123.7 161.5 
F=7.93 p=0.003 
125mg 367.4 158.7 -179.7 108.3 
250mg 325.9 124.2 -147.9 95.82 
500mg 357.1 116.3 -197.8 91.91 
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3.5.2.1 MAO-B 
There was a significant main effect of treatment on blood platelet MAO-B activity 
[F(1.3,10.8)=8.93, p=0.009]. Post hoc comparisons showed significantly reduced MAO-
B activity after supplementation of the 250mg (p=0.008) and 500mg (p=0.02) study 
treatments and a trend reduction after supplementation of the 125mg (p=0.094) study 
treatment compared to control. Blackcurrant treatments were not significantly different 
to each other. See figure 3.4a. 
 
3.5.2.2 Prolactin 
The repeated measures ANOVA revealed an overall treatment effect [F 
(2.52,17.64)=7.29, p=0.003]. After corrections for multiple comparisons, post hoc 
comparisons revealed a significant reduction in blood plasma prolactin levels after 
supplementation of the 500mg (p=0.006) and the 125mg treatment (p=0.03) when 
compared to control. See figure 3.5b. 
 
Figure 3.5 Change from baseline scores for platelet MAO-B activity (a) and plasma prolactin levels (b) 120 minutes post 
supplementation. 
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3.6 Discussion and conclusion. 
The current study assessed the effect of the three Blackadder treatment interventions 
upon several different aspects of memory, which have been shown to be sensitive to 
nutritional interventions in both human and animal models after supplementation of 
berry extracts. Retrieval memory, working memory, visuo-spatial working memory and 
memory span, as well as verbal learning memory were assessed 1 hour and 2.5 hours 
post-supplementation. None of these were significantly affected by any intervention 
dose at either post-dose cognitive assessment. From the array of cognitive tasks 
utilised in the present study, spatial and retrieval memory have previously been shown 
to be impacted in humans by flavonoid-rich extracts, albeit not in blackcurrant form 
(Pipingas et al., 2008; Ryan et al., 2008; Krikorian et al., 2010a; 2010b). Other memory 
outcomes assessed had previously proven sensitive to interventions in animal models 
(Casadesus et al., 2004; Ramirez et al., 2005; Wang et al., 2006; Van Praag et al., 
2007; Williams et al., 2008). This literature, both in humans and animal models, 
surrounding the modulation of memory after supplementation of berry constituents is, 
however, focused upon aged animal models and humans; with all results pertaining to 
modulations of cognitive behaviour after chronic supplementation. It is, therefore, 
hypothesised that the lack of behavioural effects could be associated with the age of 
the cohort used in the present study. It is probable that these healthy adult participants 
were already performing near to their peak (Salthouse, 2009). However, the 
improvement in digit vigilance response times found in chapter two, one hour post 
supplementation of the Blackadder juice, was not replicated in the present study. In 
fact, a reduction in accuracy was noted on the fast version of this task following 250mg. 
It is important to note that there are differences between the paradigms used in studies 
one and two of this thesis with different tasks preceding each repetition of the digit 
vigilance task; however, the lack of improvements in the current study suggests that 
the effects of blackcurrants in this population may be subtle or non-existent. It is 
possible that these effects are only seen under demanding conditions, outlining the 
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need for a longer and more demanding cognitive battery or an older study cohort 
before any positive modulations are exhibited.  
 
The reductions in platelet MAO-B activity reported in chapter two were replicated in the 
present study. All blackcurrant drinks reduced MAO-B activity compared to placebo 
with 250mg and 500mg treatments inhibiting by ~ 80% and the 125mg treatment 
reducing activity by 68%, with the control showing a reduction of 22%. The lack of a 
clear dose response is most likely due to the small differences in doses used but there 
is potential that this dose response is affected by the type of inhibition. Although the 
measurement of inhibition type is out of the remit of the thesis, data outlined by 
(Dreiseitel et al., 2009a) suggest that anthocyanins inhibit the MAO enzyme 
competitively, where the inhibiting compound acts as the enzyme substrate and binds 
directly to the site of action, allowing endogenous ligands to displace the active inhibitor 
competitively. If this was the case, it would be expected that the dose response in the 
present study would be greater. Instead, it is theorised that the inhibition is non-
competitive, where, rather than binding to MAO enzyme at the site of action, the 
inhibiting compound instead changes the shape of the enzyme so it is only influenced 
by the concentration of the inhibiting compound and not concentrations of substrates. 
This is a factor which requires more attention to establish an IC50 of the blackcurrant 
extract. In chapter two, the inhibition of platelet MAO-B was ~96% at 150 minutes post 
supplementation, potentially outlining that the full effects of the treatment on MAO are 
not being seen at the 120 minute time point used in the current study. 
 
To further investigate non-significant findings upon prolactin after consumption of the 
Blackadder blackcurrant extract in study one, plasma prolactin was again measured, 
this time in a larger cohort utilising a within subjects design. Prolactin was reduced after 
supplementation of all of the blackcurrant drinks, but only reaching statistical 
significance after the 125mg (48%) and 500mg (55.5%) blackcurrant drinks. The 
 
 
122 
 
reason for the inability of the 250mg treatment to significantly reduce prolactin is 
unknown; nevertheless, there was a non-significant (45.2%) reduction from baseline 
blood plasma level following 250mg, a reduction of 10% when compared to control. 
The 55.5% reduction following the 500mg drink is a 20% reduction when compared to 
placebo. As the predominant control of prolactin secretion into plasma is via 
hypothalamic inhibition of lactotroph activity (Ben-Jonathan & Hnasko, 2001) and the 
most important hypothalamic prolactin inhibiting factor is dopamine, this reduction in 
prolactin possibly indicates an increase in central dopaminergic tone after the 
supplementation of the blackcurrant drinks. Therefore, potentially outlining a 
therapeutic impact upon symptoms of neuro-degenerative disease. In order to indirectly 
measure the dose effects of the Blackadder juice extract upon MAO-A, it would have 
been beneficial to assess the effects of different doses of the study treatments upon 
plasma DHPG which was shown to be increased in chapter two of this thesis. This 
was, however, out of the remit of the current study.  
 
Results from the current study showed that there were no significant reductions in 
plasma FRAP after any dose of the Blackadder blackcurrant extract 120 minutes post 
supplementation. The purpose of measuring the plasma FRAP activity in the present 
study was not only to assess the juice’s direct potential to protect against reactive 
oxygen species and reduce oxidative stress, but to assess if the reductions in MAO-B 
activity, which are associated with deamination of amines producing H2O2 (Pizzinat et 
al., 1999), could cause an indirect effect upon FRAP. Results reported by Jin et al., 
(2011) showed no effects of a 20% blackcurrant upon blood plasma FRAP. However, 
they  used a much lower dose of blackcurrant and found no major berry constituents in 
blood plasma, whereas, anthocyanins were shown to be absorbed and measurable in 
plasma after consumption of the juice treatment in chapter two of this thesis. No effect 
upon FRAP has also been reported after consumption of a 500ml blueberry extract 
(Pedersen et al., 2000). 
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In conclusion, the findings of the present study do not suggest that supplementation of 
the blackcurrant juice acutely modulates measured memory or attention paradigms 1 or 
2.5 hours post-supplementation. Platelet MAO-B was, however, strongly inhibited in a 
dose responsive manner along with significant reductions in peripheral prolactin levels. 
The findings outline the need for a full time course of MAO inhibition to be established. 
Further to this, in line with human and animal data published in the literature, the 
impact of the blackcurrant extracts on an older population and outcomes pertaining to 
the attenuation of natural cognitive decline should be investigated. 
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CHAPTER 4. THE EFFECT OF THE BLACKADDER BLACKCURRANT 
JUICE EXTRACT UPON PRE-FRONTAL CORTICAL HAEMODYNAMICS IN 
HEALTHY ADULTS 
 
4.1 Introduction 
During natural ageing cerebral blood flow reduces by up to 0.5% per year (Leenders et 
al., 1990). Preservation of blood flow, including the maintenance of endothelial function 
and large artery elasticity, are inversely associated with the incidence of cardiovascular 
disease (CVD) (Targonski et al., 2003) and vascular dementia (Dede et al., 2007). 
Furthermore, epidemiological observations demonstrate that diets high in 
phytochemicals such as anthocyanins can significantly reduce incidence of CVD risk 
factors, dementia and stroke (Curin et al., 2006; He et al., 2006). There is a growing 
body of human nutritional intervention studies demonstrating the ability of fruit 
polyphenols to modulate haemodynamics in the brain (Francis et al., 2006; Kennedy et 
al., 2010; Krikorian et al., 2012; Wightman et al., 2012) and in the periphery 
(Matsumoto et al., 2005a; Matsumoto et al., 2005b). Regulation of blood flow, 
especially within the human brain, is complex, with multiple overlapping regulatory 
paradigms and key structural components, such as, cerebral pressure auto-regulation, 
flow metabolism coupling and neurogenic regulation (Peterson et al., 2011). Recent 
human intervention studies focusing upon cerebral blood flow and cognitive activities 
postulate increases or decreases in blood flow to levels of nitric oxide (Kennedy et al., 
2010; Wightman et al., 2012). As discussed in section 1.4.2, berry constituents have 
been shown to up-regulate eNOS (Andriambeloson et al., 1998) and inhibit iNOS 
(Chen et al., 2001), however, there is no data published detailing their effects upon 
neuronal nitric oxide synthase (nNOS), manipulation of which, is essential if changes in 
cerebral flow post-intervention are to been seen (Santizo et al., 2000; Kitaura et al., 
2007). All published human intervention studies pertaining to blackcurrants and blood 
flow have focused upon peripheral blood flow modulation with varying outcomes being 
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reported. For example, significant increases in skin blood circulation have been 
observed after supplementing eight females with 140mg of blackcurrant polyphenols, 
containing 50mg of anthocyanins (Matsumoto et al., 2005a). The same author also 
found that supplementing 17mg/kg of body weight of blackcurrant polyphenols 
increased peripheral blood flow and reduced shoulder stiffness during typing 
(Matsumoto et al., 2005b). In contrast, no effect was found using flow mediated dilation 
on peripheral blood flow after supplementation of a 20% blackcurrant drink (Jin et al., 
2011).  
 
Near Infrared Spectroscopy (NIRS) is a neuro-imaging tool which is used both clinically 
(Weber et al., 2007) and in nutritional intervention studies (Kennedy et al., 2010; 
Kennedy & Haskell, 2011) to assess the oxygen status of superficial cortical blood flow 
of human subjects at various stages of life. NIRS has been shown to be sensitive to 
age (Safonova et al., 2004; Herrmann et al., 2006) and pharmacological interventions 
(Bönöczk et al., 2002; Brassard et al., 2010; Watanabe et al., 2011). In terms of 
intervention studies investigating the effects of phytochemicals on central blood flow 
using NIRS, Kennedy et al., (2010), showed that supplementation of trans-resveratrol 
increased cerebral blood flow during cognitive demand in a dose-dependent manner. 
The intervention did not affect cognitive performance. A second intervention study 
assessed the impact of the tea polyphenol EGCG on cerebral haemodynamics in 
healthy young adults. The intervention caused a reduction in total cortical haemoglobin 
presence during cognitive tasks with no differences in hemispheric activity or effect of 
task cognitive difficulty. The authors attribute this to vasoconstriction properties 
potentially attributed to inhibition of nNOS. There were also no effects of the 
intervention on cognitive tasks. EGCG has also been associated with a significant 
overall increase in alpha, beta and theta activity, as measured by 
electroencephalogram, again, with no effect upon cognition. Reductions in self-related 
stress and increases in calmness have, however, been reported (Scholey et al., 2012). 
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Although NIRS studies are limited, modulations of central blood flow after the 
administration of a nutritional intervention can be seen using other neuroimaging 
methods such as fMRI. Supplementation of 444ml of concord grape juice per day for 
16 weeks has been shown to increase blood flow in the right anterior and posterior 
cortical regions in aged adults (65 and over) with mild cognitive decline during 
performance of the n-back working memory task (Krikorian et al., 2012). Cocoa has 
also been shown to increase blood flow to grey matter two hours after the consumption 
of a flavan-3-ol rich cocoa drink containing 516mg of flavan-3-ols when compared to a 
control (Francis et al., 2006). The same authors also reported that the short term 
chronic supplementation (5 days) of healthy adults with a cocoa drink, containing 
172mg of flavan-3-ols, increased bold signal intensity during a cognitively demanding 
letter pair switching task, 90 minutes post consumption of the intervention drink, when 
compared to control (Francis et al., 2006). Other nutritional interventions have 
highlighted that non-polyphenol compounds can also modulate haemodynamics. For 
example, Kennedy and Haskell (2011) showed that supplementation of 75mg of 
caffeine led to a decrease in total levels of haemoglobin and, therefore, a decrease in 
cerebral blood flow in the pre-frontal cortex. These effects are driven by interactions of 
caffeine with adenosine A2 receptors, which are widely distributed throughout the brain 
(Laurienti et al., 2003). Watanabe et al., (2002) demonstrated that supplementation of 
8g of creatine for five days modulated task evoked increases in oxyhaemoglobin and 
decreases in deoxyhaemoglobin during cognitive tasks in healthy volunteers. Further to 
this, Jackson et al., (2012) demonstrated a dose-related increase in total haemoglobin 
and oxyhaemoglobin during frontal cortex task performance after supplementing 
healthy adults with docosahexaenoic acid (DHA) rich omega 3 fish oils.  
 
Supplementary oxygen (Moss et al., 1998) and glucose (Kennedy & Scholey, 2000) 
have been shown to positively impact cognitive performance in healthy adults. 
Therefore, on the most basic level, increases in cerebral blood flow could potentially be 
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beneficial to acute cognitive performance via increasing the transport of blood borne 
metabolic substrates to the brain and increasing the transportation of waste products 
from the brain, which is necessary for natural brain function (Attwell et al., 2010b). In 
practice, intervention studies suggest that manipulating cerebral haemodynamics, both 
increasing and decreasing, has a diminutive effect upon acute cognitive performance in 
a healthy young population over a wide range of cognitive paradigms (Kennedy et al., 
2010; Wightman et al., 2012). However, chapter two of this thesis outlines a potential 
impact of blackcurrants upon cognitive performance in healthy young adults, 
particularly after sustained mental performance, a factor which has not been shown 
after supplementation with resveratrol or EGCG. Furthermore, neurotransmitter tone, 
which plays a key role in vasodilatation and the regulation of cerebral blood flow 
(Attwell et al., 2010a), was seen to be affected after supplementation with the 
Blackadder juice in study one. A nutritional intervention, such as the 500mg dose of the 
Blackadder juice extract used in chapters two and three of this thesis, which is rich in 
flavonoids, but also has the potential to modulate monoaminergic tone could, therefore, 
impact cerebral blood flow on two levels, regulating endothelial-dependent nitric oxide 
and via a direct effect upon neurotransmitters. 
 
In light of modulatory effects of nutritional interventions upon cerebral haemodynamics 
published in the literature (Kennedy et al., 2010; Kennedy & Haskell, 2011; Wightman 
et al., 2012), the current study will, for the first time, assess the impact of blackcurrant 
juice upon pre-frontal cortical haemodynamics using NIRS. The study will focus upon 
shallow pre-frontal cortical haemodynamics under cognitive demand, and at rest, 
utilising cognitive paradigms focusing upon central executive tasks and attention 
processing which have been shown to elicit an intervention-dependent cerebral blood 
flow response in the frontal cortex (Kennedy et al., 2010; Kennedy & Haskell, 2011; 
Wightman et al., 2012). As the timescale of any haemodynamic effects of blackcurrant 
consumption are not known, the study will observe haemodynamics during the resting 
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absorption period directly after consumption of the study intervention and throughout 
cognitive task performance, which will be completed at the same time point as in 
chapter two, 60 minutes post-dose, when anthocyanins are known to be present in 
blood plasma. 
 
The primary aim of the study was, therefore, to assess if there was an impact of the 
Blackadder blackcurrant extract upon pre-frontal cortical haemodynamics in healthy 
young adults, during rest and during cognitive demand. 
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4.2 Materials and methods 
4.2.1 Design 
The project investigated the acute effects of a single serving of the Blackadder juice 
drink standardised to contain 500mg of polyphenols per 60kg of body weight versus a 
control upon measures of NIRS. Drinks were matched for volume, taste, appearance 
and sugars but differed in the amount of total polyphenols. The study followed a 
double-blind, counterbalanced, placebo controlled, repeated measures design. 
Participants were randomly allocated to treatment orders as selected through a 
Williams Latin Square (Williams, 1949). 
 
4.2.2 Participants 
Twenty two healthy adults participated in the study, of which 20 completed the study (6 
male and 14 female). The mean age of the 20 participant’s was 22.3±3.6 years, with a 
mean body mass index of 23.14±2.66 kg/m2. Other participant characteristics can be 
found in table 4.1. 
 
 
 
 
Participants were recruited using opportunity sampling from Northumbria University, 
UK. Participants received £35 to recompense them for any expense they may have 
occurred to participate in the trial. Prior to acceptance onto the study potential 
participants attended a one hour training session. During this training session 
participants gave their signed consent to participate in the study and were screened for 
any contraindications to the study with the use of an exclusion questionnaire. A full list 
of exclusion criteria can be seen in appendix I. Participants then completed four 
repetitions of the study day tasks to ensure they met the required minimum standards 
to participate in the study.  
Table 4.1 Mean participant characteristics   
Measure 
Average 
measurement 
SD Range 
Age (years) 22.3 3.6 18-30 
Height (m) 1.69 0.07 1.58-1.85 
Mass (kg) 66.84 12.14 47-95 
BMI (kg/m
2
) 23.14 2.66 18-29 
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The study received ethical approval from the Northumbria University School of Life 
Sciences Ethics Committee and was conducted according to the Declaration of 
Helsinki (1964).  
 
4.2.3 Treatments 
Participants received two intervention drinks with at least one week washout in 
between treatments. These drinks contained either 0mg of polyphenols (control) or 
500mg polyphenols per 60kg of body weight in the form of a cold pressed blackcurrant 
juice (Blackadder cultivar, cultivated and processed in 2011 by Plant and Food 
Research Ltd, New Zealand (Blackadder Juice)). In each case, drinks comprised of 
3.44g of glucose, 4.63g of fructose, 0.8g of sucrose, 6g of SplendaTM and 50ml of 
blackcurrant flavouring (Schweppes blackcurrant cordial). The total volume of the drink 
was made up to 200ml with water. All quantities discussed are based on a 60kg 
person, drink quantities were calculated per kilo of body weight.  
 
 
 
 
Table 4.3 Anthocyanins and other phenolic compounds in each of the treatment conditions.(mg per kilo of body weight, average dose 
given (mg) and dose range (mg))  
 For 
Treatment 
Anthocyanins 
(mg/kg) 
Anthocyanin 
average dose 
(mg) 
Dose 
Range 
(mg) 
Other 
polyphenols 
(mg/kg) 
Other 
polyphenols 
average dose 
(mg) 
Dose 
range 
(mg) 
total 
polyphenols 
(mg/kg) 
Total 
polyphenols 
average 
dose (mg) 
Dose 
range 
(mg) 
Control 0 0 0 0 0 0 0 0 0 
Blackadder 6.21 415 294-594 2.11 141 100-202 8.33 556 395-798 
 
 
 
Table 4.2 Anthocyanins and other phenolic compounds in each of the 
study conditions (mg per 60kg of bodyweight) 
Treatment 
Anthocyanins 
mg/60kg 
Other phenolics 
mg/60kg 
Total 
phenolics 
(mg/60kg) 
Control 0 0 0 
Blackadder  372.8 127.1 500 
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4.2.4 Cognitive and mood measures 
All cognitive measures and mood scales were delivered using the Computerised 
Mental Performance Assessment System (COMPASS).  
 
A modified version of the 60 minute cognitive demand battery (CDB) which has been 
shown to be sensitive to nutritional interventions (Scholey et al., 2010) was used to 
assess NIRS outcomes during cognitive demand. A shortened version of the CDB has 
been shown to activate the pre-frontal cortex in brain imaging studies (Kennedy & 
Haskell, 2011). The modified cognitive demand battery lasted 30 minutes and involved 
three repetitions of the nine minute battery, consisting of serial 3 subtractions, serial 7 
subtractions and rapid visual information processing followed by a mental fatigue visual 
analogue scale. 
 
4.2.4.1 Serial threes subtraction task: Computerised versions of the serial 
subtraction tasks were implemented using tests of 2-minute duration. Participants were 
required to count backwards in threes from a given number as quickly and as 
accurately as possible using the number keys to enter each response. A random 
starting number between 800 and 999 was presented on the computer screen, which 
was cleared by the entry of the first response. The task was scored for number of 
responses, number of correct responses and number of errors. In the case of incorrect 
responses subsequent responses were scored as positive if they were scored as 
correct in relation to the new number. 
 
4.2.4.2 Serial 7 subtractions: This was identical to the Serial threes task except that it 
involved serial subtraction of sevens. 
 
4.2.4.3 Rapid visual information processing: The participant was required to monitor 
a continuous series of digits for targets of three consecutive odd or three consecutive 
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even single digits. The single digits were presented at the rate of 100 per minute and 
the participant responded to the detection of a target string by pressing the space bar 
on the computer keyboard as quickly as possible. The task was continuous and lasted 
for 5 minutes, with 8 correct target strings being presented in each minute. The task 
was scored for percentage of target strings correctly detected, average reaction time 
for correct detections (msec), and number of incorrect responses (false alarms). 
 
4.2.4.4 Fatigue: Participants were asked to subjectively rate how mentally fatiguing 
they found the cognitive tasks. The visual analogue scales were displayed 
electronically at the end of every set of tasks. The scale was anchored “Not at all” and 
“extremely”, with higher scores representing more mental fatigue. 
4.2.5 Near infrared spectroscopy 
Functional near infrared spectroscopy (NIRS) utilises the optical absorption properties 
of oxygenated haemoglobin and deoxygenated haemoglobin after the introduction of 
near-infrared light through the intact skull for the purpose of functional neuroimaging 
(Kennedy et al., 2010). When assessed by NIRS, the increase in blood flow in the 
surface layers of the cortex during localized neural activity is seen as an increase in the 
total concentration of oxyhaemoglobin and comparative decrease in deoxyhaemoglobin 
(Steinbrink et al., 2006), with both variables corresponding strongly with the fMRI 
BOLD signal (Huppert et al., 2006; Steinbrink et al., 2006). Several peer reviewed 
intervention studies have utilised NIRS to assess the effects of nutritional interventions 
upon cerebral blood flow (Watanabe et al., 2002; Jackson et al., 2012). In the current 
study, cerebral blood flow was measured using the method reported by Kennedy et al., 
(2010), a method which has previously been shown to be sensitive to nutritional 
interventions with similar goals as the current study (Kennedy et al., 2010; Kennedy & 
Haskell, 2011; Wightman et al., 2012). Whereby, a 12-channel Oxymon system (Artinis 
Medical Systems BV, Zetten, Netherlands) was used to measure relative changes in 
absorption of near-infrared light at a time resolution of 10 Hz. The system emitted two 
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wavelengths of light (765 and 855 nm). The differential path length factor was adjusted 
according to the age of the participant. A simple 2-emitter/optode pair conﬁguration 
was used in the current study with emitter/optode pairs positioned over the left and 
right frontal cortex by using a standard optode holder headband, which separated the 
emitter/optode pairs by 4 cm as seen in figure 4.1. Each pair therefore collected data 
from an area of prefrontal cortex that included the areas corresponding to the 
International 10–20 system Fp1 and Fp2 EEG positions. Proprietorial software was 
used to calculate relative concentration changes in oxyhaemoglobin, 
deoxyhaemoglobin, and total-haemoglobin by means of a modified Beer-Lambert law 
(Obrig & Villringer, 2003). The NIRS data output was time stamped at the start of each 
event segment (baseline, absorption and each cognitive task) to ensure that data 
corresponded to the relevant epoch. Events which could impact data (excessive head 
movements, head scratching, sneezing etc.)  were also recorded for the purpose of 
data cleaning. 
 
Figure 4.1 NIRS headband (picture used with permission from the Brain Performance and Nutrition Research Centre)  
 
4.2.6 Procedures 
Each participant was required to attend one screening session and two study days 
which were conducted at least seven days apart to ensure a sufficient wash out period 
between conditions. Cognitive testing took place in a laboratory where participants 
were individually tested in an environment isolated from noise and other physiological 
distractions. On arrival at their first session, participants were randomly allocated to a 
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treatment regime using a Latin square design that counterbalanced the order of 
treatments across the two active days of the study. On all testing days participants 
arrived in the laboratory at 8am (after a 12 hour overnight fast) and were firstly fitted 
with a NIRS headband as shown in figure 4.1. After a five minute seated resting period, 
NIRS recording began and continued throughout the entire session. Participants then 
completed one set of the cognitive demand battery which was used as the baseline 
cognitive measure. The participant then rested for 10 minutes, this was used as the 
pre-dose baseline measurement for NIRS paradigms. The participant was then 
supplemented with either the active treatment or matched control (depending on 
randomisation). After a one hour resting absorption period, during which the participant 
was required to sit and watch a DVD (Grand Designs, Channel4), the participant 
completed a modified version of the cognitive demand battery. The running order of the 
testing session can be seen in figure 4.2. 
 
Originally, peripheral haemodynamics were also planned to be measured with the use 
of a photoplethysmography. However, observation of the data of the first two 
participants revealed that the placing of the photoplethysmography on the participants’ 
finger impacted the primary NIRS outcome. The reason for this is not known, the 
measurement of peripheral haemodynamic measurement was, therefore, removed 
from the protocol and the data from the two participants in question was omitted from 
data analysis. 
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Figure 4.2 Test session running order (minutes). CRF=case report form, NIRS=near infrared spectroscopy. 
 
 
4.3 Statistical analysis  
Mood, cognitive scores and the NIRS measures were analysed as ‘change from 
baseline’ using the SPSS 18 statistics package. The null hypothesis was rejected with 
a p value <0.05. Baseline differences were calculated for all mood and cognitive 
measures using a one way (treatment) ANOVA.  
 
Haemodynamics outcomes were assessed using 12, five minute, epochs during the 60 
minute absorption and for the full duration of each cognitive task (2 minutes for serial 
subtraction tasks and five minutes for the RVIP task) during the cognitive demand 
battery (9 epochs). The baseline measure was calculated using the final two minutes of 
the 10 minute resting baseline period immediately prior to ingestion of the study drinks. 
Raw resting baseline measures can be found in appendix IX. 
 
Cognitive measures and fatigue ratings were analysed with repeated measures 
ANOVAs (General linear model) by treatment [control and 500mg] and completion [1 to 
3]). Repeated measures ANOVAs (General linear model) by treatment [control and 
500mg], epoch [1 to 21] and hemisphere [left and right] were conducted on the entire 
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session for haemodynamic outcomes. Where no hemispheric differences were 
observed, data for the two hemispheres were combined and this factor (hemisphere) 
was omitted from the analyses. Mauchly`s test of sphericity was used to 
assess equality of the variances of the differences between factors. Where sphericity 
had been violated, Huynh-Feldt corrections for non-sphericity were implemented. 
 
4.4 Results 
Prior to analysis of change from baseline data, mean pre-dose scores for control and 
juice treatments for each cognitive and mood outcome were subjected to a one way 
repeated measures ANOVA. There were no significant differences found between 
treatments on any measures. 
 
4.4.1 Cognitive performance and mood 
Mean pre-dose baseline and change from baseline scores for each behavioural 
measure are presented in table 4.4. Unchanged “raw” data tables can be found in 
appendix X. 
Table 4.4 Mean pre-dose baseline and change from baseline scores, standard deviations and main ANOVA and 
ANOVA interaction outcomes for all behavioural outcomes 
Measure N Treatment 
Baseline 
Repetition 
1 
Repetition 
2 
Repetition 
3 
Effect of 
treatment 
Treatment*repetition 
interaction 
Mean SD Mean SD Mean SD Mean SD 
Serial 3 incorrect 
responses 
20 
Control 1.95 12.27 0.30 10.77 0.75 8.32 1.45 13.95 
F=0.46 p>0.1 
F=0.40 p>0.1 
 Juice 2.80 17.39 -0.75 11.13 0.75 14.43 1.30 20.83 
Serial 3 correct 
responses 
20 
Control 44.20 51.11 0.45 18.83 1.30 30.58 0.70 35.16 
F=0.97 p>0.1 
F=0.72 p>0.1 
 Juice 42.85 76.74 1.20 31.04 0.90 25.00 -0.80 36.98 
Serial 3 number of 
responses 
20 
Control 46.15 54.74 0.75 15.42 2.05 28.38 2.15 30.17 
F=0.47p>0.1 
F=0.73 p>0.1 
 Juice 45.65 69.13 0.45 29.50 1.65 18.54 0.50 23.82 
Serial 7 incorrect 
responses 
20 
Control 2.95 12.09 0.00 13.30 0.10 10.25 0.90 11.42 
F=0.16 p>0.1 
F=2.1 0p>0.1 
 Juice 2.80 12.78 -0.05 9.34 0.50 12.35 -0.05 14.76 
Serial 7 correct 
responses 
20 
Control 24.25 49.01 2.80 30.53 2.80 28.75 2.55 22.45 
F=0.07 p>0.1 
F=.20 p>0.1 
 Juice 25.25 54.02 2.75 18.86 3.05 22.03 2.75 28.80 
Serial 7 number of 
responses 
20 
Control 27.20 45.06 2.80 23.11 2.90 22.14 3.45 19.71 
F=0.01 p>0.1 
F=0.71 p>0.1 
 Juice 28.05 48.87 2.70 16.93 3.55 22.31 2.70 27.34 
RVIP correct 
responses 
20 
Control 53.50 62.59 -0.25 36.44 -1.50 33.72 0.13 51.87 
F=0.45 p>0.1 
F=0.99 p>0.1 
 Juice 55.79 57.76 -0.63 42.13 -5.00 53.20 -4.38 42.28 
RVIP false alarms 20 
Control 0.85 26.59 -0.15 4.65 0.30 6.66 0.15 7.15 
F=0.03 p>0.1 
F=2.79 p>0.1 
 Juice 0.84 35.04 0.30 7.83 -0.15 4.17 0.55 5.12 
RVIP reaction time 20 
Control 482.88 54.45 0.36 193.37 -4.74 179.69 -5.81 218.41 
F=0.09 p>0.1 
F=0.39 p>0. 1 
 Juice 482.53 55.75 -1.44 162.57 17.32 269.09 -34.83 524.55 
Fatigue 20 
Control 28.60 77.90 16.00 94.66 22.10 114.89 25.80 126.20 
F=1.63 p>0.1 
F=0.56 p>0.1 
 Juice 23.75 90.30 11.15 50.14 19.25 71.48 23.35 93.59 
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4.4.2 Haemodynamics 
Mean change from baseline scores for each haemodynamic epoch are presented in 
table 4.3 and 4.4. A graphical representation is presented in figure 4.2. Resting 
baseline data was omitted from tables as it is an arbitrary figure. This data can be 
found in appendix IX. Only ANOVA results for physiological measures which generated 
significant effects are reported below. 
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Table 4.5 Mean change from baseline scores (mmol/L), standard deviations (SD) and ANOVA outcomes for left hemisphere (LH), right hemisphere (RH) and hemispheres combined (combined) for NIRS 
outcomes total-HB Oxy-HB and deoxy-HB throughout the whole testing procedure 
Measure N Treatment 
1-5 minute epoch 
6-10 minute 
epoch 
11-15 minute 
epoch 
16-20 minute 
epoch 
21-25 minute 
epoch 
26-30 minute epoch 
31-35 minute 
epoch 
36-40 minute epoch 
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Combined 
OxyHb 
20 
Control -1.33 1.33 -1.65 1.22 -1.06 1.65 -0.64 1.73 -0.41 1.97 -0.31 1.83 0.05 2.12 0.1 2.85 
Juice -0.57 1.24 -1 1.41 -0.72 1.42 -0.31 1.59 0.05 1.9 0.18 2.14 0.47 2.03 0.36 2.02 
OxyHb LH 20 
Control -1.75 1.8 -2.1 1.52 -1.45 1.96 -0.95 1.85 -0.85 2.18 -0.7 2.08 -0.2 2.38 -0.4 3.05 
Juice -0.65 1.31 -1.1 1.37 -0.95 1.57 -0.7 1.92 -0.3 2.15 -0.2 2.24 0.25 2.2 0.05 2.44 
OxyHb RH 20 
Control -1 1.3 -1.3 1.34 -0.6 1.7 -0.35 1.84 0 2.34 0.05 1.93 0.3 2.08 0.6 2.89 
Juice -0.25 -3.58 -0.45 0.45 0.5 2.24 0.65 3.35 1.25 7.16 1.95 9.84 1.95 10.73 2.15 9.84 
Combined 
DeoxyHb 
20 
Control 0.34 0.49 0.57 0.44 0.37 0.44 0.2 0.45 0.01 0.46 -0.02 0.48 -0.16 0.54 -0.1 0.86 
Juice 0.02 0.41 0.4 0.59 0.25 0.72 0.06 0.75 -0.03 0.84 -0.15 0.77 -0.33 0.66 -0.42 0.79 
DeoxyHb 
LH 
20 
Control 0.34 0.48 0.6 0.43 0.39 0.56 0.26 0.55 0.02 0.51 -0.01 0.55 -0.11 0.62 0.01 0.87 
Juice 0.05 0.39 0.45 0.55 0.26 0.61 0.07 0.77 -0.01 0.82 -0.12 0.73 -0.36 0.71 -0.31 0.65 
DeoxyHb 
RH 
20 
Control 0.35 0.57 0.54 0.56 0.35 0.49 0.13 0.52 -0.01 0.58 -0.03 0.65 -0.22 0.58 -0.2 0.98 
Juice -0.01 0.51 0.34 0.7 0.25 0.9 0.05 0.8 -0.06 0.96 -0.18 0.92 -0.29 0.72 -0.52 1.2 
Combined 
TotalHb 
20 
Control -0.99 1.26 -1.08 1.26 -0.68 1.54 -0.44 1.77 -0.41 1.99 -0.33 1.89 -0.12 2.29 0.01 3.36 
Juice -0.55 1.24 -0.6 1.33 -0.47 1.33 -0.25 1.7 0.02 2.07 0.03 2.34 0.15 2.01 -0.06 2.36 
TotalHb 
LH 
20 
Control -1.25 1.52 -1.35 1.39 -1.05 1.79 -0.65 1.79 -0.85 2.18 -0.7 2.15 -0.35 2.56 -0.3 3.37 
Juice -0.35 1.57 -0.25 1.71 -0.2 1.82 0.05 2.16 0.35 2.37 0.4 2.6 0.35 2.39 0.5 2.06 
TotalHb 
RH 
20 
Control -0.85 1.53 -0.75 1.62 -0.4 1.85 -0.1 2.1 -0.05 2.5 0.2 2.33 0.05 2.48 0.35 3.72 
Juice -0.75 1.29 -0.8 1.47 -0.75 1.86 -0.8 2.04 -0.3 2.41 -0.3 2.7 -0.1 2.27 -0.45 3.28 
                                  
Measure N Treatment 
41-45 minute 
epoch 
46-50 minute 
epoch 
51-55 minute 
epoch 
56-60 minute 
epoch 
Serial 3 repetition 1 Serial 7 repetition 1 RVIP repetition 1 Serial 3 repetition 2 
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Combined 
OxyHb 
20 
Control 0.48 3.51 0.44 3.88 0.13 3.69 0.35 3.66 1.87 4.25 1.19 4.16 1.64 3.93 1.95 4.66 
Juice 0.75 2.22 1.05 1.9 1.48 2.05 1.71 1.95 3.08 2.86 2.83 2.16 2.49 2.23 3.18 2.5 
OxyHb LH 20 
Control 0 3.74 0 4.22 -0.25 3.99 0.05 4.02 0.75 4.45 1.35 4.69 1.15 4.88 1.4 4.75 
Juice 0.3 2.45 0.6 1.9 0.95 2.28 1.25 2.4 3.7 2.77 4.2 3.64 3.8 3.5 3.9 3.86 
OxyHb RH 20 
Control 0.95 3.68 0.9 3.82 0.6 3.93 0.6 3.62 1.6 4.31 2.15 3.88 2.2 4.3 2.3 4.18 
Juice 2.4 9.84 1.85 9.17 2.15 1.41 0.42 1.99 0.45 2.21 0.55 2.37 0.44 2.55 0.53 2.3 
Combined 
DeoxyHb 
20 
Control 0.18 1.3 0.35 1.25 0.39 1.28 0.27 1.27 0.02 0.99 0.13 1.18 0.08 1.21 0.05 1.09 
Juice -0.47 0.88 -0.4 0.85 -0.38 0.86 -0.56 0.79 -0.64 0.93 -0.55 0.86 -0.61 0.88 -0.5 0.68 
DeoxyHb 
LH 
20 
Control 0.24 1.2 0.4 1.14 0.49 1.22 0.4 1.22 0.29 1.18 0.18 1.05 0.22 1.19 0.13 1.22 
Juice -0.31 0.78 -0.22 0.84 -0.21 1.04 -0.42 1.05 -0.35 1.08 -0.36 1.07 -0.36 0.82 -0.32 0.78 
DeoxyHb 
RH 
20 
Control 0.12 1.5 0.29 1.44 0.29 1.5 0.14 1.44 -0.03 1.31 -0.13 1.05 -0.07 1.32 -0.05 1.24 
Juice -0.63 1.4 -0.59 1.26 -0.55 1.04 -0.7 0.92 -0.75 0.97 -0.37 0.78 -0.86 1.35 -0.65 0.69 
Combined 
TotalHb 
20 
Control 0.66 4.42 0.78 4.82 0.52 4.66 0.62 4.63 1.9 4.85 1.32 5.03 1.72 4.74 2 5.34 
Juice 0.28 2.49 0.65 2.09 1.1 2.11 1.15 1.98 2.44 2.93 2.28 2.32 1.88 2.53 2.68 2.45 
TotalHb 
LH 
20 
Control 0.25 4.47 0.45 5.06 0.2 4.79 0.45 4.9 1.05 5.28 1.65 5.2 1.35 5.2 1.6 5.39 
Juice 0.9 2.53 1.3 2.23 1.7 2.41 1.8 2.19 3.35 3.27 3.55 4.2 2.8 3.21 3.9 3.52 
TotalHb 20 Control 1.05 4.66 1.1 4.9 0.9 4.96 0.8 4.75 1.5 5.12 2.1 4.85 2.05 4.76 2.15 4.8 
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RH Juice -0.3 3.28 0 2.64 0.25 2.51 0.45 2.63 1.3 2.54 1.25 2.65 0.8 2.63 1.85 2.43 
                                  
Measure N Treatment 
Serial 7 repetition 2 RVIP repetition 2 Serial 3 repetition 3 Serial 7 repetition 3 RVIP repetition 3 Effect of treatment 
Treatment*epoch 
interaction 
Treatment* 
hemisphere 
interaction 
Treatment* 
hemisphere
*epoch 
interaction 
Mean SD Mean SD Mean SD Mean SD Mean SD 
F=1.89 p>0.1 F=1.52 p>0.1 
F=7.26 
p=0.014 
F=5.30 
p=0.006 
Combined 
OxyHb 
20 
Control  1.83 4.15 1.57 4.05 1.82 4.66 1.67 4.44 1.72 3.95 
Juice 3.27 2.54 2.6 2.29 3.25 2.71 2.91 2.65 2.97 2.61 
OxyHb LH 20 
Control 1.7 5.07 1.3 5.01 1.05 4.35 1.05 4.47 1.3 4.16 
Juice 3.8 3.74 4.4 4.08 3.15 2.89 3.15 3.05 3.7 3.51 
OxyHb RH 20 
Control 2.3 4.62 2.4 4.48 2.15 3.95 2.15 3.88 2.2 3.86 
Juice 0.47 2.24 0.54 2.6 0.58 2.23 0.46 2.01 0.5 2.3 
Combined 
DeoxyHb 
20 
Control 0.04 1.17 0.15 1.28 0.07 1.13 0.17 1.26 0.11 1.18 
F=5.7 p=0.02 F=2.73 p=0.43 
F=2.73 
p=0.046 
F=1.50 
p>0.1  
Juice -0.48 0.67 -0.4 0.63 -0.34 0.92 -0.4 0.73 -0.38 0.76 
DeoxyHb 
LH 
20 
Control 0.15 1.23 0.24 1.33 0.25 1.41 0.14 1.29 0.18 1.24 
Juice -0.02 1.06 -0.26 0.72 -0.13 0.84 -0.62 0.73 -0.2 0.89 
DeoxyHb 
RH 
20 
Control -0.06 1.14 0.07 1.34 0.09 1.2 0 1.08 0.04 1.19 
Juice -0.93 1.24 -0.55 0.68 -0.67 1.02 -0.66 1.08 -0.56 0.77 
Combined 
TotalHb 
20 
Control 1.87 4.98 1.72 4.86 1.88 5.27 1.84 5.17 1.84 4.69 
F=0.32 p>0.1 F=0.73 p>0.1 
F=7.06 
p=0.01  
F=2.64 
p=0.02 
Juice 2.79 2.46 2.2 2.34 2.91 2.75 2.52 2.63 2.6 2.64 
TotalHb 
LH 
20 
Control 1.85 5.82 1.25 5.2 1.4 5.68 1.45 5.69 1.5 4.98 
Juice 3.5 3.87 2.9 3.26 3.65 3.72 4.3 4.39 3.55 3.76 
TotalHb 
RH 
20 
Control 2.2 5.2 2.15 4.74 2.1 5.12 2.3 5.24 2.35 4.79 
Juice 1.95 1.88 1.6 2.01 1.35 2.56 1.5 2.16 1.6 2.23 
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4.4.2.1 Oxyhaemoglobin 
Analysis of the entire session revealed a significant treatment*hemisphere interaction 
for oxyhaemoglobin [F(1,19)=7.265, p=0.01]. Pairwise comparisons showed an 
increase in oxyhaemoglobin in the left hemisphere following consumption of the 
Blackadder juice when compared to control (p=0.038), with no effect of treatment on 
the right hemisphere.  
 
There was also a significant treatment*hemisphere*epoch interaction for the entire 
session [F(2.33,44.33)=5.30, p=0.006]. Pairwise comparisons revealed an increase in 
oxyhaemoglobin in the left hemisphere after consumption of the Blackadder juice drink 
when compared to control at the following epochs; 5 minutes (p=0.003), 10 minutes 
(p=0.048), serial 3s repetition 1 (p=0.002), serial 7s repetition 1 (p=0.003), RVIP 
repetition 1 (p=0.004), serial 3s repetition 2 (p=0.004), serial 7s repetition 2 (p=0.021), 
RVIP repetition 2 (p=0.001), serial 3s repetition 3  (p=0.030), serial 7s repetition 3 
(p=0.031) and RVIP repetition 3  (p=0.003) with no interpretable effect of treatment on 
the right hemisphere. A graphical representation of all NIRS oxyhaemoglobin outcomes 
can be seen in figure 4.3. 
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Figure 4.3 Change from baseline oxyhaemoglobin throughout the 60 minute absorption period and cognitive demand 
battery (CDB) (a) the left hemisphere, (b) the right hemisphere and (c) left and right hemispheres combined. Significant 
differences are indicated on the graph (*p<0.05, **p<0.01). 
 
4.4.2.2 Deoxyhaemoglobin 
The ANOVA of the entire session revealed a significant effect of treatment on 
deoxyhaemoglobin [F(1,19)=5.70, p=0.021]. This was due to a decrease in 
deoxyhaemoglobin after consumption of the Blackadder juice when compared to 
control. 
 
The ANOVA also revealed a significant treatment*epoch interaction for the entire 
session [F(3.31,63.05)=2.73, p=0.046]. Pairwise analysis revealed a decrease in 
deoxyhaemoglobin after the Blackadder juice treatment when compared to control at 
the 5 minute (p=0.027), 50 minute (p=0.018), 55 minute (p=0.010), 60 minute 
(p=0.009), serial 3s repetition 1 (p=0.013), serial 7s repetition 3 (p=0.017) epochs. 
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Trends towards the same pattern of modulation were seen at the 45 minute (p=0.06), 
serial 7s repetition 1 (p=0.088), RVIP repetition 1 (p=0.05), serial 3s repetition 2 
(p=0.068), serial 7s repetition 2 (p=0.069), RVIP repetition 2 (p=0.076) and serial 3s 
repetition 3 (p=0.053) epochs. A graphical representation of all NIRS 
deoxyhaemoglobin outcomes can be seen in figure 4.4 
 
  
Figure 4.4 Change from baseline deoxyhaemoglobin throughout the 60 minute absorption period and cognitive demand 
battery (CDB) for (a) combined left and right hemisphere, (b) the left hemisphere and (c) the right hemisphere. 
Significant differences are indicated on the graph (*p<0.05, t p<0.1). 
 
4.4.2.3 Total haemoglobin  
There was a significant treatment*hemisphere interaction for total haemoglobin 
measured over the entire session [F(1,19)=7.06, p=0.016]. Pairwise comparisons 
revealed a trend towards an increase in total haemoglobin in the left hemisphere after 
consumption of the Blackadder juice extract when compared to control (p=0.09).  
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The ANOVA also revealed a significant treatment*hemisphere*epoch interaction for 
total haemoglobin over the entire session [F(5.93,112.68)=2.64, p=0.020]. Pairwise 
comparisons revealed an increase in total haemoglobin in the left hemisphere when 
compared to control at the; 10 minute (p=0.032), serial 3s repetition 1 (p=0.031), serial 
7s repetition 1 (p=0.040), serial 3s repetition 2 (p=0.026), serial 3s repetition 3 
(p=0.042), serial 7s repetition 3 (p=0.014) and RVIP repetition 3 (p=0.047) epochs. 
A trend towards the same pattern of modulation was seen at the 5 minute epoch 
(p=0.058). A graphical representation of all NIRS total haemoglobin outcomes can be 
seen in figure 4.5 
 
Figure 4.5 Change from baseline total haemoglobin throughout the 60 minute absorption period and cognitive demand 
battery (CDB) for (a) the left hemisphere, (b) the right hemisphere and (c) left and right hemisphere combined. 
Significant differences are indicated on the graph (tp<0.1,*p<0.05, **p<0.01). 
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4.5 Discussion and conclusion  
The aim of the current study was to assess the impact of the MAO inhibiting 
Blackadder blackcurrant juice extract upon shallow pre-frontal cortical haemodynamics. 
The study focused upon two aspects, pre-frontal cortical haemodynamics under 
cognitive demand and pre-frontal cortical haemodynamics at rest. The overall pattern 
of task-related changes in local haemoglobin concentrations independent of 
intervention was as expected (Kennedy et al., 2010; Kennedy & Haskell, 2011; 
Wightman et al., 2012), with increases in oxyhaemoglobin and decreases in 
deoxyhaemoglobin during cognitive task performance and, therefore, increases in 
regional cerebral blood flow. 
 
When compared to placebo, the consumption of the Blackadder juice extract resulted 
in significant modulations of pre-frontal cortex haemoglobin concentrations during 
resting absorption and cognitive task performance, with apparent hemispheric 
differences. An increase in oxyhaemoglobin and total haemoglobin in the left 
hemisphere, but not the right, was seen after consumption of the blackcurrant drink 
when compared to control, with significant increases being found throughout the 
cognitive demand period with no effect of task type. In relation to concentration 
changes in deoxyhaemoglobin, supplementation of the Blackadder blackcurrant extract 
caused a significant or near to significant trend reduction in overall deoxyhaemoglobin 
(left and right hemispheres combined), beginning during the resting absorption period, 
45 minutes post supplementation of the blackcurrant juice. This reduction continued 
throughout the remaining absorption period and throughout the cognitive testing period, 
again with no effect of task type.  
 
With regards to intervention-related modifications in concentrations of total and 
oxygenated haemoglobin, increases have been observed during cognitive demand 
after oral supplementation of resveratrol (Kennedy et al., 2010), anti-depressants  
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(Kohmura et al., 2013) and vinpocetine (Bönöczk et al., 2002); however, with no 
hemispheric differences seen.  As increased oxyhaemoglobin and total haemoglobin 
have been linked to increased neural activity during cognitive demand in healthy young 
adults when measured by NIRS (Hoshi & Tamura, 1993), the rise in total haemoglobin 
in response to post-dose tasks in the current study could demonstrate neurovascular 
coupling, which is further up-regulated in the left hemisphere after consumption of the 
blackcurrant juice. As the tasks in the present study have been shown to increase 
activity in the pre-frontal cortex (Coull et al., 1996) and the pre-frontal left hemisphere 
(Burbaud et al., 1999), the hemispheric differences found in the present study could be 
an effect of the study intervention amplifying a natural difference in hemispheric activity 
in response to cognitive performance. However, it must be noted that there is no 
observable difference in hemispheric activity shown in the current study after 
consumption of the control intervention. When assessed via PET without a nutritional 
intervention, the RVIP task has been shown to elicit increases in regional cerebral 
blood flow bilaterally in the inferior frontal gyri, parietal cortex and fusiform gyrus, as 
well as lateralised right-sided activation in superior frontal gyrus (Coull et al., 1996). 
When RVIP was compared to a simplified version of the task with the working memory 
element removed, the right frontal activations were no longer apparent. The authors 
consider these findings consistent with the existence of a right fronto-parietal network 
for sustained attention, and a left fronto-parietal network for working memory. 
Therefore, the increase in left hemisphere regional cerebral blood flow following 
blackcurrant supplementation in the current study, could be indicative of increased 
neuronal activation in brain areas associated with working memory.  
 
Given the increase in oxygenated haemoglobin following supplementation of the 
Blackadder extract, the relative decrease in deoxygenated haemoglobin is as 
expected. This is due to the rate of utilisation of oxygen being slower than the rate at 
which it is provided. However, the effects on deoxygenated haemoglobin do not show 
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the lateralisation observed with oxygenated haemoglobin, which, coupled with the time 
of onset of effects suggests that another mechanism is involved in the effects on 
deoxyhaemoglobin. The significant effects upon deoxyhaemoglobin seem to be 
brought about by a divergence in effects at around 35 minutes post-consumption. Prior 
to this, both treatments have followed a similar pattern of increase at 10 minutes post-
consumption followed by a decline up until 35 minutes. At this point, deoxyhaemoglobin 
levels begin to rise back up in the control group until they reach a level similar to that 
observed at baseline. Conversely, values in the Blackadder juice group continue to fall 
before levelling off for the remainder of the session. This decrease in 
deoxyhaemoglobin may outline neuronal efficiency. The reason for this pattern of 
modulation is unknown. As both the active and control drink followed the same pattern 
of modulation until 35 minutes post-dose, it would suggest that the effects are caused 
by a common denominator. Drinks are matched for sugars, a tentative explanation 
could be that more glucose is available for utilisation and is therefore the ratio of lactate 
and glucose in neuronal tissue changes in favour of glucose. As less oxygen is needed 
to use glucose as a fuel when compared to lactate (Larrabee, 1995), less oxygen is 
needed to maintain cognitive activities. It must also be noted that a significant increase 
in regional cerebral blood flow, as indexed by total haemoglobin, was seen at the ten 
minute epoch, post-consumption of the blackcurrant intervention as compared to 
control. It seems unlikely that this early effect is attributable to modulations of biological 
mechanisms by phenolic compounds within the study drinks, with a more plausible 
explanation being that it is related to subtle differences between sensory properties of 
the Blackadder juice extract and the control drink. fMRI clearly shows that a number of 
factors related to the sensory properties of a food or drink can directly modulate frontal 
cortex activity, including differing tastes (Smits et al., 2007) and flavours (Marciani et 
al., 2006).  
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Substantiated evidence of underlying mechanisms driving changes in haemodynamics 
after administration of a nutritional intervention are yet to be fully understood. Although 
anthocyanins have been found in the brains of rats after oral ingestion (Andres-
Lacueva et al., 2005), bioavailability data from chapter two, and data in the literature 
(Matsumoto et al., 2001; Jin et al., 2011) show the bioavailability of anthocyanin 
compounds to be extremely low and, therefore, their direct effect upon the site of action 
is doubtful. However, given that nitric oxide synthesis plays a major role in the 
modulation of localised blood flow in the neural tissue of animal models (Kitaura et al., 
2007), the pattern of increased oxyhaemoglobin and total haemoglobin in the left 
hemisphere during cognitive tasks only could indicate intervention-dependent, nitric 
oxide synthesis driven neurovascular coupling in the frontal cortex. This neurovascular 
coupling involves the coordinated interaction of neurons, glia, and vascular cells and is, 
therefore, a key regulator in the maintenance of normal blood flow in the cerebral 
cortex during brain activity. For this reason, nitric oxide synthesis is a suggested 
therapeutic target for improving brain function in pathologies associated with 
cerebrovascular dysfunction (Girouard & Iadecola, 2006). MAO inhibitors  act upon 
neurotransmitters which affect regional cerebral blood flow (Mckim, 2003), and are 
mediators of nitric oxide in animal models of hypertension (Sturza et al., 2013), 
therefore, the impact of MAO inhibition by the Blackadder blackcurrant extract cannot 
be overlooked as a possible mediator of the haemodynamic changes seen in the 
current study. Dopamine, which is deaminated by MAO-B, has now been established 
as a modulator of neuronal blood flow (Krimer et al., 1998) and is theorised to be 
implicated in diminished blood flow in pathological diseases such as Parkinson’s 
disease (Leenders et al., 1985).Therefore, increased CNS levels of dopamine 
modulated by inhibition of central MAO-B could potentially drive increases in neuronal 
activity and, therefore, modulated haemodynamics in the current study. Reductions in 
levels of deoxyhaemoglobin coincide with the appearance of berry anthocyanins in 
blood plasma which reach maximal concentrations at ~1 hour post consumption 
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(Matsumoto et al., 2001). Pharmacokinetics of anthocyanins pre-one hour post oral 
ingestion have not been published; however, it seems reasonable to assume that 
anthocyanins would be present in blood plasma 45 minutes post ingestion.  
 
The study treatment showed no effect upon cognitive task performance. Although 
previously shown to be sensitive to cocoa flavonoids (Scholey et al., 2010), the tasks 
employed here were chosen on the basis that they have previously been shown to 
activate the prefrontal cortex (Drummond et al., 1999; Kazui et al., 2000) and generate 
a haemodynamic response in the frontal cortex (Kennedy & Haskell, 2011; Wightman 
et al., 2012), rather than because they have been shown to be sensitive to polyphenol 
supplementation.  
 
Results from the current study outline a heightened NIRS response in brain regions 
responsible for task performance after supplementation with the Blackadder 
blackcurrant extract when compared to control. This is not coupled with an increase in 
cognitive performance in measured paradigms. To attempt to assess if blood flow 
changes are general, or solely an artefact of an amplification of neurovascular coupling 
in a specific brain region following the blackcurrant intervention, a suggestion for future 
research would be to assess cognitive tasks which are not dependent on frontal cortex 
activity alongside tasks which are. Furthermore, the cohort used in the present study 
had no apparent issues pertaining to cerebral blood flow. The tight regulation of blood 
flow in the brain could mean that sufficient blood flow already exists for maximal 
cognitive performance and, therefore, increasing blood flow above this threshold does 
not have any acute benefits upon cognitive performance. The use of an aged cohort, a 
cohort in which cerebral blood flow has potentially reduced (Leenders et al., 1990), 
could highlight differential cognitive results. Indeed, recent unpublished “pilot” findings 
from the Brain, Performance and Nutrition Research Centre indicated that 
supplementing five healthy middle aged participants with either 500mg of resveratrol or 
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an inert placebo increased regional cerebral blood flow but also increased serial three 
correct responses, a finding which was not shown in a younger cohort (unpublished 
observation, private communication). To assess if changes in blood flow are also 
evident in the periphery, it would have been beneficial to measure peripheral and 
cerebral blood flow together. However, as discussed in the methods section of this 
chapter, data from the initial two participants in this study illuminated that attempts to 
measure peripheral blood flow with a photoplethysmography (digital volume pulse) 
compromised the primary NIRS outcome and was, therefore, omitted from the study to 
be used in chapter five of this study. 
 
Reductions in cerebral blood flow are associated with natural ageing (Leenders et al., 
1990) and neurological disease (Dede et al., 2007). Results from this thesis outline the 
ability of the Blackadder blackcurrant juice extract to increase cerebral blood flow. 
Therefore, the effects of the Blackadder juice extract in addition to other types of 
blackcurrant extracts upon brain function deserves further investigation. 
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CHAPTER 5. A PHARMACODYNAMIC ASSESSMENT OF THE EFFECTS OF 
THE BLACKADDER BLACKCURRANT JUICE EXTRACT UPON PLATELET 
MAO-B, PLASMA PROLACTIN, BLOOD GLUCOSE AND PERIPHERAL 
BLOOD FLOW 
 
5.1 Introduction 
As detailed in chapter one, the phytochemical constituents in blackcurrant extracts 
have the potential to impact in vitro physiological parameters closely related to the 
regulation of human behaviour and cognitive performance. The in vivo efficacy of some 
of these physiological effects have been presented in the previous three intervention 
chapters; in particular, inhibition of peripheral MAO activity, modulation of shallow pre-
frontal cortical haemodynamics, interactions with hormone secretion and regulation of 
blood glucose. 
 
In relation to the inhibition of MAO activity, it is important to distinguish between the two 
isoforms of MAO which exist, MAO-A and MAO-B. Each MAO enzyme has a substrate 
preference, inhibitor specificity, and tissue distribution. For example the percentage of 
total MAO-B in neuronal tissue is 75% whereas only 25% is MAO-A (Saura Marti et al., 
1990). In terms of pharmacological inhibitors of the MAO enzyme, two types are 
currently used clinically. These are irreversible and reversible inhibitors. These two 
groups of MAO inhibitors contain two subgroups; selective inhibitors, which inhibit only 
one MAO enzyme isoform and non-selective inhibitors which inhibit both MAO 
isoforms. Irreversible inhibitors are used to “knock out” the MAO enzyme fully (Yamada 
& Yasuhara, 2004). This means that MAO enzyme activity only resumes once the 
enzyme has regenerated, consequently, the inhibition of MAO activity is dependent on 
both the pharmacokinetics of the inhibitor and the ability of the body to regenerate the 
enzyme, which can take up to three weeks (Pfizer.Inc., 2007). Unlike irreversible 
inhibitors, the bond between the reversible MAO inhibiting drug and the MAO enzyme 
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is reversible and, therefore, the inhibition relies solely on the pharmacokinetics and 
affinity to the enzyme of the inhibiting drug. For example, phenelzine, which is one of 
the last remaining non-selective, irreversible MAO inhibitors still prescribed for anxiety 
and depressive illness to patients who are non-responsive to more modern serotonin 
re-uptake inhibitors, has an elimination half-life of 11.6 hours and the inhibition of MAO 
enzyme lasts up to three weeks (Pfizer.Inc., 2007). In contrast, Toloxatone, a reversible 
selective inhibitor of MAO-A, inhibits MAO-A for only six hours before activity returns to 
baseline values (Berlin et al., 1990). Previous chapters have outlined the efficacy of the 
Blackadder juice drink in the inhibition of both MAO isoforms in the periphery and 
potentially for MAO-B centrally. Chapter three of this thesis also outlined a significant 
reduction in blood prolactin after consumption of the Blackadder blackcurrant juice 
drink, which can be representative of central dopaminergic tone, with reductions of 
~55% two hours post-supplementation. These findings are also consistent with 
inhibition of prolactin secretion by the central dopamine receptor D2 agonist 
Bromocriptine, 12mg of which reduces peripheral prolactin by ~60% two hours post-
dose (Luciana et al., 1998). Bromocriptine is prescribed to treat neurodegenerative 
diseases such as parkinsonism (Korczyn et al., 1999) and neuroendocrine issues such 
as hyperprolactinemia (Crosignani, 2006) via antagonism of dopamine D2 receptors on 
normal and tumour lactotrophs (Tansey & Schlechte, 2001)  
 
The active compound or compounds contained in the Blackadder juice drink 
responsible for the inhibition of MAO and the reduction in prolactin levels in previous 
chapters is not yet elucidated and the biphasic nature of blackcurrant phytochemical 
absorption (Jin et al., 2011) indicate that there could be time related effects of MAO 
inhibition with potential for more than one maximal inhibition time point. The 
pharmacodynamics of the inhibition are of great interest, to assess the maximal levels 
of MAO inhibition (Cmax), the time to this maximum inhibition (Tmax) and the total 
duration of the MAO inhibition. This data is also invaluable with regards to the timing of 
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dosing, and safety. For example, the inhibition of both MAO isoforms inhibits the 
degradation of dietary amines in the digestive tract. It is know that if both isoforms are 
inhibited for prolonged periods tyramine can accumulate to dangerous levels 
potentiating a hypotensive crisis (tyramine effect). As data pertaining to the duration of 
the inhibition is essential, a measure will, therefore, be taken 24 hours post-
supplementation. 
 
Results from chapter two illustrate a modulation of blood glucose after consumption of 
the blackcurrant extracts. Glucose levels were greater at 60 and 150 minutes post-
supplementation of the Blackadder juice. Although the major phenolic constituents of 
blackcurrants are anthocyanins, there are less abundant phenolic structures present in 
smaller quantities. There is evidence to show that when phenolic compounds are 
consumed orally with glucose tolerance test the rate and pattern of glucose uptake is 
modulated in rats. This pattern of modulation was not seen after intravenous 
administration, potentially outlining an attenuation of glucose absorption from the small 
intestine (Bassoli et al., (2008). Further to this, Manzano & Williamson (2010) 
demonstrated an inhibition of sodium-glucose transport proteins and glucose 
transporter two in Caco2 cell monolayers after exposure to apple phenolic acids, 
supporting a reduction of glucose transport from the intestinal lumen after 
supplementation of phenolic acids. It is believed that data presented in chapter two 
could be a misrepresentation of the pattern of glucose absorption. Instead of increasing 
overall absorption, it is hypothesised that like apple juice (Johnston et al., 2002), the 
blackcurrant drink reduces the post-prandial peak in blood glucose level resulting in a 
slower release of glucose from the digestive tract. Therefore, the higher blood glucose 
reading one hour post-supplementation of the Blackadder juice extract compared to 
control in chapter two may have been due to a slowing of glucose uptake rather than 
an overall increase in blood glucose. It is, therefore, important that the current study 
investigates more frequent time points to establish a pattern of glucose modulation 
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after consumption of the Blackadder juice extract. In addition, as blood lactate is a 
substrate of glucose metabolism and, therefore, rises with the presence of glucose in 
peripheral blood (Jackson et al., 1973), blood lactate will be used as a measure to 
ensure that reduced glucose levels are due to a slowing of glucose absorption, rather 
than an increased utilisation. 
 
There is an increasing body of data outlining the ability of nutritional interventions to 
modulate haemodynamics in humans. Chapter four of this thesis also highlighted a 
hemispheric-dependent modulation in cerebral haemodynamics after ingestion of the 
Blackadder juice. It is theorised that given that nitric oxide synthesis plays a major role 
in the modulation of localised blood flow in the neural tissue of animal models (Kitaura 
et al., 2007), the pattern of increased oxyhaemoglobin and total haemoglobin in the left 
hemisphere during cognitive tasks, could indicate intervention-dependent, nitric oxide 
synthesis driven neurovascular coupling in the frontal cortex. Berry anthocyanins have 
been shown to induce endothelial dependent relaxation facilitated by up regulation of 
eNOS (Andriambeloson et al., 1998) and to inhibit iNOS (Chen et al., 2001) in vitro. 
Published in vivo human intervention studies, however, reveal contrasting results after 
supplementation of blackcurrant extracts. For example, Jin et al,. (2011) found no 
effects upon flow mediated dilation after acute supplementation of a 20% blackcurrant 
drink containing 52mg of polyphenols, the majority of which were phenolic acids. 
Whereas Matsumoto et al., (2005a) showed increases in skin blood circulation after 
supplementing eight females with 140mg of blackcurrant polyphenols, containing 50mg 
of anthocyanins. A further study by Matsumoto et al., (2005b) showed that 
supplementing 17kmg/kg of body weight of blackcurrant polyphenols increased 
peripheral muscle blood flow as measured by NIRS, and reduced shoulder stiffness 
during typing. Although there are methodological differences between these studies in 
relation to the haemodynamic methods, there are also major difference between 
phenolic profiles of the intervention drinks, most noticeably the amount and type of 
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anthocyanins and phenolics making a direct comparison between studies impossible. 
Although the specific literature outlining effects of blackcurrants upon peripheral 
haemodynamics seems to be ambiguous, endothelium dependent vasodilation and 
large artery stiffness have been shown to be positively affected by cocoa consumption 
in flow mediated dilation studies two hours post-dose (Heiss et al., 2007; Faridi et al., 
2008a) using non-invasive methods, such as digital pulse amplitude tonometry in the 
index finger of healthy young (Fisher et al., 2003) and healthy aged (Fisher & 
Hollenberg, 2006) adults. It is therefore reasonable to suggest that, as well as 
modulation of cerebral blood flow, a blackcurrant intervention with high levels of 
polyphenols, such as the Blackadder juice extract, could affect peripheral 
haemodynamics as measured via a non-invasive digital pulse amplitude tonometry 
method allowing several non-invasive measurements throughout a set time frame. 
 
Given the evidence above, in order to create a sound platform for future behavioural 
research, it is necessary to further investigate the physiological findings from the 
previous investigational chapters of this thesis. In an attempt to establish a “therapeutic 
window”, the current study will assess the Tmax and time course of the MAO-B inhibition 
outlined in chapters two and three of this thesis. The 500mg dose of the Blackadder 
juice extract will be used as this gave the most constant and highest inhibition of MAO-
B. Further to this, a time scale of plasma prolactin levels, which have been shown to be 
reduced after supplementation of the Blackadder juice extract, will be investigated. 
Thirdly to extend the effects of the Blackadder juice extract upon blood glucose levels, 
a full post-prandial blood glucose profile will be taken following supplementation of the 
intervention drink. Finally, the effect of the Blackadder juice extract upon endothelium 
dependent vasodilation and large artery stiffness as measured by digital volume pulse 
will be investigated. 
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5.2 Materials and methods 
5.2.1 Design 
The project investigated the acute effects of a blackcurrant drink made from pressed 
blackcurrant berries (blackcurrant cultivar) standardised to contain 500mg of 
polyphenols and a sugar matched control drink on, blood platelet MAO-B activity, blood 
plasma prolactin, blood glucose and peripheral blood flow. Drinks were matched for 
volume, taste, appearance and sugars. The study followed a double-blind, 
counterbalanced, placebo controlled, repeated measures design.  
Participants were randomly allocated to treatment orders as selected through a 
Williams Latin Square (Williams, 1949)..  
 
5.2.2 Participants 
Eight healthy male adults participated in the study. The mean age of the participants 
who completed the study was 25 years±1.7, with a mean body mass index of 24.99± 
0.71 kg/m2. 
 
 
 
 
 Participants were recruited using opportunity sampling from Northumbria University, 
UK. Participants received £70 to recompense them for any expense they may have 
occurred to participate in the trial. Before participants were enrolled in the study they 
attended a 20 minute screening session. During this screening session participants 
gave their signed consent to participate in the study and were screened for any 
contraindications to the study with the use an exclusion questionnaire (an example can 
be seen in appendix I). Participants were also asked to confirm that they had never had 
issues giving blood. 
 
Table 5.1 Mean participant characteristics   
Measure 
Average 
measurement 
SD Range 
Age (years) 25.3 4.7 20-35 
Height (m) 1.81 0.07 1.7-1.95 
Mass (kg) 82.31 4.73 75-89 
BMI (kg/m
2
) 24.99 2.01 21-27 
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The study received ethical approval from the Northumbria University School of Life 
Sciences Ethics Committee and was conducted according to the Declaration of 
Helsinki (1964). All participants gave their informed consent before their inclusion in the 
study. 
 
5.2.3 Treatments 
The Blackadder juice which was given to participants in chapter three and four was 
again used in this present study (Blackadder cultivar, cultivated and processed in 2011 
by Plant and Food Research Ltd, New Zealand. As discussed in chapter three, the 
Blackadder juice extract is a crude juiced extract yielding approximately 70ml of juice 
containing ~500mg of polyphenols per 100g of fresh fruit, an amount of fruit easily 
eaten or drank in one sitting ensuring the ecological validity of the study. Participants 
received two treatment drinks with at least one week washout in between treatments. 
These drinks contained either 0mg of polyphenols (control) or 500mg polyphenols in 
the form of a cold pressed blackadder juice extract. Drinks were matched for sugars 
and taste as outlined in chapter four. The total volume of the drink was made up to 
200ml with water. All quantities discussed are based on a 60kg person, drink quantities 
were calculated per kilo of body weight. A breakdown of anthocyanins and other 
phenolics in study drinks can be seen in tables 5.2 and 5.3. 
Table 5.2 Anthocyanins and other phenolic compounds in each of the 
treatment conditions (mg per 60kg of bodyweight) 
Treatment 
Anthocyanins 
mg/60kg 
Other phenolics 
mg/60kg 
Total 
phenolics 
(mg/60kg) 
Control 0 0 0 
Blackadder  372.8 127.2 500 
 
Table 5.3 Anthocyanins and other phenolic compounds in each of the treatment conditions.(mg per kilo of body weight, average dose 
given (mg) and dose range (mg))  
Treatment 
Anthocyanins 
(mg/kg) 
Anthocyanin 
average dose 
(mg) 
Dose 
Range 
(mg) 
Other 
polyphenols 
(mg/kg) 
Other 
polyphenols 
average dose 
(mg) 
Dose 
range 
(mg) 
total 
polyphenols 
(mg/kg) 
Total 
polyphenols 
average 
dose (mg) 
Dose 
range 
(mg) 
Control 0 0 0 0 0 0 0 0 0 
Blackadder 6.21 511 465-555 2.11 173 158-188 8.33 685 624-744 
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5.2.4 Peripheral blood flow 
Transmission of infrared light through the finger is proportional to blood volume, 
measurement of which gives a digital volume pulse (DVP). DVP is a non-invasive 
method of measuring reflective index and stiffness index via a photoplethysmography 
transducer placed on the figure that can been used as a sensitive index of nitrate 
bioavailability (Bass et al., 1989). DVP has been shown to be sensitive to NO synthase 
manipulation (Klemsdal et al., 1994), administration of vasoactive drugs and vascular 
ageing (Takazawa et al., 1998). There are two factors pertaining to the DVP waveform. 
The first is formed as a result of the direct propagation of this pulse from the aortic root 
to the finger (figure 5.1a). As well as travelling down the arm, the direct pulse 
propagates along the aorta toward the lower body. At every change in diameter and at 
arterial bifurcations, part of the pulse is reflected back. All these reflections add up and 
can be considered as a single reflected wave arising from the lower body. This 
reflected wave travels back up the aorta and then down the arm to the finger to form 
the second, diastolic, part of the DVP waveform (figure 5.1b). The upper limb provides 
a common conduit for both the directly transmitted wave and the reflected wave and, 
therefore, has little influence on the contour of the DVP.  Depending on the vascular 
tone and large artery stiffness, the characteristics of the DVP waveform may change. 
The PulseTrace PCA2 (Carefusion) was used to derive two indices from the contour 
analysis of the DVP: the reflection index (RI) and the stiffness index (SI). RI was used 
to assess endothelial function by measuring its change to potential endothelium 
dependent vasodilatory properties of the blackcurrant intervention and SI was used as 
a measure of large artery stiffness.  
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Figure 5.1 An example DVP waveform. showing (a) pulse from the aortic root to the finger and (b) the reflected wave. 
 
5.2.5 Blood collection and storage 
Blood was collected from an inlaying cannula in the left median cubital vein. Venous 
blood samples (15ml) were collected at baseline and 10 further time points post-
supplementation of study treatments. Cannulae and connecting tubes were kept patent 
with saline solution containing 0.9% sodium chloride (Posiflush, BD Becton Dickinson 
Ltd, Oxford, UK). Samples were collected in either BD vacutainers© (Becton, Dickinson 
and company) or a with a 20µl end-to-end capillary (EKF Diagnostics). Vacutainer 
receptacles were treated with anticoagulants, one with lithium heparin (LH) and one 
with (EDTA). Blood samples were kept on ice and centrifuged within 30 minutes of 
collection. Whole blood samples treated with LH and EDTA were prepared for storage 
using the methods described in section 2.2.5. Prepared samples were stored at -80ºC 
until analysis was performed. 
 
5.2.5.1 MAO-B analysis 
Isolated platelet pellets were tested for MAO-B activity using the same methods as 
described in section 2.2.5.1.  
 
Si
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5.2.5.2 Prolactin analysis 
Prolactin analysis was measured by diagnostic Medlab, Auckland, New Zealand. 
Prolactin was analysed in 300µl of blood plasma collected in LH treated vacutainers 
and prepared for storage using the method outlined in section 2.2.5.4 
 
5.2.5.3 Glucose and lactate analysis 
Twenty microlitres of whole blood was collected from the inlaying cannula in an end-to-
end capillary (EKF Diagnostics) and immediately transferred into an EKF safe-lock cup 
prefilled with 1ml of haemolysis solution. The whole blood and haemolysis solution was 
then analysed using a Biosen C_line analyser (EKF diagnostics) for glucose (mmol/L) 
and lactate (mmol/L) within 30 minutes of collection. The manufacturer reports that the  
Biosen C_line analyser has a coefficient of variance (CV) of 1.5%. 
 
5.2.6 Procedures 
Participants were required to attend the laboratory a total of three times. The first was a 
screening visit to ensure eligibility, the second and third were study visits lasting a total 
of 4.5 hours. On all study day visits, participants arrived in the laboratory at 8am, and 
firstly gave a baseline DVP measurement after a five minute seated resting period. 
Participants were then cannulated in the left median cubital vein by a qualified 
phlebotomist. After a five minute seated rest, a DVP measurement was taken from the 
left index figure. Fifteen millilitres of blood was then drawn from the cannula using a 
5ml vacutainer containing EDTA and a 10ml vacutainer containing LH. Dependent 
upon treatment allocation, the participant was then randomly supplemented with either 
the Blackadder juice drink or the matched control. A further 15ml of blood was then 
removed via the cannula; at; 15, 30, 45 60, 100, 120, 150, 180 and 240 minutes post-
supplementation. DVP  measurements were also taken in triplicate immediately prior to 
every cannulation blood sample. Participants were then free to leave. The participant 
was required to attend a 24 hour follow up visit where a further DVP measurement was 
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taken and 15ml of blood was removed via venepuncture. A graphical representation of 
the study running order can be seen in figure 5.2. 
 
Figure 5.2 Study day running order. Scale depicts minutes post supplementation of the study intervention. DVP=Digital 
volume pulse, CRF= case report form. 
 
5.2.7 Statistical analysis  
For all outcomes, data was separated for the purpose of two analyses. These were, 
study day epochs, baseline through to 240 minutes post-supplementation for the 
purpose of assessing the Cmax and Tmax of the biological parameters up to four hours 
post-dose; and the 24 hour follow up visit to assess if values had returned to baseline 
24 hours post-dose. 
 
For blood parameters MAO-B activity, prolactin, glucose and lactate, an estimation of 
the area under the curve (AUC) was calculated using the incremental trapezoidal 
method. Data points below quantification (zero) were replaced with zero. AUC was 
calculated incrementally from time point; 0 to 15, 15 to 30, 30 to 45, 45 to 60, 60 to 
100, 100 to 120, 120 to 150, 150 to 180 and 180 to 240 minutes using “unchanged” 
raw data (iAUC). Increments were then summed to give an area under the curve from 
time point zero, to the last observed study day concentration at 240 minutes post-
supplementation (AUCo-t). DVP parameters and 24 hour assesments were analysed as 
‘change from baseline’. In addition to AUC, blood lactate and blood glucose data were 
also analysed using repeated measures ANOVA of change from baseline data (as 
used in chapter two of this thesis). This allowed comparisons to be made between 
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results from chapter two and the current data set so the hypothesis of a blunted blood 
glucose post-prandial peak could be tested. Both AUC and change from baseline 
analyses are therefore presented below in section 5.3 where any significant differences 
were found. 
 
The null hypothesis was rejected with a p value <0.05. Baseline differences were 
calculated for all measures using a one way (treatment) repeated measures ANOVA. 
Statistical analysis was performed in the SPSS 18 statistics package using repeated 
measures ANOVAs (General linear model). Treatment [control and juice] × time point 
[1 to 9] for all outcomes and a one way repeated measures ANOVA (treatment [control 
and juice]) for AUCo-t, 24 hour prolactin, 24 hour MAO-B, 24 hour DVP, 24 hour glucose 
and 24 hour lactate. Pairwise comparisons were conducted on all outcomes with a p 
value <0.5 from the initial ANOVA to ascertain any differences between treatments for 
the whole session and at specific epochs. Mauchly`s test of sphericity was used to 
assess equality of the variances of the differences between factors. Where sphericity 
had been violated, Huynh-Feldt corrections for non-sphericity were implemented. As 
only one treatment was being compared to control, no Bonferroni corrections were 
made. 
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5.3 Results 
Prior to analysis of change from baseline data, mean pre-dose scores for control and 
juice treatments for each outcome were subjected to a one way repeated measures 
ANOVA. There were no significant differences found between treatments on any 
measures. Area under the curve data can be found in table 5.4. Mean pre-dose and 
post-dose change from baseline results for each haemodynamic and blood outcome 
are presented in table 5.5, 24 hour post-data presented in table 5.6. Unchanged “raw” 
data tables can be found in appendix X. Outcomes that elicited a significant effect in 
the initial ANOVA are outlined below and depicted in figure 5.3. 
 
5.3.1 Blood glucose  
There were no significant differences found for the AUC between treatments with 
regards blood glucose levels. The repeated measures ANOVA of change from baseline 
data revealed a significant treatment*epoch interaction [F(3.65,25.60=3.19, p=0.033]. 
Pairwise analysis revealed a significant reduction in blood glucose 15 minutes after 
supplementation of the juice treatment when compared to control (p=0.027). There 
were no significant effects of treatment at the 24 hour time point. 
 
5.3.2 Prolactin 
The one way treatment repeated measures ANOVA revealed a significant effect of 
treatment for the AUCo-t outcome prolactin [F(1,7)=64.92, p<0.001]. This was observed 
to be a significant reduction in prolactin after supplementation of the juice treatment 
when compared to control The treatment*increment ANOVA revealed a significant 
interaction [F(2.7,18.88)=12.48, p<0.001]. Pairwise analysis of the increments revealed 
significantly lower iAUC at 45-60 (p=0.006), 60-100 (p=0.001), 100-120 (p<0.001), 120-
150 (p=0.001), 150-180 (p=0.001) and 180-240 minutes (p=0.001). There were no 
significant effects of treatment at the 24 hour time point. 
 
 
 
163 
 
5.3.3 Platelet MAO-B activity 
The one way treatment repeated measures ANOVA revealed a significant effect of 
treatment for the AUCo-t [F(1,6)=61.1, p<0.001]. This was observed to be a significant 
reduction in AUC platelet MAO-B activity after supplementation of the juice treatment 
when compared to control The treatment*increment ANOVA revealed a significant 
treatment*increment interaction [F(2.04,12.28)=34.5, p<0.001]. Pairwise analysis of the 
increments revealed significantly lower iAUC at 0-15 (p=0.04), 15-30 (p<0.001), 30-45 
(p<0.001), 45-60 (p<0.001), 60-100 (p<0.001), 100-120 (p<0.001), 120-150 (p<0.001), 
150-180 (p=0.001) and 180-240 minutes (p=0.001). There were no significant effects of 
treatment at the 24 hour time point. 
 
Table 5.4 Incremental and total AUC data for the control and juice treatment for blood outcomes 
MAO-B prolactin, glucose and lactate and ANOVA outcomes 
iAUC 
MAO-B Prolactin Glucose Lactate 
Control Juice Control Juice Control Juice Control Juice 
0 to 15 minutes 17305 12757 59983 46686 1.27 1.15 0.22 0.24 
15 to 30 minutes 16850 1375 61751 43898 1.45125 1.29 0.32 0.27 
30 to 45 minutes 14774 62.70 42613 35083 1.2275 1.25 0.36 0.35 
45 to 60 minutes 15052 0 32320 22589 0.96 1.07 0.33 0.37 
60 to 100 minutes 34648 0 68240 53746 2.38 2.47 0.67 0.80 
100 to 120 minutes 40410 0 34665 27514 1.2875 1.28 0.24 0.31 
120 to 150 minutes 43399 1195 34906 25365 1.9775 1.98 0.33 0.40 
150 to 180 minutes 44436 2338 61293 43778 2.03625 2.06 0.36 0.38 
180 to 240 minutes 91500 8833 59983 46686 4.16125 4.14 0.73 0.77 
Total AUC 318379 26564 49471 37333 16.75 16.72 3.60 3.92 
Effect of treatment F=61 p<0.001 F=64 p<0.001 F=0.12 p>0.1 F=1.55 p>0.1 
Treatment*increment interaction F=34 p<0.001 F=12 p<0.001 F=2.08 p=0.07 F=1.58 p>0.1 
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Figure 5.3 Change from baseline scores for blood 
glucose levels (a), and “unchanged raw values for blood 
plasma prolactin (b) and platelet MAO-B activity (c). 
*(p<0.05). Shaded areas depict increments where 
p<0.05 in the treatment*increment pairwise 
comparisons.  
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Table 5.5 Mean pre-dose baseline and change from baseline scores, standard deviations and ANOVA outcomes for all haemodynamic parameters 
Measure Treatment N 
Baseline 15 minutes 30 minutes 45 minutes 1 hour 1.5 hours 2 hours 2.4 hours 3 hours 4 hours Effect of 
treatment 
Treatment*epoch 
interaction Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Heart rate  
(BPM) 
Control 
8 
60.5 11.22 0.88 4.55 4.75 11.8 5 3.42 5 4.54 2.38 6.86 0.5 4.34 -4.5 4.87 -2.38 5.5 -1.88 5.11 
F=0.16 p>0.1 F=1.60 p>0.1 
Juice 63.63 8.52 1 6.19 -3.13 3.68 -1 6.39 0.63 4.17 1.75 2.25 0.13 6.22 -5.75 4.71 -4.38 2.62 -7.5 3.38 
DVP - SI 
Control 
8 
5.71 1.08 -0.12 0.72 0.73 2.9 -0.18 0.52 0.06 0.65 -0.39 0.71 -0.25 0.48 -0.3 0.88 -0.31 0.89 -0.52 0.77 
F=0.51 p>0.1 F=1.62 p>0.1 
Juice 6.63 0.97 0.34 0.45 -0.08 0.45 0.48 1.27 0.12 0.97 0.1 0.88 0.07 0.74 -0.22 0.73 0.01 0.38 -0.29 0.6 
DVP - RI 
Control 
8 
61.88 16.34 7.13 12.15 -4.88 7.02 3.75 15.97 5.75 7.23 -5.88 10.91 -0.75 5.85 5.13 13.57 5.5 17.39 -1.75 21.47 
F=1.23 p>0.1 F=1.29 p>0.1 
Juice 69.13 12.98 7.25 9.59 -1 11.34 -7.38 13.88 -4.38 12.77 -4.88 15.49 -5.88 17.33 -2.88 12.47 -1.63 11.31 -4.5 10.24 
Glucose Control 
8 
4.25 0.47 1.65 1.4 1.45 1.24 -0.14 1.06 -0.7 0.75 -0.6 0.42 -0.33 0.45 -0.27 0.48 -0.09 0.39 -0.11 0.44 
F=0.028 p>0.1 F=3.19 p=0.033 
(mmol/L) Juice 4.23 0.44 0.79 1.04 1.1 0.93 0.48 1.17 -0.41 0.92 -0.57 0.5 -0.33 0.42 -0.2 0.38 -0.02 0.41 -0.16 0.46 
Lactate Control 
8 
0.72 0.24 0.33 0.63 0.68 0.55 0.6 0.49 0.47 0.33 0.07 0.23 -0.05 0.16 -0.04 0.13 0.03 0.14 -0.02 0.16 
F=1.72 p>0.1 F=2.27 p=0.069 
(mmol/L) Juice 0.93 0.37 0.06 0.24 0.33 0.28 0.6 0.39 0.53 0.38 0.05 0.23 -0.05 0.26 -0.17 0.37 -0.14 0.28 -0.18 0.41 
 
 
 
 
 
 
 
Table 5.6Mean change from baseline scores, standard deviations and ANOVA outcomes for 
MAO-B, prolactin glucose, lactate and DVP 24 hour parameters 
Measure Treatment N 
24h 
Effect of treatment 
Mean SD 
MAO-B Control 
6 
665.59 596.15 
F=2.54 p>0.1  
(nmol H2O2) Juice -108.15 863.12 
Prolactin Control 
6 
26.16 137.91 
F=0.23 p>0.1  
(mIU/L) Juice 19.88 109.28 
Glucose Control 
8 
0.25 0.32 
F=0.20 P>0.1 
(mmol/L) Juice 0.11 0.75 
Lactate Control 
8 
0.21 0.54 
F=0.041 p>0.1 
(mmol/L) Juice -0.21 0.35 
Heart Rate Control 
8 
3 4.41 
F=2.95 p>0.1 
(BPM) Juice -6 8.93 
DVP -SI 
Control 
8 
-0.15 0.51 
F=0.14 p>0.1 
juice -0.01 0.71 
DVP -RI 
Control 
8 
-6.13 14.25 
F=0.041 p>0.1 
Juice -4.13 12.7 
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5.4 Discussion 
The current study details a fast and absolute inhibition of blood platelet MAO-B and a 
significant reduction in plasma prolactin after consumption of the Blackadder 
blackcurrant juice extract when compared to control. The data also demonstrate a 
blunted post-prandial blood glucose peak after consumption of the Blackadder 
blackcurrant juice extract when compared to control. 
 
The current study illustrates a sustained significant reduction in platelet MAO-B of 
~100% when compared to control. This reduction began 15 minutes post 
supplementation, the first post-dose epoch measured, and continued through to four 
hours post does, the last day one measurement. MAO-B activity had then returned 
close to the pre-dose baseline level 24 hours post-dose. These results show an 
increased inhibition compared to findings in chapters two and three, which revealed an 
inhibition closer to 85%. Unfortunately, because of the rapid inhibition of the MAO-B 
enzyme, it is not possible, from these data, to calculate a time to maximal inhibition. It 
would, therefore, be useful if future studies were conducted using several doses and 
shorter initial blood collection epochs. The active compound or compounds driving this 
inhibition are not known. Data in the literature outlines an inhibition of MAO-B by 
anthocyanins in vitro (Dreiseitel et al., 2009a); however, this study used levels 1000 
times higher than quantified in plasma after oral consumption. In addition maximal 
plasma concentrations do not occur until one to two hours post consumption (Mazza et 
al., 2002), making it unlikely that they explain the effects seen at 15 minutes in the 
current study. Coupled with the inability of the DelcyanTM treatment (an anthocyanin-
enriched extract) to inhibit MAO-B in chapter two, this outlines that at least alone, 
anthocyanins are not likely to be the compound driving MAO inhibition. No significant 
effects of the Blackadder blackcurrant juice extract were evident at the 24 hour post-
dose follow up visit when compared to control.  This result outlines a distinct reversible 
complete inhibition of peripheral MAO-B activity from the Blackadder juice extract. 
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When compared to pharmaceutical reversible MAO-B specific inhibitors such as 
Lazamabemide, the profile of MAO-B inhibition of Blackadder juice bears a remarkable 
similarity, with rapid inhibition of MAO-B in platelets of >90%, 30 minutes post-dose, 
maximal inhibition subsiding 16 hours post-dose and full restoration of enzyme activity 
returning 48 hours post-dose following a 100mg dose (Dingemanse et al., 1997). 
 
As anticipated, peripheral prolactin was significantly reduced after supplementation of 
the Blackadder juice drink when compared to placebo. Reductions were seen 30 
minutes post-consumption, with significantly lower area under the curve increments 
beginning 45 minutes post-dose and continuing until the last measured concentration 
at 240 minutes post-dose. The maximal reduction appeared at the 120 minute epoch 
with a reduction of 61%. This reduction in prolactin coincides with that reported in 
chapter three, where a reduction of 55% was reported 120 minutes post-
supplementation of the 500mg Blackadder juice drink. These findings are also 
consistent with inhibition of prolactin secretion by the central D2 receptor agonist 
Bromocriptine, 12mg of which reduces peripheral prolactin by ~ 60% two hours post-
dose (Luciana et al., 1998). These reductions in prolactin could have positive 
implications upon symptoms associated with hyperprolactinaemia, such as libido and 
sexual health (Buvat, 2003), but more importantly, as predominant control of prolactin 
is via hypothalamic inhibition of lactotroph activity and the most important hypothalamic 
prolactin inhibiting factor is dopamine (Ben-Jonathan & Hnasko, 2001), they indicate 
the possibility of a centrally active inhibition of MAO after ingestion of the Blackadder 
juice extract. 
 
With regards to blood glucose modulation, it was hypothesised in chapter two that the 
time points used did not allow for a clear representation of the effect of the blackcurrant 
intervention upon post-prandial glucose profiles. As hypothesised, supplementation of 
the Blackadder juice significantly reduces the post-prandial peak of blood glucose, and 
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delays the peak by 15 minutes when compared to the control beverage, as shown in 
figure 5.3a. Although further time points were not significant a modulation of blood 
glucose occurs until 100 minutes post-consumption of the Blackadder extract with 
decreased levels until ~35 minutes post-dose then increased blood glucose levels until 
100 minutes post-dose where glucose levels return to a level similar to control and 
remain that way until the last measured time point at 240 minutes post-dose. Blood 
glucose followed a similar pattern of modulation described by Törrönen et al., (2012) 
and Wilson et al., (2008), with reduced levels from the first post-dose measurement at 
15 minutes until one hour post-dose. Peak plasma glucose levels published by 
Törrönen et al., (2012) were, however, later than the findings in the current study with 
peaks at ~40 minutes post-consumption. However, Törrönen et al., (2012) used 
sucrose meal, a disaccharide composed of the monomers fructose and glucose. 
Therefore, some digestion would need to take place for the glucose molecule to be 
cleaved from the sucrose compound before it could be transported to the blood stream, 
slowing absorption in both the active and control treatments. In the current study, 
glucose findings are coupled with a non-significant trend towards reduction in post-
prandial lactate 15 minutes post-supplementation of the Blackadder blackcurrant juice 
extract when compared to control. As lactate is a by-product of glucose metabolism, 
this further supports the hypothesis that the pattern of glucose modulation was a result 
of slowed glucose absorption rather than an increase in metabolism (a graphical 
representation of this can be seen in appendix VII). Although samples in the current 
study were taken at regular time points via cannulation, it must be noted that the 
infrequent samples make the assumption that the modulation in blood glucose is linear 
between each sample. It would be beneficial to use such methods as interstitial 
continuous glucose monitoring as used by Dye et al., (2010) to allow for a full “real 
time” profile of the effects of the blackcurrant extract upon blood glucose to be 
monitored. 
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In contrast with Matsumoto et al., (2005a; 2005b), measures of endothelial dependent 
peripheral haemodynamics were not impacted by the Blackadder juice drink. However, 
Matsumoto et al., (2005b) used a different technique, NIRS, and measured blood flow 
during typing. This measurement of blood flow could indicate an increase in 
haemodynamics due to an increased demand because of the typing task used. 
Therefore, like neuronal findings in chapter four this may suggest that a metabolic 
demand must be placed on the area, to increase blood flow, before a treatment effect 
can be seen. The results from the current study are in line with findings by Jin et al., 
(2011) who showed that measures of endothelial dependent peripheral 
haemodynamics were unchanged after consumption of a 20% blackcurrant drink. 
However, it must be noted that the dose of blackcurrant juice used by Jin et al., (2011) 
contained majorly phenolic acids (80mg) whereas the extract in the current study 
contained a broad profile of polyphenols, including 372mg of anthocyanins. Therefore, 
direct comparison cannot be made. In light of results presented in chapter four of this 
thesis, it is, however clear that, more structured research needs to be conducted in 
relation to the effect of blackcurrants upon peripheral and cerebral blood flow, utilising 
standardised techniques, consistent methodologies and standardised extracts from 
varying post-harvest preparations at different doses. 
 
In conclusion, along with a growing body of blackcurrant polyphenol pharmacokinetic 
data in the literature, these data provide invaluable pharmacodynamic information 
pertaining to the impact of the Blackadder juice upon blood glucose, platelet MAO-B 
and peripheral prolactin; therefore, creating a sound platform and an indication of a 
therapeutic window for future behavioural and physiological methodologies to be 
based. 
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CHAPTER 6. THE SHORT TERM EFFECTS OF TWO BLACKCURRANT 
EXTRACTS ON MOOD AND COGNITION IN MIDDLE AGED ADULTS 
6.1 Introduction 
Chapter three of this thesis indicated no improvements upon any aspects of working 
memory, spatial memory, verbal memory, retrieval memory or motor processing 
outcomes in healthy young adults after acute supplementation of the Blackadder juice 
drink extract standardised at 125mg, 250mg or 500mg of total polyphenols. Data from 
the initial intervention study in this thesis, however, suggested that acute 
supplementation of blackcurrant extracts can attenuate reductions in cognitive 
behaviour associated with mental fatigue in healthy young adults, in particular, 
attention. It is hypothesised that the null effects of the Blackadder juice extract on 
memory in chapter three of this thesis could be associated with the age of the cohort 
used. These healthy adult participants were likely to be performing near to their 
cognitive peak (Salthouse, 2009), and unlike the initial intervention study, participants 
may not have been mentally fatigued to a high enough level to reveal subtle cognitive 
benefits. As discussed in previous chapters, epidemiological data suggest that diets 
high in fruit based phytochemicals, particularly flavonoids, can attenuate age related 
reductions in cognition  (Letenneur et al., 2007; Nurk et al., 2009; Devore et al., 2012; 
Kesse-Guyot et al., 2012). Shorter, chronic, intervention studies in elderly humans 
have also demonstrated a very mild attenuation of age related cognitive decline, 
particularly with respect to episodic memory, recall memory, visual attention, visuo-
spatial and verbal memory (Krikorian et al., 2010a; Krikorian et al., 2010b; Krikorian et 
al., 2012). No such reports have been published in the literature in relation to acute 
studies or in a middle aged population. 
 
Decrements in memory, spatial visualisation and reaction times have been shown by 
the age of 50 (Salthouse, 2009). These age related cognitive declines are coupled with 
age related changes in several neurobiological variables such as; reductions in 
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serotonin receptor binding (Sheline et al., 2002), reductions in striatal dopamine 
binding (Volkow et al., 2000), increases in brain MAO activity (Fowler et al., 1997) and 
reductions in cortical blood flow (Leenders et al., 1990); all of which are theorised to 
play a role in natural cognitive decline and could, therefore, be therapeutic targets in 
the battle against age related cognitive decline. Chapters two, three and five of this 
thesis have demonstrated a robust and powerful inhibition of peripheral MAO-A and -B 
and potentially central MAO-B following acute supplementation of the Blackadder juice 
extract. Coupled with reductions in levels of peripheral prolactin, at similar levels to that 
of D2 receptor agonists, it can be theorised that there is a potential inhibition of either 
or both MAO isoforms within the brain and, therefore, a potential increase in central 
nervous system levels of dopamine after consumption of the Blackadder juice drink; 
reductions of which, are thought to be a key factor in cognitive decline associated with 
natural ageing (Volkow et al., 1998; Bãckman et al., 2000). Unlike most central nervous 
system  enzyme systems, MAO-B presence in neuronal tissue has been shown to 
increase with age. For example, in a positron emission tomography analysis of 21 
participants aged between 23 and 86 years, Fowler et al., (1997) reported an increase 
in brain MAO-B activity of 7% per decade. These increases in MAO activity with age 
are linked with reduced levels of striatal dopamine and an increase in extracellular 
H2O2
 (Kish et al., 1992). Further to MAO inhibition, results from chapter four of this 
thesis highlight modulations of shallow pre-frontal cortical haemodynamics during 
cognitive demand after consumption of the Blackadder juice extract. As mentioned 
earlier, reductions in cortical blood flow of up to 0.5% per year are evident during 
natural ageing (Leenders et al., 1990) and are associated with age related dementia 
(Dede et al., 2007). Although acute increases in regional cerebral blood flow by a 
nutritional intervention has not been shown to influence acute cognitive performance in 
young adults, recent unpublished “pilot” findings from Northumbria University (The 
Brain, Performance and Nutrition Research Centre) indicated that supplementing five 
healthy middle aged participants with 500mg of resveratrol increased regional cerebral 
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blood flow. Additionally, serial three cognitive task correct responses increased, a 
response to the intervention which has not been seen in a young cohort (unpublished 
observation, private communication). Although other factors could have influenced the 
positive findings, this potentially indicates a beneficial effect of the modulation of 
cerebral haemodynamics upon cognitive performance in a middle aged cohort. Utilising 
data from previous studies and prior findings from this thesis, the current study will 
assess the time course of any behavioural effects of the intervention. These facets will 
be accessed via conducting multiple cognitive assessments throughout the day at time 
points when MAO activity is known to be inhibited, central blood flow is known to be 
modulated and time points when the “parent” compounds and biphasic metabolites of 
the blackcurrant extracts are known to be in the periphery. 
 
There is some evidence suggesting that polyphenol rich fruits can attenuate the onset 
of natural ageing as outlined in animal models, and long term epidemiological 
observations indicate slower cognitive decline in cohorts with higher polyphenol intake. 
It, therefore, makes sense that cohorts who are suffering cognitive and psychomotor 
decline (which could be associated with reduced dopaminergic tone, reductions in 
cortical blood flow and increased MAO activity but not to an extent where any 
pathological effects can be seen), such as the middle aged (Leenders et al., 1990; 
Fowler et al., 1997; Volkow et al., 1998; Salthouse, 2009), could respond positively to a 
flavonoid-rich, haemodynamic modulating and MAO inhibiting blackcurrant extract. 
Acute supplementation could heighten short term cognitive function whilst the long term 
consumption could delay the onset of age related cognitive decrements later in life. 
Although measurement of the effect of long term blackcurrant supplementation is not 
within the remit of this thesis, acute supplementation of the Blackadder juice drink in a 
middle aged cohort could positively affect dopamine related cognitive tasks that have 
been shown to be sensitive to natural ageing, such as finger tapping, working memory, 
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mental flexibility, attention related tasks and response inhibition (Salthouse, 1991; 
Volkow et al., 1998; Salthouse, 2009).  
 
Previous chapters in this thesis have shown a mild modulation of blood glucose after 
consumption of the Blackadder juice drink, more specifically, a reduction in immediate 
post-prandial blood glucose levels. These reductions are theorised to be brought about 
by the interaction of phenolic compounds with sodium-glucose transport proteins and 
glucose transporter 2, resulting in a slower uptake of glucose into the blood stream 
(Manzano & Williamson, 2010). These effects have been documented by other authors 
acutely after simultaneous consumption of sugars and phenolic rich cranberry juice 
(Wilson et al., 2008b) and berry purée (Törrönen et al., 2012). However, a later post-
dose glucose challenge, without further phenolic supplementation, has not been 
documented. A secondary focus of this study will, therefore, assess whether a later 10g 
glucose load in the form of a drink will facilitate a similar pattern of glucose modulation 
as that seen with simultaneous glucose and blackcurrant polyphenol consumption in 
chapter five.  
 
Given the above evidence, the current study aims to examine if acute supplementation 
of blackcurrant extracts in a middle aged population, whom will potentially be exhibiting 
early age related cognitive deficits, can augment memory, attention and executive 
function. The study will utilise two active treatments; the DelcyanTM powdered extract 
used in chapter two of this thesis, which is an anthocyanin-enriched extract and has 
been shown to have no effect upon central or peripheral MAO-B activity in vivo; and the 
Blackadder cultivar juice extract which contains the full blackcurrant phenolic profile 
and has been shown to inhibit both MAO isoforms and to modulate cortical 
haemodynamics in vivo. This will allow differentiation between the effects of a berry 
extract with a MAO-B inhibiting effect and an extract lacking this ability. 
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6.2 Materials and methods 
6.2.1 Design 
The project investigated the acute effects of two blackcurrant extracts on cognition, 
blood platelet MAO-B activity, monoamines and associated metabolites, blood plasma 
prolactin and blood glucose. Drinks were matched for volume, taste, appearance and 
sugars but differed in the amount of total polyphenols. The study followed a double-
blind, counterbalanced, placebo controlled, repeated measures design.  
Participants were randomly allocated to treatment orders as selected through a 
Williams Latin Square (Williams, 1949).. 
 
6.2.2 Participants 
Thirty-nine healthy participants aged between 40 and 60 took part. Of these, 35 
participants (9 male, 26 female) aged 53.5±6.03 with an average BMI of 24.4±0.46 
completed the study.  
 
 
 
 
Participants were recruited from the general Newcastle area and received £120 on 
completion of the study. Participants were required to participate in three study visits 
with at least one week washout period between visits plus a 90 minute screening 
session. During the screening session, participants gave their signed consent to 
participate in the study and were screened for any contraindications to the study with 
the use an exclusion questionnaire (an example exclusion questionnaire can be seen 
in appendix I). Participants reported themselves to be healthy, not pregnant, non-
tobacco users. Participants were not using dietary supplements or over the counter or 
recreational drugs (excluding the contraceptive pill), did not have any sensitivities to 
any of the study treatments and had a body mass index below 35kg/m2. Eligible 
Table 6.1 Mean participant characteristics   
Measure 
Average 
measurement 
SD Range 
Age (years) 53.4 6 40-60 
Height (m) 1.65 0.07 1.5-1.83 
Mass (kg) 67.24 10.11 49-84 
BMI (kg/m
2
) 24.40 2.70 19-31 
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participants then practiced the study cognitive battery two times to assure familiarity 
with the study protocol and to ensure minimum scores on all tasks were obtained. 
 
The study received ethical approval from the Northumbria University School of Life 
Sciences Ethics Committee and was conducted according to the Declaration of 
Helsinki (1964). All participants gave their informed consent before their inclusion in the 
study. 
 
6.2.3 Treatments 
Participants received three treatment drinks with at least one week washout in between 
visits. These drinks contained either 0mg of polyphenols (control) or 500mg of 
polyphenols from an anthocyanin enriched powdered blackcurrant extract (DelcyanTM, 
Just The Berries, New Zealand (Delcyan)) or from a cold pressed blackcurrant juice 
drink, ((Blackadder cultivar, cultivated and processed in 2011 by Plant and Food 
Research Ltd, New Zealand (Blackadder Juice)). In each case, drinks comprised of 
4.7g of glucose, 7.8g of fructose, 5.4g of Splenda® sweetener and 50ml of blackcurrant 
flavouring (Schweppes blackcurrant flavouring). The total volume of the drink was 
made up to 200ml with water. Unlike previous intervention chapters in this thesis, 
drinks were not calculated by kilo of body weight but were instead quantified at 500mg 
of polyphenols per drink. This was in light of findings from chapter three of this thesis, 
which highlighted a negligible dose response between 250mg and 500mg when 
standardised per 60kg of body weight and allowed the efficacy of a standard dose to be 
investigated, increasing ecological validity of the study. 
 
Table 6.2 Anthocyanins and other polyphenols in each of the 
intervention drinks(mg/60kg) 
Treatment 
Anthocyanins 
(mg) 
Other phenolics 
(mg) 
Total 
phenolics 
(mg) 
Control 0 0 0 
Juice 372.8 127.2 500 
Delcyan
TM
 483.2 16.8 500 
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Table 6.3 Anthocyanins and other phenolic compounds in each of the treatment conditions.(mg per kilo of body weight, average dose 
given (mg) and dose range (mg))  
 For 
Treatment 
Anthocyanins 
(mg/kg) 
Anthocyanin 
average dose 
(mg) 
Dose 
Range 
(mg) 
Other 
polyphenols 
(mg/kg) 
Other 
polyphenols 
average dose 
(mg) 
Dose 
range 
(mg) 
total 
polyphenols 
(mg/kg) 
Total 
polyphenols 
average 
dose (mg) 
Dose 
range 
(mg) 
Control 0 0 0 0 0 0 0 0 0 
Blackadder 6.21 417 308-324 2.11 141 104-178 8.33 560 414-703 
Delcyan
TM
 8.05 541 400-679 0.28 18.82 13-23 8.33 560 415-703 
 
6.2.4 Study tasks 
Eleven cognitive measures and two mood scales were delivered using the 
Computerised Mental Performance Assessment System (COMPASS). Task stimulus 
was responded to using a peripheral response box (Cedrus RB-530) as shown in figure 
2.1. The finger tap task was custom designed using Microsoft Visual Basic (version 
1.5) and the digit symbol substitution task (DSST) was completed in pen and paper 
format. For the purpose of behavioural analysis, cognitive tasks were selected with the 
intention that a wide variety of cognitive functions could be assessed, including fine 
motor movement, verbal memory, retrieval memory, spatial memory, response 
inhibition, attention and cognitive flexibility. Progress through the battery of tasks was 
controlled by the participant with brief instructions given on screen prior to the start of 
each task. 
 
6.2.4.1 Finger tap: The finger tap task is one of the most frequently used paradigms to 
investigate human psychomotor function in neuro-imaging studies (Witt et al., 2008) 
and is closely related to central dopaminergic tone (Jahanshahi et al., 2010), with 
decrements in tapping performance observed in dopamine associated neurological 
diseases (Jahanshahi et al., 2010). The constant finger tapping task, which has been 
shown to have good intra-person repeatability (Arias et al., 2012), was used as a 
measure of psychomotor performance in the current study. Participants were required 
to press the space bar on the computer keyboard as many times as they could in 90 
seconds, only using their dominant index finger. The outcome measure was number of 
taps per 90 seconds. 
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6.2.4.2 Bond-Lader mood scales: Bond-Lader visual analogue mood scales (Bond & 
Lader, 1974). Scores from the 16 Bond-Lader visual analogue scales were combined 
as recommended by the authors to form three mood factors: ‘alert’, ‘calm’ and ‘content’. 
 
6.2.4.3 Visual analogue scales: Participants were asked to subjectively rate how 
physically energised, mentally energised and mentally fatigued they felt before and 
after the cognitive tasks. The scale was anchored “Not at all” and “extremely”. With 
higher scores representing more physically energised, mentally energised and  
fatigued. 
6.2.4.4 Picture presentation: A series of 15 photographic images of everyday objects 
and scenes were presented on the screen at the rate of 1 every 3 seconds, with 
stimulus duration of 1 second, for the participant to remember. 
 
6.2.4.5 Word presentation: Fifteen words, matched for frequency and concreteness, 
were presented in sequence on the screen for the participant to remember. Stimulus 
duration was 1 second, as was the inter-stimulus interval. Immediately after, a 60 
second timer displayed on the screen.  
 
6.2.4.6 Immediate word recall: As a measure of episodic memory, participants were 
faced with a 60 second clock and instructed to write down as many of the words 
presented during the word presentation as they could recall. The number of words 
correctly recalled were scored as a percentage and the number of incorrect recalls 
were recorded as errors. 
 
6.2.4.7 Digit symbol substitution working memory task: (Weschler., 1958) This task 
is a timed paper and pencil task in which the participant was given 90 seconds to 
match the numbers 1 to 9 with a specific symbol. The task was scored as number  of 
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correct responses. The DSST is a measure of working memory and speed of 
processing. 
 
6.2.4.8 Numeric working memory: Five digits were presented sequentially for the 
participant to hold in memory. This was followed by a series of 30 probe digits for each 
of which the participant decided whether or not it had been in the original series and 
pressed the 'YES' or 'NO' response button as appropriate as quickly as possible. This 
was repeated two further times with different stimuli and probe digits. Mean reaction 
times were measured in msec, and accuracy of responses to both original and novel 
(distractor) stimuli were recorded. 
6.2.4.9 Corsi blocks: A computerised adaptation of the Corsi blocks (Miner, 1971) task 
was used to assess visuo-spatial working memory. Nine blue squares were presented 
on a black background screen. The blue squares then changed to red and back to blue 
in a random sequence. Participants were asked to follow the sequence and respond 
via a mouse click. The task began at level four with four of the nine blue squares 
lighting up in sequence, and was repeated five times at each level. Task difficulty 
increased in increments with the number of blue squares lighting up as the levels 
increased. The task ended if the participant did not correctly recall 3 or more 
sequences on a level. The task was scored as span score derived from the average of 
the last 3 correctly completed trials. 
 
6.2.4.10 Peg and ball: The peg and ball task is a measure of higher level executive 
function, planning and problem solving. Participants were presented with two 
configurations of three coloured balls (blue, green, red), a target configuration and a 
working configuration. The participant’s task was to rearrange the balls in the working 
configuration so that they matched the position of the balls in the target configuration, 
moving one ball that did not have a ball above it at a time. Participants were asked to 
work out the entire planning sequence and calculate the minimum number of moves 
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required prior to moving the balls using the mouse/cursor. Participants completed a 
total of 18 trials, comprising six trials each that could be solved in three, four and five 
moves, respectively, in ascending order of difficulty. Each trial generated scores for 
planning times prior to moving, time to complete and number of moves made above the 
minimum required. 
 
6.2.4.11 Digit vigilance: A single target digit was randomly selected and constantly 
displayed to the right of the screen. A series of single digits were presented in the left 
of the screen at the rate of 80 per minute. The participant was required to press the 
target button on the peripheral response box as quickly as possible every time the digit 
in the series matched the target digit. The task lasted two minutes and there were 30 
stimulus-target matches. Task outcomes were accuracy (%), reaction time for number 
of correct responses (msec) and number of incorrect responses. 
 
6.2.4.12 Stroop: (Stroop 1935) Participants were presented with a written colour. The 
colour presented was written in a coloured font which could be the same as the written 
colour or different. Participants had to indicate the colour of the font using colour 
buttons on the peripheral response box. Task measures were accuracy (percent 
correct) and reaction time (msec). 
 
6.2.4.13 RVIP: The RVIP task is a measure of sustained attention and working 
memory. The participant was required to monitor a continuous series of digits for 
targets of three consecutive odd or three consecutive even single digits. The single 
digits were presented at the rate of 100 per minute and the participant responded to the 
detection of a target string by pressing the space bar on the computer keyboard as 
quickly as possible. The task was continuous and lasted for 5 minutes, with 8 correct 
target strings being presented in each minute. The task was scored for percentage of 
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target strings correctly detected, average reaction time for correct detections (msec), 
and number of incorrect responses (false alarms). 
 
6.2.4.14 Delayed word recall: The participant was given 60 seconds to write down as 
many of the words presented during the word presentation at the start of the cognitive 
battery. The number of words correctly recalled was recorded as a percentage of the 
total possible.  
6.2.4.15 Delayed picture recognition: the original pictures plus 15 distractor pictures 
were presented one at a time in a randomised order. For each picture, participants 
indicated whether or not it was recognised as being from the original series by pressing 
the 'YES' or 'NO' button as appropriate and as quickly as possible. Mean reaction times 
were measured in msec, and accuracy of responses to both original and novel 
(distractor) stimuli were recorded. 
 
6.2.4.16 Delayed word recognition: The original words plus 15 distractor words were 
presented one at a time in a randomised order. For each word the participant indicated 
whether or not it was recognised as being included in the original list of words by 
pressing the 'YES' or 'NO' button as appropriate and as quickly as possible. Mean 
reaction times were measured in msec, and accuracy of responses to both original and 
novel (distractor) stimuli were recorded. The tasks are presented in the order of 
completion in figure 6.1 
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Figure 6.1- 35 minute cognitive battery. Numeric WM=numeric working memory, RVIP= rapid visual information 
processing, DSST= digit symbol substitution task. 
 
6.2.5 Blood analysis 
Venous blood samples (2x5ml) were collected at baseline and six hours post 
supplementation of treatments. Samples were collected in 5ml BD vacutainers© 
(Becton, Dickinson and company, Plymouth, New Zealand). Both receptacles were 
treated with anticoagulants, one with LH and one with EDTA. Whole blood samples 
treated with LH and EDTA were prepared for storage using the methods described in 
section 2.2.5.  
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6.2.5.1 MAO-B 
MAO-B analysis was conducted as described in section 2.2.5.1. Some issues arose 
during analysis of platelet MAO-B analysis where several plates did not work. 
Therefore, the platelets of a subsection of only five participants were successfully 
analysed for MAO-B activity. Results must, therefore, be interpreted with caution. 
 
6.2.5.2 Prolactin 
Prolactin analysis was measured by diagnostic Medlab, Auckland, New Zealand. 
Prolactin was analysed in 300µl of blood plasma collected in LH treated vacutainers. 
Twelve sets of blood samples were available for prolactin analysis, of which two 
participants were removed from analysis before unbinding due to readings above 
maximal “normal” levels during at least one visit. 
 
6.2.5.3 Blood glucose and lactate analysis 
Twenty microliters of whole blood was collected in an end-to-end capillary (EKF 
Diagnostics) from a finger prick puncture at seven time points throughout each study 
session. Filled capillaries were immediately transferred into an EKF safe-lock cup 
prefilled with 1ml of haemolysis solution. The whole blood and haemolysis solution was 
then analysed using a Biosen C_line analyser (EKF diagnostics) for glucose (mmol/L) 
and lactate (mmol/L) within 30 minutes of collection. The manufacturer reports that the  
Biosen C_line analyser has a coefficient of variance (CV) of 1.5%. All participants who 
completed the study provided full sets of finger prick blood samples. 
 
6.2.6 Procedure 
Participants were required to attend the laboratory a total of four times. The first was a 
90 minute screening visit to ensure eligibility, the second, third and fourth were study 
day visits lasting a total of eight hours. On study day visits participants arrived at the 
research centre at 8am after a 12 hour fast and firstly give a venous blood sample, 
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finger prick blood sample, and completed the baseline cognitive assessment. 
(Participants were given the option to opt out of venous blood sampling, which 23 
participants opted to do, leaving 12 participants to give samples). Participants were 
then given their treatment drink which they had five minutes to drink. After a one hour 
resting absorption period participants completed the post-dose cognitive battery (figure 
6.1) 60, 150, 240 and 360 minutes post-supplementation and gave blood glucose 
samples 50, 140, 180, 200, 230, and 350 minutes post-supplementation. A final venous 
blood sample was also taken 345 minutes post-supplementation from those 
participants who opted to do so. Lunch was administered three hours post-dose at 
~12pm and  comprised pasta and a tomato based pasta sauce. Participants were 
served 250g of pasta (finished wet weight including sauce providing 750kcals) along 
with a drink containing 10g of glucose, 50ml of Schweppes blackcurrant cordial and 
200ml of water. Participants were instructed to eat all of the pasta and consume all of 
the drink. The 10g glucose dose was chosen as this is a high enough glucose load to 
initiate a glucose response, but not high enough to impact cognitive performance 
(Messier, 2004; Sünram-Lea et al., 2011). Participants were permitted to leave the 
research centre during breaks between bouts of cognitive assessment with instructions 
not to participate in any physical activity other than slow/moderate walking and not to 
consume anything other than water. See figure 6.2 for a diagram of the study day 
running order. 
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Figure 6.2 – Study day running order. 
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6.2.7 Statistical analysis  
All ANOVAs were conducted in the SPSS statistics package using “change from 
baseline” data.  
 
Repeated measures ANOVAs (General linear model); by treatment [control, juice and 
DelcyanTM] × repetition [1 to 4] for all behavioural measures; and treatment [control, 
juice and DelcyanTM] × epoch [1 to 6] for blood glucose and lactate; and treatment 
[control, juice and DelcyanTM] for prolactin and MAO-B. Mauchly`s test of sphericity was 
used to assess equality of the variances of the differences between factors. Where 
sphericity had been violated, Huynh-Feldt corrections for non-sphericity were 
employed. Post hoc comparisons (pairwise) were implemented upon outcomes which 
evinced a p value less than 0.05 to ascertain any differences between treatments at 
each measurement. Partial Bonferroni corrections were applied to protect for error 
against multiple comparisons, therefore the p value was multiplied by the number of 
treatments being compared to control, in this case x 2. Adjusted p values are presented 
throughout. 
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6.3 Results 
Prior to analysis of change from baseline data, mean pre-dose scores for all three 
treatments (control, DelcyanTM, juice) for each outcome were subjected to a one way 
repeated measures ANOVA. No significant differences were found.  
 
Mean pre-dose baseline and change from baseline scores for all behavioural and blood 
parameters are presented in tables 6.4 and 6.5. Unchanged “raw” data tables can be 
found in appendix X. Significant differences with interpretable effects of intervention are 
presented in figure 6.3. Only ANOVA results for measures which generated significant 
effects are reported below.  
 
 
187 
 
Table 6.4 Mean pre-dose baseline and change from baseline scores, standard deviations and ANOVA outcomes for all 
behavioural parameters 
Measure N Treatment 
Baseline 
Repetition 
1 
Repetition 
2 
Repetition 
3 
Repetition 
4 
Effect of 
treatment 
Treatment * 
repetition 
interaction Mean SD Mean SD Mean SD Mean SD Mean SD 
Finger tap  
number of taps 
34 
Control 500.4 63.1 1.39 23.6 10.38 31.7 6.97 19.9 5.63 17.1 
F=0.69 p>0.1 F=0.61 p>0.1 Delcyan
TM
 508.8 51.19 3.10 24.2 2.94 20.5 -2.60 20.5 -3.59 13.6 
Juice 523.1 101.9 7.91 13.51 7.63 14.8 8.91 8.93 11.35 35.9 
Immediate word 
recall correct 
34 
Control 6.03 0.61 -0.07 0.95 -0.11 0.98 -0.14 1.13 0.07 0.95 
F=0.71 p>0.1 F=0.39 p>0.1 Delcyan
TM
 6.09 0.51 0.21 0.84 0.14 1.13 -0.18 0.90 -0.21 0.84 
Juice 6.31 0.53 -0.03 0.87 0.18 0.90 0.11 0.98 0.03 0.87 
Immediate word 
recall incorrect 
34 
Control 0.71 0.30 -0.09 1.13 -0.29 1.23 0.03 1.03 0.06 1.17 
F=1.76 p>0.1 
 
F=1.84 p=0.09 Delcyan
TM
 0.77 0.35 -0.20 1.35 0.06 1.24 0.29 1.47 0.23 1.57 
Juice 0.49 0.25 0.37 0.93 0.66 1.41 0.26 1.25 0.26 1.18 
DSST correct 34 
Control 57.77 4.05 2.51 5.27 2.54 5.64 3.69 6.62 2.60 4.96 
F=2.78 p>0.1 
 
F=4.74 p=0.037 Delcyan
TM
 54.91 2.69 4.23 3.81 6.34 6.52 5.54 5.80 6.29 5.44 
Juice 55.91 3.81 3.71 6.58 3.49 6.60 5.57 6.29 6.94 8.54 
DSST incorrect 34 
Control 0.14 0.11 -0.09 0.44 -0.03 0.38 -0.03 0.38 -0.09 0.37 
F=1.62 p>0.1 F=0.73 p>0.1 Delcyan
TM
 0.11 0.10 0.00 0.41 0.00 0.48 -0.11 0.32 -0.03 0.45 
Juice 0.11 0.13 0.00 0.41 0.03 0.51 0.00 0.63 -0.06 0.41 
Numeric working 
memory % correct 
34 
Control 96.36 3.90 -0.42 3.62 0.24 4.45 -0.39 4.88 -0.85 5.14 
F=0.24 p>0.1 F=0.25 p>0.1 Delcyan
TM
 95.99 3.26 0.33 3.67 0.33 3.85 -0.21 4.77 0.00 4.56 
Juice 96.13 3.48 0.48 3.95 0.09 3.02 -0.15 3.73 -0.06 4.57 
Numeric working 
memory RT (msec) 
34 
Control 860.5 210 -24.82 126 -18.55 134 -24.36 133 -25.91 114 
F=0.742 p>0.1 F=0.87 p>0.1 Delcyan
TM
 834.3 231 -11.36 131 -31.85 110 20.58 310 -10.21 155 
Juice 867.8 255 -57.21 100 -47.18 122 -42.67 146 -89.06 124 
Corsi blocks RT 
(msec) 
34 
Control 6424.48 1775 -354.6 1678 -582.5 1863 -141.4 1596 -610.4 1567 
F=0.83 p>0.1 F=1.23 p>0.1 Delcyan
TM
 6273 1468 454.9 1428 -75.65 1489 -125.9 1605 -450.5 1130 
Juice 6360 1384 -121.9 1275 -299.8 1135 -275.2 1445 -376.4 1533 
Corsi blocks span 34 
Control 5.87 0.93 -0.10 0.84 -0.23 0.82 -0.11 0.79 -0.20 0.82 
F=0.66 p>0.1 F=1.30 p>0.1 Delcyan
TM
 5.89 0.73 0.05 0.82 0.08 0.83 0.03 0.92 -0.27 0.80 
Juice 5.87 0.94 0.04 0.93 0.20 0.69 -0.17 1.35 -0.02 0.99 
Peg and ball thinking 
time 
34 
Control 3129 1824 -317.6 963 -355.9 1023 -510.6 880 -453.8 1080 
F=1.539 p>0.1 F=0.16 p>0.1 Delcyan
TM
 2939 1214 -82.53 486 -88.38 546 -239.8 713 -176.1 582 
Juice 2934 1029 -138.2 556 -133.9 551 -230.9 633 -268.2 546 
Peg and ball working 
time (msec) 
34 
Control 9623 2660 -580.2 1498 -818.0 1438 -850.8 1246. -825.2 1584 
F=0.24 p>0.1 F=0.49 p>0.1 Delcyan
TM
 9467 2091 -564.5 929 -704.8 1033 -743.8 1362 -731.0 1466 
Juice 9232 1952 -438.0 1217 -381.79 1386 -716.9 1409 -813.94 1581 
Peg and ball errors 34 
Control 3.88 4.29 0.12 4.58 -0.91 3.38 -0.21 3.10 0.09 4.00 
F=0.21 p>0.1 F=1.11 p>0.1 Delcyan
TM
 4.35 3.89 -1.26 4.22 -1.65 3.95 -0.29 4.31 -1.03 5.22 
Juice 3.18 3.20 -0.18 4.06 0.62 3.95 -0.21 3.72 0.21 3.71 
Digit vigilance % 
correct 
34 
Control 95.29 4.70 -2.55 9.04 -1.93 9.55 -4.62 9.52 -1.41 8.44 
F=0.24 p>0.1 
F=0.81 p>0.1 
 
DelcyanTM 93.33 16.1 0.93 19.1 1.45 17.61 -3.97 24.3 0.21 18.8 
Juice 95.75 5.37 -1.76 9.35 -1.90 8.84 -2.45 7.70 -0.21 6.28 
Digit vigilance RT 
(msec) 
34 
Control 453.1 41.6 5.93 25.1 16.55 26.0 20.28 32.9 16.86 28.9 
F=0.37 p>0.1 F=1.05 p>0.1 Delcyan
TM
 448.7 51.7 22.62 57.1 22.52 66.4 24.31 65.7 23.07 59.9 
Juice 448.1 41.2 12.45 30.8 14.55 29.3 23.10 31.3 23.79 29.1 
Digit vigilance false 
alarms (number) 
29 
Control 0.07 0.23 0.24 0.51 0.10 0.49 0.17 0.54 0.10 0.41 
F=0.57 p>0.1 F=1.28 p>0.1 Delcyan
TM
 0.31 1.04 0.00 1.25 -0.14 1.06 0.03 1.15 -0.10 1.29 
Juice 0.14 0.32 -0.03 0.50 0.24 1.06 0.17 0.60 0.10 0.86 
Stroop accuracy (%) 29 
Control 98.38 -2.35 -0.15 2.42 0.35 2.18 -0.59 2.42 -0.24 2.48 
F=0.24 p>0.1 F=0.49 p>0.1 Delcyan
TM
 98.38 -1.99 0.32 2.02 0.38 1.96 -0.06 1.87 -0.03 1.71 
Juice 98.48 -1.62 -0.03 1.81 -0.06 2.01 -0.18 1.88 -0.32 2.12 
Stroop reaction time 
(msec) 
29 
Control 810.0 -177 -18.76 106 -18.76 135 -28.29 115 -33.03 146 
F=0.66 p>0.1 F=1.83 p>0.1 Delcyan
TM
 788.2 -131 -29.38 72.7 -18.15 84.0 -1.21 208 11.41 212 
Juice 799.4 -137 -35.68 66.9 -34.65 91.4 -14.24 105 -63.26 82.6 
RVIP accuracy (%) 29 
Control 55.39 19.2 3.00 14.25 2.09 18.5 1.47 14.7 1.28 15.6 
F=0.86 p>0.1 F=0.24 p>0.1 Delcyan
TM
 53.67 17.7 3.91 10.62 2.56 9.82 2.38 12.7 3.81 13.6 
Juice 58.91 20.9 0.03 9.54 0.88 9.35 -1.59 11.5 -0.63 11.4 
RVIP false alarms 
(number) 
29 
Control 1.31 1.2 0.34 1.72 0.25 1.83 0.03 1.67 -0.19 1.54 
 
F=0.56 p>0.1 
F=0.94 p>0.1 Delcyan
TM
 1.13 1.2 0.34 1.52 0.06 1.37 0.03 1.44 -0.19 1.33 
Juice 1.59 1.8 0.00 2.37 -0.59 1.95 -0.16 1.64 -0.22 1.81 
RVIP reaction time 
(msec) 
29 
Control 501.5 49.9 3.69 35.1 5.28 41.6 -3.63 32.4 3.34 43.1 
F=2.14 p>0.1 F=1.10 p>0.1 Delcyan
TM
 507.2 46.8 0.06 31.8 4.59 32.7 -0.22 39.3 5.50 42.9 
Juice 513.3 50.8 -8.50 31.8 -7.47 29.7 -6.38 34.1 -19.25 35.5 
Delayed word recall 
% correct (number) 
35 
Control 3.83 0.68 -1.77 2.19 -1.74 2.13 -1.89 2.58 -1.94 2.25 
F=0.89 p>0.1 F=0.78 p>0.1 Delcyan
TM
 4.03 0.51 -2.06 1.79 -2.26 1.70 -2.09 1.98 -1.66 1.71 
Juice 3.57 0.53 -1.31 1.62 -1.43 1.93 -1.83 1.87 -1.46 2.31 
Delayed word recall 
incorrect (number) 
35 
Control 1.17 0.37 0.17 1.18 0.00 1.29 0.26 1.73 -0.17 1.13 
F=4.10 p=0.02 F=2.07 p=0.058 Delcyan
TM
 1.06 0.37 0.09 1.27 0.54 1.36 -0.06 1.24 0.69 2.00 
Juice 0.54 0.61 0.91 2.18 1.11 2.15 0.94 2.15 0.71 2.26 
Word recognition RT 
(msec) 
35 
Control 972.9 218 39.29 114 -3.74 170 33.60 209 -17.26 170 
F=4.32 p=0.017 F=0.89 p>0.1 Delcyan
TM
 933.3 189 46.94 161 34.23 133 29.00 177 29.80 194 
Juice 992.1 245. -17.71 225 -23.06 194 -47.00 200 -86.83 169 
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Word recognition % 
correct 
35 
Control 75.81 9.51 -3.60 10.9 -2.74 10.3 -6.66 11.5 -2.63 10.2 
F=1.37 p>0.1 F=1.58 p>0.1 Delcyan
TM
 77.71 8.61 -4.60 10.2 -9.40 10.1 -7.29 9.24 -6.94 10.1 
Juice 77.24 9.03 -4.20 11.6 -4.60 10.8 -6.40 11.0 -6.66 11.4 
Picture recognition 
RT (msec) 
35 
Control 872.9 155 9.63 131 41.77 149 48.57 147 14.43 144 
F=0.89 p>0.1 F=1.95 p=0.78 Delcyan
TM
 830.9 120 26.57 124 47.49 118 83.29 144 41.74 128.3 
Juice 857.7 221 40.77 180 -8.49 160 14.97 180 9.09 142 
Picture recognition 
% correct 
35 
Control 94.95 6.39 -0.46 6.11 -1.94 4.63 -1.91 6.72 -2.77 6.45 
F=0.63 p>0.1 F=1.08 p>0.1 Delcyan
TM
 95.43 5.11 -0.97 6.20 -0.80 5.99 -3.17 7.51 -3.74 7.48 
Juice 95.43 4.37 -2.49 6.39 -0.86 5.22 -1.77 5.71 -3.37 7.13 
Bond-Lader alert 
(mm) 
35 
Control 65.83 13.8 -3.74 11.6 -5.86 11.96 -8.96 17.9 -7.45 14.8 
F=0.13 p>0.1 F=0.69 p>0.1 Delcyan
TM
 65.34 13.3 -4.71 11.4 -7.88 12.02 -8.91 14.9 -5.56 15.0 
Juice 66.47 14.6 -2.47 8.63 -5.73 13.92 -8.63 16.1 -6.40 14.1 
Bond-Lader content 
(mm) 
35 
Control 71.03 13.7 0.66 5.37 0.29 5.20 1.61 9.33 1.11 8.17 
F=1.00 p>0.1 F=0.77 p>0.1 Delcyan
TM
 71.77 10.9 -0.74 7.54 -1.06 6.84 -1.37 8.24 0.42 8.40 
Juice 73.08 11.5 -0.39 4.94 -0.53 6.18 0.22 6.06 0.78 6.49 
Bond-Lader calm 
(mm) 
35 
Control 61.81 14.2 2.63 10.8 1.67 9.88 6.01 11.6 3.89 9.48 
F=0.45 p>0.1 
 
F=1.95 p=0.07 Delcyan
TM
 63.10 15.1 2.86 13.3 2.67 13.0 1.71 13.8 1.41 10.9 
Juice 63.39 13.6 0.30 8.21 2.97 11.1 3.79 11.2 1.23 9.31 
VAS fatigue (mm) 35 
Control 37.23 18.2 5.23 21.6 7.34 20.4 15.00 24.3 10.29 21.3 
F=0.27 p>0.1 F=0.70 p>0.1 Delcyan
TM
 39.69 16.4 2.89 15.8 8.34 17.3 10.37 18.6 9.80 17.6 
Juice 34.46 17.1 4.29 14.3 8.94 19.9 16.03 21.6 12.37 19.3 
VAS mentally 
energised (mm) 
35 
Control 56.91 15.3 -5.60 17.7 -7.51 15.9 -10.66 20.2 -10.43 16.3 
F=0.39 p>0.1 F=1.10 p>0.1 Delcyan
TM
 54.63 16.7 -6.97 18.4 -8.37 18.8 -10.06 19.0 -6.26 21.2 
Juice 58.23 18.9 -1.83 15.4 -6.20 18.3 -8.09 22.6 -8.80 19.1 
VAS physically 
energised (mm) 
35 
Control 58.46 15.2 -2.40 13.3 -4.57 15.2 -9.31 21.2 -7.23 17.3 
F=0.25 p>0.1 F=1.25 p>0.1 Delcyan
TM
 56.89 15.9 -3.80 19.1 -7.06 19.1 -7.66 15.2 -2.74 21.4 
Juice 57.03 17.8 -7.09 20 -10.89 18.7 -11.86 24.9 -11.83 23.2 
 
Table 6.5 Mean pre-dose baseline and change from baseline scores, standard deviations and ANOVA outcomes for all 
blood parameters 
Measure N Treatment 
Baseline 60 Minutes 
140 
minutes 
180 
minutes 
200 
minutes 
230 
minutes 
350 
minutes 
Effect of 
treatment 
Treatment * 
repetition 
interaction Mean se Mean se Mean se Mean se Mean se Mean se Mean se 
Blood 
glucose 
(mmol/L) 
35 
Control 4.79 0.08 0.30 0.14 -0.52 0.08 -0.40 0.10 0.70 0.15 2.92 0.16 0.79 0.11 
 
F=0.35 p>0.1 
F=1.22 p>0.1 Delcyan
TM 4.80 0.09 0.53 0.15 -0.48 0.09 -0.36 0.12 0.82 0.17 2.90 0.18 0.76 0.12 
Juice 4.78 0.12 0.80 0.17 -0.63 0.10 -0.54 0.10 0.50 0.19 2.86 0.16 0.76 0.15 
Blood 
lactate 
(mmol/L) 
35 
Control 1.47 0.13 0.56 0.15 -0.13 0.11 -0.33 0.15 0.08 0.16 0.35 0.16 -0.22 0.15 
 
F=0.24 p>0.1 
F=1.14 p>0.1 Delcyan
TM 1.35 0.15 0.50 0.17 -0.05 0.16 -0.21 0.16 0.13 0.17 0.30 0.14 -0.05 0.16 
Juice 1.36 0.12 0.79 0.12 -0.03 0.13 -0.24 0.11 0.22 0.15 0.55 0.13 -0.12 0.15 
MAO- 
activity 
(nmol 
H2O2) 
5 
Control 1192 446 -72.96 400 
 
 
F=0.742 p>0.1 
 Delcyan
TM 1090 328 -279.0 193 
Juice 906.0 394 229.4 282 
Prolactin 
(mIU/L) 
11 
Control 270.2 30.9 62.97 43.8 
 
 
F=1.05 p>0.1 
 Delcyan
TM 287.2 55.5 6.08 22.7 
Juice 232.4 17.4 37.75 30.1 
 
6.3.1 Behaviour 
6.3.1.1 Delayed word recall 
The repeated measures ANOVA revealed a significant main treatment effect for the 
delayed word recall outcome incorrect responses [F(2,68)=4.096, p=0.021). Pairwise 
analysis revealed a significant increase in incorrect delayed word recalls after 
supplementation of the Blackadder juice group when compared to control (p=0.04). 
See figure 6.3a. 
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6.3.1.2 Word recognition 
The repeated measures ANOVA revealed a significant treatment effect for the word 
recognition reaction time [F (1.63,55.66)=4.32, p=0.024). Pairwise analysis revealed no 
significant differences between either active treatment and placebo. 
 
6.3.1.3 DSST 
The repeated measures ANOVA revealed a significant treatment*repetition interaction 
for DSST correct responses [F(5.06,172.22)=2.92,p=0.047). Pairwise analysis revealed 
a significant increase in correct responses after supplementation of the DelcyanTM drink 
at repetition 2 (p=0.042) and 4 (p=0.02) when compared to control. See figure 6.3b. 
 
Figure 6.3 Delayed word recall incorrect responses (a) and DSST correct responses (b). Time points which are 
significantly different to control are labelled. (*p<0.05) 
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6.4 Discussion 
The main aims of the current study were to assess if acute supplementation of 
blackcurrant extracts can augment memory, attention and executive function in a 
middle aged population, likely to be exhibiting natural age related declines in cognitive 
function. To account for the biphasic nature of polyphenol pharmacodynamics, and to 
assess the time course of any behavioural effects, multiple cognitive assessments 
were undertaken throughout the day after consumption of the extracts. The study 
utilised two active treatments, DelcyanTM powdered extract and the Blackadder juice 
extract. Definitive effects upon memory and executive function were not evident after 
supplementation of the DelcyanTM or Blackadder juice blackcurrant in healthy middle 
aged adults.    
 
Supplementation with the DelcyanTM treatment produced a significant increase in 
correct responses in the DSST task at post-dose repetition two, two hours post-dose, 
and repetition four, six hours post-dose, with an increase of ~6 correct responses at 
each time point when compared to control. As age related decreases in DSST scores 
are primarily related to decreased processing speed, rather than decrements in 
memory (Salthouse, 1992), positive acute effects of the DelcyanTM treatment upon the 
DSST task could be associated with an increase in processing speed, rather than a 
direct augmentation of working memory. Supplementation of the Blackadder juice drink 
produced an increase in incorrect responses during the delayed recall task. The main 
increase in incorrect responses came at repetition two, two hours post supplementation 
with a mean increase of ~1 incorrect response compared to control. Although only a 
trend on the main ANOVA, this decrement is partially supported by an increase in 
incorrect responses evident at repetition two of the immediate word recall task (with an 
increase of ~1 incorrect response) after supplementation of the Blackadder juice drink 
when compared to control. Both results indicate decrements in episodic memory after 
supplementation of the Blackadder juice drink in a middle aged cohort. This negative 
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impact is difficult to explain but it must be considered that, given the number of 
outcomes, these effects (both positive and negative) are highly likely to be type 1 
errors. 
 
A major factor driving the hypothesis of improved cognitive performance in middle aged 
adults after supplementation of the blackcurrant extracts, was the inhibition of MAO 
enzymes observed post consumption of the Blackadder juice extract in previous 
chapters of this thesis. This extract had no positive effect upon behavioural paradigms 
in the current study and also no inhibition of MAO-B was observed following either 
blackcurrant extracts when compared to control. This inhibition, by the Blackadder juice 
extract, has proven to be robust throughout earlier intervention chapters in this thesis. 
As the present study and the latter part of study four were run together, and results 
from all participants in chapter four show a powerful inhibition of MAO-B, there is no 
doubt that the compound or compounds driving the inhibition are present and active in 
the Blackadder juice extract. There are several reasons which could pertain to the null 
findings, these are 1) the sample size, 2) the administration of lunch and 3) the time of 
which the sample was taken. Due to issues with the MAO-B Amplex-Red assay, only 
five sets of blood samples were successfully analysed for MAO-B activity. Although the 
inhibition outlined in chapters two, three and five showed a robust effect of Blackadder 
juice extract upon MAO-B activity, the small N size cannot be ruled out as a potential 
reason for the lack of positive findings. Additionally, due to the time needed to be spent 
in the laboratory (8 hours) after an overnight fast, participants were fed a pasta meal 
180 minutes post supplementation. Although food interactions with MAO inhibitors are 
well documented (i.e. the tyramine effect), no such information is available regarding 
food intake and potency reductions. It was, therefore, not thought that the lunch would 
impact the inhibition. The final issue is the timing of the post-dose blood sampling. In 
the current study, MAO-B activity was measured six hours post consumption of the 
blackcurrant extracts, whereas, previously the last time point where MAO-B was shown 
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to be significantly inhibited by supplementation of the Blackadder juice drink was at four 
hours post-dose (the last study day dose measured). However, as the level of inhibition 
was at such a level (100%) and as MAO-B activity had not fully returned to baseline 
after 24 hours, it was expected that the MAO inhibition would still be evident six hours 
post-dose. Although age related sensitivities to doses of pharmacological MAO 
inhibitors are not evident in the literature, it must also be noted that the inhibition of 
MAO by a blackcurrant extract has not been quantified in a middle aged cohort. Since 
the presence of central MAO-B increases at a rate of 7% per decade (Fowler et al., 
1997), a higher dose may be needed to elicit an inhibitory response in an older cohort. 
This highlights the need for further research focusing upon dose ranges and further 
post-dose time points, in a similarly designed study to chapter five of this thesis, to 
allow the efficacy of MAO inhibition via consumption of the Blackadder juice extract to 
be determined in a healthy middle aged population. Levels of blood plasma prolactin 
were not reduced in the current study after consumption of either blackcurrant extract. 
Plasma prolactin was shown to be reduced after consumption of the Blackadder 
blackcurrant juice extract standardised at a dose as low as 125mg of polyphenols in 
chapter three of this thesis. Therefore, the lack of a reduction after the consumption of 
the Blackadder juice treatment in the current study is more than likely associated with 
the null effects upon MAO-B. 
 
Despite not being significant, it is important to discuss the fact that blood levels of 
glucose followed a similar pattern to that observed in chapter two and were 
~0.5mmol/L higher after supplementation of the Blackadder juice drink 60 minutes 
post-supplementation of the Blackadder juice extract. Due to the number of fingertip 
blood samples taken throughout the session it was not possible to measure earlier time 
points in the present study, it was outlined in chapter five that this increase in blood 
glucose is a result of a lower post-prandial peak in blood glucose associated with the 
intervention. An aim of the study was to assess if a similar pattern was observed after a 
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glucose load at a later time point, in the case of this study, three hours post-
supplementation of the study drinks. This pattern of glucose modulation was not 
observed a second time at the later post-supplementation, potentially highlighting that a 
glucose load needs to be co-consumed with phenolic compounds for the modulatory 
effect to be seen. A graphical representation of this data can be seen in appendix VII.  
 
In conclusion, results from the current study reveal no reliable positive effects upon 
memory or psychomotor function of either the Blackadder or DelcyanTM treatment.  This 
may outline the potential need for chronic consumption of polyphenol rich extracts for 
positive modulations to be observed. There were no measured effects upon MAO-B 
activity and blood plasma prolactin in a middle aged cohort six hours post 
supplementation. Caution must be used when interpreting the MAO-B data due to the 
discussed methodological issues. More research needs to be undertaken to measure 
the chronic effects of a blackcurrant extract upon cognitive performance in middle aged 
adults. Further examinations of the pharmacodynamics of MAO-B inhibition in a middle 
aged cohort also need to be carried out, so the MAO inhibitory efficacy of the 
Blackadder juice extract can be determined. 
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CHAPTER 7. DISCUSSION 
 
7.1 Summary of the objectives of the thesis 
In recent times, self-medication through “off the shelf” herbal products, derived from 
functional foods, has increased to such a level that over 20% of the North American 
populous use them daily (Bent, 2008). There is, therefore, an increasing interest in the 
development of nutraceutical compositions which may improve health, wellbeing and 
mental performance in healthy cohorts. Natural products which enable improvements in 
learning, memory and alertness are, therefore, highly desirable for both their 
commercial and health impact. Within this field there is a growing body of literature 
suggesting the potential of foods rich in flavonoids, especially those present in berries, 
to exert a number of behavioural effects both in animal models (Joseph et al., 1999; 
Sweeney et al., 2002; Casadesus et al., 2004; Bastianetto et al., 2007; Williams et al., 
2008) and aged humans (Krikorian et al., 2010a; Krikorian et al., 2010b; Krikorian et 
al., 2012). Although flavonoid compounds found in berries have shown promising 
results, definitive in vivo effects, especially in humans, are lacking. A growing 
discussion regarding potential in vivo mechanisms driving purported health promoting 
properties is also emerging in the literature; outlining their potential to exert clinically 
significant physiological effects (Matsumoto et al., 2005b; Dreiseitel et al., 2008; 
Rendeiro et al., 2013). Although a potentially beneficial effect of flavonoid-rich 
blackcurrant consumption has been outlined in a patent application by Bormann and 
Shatton (1996), indicating that blackcurrant extracts improve attention in healthy adults; 
no published, peer reviewed reports of a modulation of human behaviour after 
consumption of blackcurrants are evident in the literature. Bormann and Shatton (1996) 
also outlined significant reductions in platelet MAO-B activity in the same patent; 
therefore, potentially highlighting a modulatory effect of blackcurrant extracts upon 
monoaminergic tone. The importance of this is highlighted by disorders in 
monoamines, such as dopamine, that have been shown to lead to decline in 
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neurocognitive functions, especially memory (Costa et al., 2012), attention (Lahoste et 
al., 1996) and cognitive flexibility (Cools et al., 2010).  
 
The main aim of this thesis was to assess the impact of blackcurrant extracts upon 
human cognitive performance and mood; two factors which have received little 
attention in the literature. Chapter two of this thesis compared the effects of two 
blackcurrant extracts, upon attention processes in healthy adults, utilising cognitive 
domains shown to be sensitive to flavonoid consumption in animal models and human 
interventions. Chapter three explored the acute impact of supplementation with 
differing doses of the Blackadder blackcurrant extract upon aspects of memory and 
learning in healthy young adults. The ability of the Blackadder juice extract to modulate 
cerebral haemodynamics was then explored in chapter four, assessing its acute effects 
during cognitive tasks known to activate the brain regions under investigation and 
during a resting absorption period. Chapter six further explored the impact of the two 
blackcurrant extracts employed in chapter two of this thesis upon memory and learning, 
utilising a healthy middle aged cohort. 
 
A secondary aim of the thesis was to assess the physiological and biological impact of 
blackcurrant consumption. Throughout the behavioural intervention studies of this 
thesis, physiological mechanisms with the potential to modulate human behaviour were 
measured, with a particular focus upon MAO inhibition and blood glucose. Positive 
effects of the intervention were evident throughout. In order to create a concrete 
foundation for future methodologies to be based, chapter five solely focused upon 
biological parameters, utilising cannulation to assess the pharmacodynamics of these 
physiological mechanisms. 
 
Two extracts were used at several points throughout this thesis. These extracts were, 
DelcyanTM, a commercially available freeze-dried powdered extract and Blackadder 
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juice, a fresh from frozen crude cold pressed juice extract. Since berry cultivar and 
post-harvest preparation of food is an important factor underlying the phytochemical 
makeup of blackcurrants (Hollands et al., 2008) and, therefore, potentially affects their 
ability to influence human behaviour, phenolic profiles of the extracts used in this thesis 
were assessed.  
 
7.2 General summary of the findings 
The remainder of this chapter will discuss the findings of each intervention chapter of 
this thesis with initial commentary focusing upon the pattern of behavioural results and 
how this relates to the literature. This will be followed by a depiction of the physiological 
mechanisms of action, which could potentially outline a basis for future research. 
 
7.2.1 Behavioural effects 
The primary aim of the thesis was to assess the impact of standardised blackcurrant 
extracts upon human behaviour. Data from the investigational chapters of this thesis 
give some indication of an augmentation of behaviour and cognitive performance in 
healthy humans after acute supplementation of the blackcurrant extracts. It must, 
however, be noted that there was no clear pattern of modulation. In chapter two, 
increased accuracy on the RVIP task was seen after supplementation of the DelcyanTM 
extract (containing ~500mg polyphenols) and reduced digit vigilance reaction times 
were seen after consumption of the Blackadder blackcurrant juice extract (500mg 
dose) in young healthy adults. Conversely, in chapter three, the Blackadder juice 
extract containing ~250mg of polyphenols led to a decrease in accuracy on a faster 
version of the digit vigilance task employed in chapter two. A significant increase in 
correct responses in the DSST task was shown in chapter 6 after supplementation of 
the DelcyanTM extract (500mg) in middle aged adults. Whereas, decrements in episodic 
memory in the form of increased word recall errors were found after supplementation of 
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the Blackadder juice extract. A summary of behavioural findings can be found in table 
7.1. 
Table7.1 Significant effects of the different doses of the Blackadder and Delcyan
TM
 extracts employed on cognitive and 
mood outcomes 
Measure  
Blackadder Juice Delcyan
TM
 
125mg 250mg 500mg 500mg 
Mood 
Bond Lader Alert - - - - 
Bond Lader Content - - - - 
Bond Lader Calm - - - - 
Mental Fatigue - - - - 
Physical Fatigue - - - - 
Attention 
Simple RT - - - 
 
Digit vigilance accuracy (%) - - - - 
Digit vigilance false alarms 
(Number) 
- - - - 
Digit vigilance reaction time 
(msec) 
- - Ch 1 - 
RVIP accuracy (%) - - - Ch 1 
RVIP false alarms - - - - 
RVIP reaction time (msec) - - - - 
Stroop accuracy (%) 
  
- - 
Stroop reaction time (msec) 
  
- - 
Working Memory  
Numeric Working Memory 
Accuracy   
- - 
Numeric working memory % 
correct     
Numeric working memory RT 
(msec)     
3-back % correct - - - 
 
3-back missed sequences - - - 
 
Serial 3 incorrect responses 
  
- 
 
Serial 3 correct responses 
  
- 
 
Serial 3 number of responses 
  
- 
 
Serial 7 incorrect responses 
  
- 
 
Serial 7 correct responses 
  
- 
 
Serial 7 number of responses 
  
- 
 
Corsi blocks span - - - - 
DSST correct 
  
- Ch 6 
DSST incorrect 
  
- - 
Secondary Memory  
Picture Recognition Accuracy 
  
- - 
Picture Recognition RT 
  
- - 
Word recognition % correct - - - 
 
Word recognition reaction time - - - 
 
Immediate word recall % correct - - - - 
Immediate word recall error - - - - 
Delayed word recall % correct - - - - 
Delayed word recall error - - Ch 6 - 
central exec 
Stroop accuracy (%) 
  
- - 
Stroop reaction time (msec) 
  
- - 
Corsi blocks - - - - 
Logical reasoning reaction time 
  
- - 
Logical reasoning accuracy (%) 
  
- - 
Peg and ball thinking time 
  
- - 
Peg and ball working time (msec) 
  
- - 
Peg and ball errors 
  
- - 
Psychomotor 
Tracking accuracy (twips) - - - 
 
Finger tap - Number of taps 
  
- - 
Where:  or = significant improvement/impairment in the parameter tested, along with the chapter where the 
significant effect was found. Where: - = no effect found. Where                = parameter not assessed at that dose. 
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Initial findings were supportive of data outlined by Borman and Shatton (1996), where, 
in a patent application, it was reported that an undisclosed blackcurrant extract could 
improve aspects of attention in healthy young adults. Data from chapter two 
demonstrated a modulation of aspects of attention during mentally fatiguing cognitive 
assessment. Each blackcurrant extract caused a similar impact upon behavioural 
outcomes. An increase in accuracy was revealed during the RVIP task after 
supplementation with the DelcyanTM treatment, irrespective of task repetition, with no 
evidence of increased reaction times. With regards to the juice treatment, there was 
evidence of an attenuation of the increase in digit vigilance reaction times seen with 
repeated testing, with no evidence of decreased accuracy. The RVIP task contains a 
larger working memory element than the digit vigilance task, potentially indicating 
changes in working memory processing as well as attention. Working memory is a 
cognitive outcome which, in the literature, has been shown to be sensitive to flavonoid-
rich cocoa (Scholey et al., 2010) and ginkgo biloba (Rigney et al., 1999) in healthy 
young adults. Non-significant trends towards a reduction in self-reported mental fatigue 
and increased feelings of alertness were also evident after the last repetition of the 70 
minute cognitive battery following supplementation of the DelcyanTM extract. Although 
not significant, this data could provide support for a beneficial effect of standardised 
blackcurrant extracts upon cognitive performance during mentally fatiguing cognitive 
demand an outcome similar to that highlighted during and after a bout of sustained 
mental demand following supplementation of a flavonoid-rich cocoa (Scholey et al., 
2010). However, as described later in this chapter, these effects could not be replicated 
in further studies.  
 
The initial intervention chapter of this thesis focused upon the effect of standardised 
blackcurrant extracts upon attention, as this is a cognitive domain most sensitive to 
dopaminergic tone (Nieoullon, 2002), and the only domain previously reported to be 
impacted by blackcurrant extract supplementation (Bormann & Schatton, 1996). 
 
 
199 
 
Positive findings in animal models, in limited published human epidemiologic 
observations and in intervention studies, outline positive effects of berries and their 
flavonoid constituents upon several aspects of memory (Joseph et al., 1999; Joseph et 
al., 2003; Casadesus et al., 2004; Goyarzu et al., 2004; Galli et al., 2006; Williams et 
al., 2008; Rendeiro et al., 2013). However, only a limited number of these memory 
paradigms have been investigated in humans after consumption of flavonoid-rich berry 
extracts, with positive findings limited to improvements in verbal learning and 
recognition memory in aged adults (Krikorian et al., 2010a; Krikorian et al., 2010b). It 
must be noted that these studies have obvious methodological issues and results are 
based on data from small sample sizes. Evidence of a modulation of memory can, 
however, be drawn from studies investigating the effects of other flavonoid-rich foods in 
healthy cohorts such as cocoa (Scholey et al., 2010; Field et al., 2011) and ginkgo 
biloba (Kennedy et al., 2000; Singh et al., 2004). Further to this, published data outlines 
the impact of dose choice upon behavioural effects of flavonoid-rich cocoa in humans 
(Scholey et al., 2010), anthocyanin supplementation in children (Whyte & Williams, 
2012) and grape juice in rats (Shukitt-Hale et al., 2006). In an attempt to assess the 
impact of blackcurrant supplementation upon human memory, chapter three explored 
the acute effects of three different doses of the Blackadder juice extract on episodic 
memory, working memory, memory span, visuo-spatial memory and verbal memory in 
healthy young adults at several different time points throughout the day. Drinks were 
reduced in dose sequentially from that shown to have an impact upon behaviour and 
biological mechanisms in chapter two of this thesis, and were standardised at 125mg, 
250mg and 500mg of total polyphenols. Cognitive assessments were conducted 1 hour 
and 2.5 hours post supplementation. These time points were selected on the basis of 
findings from chapter two showing modulation of glucose uptake (60 mins) and MAO 
activity (150 mins) at these time points; as well as detectable levels of potentially active 
anthocyanin constituents of the extracts at 150 minutes. The Blackadder juice extract 
was found to have no positive impact upon aspects of memory measured at any dose 
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or at any time point. There was, however, a sustained reduction in digit vigilance 
correct responses after supplementation of the 250mg intervention. It is hypothesised 
that the lack of positive behavioural effects could be associated with the fact that the 
healthy adult cohort used were already performing at, or near to, their peak (Salthouse, 
2009), and unlike the initial intervention study, participants were not mentally fatigued 
to a high enough level to reveal subtle cognitive benefits. These data, coupled with 
data from the literature, potentially highlight the need for a longer intervention or an 
older cohort before any positive modulations upon memory can be exhibited. 
 
A limited number of articles exist supporting improvement of learning and memory in 
animal models and older human adults (60+). However, no such data are available in 
middle aged healthy adults, who are potentially exhibiting natural age related 
reductions in memory, and reaction times, when compared to the cohorts used in 
chapters two and three of this thesis (Salthouse, 2009). These age-related decrements 
are coupled with neurobiological markers such as; increased MAO activity, reduced 
cerebral blood flow and reduced monoaminergic tone, which are theorised to play a 
role in natural cognitive decline and could, therefore, be potential therapeutic targets to 
attenuate reductions in cognitive performance associated with age (Leenders et al., 
1990; Fowler et al., 1997; Volkow et al., 2000; Sheline et al., 2002). These 
neurobiological mechanisms could potentially be modulated through the inhibition of 
MAO and increases in cerebral blood flow documented after consumption of the 
Blackadder blackcurrant juice extract in the intervention chapters of this thesis. Chapter 
six of this thesis, therefore, attempted to assess the acute impact of the DelcyanTM 
powdered extract and the Blackadder juice blackcurrant extracts upon memory, 
attention and executive processing in a middle aged cohort. The study utilised similar 
standardised cognitive tests as used in the previous intervention studies of this thesis 
as well as additional tasks that assessed mood, recall memory, working memory, 
cognitive flexibility, episodic memory and recognition memory over several acute post 
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supplementation time points (1.2.5, 4 and 6 hours post-dose). These time points were 
selected on the basis of when MAO activity is known to be inhibited, central blood flow 
is known to be modulated and when the “parent” compounds and biphasic metabolites 
of the blackcurrant extracts are known to be in the periphery. Although significant 
effects were observed in chapter six after supplementing healthy middle aged adults 
with the intervention drinks, no definitive pattern of cognitive modulation was observed 
and, given the number of cognitive outcomes, these findings must be interpreted with 
caution. A significant increase in correct responses at time point two (2 hours post-
dose) and time point four (6 hours post-dose) in the DSST task were illustrated after 
supplementation of the DelcyanTM extract only. As age related decreases in DSST 
scores are associated with decreased processing speed, rather than decrements in 
memory (Salthouse, 1992), the effects of the DelcyanTM treatment upon the DSST are 
hypothesised to be associated with an increase in processing speed, rather than a 
direct augmentation of working memory. The only significant treatment effect upon 
memory performance after supplementation of the Blackadder juice extract was a 
decrement to the recall task scores, with increases in incorrect responses on the 
delayed recall task following supplementation of the Blackadder juice. This increase in 
incorrect responses was also evident at repetition two of the immediate word recall task 
after supplementation of the Blackadder juice drink when compared to a control but this 
was only a trend treatment*repetition interaction on the main ANOVA. Both results 
indicate decrements in verbal episodic memory after supplementation of the 
Blackadder juice drink, an outcome which has been shown to be improved after chronic 
supplementation of blueberries (Krikorian et al., 2010b) and concord grapes (Krikorian 
et al., 2010a) in aged adults.  
 
To conclude, the behavioural findings from this thesis; initial findings would suggest 
that cognitive performance, particularly attention based processes and speed of 
processing can be positively impacted by the acute supplementation of blackcurrant 
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extracts. The pattern of evidence from the subsequent studies in this thesis are, 
however, not as clear with no replication of the aforementioned modulations upon 
attention and no definitive effects upon memory. Therefore, no real evidence of 
cognitive enhancement after supplementation of blackcurrant extracts is apparent from 
the intervention chapters of this thesis. The literature would suggest that for flavonoid-
rich extracts to be effective as modulators of human cognitive performance chronic 
supplementation needs to be undertaken. The theory would, therefore, be that the long 
term consumption of blackcurrants in healthy humans would not improve cognitive 
performance from the basal point, but attenuate decrements in cognitive performance 
associated with natural ageing over the natural lifespan. Therefore, both short term 
chronic (several months) and long term chronic (several years) assessments need to 
be undertaken to establish if blackcurrant extracts can indeed slow the natural ageing 
process. It may also be the case that the doses used in the intervention chapters of this 
thesis were too low or post dose cognitive assessments were conducted too long after 
consumption. Higher doses or cognitive assessments pre-one hour post-dose could 
prove to be more effective. The possibility also remains that blackcurrant simply has no 
measurable effects on cognition in humans. 
 
7.2.2 Physiological effects 
A secondary aim of this thesis was to assess the physiological and haemodynamic 
effects of blackcurrant extracts. Throughout the behavioural intervention trials in this 
thesis, several physiological parameters, which could potentially impact human 
behaviour, were measured. These include central and peripheral haemodynamics and 
the regulation of blood glucose. A summary of physiological and bilological findings can 
be found in table 7.2 
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Table 7.2 Significant effects of the different doses of the Blackadder and Delcyan
TM
 extracts employed on 
physiological outcomes 
Measure  
Blackadder Juice Delcyan
TM
 
125mg 250mg 500mg 500mg 
Peripheral 
haemodynamics 
Heart rate (BPM) 
  
- - 
Diastolic blood pressure 
(mmHg)   
- - 
Systolic blood pressure 
(mmHg)   
- 
 
DVP - SI 
  
- 
 
DVP - RI 
  
- 
 
Central 
haemodynamics 
NIRS 
Combined OxyHb 
  
- 
 
OxyHb LH 
  Ch 4 
 OxyHb RH 
  
- 
 
Combined DeoxyHb 
  Ch 4  
DeoxyHb LH 
  
- 
 
DeoxyHb RH 
  
- 
 
Combined TotalHb 
  
- 
 
TotalHb LH 
  Ch 4  
TotalHb RH 
  
- 
 
Blood Parameters 
Platelet MAO-B activity 
(nmol H
2
O
2
) Ch 3 Ch 3 Ch 2,3 & 5 
- 
Prolactin (mIU/L) Ch 3 Ch 3 Ch 2 & 5 - 
Glucose (mmol/L) 
  Ch 2  Ch5 
- 
Lactate (mmol/L) 
  
- - 
Frap - - - 
 
Phenylethylamine (ng/ml) 
  
- - 
Dopamine (ng/ml) 
  
- - 
Serotonin (ng/ml) 
  
- - 
Normetanephrine (ng/ml) 
  Ch 1 
- 
Noradrenaline (ng/ml) 
  
- - 
Adrenaline (ng/ml) 
  
- - 
DHPG (ng/ml) 
  Ch 1 
- 
Homovanillic acid (ng/ml) 
  
- - 
Where:  or = significant increase/decrease in the parameter tested along with the chapter where the significant 
effect was found. Where: - = no effect found. Where                = parameter not assessed at that dose. 
 
7.2.2.1 Haemodynamics 
Peripheral haemodynamics 
In the literature, there is some evidence towards a modulation of peripheral blood flow 
after supplementation of blackcurrants (Matsumoto et al., 2005a; Matsumoto et al., 
2005b) and a plethora of data suggesting increases in peripheral blood flow after the 
consumption of flavonoid-rich cocoa (Matsumoto et al., 2005a; Matsumoto et al., 
2005b; Heiss et al., 2007; Faridi et al., 2008a). Throughout this thesis, however, no 
observable impact of any of the study interventions upon peripheral haemodynamics 
was observed. These include; measures of, blood pressure, large artery stiffness and 
endothelial dependent vasodilation. In chapter two, blood pressure and heart rate were 
assessed 60 and 150 minutes post supplementation of the Blackadder juice and 
DelcyanTM extracts, with no significant effects found. These findings are consistent with 
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those of Jin et al., (2011) who found no acute effect of a 20% blackcurrant extract upon 
blood pressure or heart rate. Berry anthocyanins have, however, been shown to induce 
endothelial dependent relaxation facilitated by up-regulation of eNOS (Andriambeloson 
et al., 1998) and to inhibit iNOS (Chen et al., 2001) in vitro. Therefore, pulse wave 
velocity, a measure of endothelial dependent vasodilation and large artery stiffness, 
which has been shown to be sensitive to NO synthase manipulation (Klemsdal et al., 
1994), administration of vasoactive drugs and vascular ageing (Takazawa et al., 1998) 
was implemented in chapter five of this thesis. As with blood pressure, no significant 
effects were found after supplementation of the 500mg Blackadder juice drink (the only 
extract used in the study).  
 
Cerebral haemodynamics 
Modulations of central haemodynamics were observed after supplementation of the 
500mg Blackadder blackcurrant juice extract, the only extract examined in this context. 
When compared to placebo, consumption of the Blackadder juice extract resulted in 
significant modulations in prefrontal cortex haemoglobin concentrations during resting 
absorption and cognitive task performance. Hemispheric differences in the modulation 
of haemodynamics were also illustrated. Increases in oxyhaemoglobin and total 
haemoglobin in the left hemisphere, but not the right, were seen during the cognitive 
task period after consumption of the blackcurrant drink when compared to control. No 
effect of task type was evident. The Blackadder juice extract also caused a significant 
reduction in deoxyhaemoglobin with no hemispheric differences being seen. Unlike 
oxyhaemoglobin, the modulation of deoxyhaemoglobin began 45 minutes post 
consumption of the blackcurrant juice, during the resting absorption period. Reductions 
in levels of deoxyhaemoglobin coincide with the potential appearance of berry 
anthocyanins in blood plasma, which previous research has shown to reach maximal 
concentrations at ~1 hour post consumption (Matsumoto et al., 2001). The significant or 
near to significant modulation of deoxyhaemoglobin continued throughout the 
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remaining 15 minutes of the absorption period and throughout the cognitive testing 
period; again, no effect of task type was evident.  
 
The rise in total haemoglobin in response to post-dose tasks in chapter four, 
irrespective of intervention, reflects neurovascular coupling via the natural nitric oxide 
mediated drive for more fuel. It is possible that this is further up-regulated in the left 
hemisphere after consumption of the blackcurrant juice. Hemispheric differences found 
in the present study could, therefore, be indicative of the study intervention amplifying a 
natural difference in hemispheric activity in response to cognitive demand as previously 
shown during mental subtractions (Baurbaud et al., 1999) and during the RVIP task  
(Coull et al., (1996) employed.  
 
As rate of utilisation of oxygen is slower than the rate at which it is provided, the 
relative decrease in deoxygenated haemoglobin during cognitive performance following 
blackcurrant is as expected, given the observed increase in oxygenated haemoglobin. 
However, the effects on deoxygenated haemoglobin do not show the lateralisation 
observed with oxygenated haemoglobin. Further to this, the pattern of effects upon 
deoxyhaemoglobin does not follow that of oxygenated blood flow. The effects on 
oxyhaemoglobin following control and Blackadder juice interventions exhibit a similar 
pattern until cognitive demand is imposed, whereas reductions in deoxyhaemoglobin 
seen after consumption of both treatments begin to diverge at 40 minutes post-dose. 
This divergence manifests as a rise in the control arm taking deoxyhaemoglobin back 
up to levels similar to these observed at the start of the session, whereas levels in the 
Blackadder juice arm continue to reduce throughout the remainder of the absorption 
period and throughout the cognitive assessment period. The time of onset and the lack 
of lateralisation of effects on deoxyhaemoglobin suggest that these are independent of 
effects on oxyhaemoglobin. A definitive mechanism behind this effect is not known, 
however, one tentative suggestion is, after consumption of the sugar matched drinks 
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more glucose is available for utilisation and, therefore, the ratio of lactate and glucose 
in neuronal tissue changes in favour of glucose, a ratio which could be exacerbated by 
the 12 hour fast prior to treatment consumption. As less oxygen is needed to utilise 
glucose as a fuel when compared to lactate (Larrabee, 1995), less oxygen may be 
needed to maintain cognitive activities post consumption of the sugar matched drinks, 
therefore, oxygen turnover is reduced. As glucose absorption is slowed after the 
consumption of the Blackadder juice extract and therefore glucose is available 
systemically for longer than control, this utilisation of glucose may continue throughout 
the cognitive assessment after consumption of the Blackadder juice extract but return 
to baseline 45 minutes post consumption of the control drink. 
 
The blackcurrant components responsible for the effects upon oxyhaemoglobin and 
total haemoglobin are unknown. A factor which is further hindered by the absence of 
data assessing the pharmacodynamics of anthocyanins pre-one hours post 
consumption. As anthocyanins levels in blood plasma are either at or near to their 
maximal concentration one hour post consumption, it seems reasonable to assume 
that anthocyanins are present in plasma at the start of the cognitive battery and, 
therefore, could be modulating the effects seen on haemodynamic parameters. 
However, as discussed in section 1.2 of this thesis, blackcurrants contain conjugates of 
other flavonoids as well as phenolic acids. Phenolic acids have been shown to be 
present in the periphery 30 minutes after consumption of a blackcurrant drink (Jin et al., 
2011) and, therefore, cannot be ruled out as the compounds modulating the observed 
haemodynamic changes. To attempt to explore potential compounds driving these 
haemodynamic changes, a direction for future research would be to assess several 
different extract types with differing phenolic profiles at differing doses. Further to this, 
compounds in isolation could be assessed. 
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Reductions in cerebral blood flow are associated with natural ageing (Leenders et al., 
1990) and neurological disease (Dede et al., 2007). Results from this thesis outline the 
ability of the Blackadder blackcurrant juice extract to increase cerebral blood flow in a 
young healthy population. Therefore, the effects of the Blackadder juice and other 
types of blackcurrant extracts upon brain function deserve further investigation. 
 
7.2.2.2 Glucose uptake 
The findings from chapters two and five of this thesis demonstrate that the 
consumption of a blackcurrant extract can modulate blood glucose profiles. Data from 
chapter two demonstrates that the Blackadder juice treatment can increase capillary 
blood glucose at 60 and 150 minutes post supplementation when compared to control. 
A finding not present after the consumption of the DelcyanTM extract. This modulation 
of blood glucose is apparent despite all intervention drinks being sugar matched. A 
more thorough investigation of this glucose modulation was conducted in chapter five 
utilising an inlying cannula and nine post-dose blood samples over four hours. Chapter 
five showed that increases in blood glucose found in chapter two were a 
misrepresentation of the post-prandial blood glucose profile. Results showed that 
instead of increasing overall glucose absorption, the Blackadder blackcurrant juice 
drink reduces the post-prandial peak in blood glucose levels. This blunted peak is 
theorised to be due to reduced glucose uptake from the stomach to the blood stream, 
slowing glucose absorption and, therefore, resulting in a higher blood glucose reading 
one hour post supplementation when compared to placebo. The only statistically 
significant effect of the Blackadder juice extract upon blood glucose in chapter five was 
at 15 minutes post supplementation, where glucose levels were lower than when 
compared to control. However, a non-significant regulation of blood glucose occurred 
until 100 minutes post-dose, where it returned to a level similar to baseline and control. 
This phenomena of a blunted blood glucose peak is not unique to the consumption of 
blackcurrant extracts, it has also been outlined after the consumption of other phenolic-
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rich meals such as cloudy apple juice (Johnston et al., 2002) berry purée (Törrönen et 
al., 2012) and cranberry juice (Wilson et al., 2008b). On the most basic level, research 
has shown glucose to be a modulator of cognitive performance when high demand is 
placed on the brain (Donohoe & Benton, 2000; Kennedy & Scholey, 2000; Scholey et 
al.2001; Riby et al., 2004; Scholey & Kennedy, 2004). As glucose is the primary fuel of 
the brain, it is hypothesised that this control of glucose uptake by phenolic compounds 
allows glucose to be available systemically for longer, which may have a positive 
impact on cognition during bouts of high demand.  
 
Chapter six aimed to assess the impact of blackcurrant supplementation on glucose 
levels in a middle aged cohort, where glucose regulation might be impaired when 
compared to the young healthy cohorts used in the earlier interventions of this thesis 
(Shimokata et al., 1991). Although not significant, blood glucose followed a similar 
pattern to that observed in chapter two with levels ~0.5mmol/L higher after 
supplementation of the Blackadder juice drink one hour post supplementation, an effect 
not observed after supplementation of the DelcyanTM extract. Although earlier time 
points were not measured, it was outlined in chapter five that this increase in blood 
glucose is a result of a lower post-prandial peak in blood glucose, associated with 
consumption of the intervention drink. The second aim, in terms of glucose modulation 
in chapter six was to assess if a similar pattern of glucose modulation was observable 
after a 10g glucose load at a later time point without co-consumption with polyphenols. 
This pattern of glucose modulation was not observed 200 minutes post 
supplementation of the blackcurrant extracts (10 minutes post consumption of the 10g 
glucose load). However, no significant effect was observed one hour post-dose so no 
conclusion can be drawn from the data available from chapter six. As mentioned 
earlier, it is noteworthy that an increase in blood glucose was documented in 
participants aged 18-35 in earlier chapters of this thesis but did not reach statistical 
significance in chapter six. This could be a consequence of reduced glucose regulation 
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in middle aged adults (Tuomilehto et al., 2003), however, a more obvious explanation 
would be dose selection. Doses were standardised at 500mg of polyphenols per 
person, regardless of weight, reducing, on average, the amount of polyphenols per kg 
of body weight by 1mg compared to that in chapters one and five. Therefore, reducing 
the impact of the intervention upon blood glucose. In order to explore this further, it 
would be beneficial to examine these effects again in this population using the weight-
linked doses employed in chapter two. It would also be beneficial to include 
administration of a later blood glucose load in young adults (18-30) in order to explore 
these effects in a population which have been shown to be sensitive to concomitant 
glucose and polyphenol consumption in the current thesis. 
 
To conclude, the supplementation of the Blackadder juice extract but not the DelcyanTM 
extract significantly reduced the post-prandial glucose peak after consumption. This, 
therefore, highlights an impact of post-harvest preparation techniques upon blood 
glucose effects. The slowing of absorption is hypothesised to be facilitated by the 
inhibition of sodium glucose transporters by phenolic compounds (Manzano & 
Williamson, 2010) in the Blackadder juice extract, reducing gastric emptying and, 
therefore, attenuating the speed of transport of glucose to the blood stream. These 
phenolic acid compounds are in much lower quantities in the DelcyanTM extract which 
is theorised to be the reason why no effects were found on blood glucose after its 
consumption. Findings would highlight a possible role of some, but not all blackcurrant 
extracts as a glycaemic index lowering agent. 
 
7.2.3 Biological mechanisms of action 
The final aim of this thesis was to examine underlying mechanisms, in particular 
potential in vivo monoamine oxidase inhibitory properties of blackcurrants and 
associated biomarkers. Throughout the behavioural intervention trials in this thesis, 
several underlying biomarkers that could potentially impact human behaviour were 
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assessed. These include MAO inhibition, monoaminergic tone and prolactin secretion. 
Both isoforms of MAO were shown to be inhibited in healthy young adults after 
supplementation of the Blackadder juice extract but not the DelcyanTM extract. A 
modulation of monoaminergic tone and reductions in blood plasma prolactin were also 
observed after consumption of the Blackadder juice extract. 
 
7.2.3.1 Monoamine oxidase inhibition and associated monoaminergic tone 
The initial intervention study of this thesis attempted to assess the impact of two 
blackcurrant extracts, with differing phenolic profiles, upon MAO-A and MAO-B. Data 
from this study demonstrated that platelet MAO-B activity was inhibited by 96% at 2.5 
hours post consumption of the Blackadder juice extract when compared to control. This 
level of platelet MAO-B inhibition is similar to that of pharmacological MAO-B inhibitors 
currently prescribed as anti-Parkinsonian agents (Dingemanse et al., 1997). A 
significant reduction in MAO-A activity (~35.5%) as indicated by reduced plasma 
DHPG levels (Koulu et al., 1989; Zimmer, 1990), was also observed. Reductions in 
DHPG concentrations and platelet MAO-B activity in chapter two did not coincide with 
an accumulation of the measured associated monoamines (adrenalin, serotonin and 
dopamine), which is in line with previous research utilising acute administration of 
pharmaceutical MAO inhibitors (Eisler et al., 1981; Illi et al., 1996). However, an 
increase in normetanephrine was found after consumption of the Blackadder juice 
extract compared to control. This increase is theorised to be indicative of increased 
noradrenalin breakdown through COMT, due to inhibition of the MAO-A enzyme. The 
compounds which were previously theorised to be driving the reported inhibition of the 
MAO enzymes were anthocyanins (Dreiseitel et al., 2009a). However, findings outlined 
in chapter two of this thesis demonstrate that this may not be the case. Despite blood 
plasma levels of all measured anthocyanins being higher after the consumption of the 
DelcyanTM extract when compared to the Blackadder juice extract, there was no 
significant inhibition of platelet MAO-B activity after consumption of the DelcyanTM. This 
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highlights, that at least alone, the measured anthocyanins are unlikely to be the 
compound responsible for the inhibition of the enzyme. It is possible that another 
compound in the blackcurrant extract is the active inhibitor or an in vivo metabolite of a 
compound in the blackcurrant extract is inhibiting MAO in vivo. This, however, does not 
rule out potential for a synergy within the blackcurrant profile. For example, Dreiseitel et 
al., (2009b) showed that anthocyanins have an affinity for breast cancer resistant 
protein (BCRP) efflux transporters in endothelial cell model (caco2 monolayers). This 
efflux away from the site of action may limit the bioavailability of anthocyanins in 
plasma and the brain, but could allow other compounds and metabolites in 
blackcurrants, which have potential to be MAO inhibitors, but have a lesser affinity to 
the efflux transporters to accumulate at the site of action, thereby, increasing their 
effectiveness. 
 
Chapter three of this thesis assessed the sensitivity of the MAO-B inhibitory properties 
outlined in chapter two, to a range of doses of the Blackadder blackcurrant juice 
extract. Doses of 125mg, 250mg and 500mg of total polyphenols per 60kg of 
bodyweight were utilised. All blackcurrant drinks reduced MAO-B activity compared to 
placebo 120 minutes post supplementation. The 250mg and 500mg treatments 
inhibited MAO-B activity by ~80% and the 125mg treatment reduced activity by 68%. 
This limited dose effect of the Blackadder blackcurrant juice extract potentially further 
highlights that anthocyanins are not the inhibiting compound in the Blackadder juice 
extract. Dreiseitel et al., (2009a) showed that anthocyanins inhibited the MAO-B 
enzyme competitively. However, if the MAO-B inhibition was competitive, a larger effect 
of dose would be expected. This was further highlighted in chapter five where the 
pharmacodynamics of the inhibitory properties of the 500mg Blackadder juice extract 
were investigated, utilising intravenous cannulation and 10 post-dose blood samples 
over 24 hours. This pharmacodynamic investigation revealed a sustained reduction in 
MAO-B of 100% when compared to control. This reduction began 15 minutes post 
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supplementation (the first time post-dose measurement), continued throughout the 
subsequent measures and was still present at the final measurement on that day (four 
hours post-dose). This is a finding which is similar to pharmaceutical reversible MAO-B 
specific inhibitors such as the anti-Parkinsonian drug Lazamabemide. These data from 
chapter five of this thesis, and the lack of significant effects of the Blackadder juice 
extract upon MAO-B 24 hours post supplementation, outline a distinct reversible and 
complete inhibition of platelet MAO-B activity from the Blackadder juice extract. 
 
In light of the robust findings above, it was surprising to find that in chapter six, there 
was no observable inhibition of MAO-B after supplementation of either the Blackadder 
juice extract or the DelcyanTM extract when compared to control within a cohort of 
healthy middle aged adults. There is no doubt that the active compound or compounds 
driving the inhibition are still present in the Blackadder juice extract, however, there are 
several methodological limitations as discussed in section 6.4, which could pertain to 
the null findings. Firstly, due to technical difficulties, only five sets of blood samples 
were successfully analysed for MAO-B activity, therefore, the statistical analysis may 
have been underpowered, however, findings do not follow the same pattern as 
previous studies. Secondly, due to the time needed to be spent in the laboratory after 
an overnight fast, participants were fed a pasta meal 180 minutes post 
supplementation. Food interactions with MAO inhibitors are well documented in terms 
of safety (i.e. the tyramine effect), however, no such information is available regarding 
food intake and potency reductions making the link between food intake and the null 
findings upon MAO activity unclear. Thirdly, MAO-B activity was measured six hours 
post consumption of the blackcurrant extracts, whereas the last time point where MAO-
B was previously shown to be significantly inhibited by supplementation of the 
Blackadder juice drink was at four hours post-dose. However, the inhibition was at such 
a level (100%), that it was expected that the MAO inhibition would still be evident six 
hours post-dose. A final point to note is the increase in MAO activity with age. This 
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increase is reported to be at a rate of 7% per decade (Fowler et al., 1997). As effects of 
the Blackadder juice extract have been shown after consumption of a dose 
standardised at 125mg/60kg of body weight in chapter two, these results and increase 
in MAO activity with age may highlight that a higher dose may be needed to elicit an 
inhibitory response in an older cohort. This highlights the need for further research 
focusing upon dose ranges and more time points, in a similarly designed study to 
chapter five of this thesis, to allow the efficacy of MAO inhibition via consumption of the 
Blackadder juice extract to be determined in a healthy middle aged and older 
population. 
 
7.2.3.2 Prolactin secretion 
It is theorised that as MAO-B inhibition is associated with increased dopaminergic tone 
(Riederer & Youdim, 1986), which is the most important hypothalamic prolactin 
inhibiting factor (Fitzgerald & Dinan, 2008), inhibition of MAO-B by the Blackadder juice 
extract would impact dopaminergic tone and lower peripheral prolactin levels. The 
initial measurement of prolactin in the thesis was conducted in chapter two, with data 
revealing a potential lowering effect of the Blackadder juice extract. This potential 
modulation was illustrated in a between subjects fashion with a sample size too small 
for a reliable conclusion to be established. In chapter three, this potential prolactin 
lowering effect of the Blackadder blackcurrant juice extract was investigated further in a 
dose ranging study (125, 250 and 500mg of total polyphenols), this time in a larger 
cohort utilising a within subjects design. Peripheral prolactin was reduced after 
supplementation of all doses of the Blackadder blackcurrant juice drinks, but only 
statistically significantly reduced after consumption of the 125mg and 500mg 
polyphenol Blackadder blackcurrant juice drinks. The efficacy of the prolactin lowering 
effect of the Blackadder blackcurrant juice extract was further scrutinised in chapter five 
where the pharmacodynamics of the neuroendocrinological impact were investigated. 
A dose standardised at 500mg of total polyphenols was utilised and 10 post-dose blood 
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samples were extracted from an inlying cannula. Non-significant reductions in prolactin 
were seen 30 minutes post consumption of the Blackadder juice extract when 
compared to placebo. The first statistically significant area under the curve increment in 
prolactin levels between control and the Blackadder juice extract began 45 minutes 
post supplementation and continued until the last measured concentration at four hours 
post consumption of the intervention drinks. The maximal reduction appeared two 
hours post supplementation with 61% reduction being seen when compared to control. 
A reduction similar to that reported in chapter three, where a reduction of 55% was 
reported 120 minutes post supplementation of the same treatment. Prolactin levels had 
returned to a level similar to baseline 24 hours post supplementation of both 
intervention drinks. This finding was not seen in chapter six, where the effects of both 
the Blackadder blackcurrant juice drink and the DelcyanTM powdered extract had no 
significant effect at six hours post supplementation in a cohort of healthy middle aged 
adults. This result is unsurprising as there was no effect of the Blackadder juice 
intervention upon MAO activity, the underlying mechanism believed to be driving the 
prolactin lowering effect.  
 
The neuroendocrinological impact of the Blackadder juice extract presented throughout 
the intervention chapters of this thesis is consistent with inhibition of prolactin secretion 
by the central D2 receptor agonist Bromocriptine, of which, 12mg reduces peripheral 
prolactin by ~60% two hours post-dose (Luciana et al., 1998). These reductions in 
prolactin could have positive implications upon sexual health and libido and play a 
major role in alleviation of symptoms associated with hyperprolactinaemia (Buvat, 
2003). More importantly, although it cannot be definitively proven from the body of 
evidence presented in this thesis, as predominant control of prolactin is via 
hypothalamic inhibition of lactotroph activity and the most important hypothalamic 
prolactin inhibiting factor is dopamine (Ben-Jonathan & Hnasko, 2001), results indicate 
the possibility of a centrally active inhibition of MAO after ingestion of the Blackadder 
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juice extract which could have implications in the treatment of neurodegenerative 
diseases and potentially help attenuate natural cognitive decline. 
 
7.2.4 Summary of physiological effects and biological mechanisms 
Physiological and biological mechanisms which have the potential to impact human 
behaviour were documented and quantified throughout this thesis. The efficacy of 
these mechanisms to impact human behaviour acutely after consumption of 
blackcurrant extracts, especially in the investigational chapters of this thesis are 
unclear. Results from chapter six showed that there is no clear pattern of effects upon 
memory and learning after consumption of blackcurrant extracts in a middle aged 
cohort. However, a lack of reliable acute improvements to cognitive performance 
following blackcurrant does not rule out the potential for promotion of long term 
maintenance of cognitive flexibility. For instance, mechanisms mediated by flavonoid 
consumption and related to hippocampal plasticity, such as up regulation of CREB 
(Brightwell et al., 2007) and increased levels of BDNF (Rendeiro et al., 2013) in animal 
models, suggest that benefits may be conferred following chronic supplementation. As 
MAO inhibition in a young healthy cohort could not be replicated in a middle age cohort 
following blackcurrant and as MAO activity increases, and cerebral blood flow 
decreases, with age, there is an argument for the need of a larger dose in aged 
populations for an impact to be seen. If inhibition of MAO-A and MAO-B and 
modulation of cerebral blood flow, decrements in which have been shown to be 
implicated in cognitive decline, can be shown to be mediated in an older population, 
there is potential for blackcurrant consumption to attenuate natural age related 
cognitive decline. These potential mechanisms are shown below in figure 7.1. Finally, if 
the MAO inhibiting effects of the Blackadder juice can be proven to be centrally active, 
blackcurrant extracts could, potentially, be used as therapeutic agents in the treatment 
of neurological diseases such as Parkinson’s, Huntington’s and Alzheimer’s disease. 
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Figure 7.1 Potential mechanisms which could synergistically impact natural cognitive decline. 
Blackcurrant extract
Shallow pre-frontal 
haemodynamic effectsInhibition of MAO Glucose regulation
Neuroendocrinological
effects
Attenuation of age related cognitive 
decline?
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7.3 Potential methodological limitations 
Although the intervention studies which make up this thesis provide novel findings with 
regards to the impact of acute blackcurrant consumption, it is sensible to acknowledge 
some methodological limitations.  
 
A potential issue arises from the large amount of behavioural outcome measures used 
in chapters three and six of this thesis. Although the aim of said investigations was to 
acquire a broad understanding of the impact of blackcurrant extracts upon cognitive 
performance and educated decisions on task choice were made, there was inevitably 
an increased risk of detecting a significant effect by chance. In recognition of this 
potential limitation, interpretation and discussion of results throughout this thesis have 
been focused upon outcomes which fall into patterns, rather than discussing every 
result at length. 
 
Throughout the thesis, blood glucose was measured using finger prick blood samples. 
Although this method has been used in many glucose studies to measure glycaemic 
response to a glucose challenge, more up to date methodologies are now available, 
offering continuous non-invasive methods of glucose quantification. Such methods as 
interstitial continuous glucose monitoring as used by Dye et al., (2010) would allow for 
a full profile of the effects to be monitored during cognitive assessment. 
 
In chapter six, MAO-B inhibition was measured in a very small sub sample (N=5 after 
errors with the assay) at a time point which had not previously been proven to be 
effective. Given the powerful inhibition (100%) shown in chapter five of this thesis after 
consumption of the Blackadder blackcurrant extract standardised at 500mg of 
polyphenols, it was deemed highly likely that the inhibition would still be evident six 
hours post-dose. Given that the effects had never been confirmed in the middle aged 
cohort used, and lunch was administered, an earlier time point where MAO is known to 
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be inhibited in younger participants should have been used. This would have allowed a 
direct comparison between the young and middle aged cohort. 
 
Finally, there is no clear pattern of modulation upon cognitive or mood parameters 
assed in this thesis after consumption of either the Blackadder Juice or DelcyanTM 
blackcurrant extract. There are several methodological factors which could have 
impacted findings. Epidemiological studies have shown that diets habitually high in 
polyphenols are linked with an attenuation of cognitive decline associated with natural 
ageing in humans, when compared to diets lower in polyphenols (Letenneur et al., 
2007; Nurk et al., 2009; Devore et al., 2012; Kesse-Guyot et al., 2012). Socio-
economic factors have been shown to impact a person’s habitual diet. For instance, a 
review of the literature by Darmon & Drewnowski (2008) showed that better quality 
diets are consumed by more educated and affluent people. Findings also show that 
people with a high socio-economic status consume a significantly higher quantity and 
variety of fruits and vegetables when compared to their counterparts in low socio-
economic groups. In the intervention chapters of this thesis, no data was collected in 
regards to socio-demographics of the research cohort, a factor which could effect the 
habitual diet of participants. In addition habitual diets of participants were not assessed 
in this thesis, therefore, differences in participant diets cannot be ruled out as factors 
impacting observed results throughout. Further to this, the glycaemic index of an 
evening meal has been shown to significantly impact cognitive performance the next 
day (Lamport et al., 2012). This is a factor which was not controlled for in the current 
thesis, therefore, the 12 hour fasting period prior to cognitive assessment may not have 
been sufficient of a control for this phenomena. It is also possible that geographical 
location could have played a role in the study findings in chapter two and lack of 
replication in chapter three. The initial intervention (chapter two) was conducted in 
healthy adults in New Zealand. In this population, improvements in attention based 
tasks were seen after consumption of the Blackadder juice extracts. In the second 
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intervention (chapter three), these results were not replicated, however, the study was 
conducted in Newcastle, England. Although it cannot be confirmed as participant diets 
were not recorded, it is theorised that a difference in habitual diet between countries 
could have impacted results.  
Lastly, the gender of participants was not taken into consideration during the analysis 
of findings in chapters 2,3,4 and 6 of this thesis. Therefore, physiological and 
psychological differences between sexes of participants were not accounted for, 
potentially impacting study findings. 
 
7.4 Recommendations for future research 
Whilst the limitations described in section 7.3 highlight several methodological issues 
from this thesis which need to be addressed in future research, there is also 
considerable scope for future research which can be drawn from the intervention 
studies of this thesis. 
 
The major recommendation would be to assess the impact of chronic supplementation 
of blackcurrant extracts in young, middle aged and elderly adults, utilising cognitive 
domains which have been shown to be sensitive in animal models. It would also be a 
recommendation to use a baseline measure and a control with several intervention 
testing sessions to assess the optimum time point, dose and potential ceiling effects, 
for example, measurements, taken at baseline and after acute supplementation, then 
monthly measurements until the end of the intervention period. These behavioural 
measures should be coupled with a non-invasive measure of cerebral blood flow, such 
as quantitative NIRS, (which allows the quantification of haemoglobin rather than an 
arbitrary value as seen in the continuous wave NIRS utilised in chapter four of this 
thesis, therefore, allowing for multiple measurements in a chronic study), and 
measurements of MAO activity to assess if intervention driven modulations of blood 
flow and MAO activity correlate with changes in cognitive performance. These 
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recommendations are, however, hindered by results highlighted in chapter two of this 
thesis where physiological (blood glucose) and biological (MAO) responses to the 
blackcurrant extracts differed after consumption of differently prepared extracts. The 
final recommendation would, therefore, be the measurement of peripheral and cerebral 
MAO activity after consumption of several blackcurrant extracts, assessing the impact 
of differing cultivars and post-harvest preparations. This would highlight if the inhibition 
is unique within cultivars, geographical growing locations and post-harvest 
preparations. It is acknowledged that the measurement of central MAO activity would 
involve expensive neuroimaging techniques such as positron emission tomography, a 
neuro-imaging technique which is capable of detecting radioactively labelled 
metabolically active substances which have been infused into the bloodstream. 
However, such research is essential to determine centrally active MAO effects. 
 
In addition to results from this thesis, the above suggested research would create a 
foundation for future studies investigating the impact of blackcurrant extracts upon 
cognitive performance and potentially symptoms of neurodegenerative disease to be 
based. 
 
7.5 General conclusion 
The main aim of this thesis was to assess the impact of standardised blackcurrant 
extracts upon human behaviour in healthy participants. Single doses of each of the 
blackcurrant extracts used in this thesis yielded some positive results with effects of 
post-harvest extraction evident. Increases in attention processing were observed in 
young healthy adults, with limited effects being evident upon any other cognitive 
paradigm. The overarching recommendation for future research would be a chronic 
study assessing the effects of standardised blackcurrant extracts on a broad range of 
cognitive outcomes, especially memory, attention and executive functioning in young, 
middle aged and elderly cohorts.  
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Underlying physiological mechanisms with potential to modulate human behaviour 
were also evaluated throughout the thesis. Modulations of post-prandial glucose and 
shallow pre-frontal cortical haemodynamics were seen, but most striking were robust 
inhibitions of peripheral MAO in young healthy cohorts, at a level great enough to 
modulate hormone secretion.  
 
In summary the original contribution to knowledge arriving from the intervention 
chapters in this thesis are: 
 A suggestion of enhanced cognitive performance in young healthy adults after 
the acute administration of blackcurrant extracts 
 Confirmation of the monoamine oxidase inhibitory properties of blackcurrant 
extracts; including the first demonstration of an impact of post-harvest 
processing techniques upon in vivo effects 
 The first demonstration of the effect of blackcurrant consumption upon 
peripheral prolactin, potentially outlining modulations of CNS monoaminergic 
tone 
 The first demonstration of modulations in cerebral blood flow after the 
consumption of a blackcurrant extract 
 The first demonstration of the modulation of blood glucose after the ingestion of 
blackcurrant extracts; including demonstration of the impact of post-harvest 
processing upon this effect  
  
 
 
222 
 
REFERENCES 
 
Agewall, S., Wright, S., Doughty, R. N., Whalley, G. A., Duxbury, M., & Sharpe, N. 
(2000). Does a glass of red wine improve endothelial function? European Heart 
Journal, 21(1), 74-78. doi: 10.1053/euhj.1999.1759 
Ahearn, P. (1997). The use of visual analog scales in mood disorders: A critical review. 
Journal of Psychiatric Research, 31(5), 569-579.  
Allaby, M. (1996). The concise oxford dictionary of botany: Oxford University Press. 
Alper, G., Girgin, F. K., Ozgönül, M., Menteş, G., & Ersöz, B. (1999). Mao inhibitors 
and oxidant stress in aging brain tissue. European Neuropsychopharmacology, 
9(3), 247-252. doi: http://dx.doi.org/10.1016/S0924-977X(98)00035-2 
Aluf, Y., Vaya, J., Khatib, S., Loboda, Y., & Finberg, J. P. M. (2013). Selective inhibition 
of monoamine oxidase a or b reduces striatal oxidative stress in rats with partial 
depletion of the nigro-striatal dopaminergic pathway. Neuropharmacology, 
65(0), 48-57. doi: 10.1016/j.neuropharm.2012.08.023 
Amalric, M., & Koob, G. (1987). Depletion of dopamine in the caudate nucleus but not 
in nucleus accumbens impairs reaction-time performance in rats. The Journal of 
Neuroscience, 7(7), 2129-2134.  
Amalric, M., Berhow, M., Polis, I., & Koob, G. F. (1993). Selective effects of low-dose 
d2 dopamine receptor antagonism in a reaction-time task in rats. 
Neuropsychopharmacology, 8(3), 8.  
Andres-Lacueva, C., Shukitt-Hale, B., Galli, R. L., Jauregui, O., Lamuela-Raventos, R. 
M., & Joseph, J. A. (2005). Anthocyanins in aged blueberry-fed rats are found 
centrally and may enhance memory. Nutritional Neuroscience, 8(2), 111-120.  
Andriambeloson, E., Magnier, C., Haan-Archipoff, G., Lobstein, A., Anton, R., Beretz, 
A., Stoclet, J. C., & Andriantsitohaina, R. (1998). Natural dietary polyphenolic 
compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. 
The Journal of nutrition, 128(12), 2324-2333.  
Anttonen, M. J., & Karjalainen, R. O. (2006). High-performance liquid chromatography 
analysis of black currant (ribes nigrum l.) fruit phenolics grown either 
conventionally or organically. Journal of agricultural and food chemistry, 54(20), 
7530-7538. doi: 10.1021/jf0615350 
Arias, P., Robles-García, V., Espinosa, N., Corral, Y., & Cudeiro, J. (2012). Validity of 
the finger tapping test in parkinson’s disease, elderly and young healthy 
subjects: Is there a role for central fatigue? Clinical Neurophysiology, 123(10), 
2034-2041. doi: http://dx.doi.org/10.1016/j.clinph.2012.04.001 
Arzi, A., Hemmati, A. A., & Razian, A. (2004). Effect of vitamins c and e on cognitive 
function in mouse. Pharmacological Research, 49(3), 249-252. doi: 
http://dx.doi.org/10.1016/j.phrs.2003.10.004 
Asamoah, S., Siegler, J., Chang, D., Scholey, A., Yeung, A., & Cheema, B. S. (2013). 
Effect of aerobic training on cognitive function and arterial stiffness in sedentary 
young adults: A pilot randomized controlled trial. Physiology Journal, 2013, 9. 
doi: 10.1155/2013/847325 
 
 
223 
 
Attwell, D., Buchan, A. M., Charpak, S., Lauritzen, M., MacVicar, B. A., & Newman, E. 
A. (2010a). Glial and neuronal control of brain blood flow. Nature, 468(7321), 
11.  
Attwell, D., Buchan, A. M., Charpak, S., Lauritzen, M., MacVicar, B. A., & Newman, E. 
A. (2010b). Glial and neuronal control of brain blood flow. Nature, 468(7321), 
232-243.  
Aviram, M., & Dornfeld, L. (2001). Pomegranate juice consumption inhibits serum 
angiotensin converting enzyme activity and reduces systolic blood pressure. 
Atherosclerosis, 158(1), 195-198.  
Aviram, M., Rosenblat, M., Gaitini, D., Nitecki, S., Hoffman, A., Dornfeld, L., Volkova, 
N., Presser, D., Attias, J., Liker, H., & Hayek, T. (2004). Pomegranate juice 
consumption for 3 years by patients with carotid artery stenosis reduces 
common carotid intima-media thickness, blood pressure and ldl oxidation. 
Clinical nutrition (Edinburgh, Scotland), 23(3), 423-433.  
Awad, N., Gagnon, M., Desrochers, A., Tsiakas, M., & Messier, C. (2002). Impact of 
peripheral glucoregulation on memory. Behavioral Neuroscience, 116(4), 12.  
Bãckman, L., Ginovart, N., Dixon, R. A., Wahlin, T.-B. R., Wahlin, A. E., Halldin, C., & 
Farde, L. (2000). Age-related cognitive deficits mediated by changes in the 
striatal dopamine system. American Journal of Psychiatry, 157(4), 635-637. doi: 
10.1176/appi.ajp.157.4.635 
Bal-Price, A., & Brown, G. C. (2001). Inflammatory neurodegeneration mediated by 
nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate 
release and excitotoxicity. The Journal of Neuroscience, 21(17), 6480-6491.  
Balzer, J., Rassaf, T., Heiss, C., Kleinbongard, P., Lauer, T., Marx, M., Heussen, N., 
Gross, H., Keen, C., Schroeter, H., & Kelm, M. (2008). Sustained benefits in 
vascular function through flavanol-containing cocoa in medicated diabetic 
patients: A double-masked, randomized, controlled trial. Circulation, 118(18), 
S1123-S1123.  
Bass, A., Walden, R., Hirshberg, A., & Schneiderman, J. (1989). Pharmacokinetic 
activity of nitrites evaluated by digital pulse volume recording. Journal of 
Cardiovascular Surgery, 3(30), 3.  
Bassoli, B. K., Cassolla, P., Borba-Murad, G. R., Constantin, J., Salgueiro-
Pagadigorria, C. L., Bazotte, R. B., da Silva, R. S. d. S. F., & de Souza, H. M. 
(2008). Chlorogenic acid reduces the plasma glucose peak in the oral glucose 
tolerance test: Effects on hepatic glucose release and glycaemia. Cell 
Biochemistry and Function, 26(3), 320-328. doi: 10.1002/cbf.1444 
Bastianetto, S., Brouillette, J., & Quirion, R. (2007). Neuroprotective effects of natural 
products: Interaction with intracellular kinases, amyloid peptides and a possible 
role for transthyretin. Neurochem Res, 32(10), 1720-1725. doi: 
10.1007/s11064-007-9333-x 
Beecher, G. R. (2003). Overview of dietary flavonoids: Nomenclature, occurrence and 
intake. The Journal of nutrition, 133(10), 3248S-3254S.  
Ben-Jonathan, N., & Hnasko, R. (2001). Dopamine as a prolactin (prl) inhibitor. 
Endocrine Reviews, 22(6), 724-763. doi: 10.1210/er.22.6.724 
 
 
224 
 
Bent, S. (2008). Herbal medicine in the united states: Review of efficacy, safety, and 
regulation. Journal of General Internal Medicine, 23(6), 854-859. doi: 
10.1007/s11606-008-0632-y 
Benzie, I. F. F., & Strain, J. J. (1996). The ferric reducing ability of plasma (frap) as a 
measure of “antioxidant power”: The frap assay. Analytical biochemistry, 
239(1), 70-76. doi: http://dx.doi.org/10.1006/abio.1996.0292 
Benzie, I. F. F., & Strain, J. J. (1999). Ferric reducing antioxidant power assay: Direct 
measure of total antioxidant activity of biological fluids and modified version for 
simultaneous measurement of total antioxidant power and ascorbic acid 
concentration Oxidants and antioxidants, pt a (Vol. 299, pp. 15-27). 
Berlin, I., Zimmer, R., Thiede, H. M., Payan, C., Hergueta, T., Robin, L., & Puech, A. J. 
(1990). Comparison of the monoamine oxidase inhibiting properties of two 
reversible and selective monoamine oxidase-a inhibitors moclobemide and 
toloxatone, and assessment of their effect on psychometric performance in 
healthy subjects. British Journal of Clinical Pharmacology, 30(6), 805-816.  
Berry, N. M., Davison, K., Coates, A. M., Buckley, J. D., & Howe, P. R. C. (2010). 
Impact of cocoa flavanol consumption on blood pressure responsiveness to 
exercise. British Journal of Nutrition, 103(10), 1480-1484. doi: 
10.1017/s0007114509993382 
Bhat, N. R., Zhang, P., Lee, J. C., & Hogan, E. L. (1998). Extracellular signal-regulated 
kinase and p38 subgroups of mitogen-activated protein kinases regulate 
inducible nitric oxide synthase and tumor necrosis factor-α gene expression in 
endotoxin-stimulated primary glial cultures. The Journal of Neuroscience, 18(5), 
1633-1641.  
Bishayee, A., Mbimba, T., Thoppil, R. J., Háznagy-Radnai, E., Sipos, P., Darvesh, A. 
S., Folkesson, H. G., & Hohmann, J. (2011). Anthocyanin-rich black currant 
(ribes nigrum l.) extract affords chemoprevention against diethylnitrosamine-
induced hepatocellular carcinogenesis in rats. The Journal of Nutritional 
Biochemistry, 22(11), 1035-1046. doi: 
http://dx.doi.org/10.1016/j.jnutbio.2010.09.001 
Blackwell, B., Marley, E., Price, J., & Taylor, D. (1967). Hypertensive interactions 
between monoamine oxidase inhibitors and foodstuffs. The British Journal of 
Psychiatry, 113(497), 349-365. doi: 10.1192/bjp.113.497.349 
Bond, A., & Lader, M. (1974). The use of analogue scales in rating subjective feelings. 
British Journal of Medical Psychology, 47(3), 211-218. doi: 10.1111/j.2044-
8341.1974.tb02285.x 
Bönöczk, P., Panczel, G., & Nagy, Z. (2002). Vinpocetine increases cerebral blood flow 
and oxygenation in stroke patients: A near infrared spectroscopy and 
transcranial doppler study. European Journal of Ultrasound, 15(1–2), 85-91. 
doi: http://dx.doi.org/10.1016/S0929-8266(02)00006-X 
Bormann, J., & Schatton, W. (1996). USA Patent No.US5262162 European Patent 
Office. 
Brassard, P., Seifert, T., Wissenberg, M., Jensen, P. M., Hansen, C. K., & Secher, N. 
H. (2010). Phenylephrine decreases frontal lobe oxygenation at rest but not 
during moderately intense exercise. Journal of Applied Physiology, 108(6), 
1472-1478. doi: 10.1152/japplphysiol.01206.2009 
 
 
225 
 
Brattstram, A. (2009). Long-term effects of st. John's wort (hypericum perforatum) 
treatment: A 1-year safety study in mild to moderate depression. 
Phytomedicine, 16(4), 277-283.  
Bravo, L. (1998). Polyphenols: Chemistry, dietary sources, metabolism, and nutritional 
significance. Nutrition reviews-Washington-, 56, 317-333.  
Brody, S. (2002). High-dose ascorbic acid increases intercourse frequency and 
improves mood: A randomized controlled clinical trial. Biological Psychiatry, 
52(4), 371-374. doi: http://dx.doi.org/10.1016/S0006-3223(02)01329-X 
Burbaud, P., Camus, O., Guehl, D., Bioulac, B., Caillé, J.-M., & Allard, M. (1999). A 
functional magnetic resonance imaging study of mental subtraction in human 
subjects. Neuroscience Letters, 273(3), 195-199. doi: 
http://dx.doi.org/10.1016/S0304-3940(99)00641-2 
Buvat, J. (2003). Hyperprolactinemia and sexual function in men: A short review. 
International Journal of Impotance Research, 15(5), 373-377.  
Camfield, D. A., Scholey, A., Pipingas, A., Silberstein, R., Kras, M., Nolidin, K., 
Wesnes, K., Pase, M., & Stough, C. (2012). Steady state visually evoked 
potential (ssvep) topography changes associated with cocoa flavanol 
consumption. Physiology & behavior, 105(4), 948-957.  
Casadesus, G., Shukitt-Hale, B., Stellwagen, H. M., Zhu, X., Lee, H.-G., Smith, M. A., 
& Joseph, J. A. (2004). Modulation of hippocampal plasticity and cognitive 
behavior by short-term blueberry supplementation in aged rats. Nutritional 
Neuroscience, 7(5-6), 309-316. doi: 10.1080/10284150400020482 
Casper, D., Yaparpalvi, U., Rempel, N., & Werner, P. (2000). Ibuprofen protects 
dopaminergic neurons against glutamate toxicity in vitro. Neuroscience Letters, 
289(3), 201-204. doi: http://dx.doi.org/10.1016/S0304-3940(00)01294-5 
Cavazzoni, M., Barogi, S., Baracca, A., Parenti Castelli, G., & Lenaz, G. (1999). The 
effect of aging and an oxidative stress on peroxide levels and the mitochondrial 
membrane potential in isolated rat hepatocytes. FEBS Letters, 449(1), 53-56. 
doi: http://dx.doi.org/10.1016/S0014-5793(99)00400-7 
Chaudhuri, K. R., & Schapira, A. H. V. (2009). Non-motor symptoms of parkinson's 
disease: Dopaminergic pathophysiology and treatment. The Lancet Neurology, 
8(5), 464-474. doi: http://dx.doi.org/10.1016/S1474-4422(09)70068-7 
Chen, Y.-C., Shen, S.-C., Lee, W.-R., Hou, W.-C., Yang, L.-L., & Lee, T. J. F. (2001). 
Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced 
inducible nos and cyclooxygenase-2 gene expressions by rutin, quercetin, and 
quercetin pentaacetate in raw 264.7 macrophages. Journal of Cellular 
Biochemistry, 82(4), 537-548. doi: 10.1002/jcb.1184 
Chen, Y., & Parrish, T. B. (2009). Caffeine dose effect on activation-induced bold and 
cbf responses. NeuroImage, 46(3), 577-583. doi: 
http://dx.doi.org/10.1016/j.neuroimage.2009.03.012 
Ciccone, C. D. (1998). Free-radical toxicity and antioxidant medications in parkinson's 
disease. Physical Therapy, 78(3), 313-319.  
Claustre, J., Pequignot, J. M., Bui-xuan, B., Muchada, R., Cottet-Emard, R. M., & 
Peyrin, L. (1990). Conjugation and deamination of circulating dopamine: 
Relationship between sulfated and free dopamine in man. Journal of the 
 
 
226 
 
Autonomic Nervous System, 29(2), 175-181. doi: 
http://dx.doi.org/10.1016/0165-1838(90)90183-J 
Coimbra, S. R., Lage, S. H., Brandizzi, L., Yoshida, V., & da Luz, P. L. (2005). The 
action of red wine and purple grape juice on vascular reactivity is independent 
of plasma lipids in hypercholesterolemic patients. Brazilian Journal of Medical 
and Biological Research, 38, 1339-1347.  
Connor, A. M., Luby, J. J., Tong, C. B. S., Finn, C. E., & Hancock, J. F. (2002). 
Genotypic and environmental variation in antioxidant activity, total phenolic 
content, and anthocyanin content among blueberry cultivars. Journal of the 
American Society for Horticultural Science, 127(1), 89-97.  
Convit, A., Wolf, O. T., Tarshish, C., & De Leon, M. J. (2003). Reduced glucose 
tolerance is associated with poor memory performance and hippocampal 
atrophy among normal elderly. Proceedings of the National Academy of 
Science of the United states of America, 100(4), 13.  
Cools, R. (2006). Dopaminergic modulation of cognitive function-implications for l-dopa 
treatment in parkinson's disease. Neuroscience & Biobehavioral Reviews, 
30(1), 1-23. doi: http://dx.doi.org/10.1016/j.neubiorev.2005.03.024 
Cools, R., Miyakawa, A., Sheridan, M., & D’Esposito, M. (2010). Enhanced frontal 
function in parkinson’s disease. Brain, 133(1), 225-233. doi: 
10.1093/brain/awp301 
Cooper, J. A., Sagar, H. J., Jordan, N., Harvey, N. S., & Sullivan, E. V. (1991). 
Cognitive impairment in early, untreated parkinson's disease and its relationship 
to motor disability. Brain, 114(5), 2095-2122. doi: 10.1093/brain/114.5.2095 
Corash, L. (1980). Platelet heterogeneity: Relevance to the use of platelets to study 
psychiatric disorders. Schizophr Bull, 6(2), 254-258.  
Costa, C., Sgobio, C., Siliquini, S., Tozzi, A., Tantucci, M., Ghiglieri, V., Di Filippo, M., 
Pendolino, V., de Iure, A., Marti, M., Morari, M., Spillantini, M. G., Latagliata, E. 
C., Pascucci, T., Puglisi-Allegra, S., Gardoni, F., Di Luca, M., Picconi, B., & 
Calabresi, P. (2012). Mechanisms underlying the impairment of hippocampal 
long-term potentiation and memory in experimental parkinson’s disease. Brain, 
135(6), 1884-1899. doi: 10.1093/brain/aws101 
Coull, J. T., Frith, C. D., Frackowiak, R. S. J., & Grasby, P. M. (1996). A fronto-parietal 
network for rapid visual information processing: A pet study of sustained 
attention and working memory. Neuropsychologia, 34(11), 1085-1095. doi: 
http://dx.doi.org/10.1016/0028-3932(96)00029-2 
Craft, S., Murphy, C. G., & Wemstrom, J. (1994). Glucose effects on complex memory 
and nonmemory tasks: The influence of age, sex, and glucoregulatory 
response. Psychobiology, 22(2), 10.  
Crews, W. D., Harrison, D. W., & Wright, J. W. (2008). A double-blind, placebo-
controlled, randomized trial of the effects of dark chocolate and cocoa on 
variables associated with neuropsychological functioning and cardiovascular 
health: Clinical findings from a sample of healthy, cognitively intact older adults. 
The American Journal of Clinical Nutrition, 87(4), 872-880.  
Crews, W. D. J., Harrison, D. W., Griffin, M. L., Addison, K., M., Y. A., Giovenco, M. A., 
& Hazell, J. (2005). A double-blinded, placebo-controlled, randomized trial of 
the neuropsychologic efficacy of cranberry juice in a sample of cognitively intact 
 
 
227 
 
older adults: Pilot study findings. Journal of alternitive complementory medicine, 
2(11), 5. doi: 10.1089 
Cropley, V., Croft, R., Silber, B., Neale, C., Scholey, A., Stough, C., & Schmitt, J. 
(2012). Does coffee enriched with chlorogenic acids improve mood and 
cognition after acute administration in healthy elderly? A pilot study. 
Psychopharmacology, 219(3), 737-749. doi: 10.1007/s00213-011-2395-0 
Crosignani, P. G. (2006). Current treatment issues in female hyperprolactinaemia. 
European Journal of Obstetrics & Gynecology and Reproductive Biology, 
125(2), 152-164. doi: http://dx.doi.org/10.1016/j.ejogrb.2005.10.005 
Curin, Y., Ritz, M. F., & Andriantsitohaina, R. (2006). Cellular mechanisms of the 
protective effect of polyphenols on the neurovascular unit in strokes. 
Cardiovascular &#38; Hematological Agents in Medicinal Chemistry (Formerly 
Current Medicinal Chemistry - Cardiovascular &#38; Hematological Agents), 
4(4), 277-288. doi: 10.2174/187152506778520691 
Darmon, N., & Drewnowski, A. (2008). Does social class predict diet quality? The American 
Journal of Clinical Nutrition, 87(5), 1107-1117.  
 
Davison, K., Coates, A. M., Buckley, J. D., & Howe, P. R. C. (2008). Effect of cocoa 
flavanols and exercise on cardiometabolic risk factors in overweight and obese 
subjects. International Journal of Obesity, 32(8), 1289-1296. doi: 
10.1038/ijo.2008.66 
Dede, D. S., Yavuz, B., Yavuz, B. B., Cankurtaran, M., Halil, M., Ulger, Z., 
Cankurtaran, E. S., Aytemir, K., Kabakci, G., & Ariogul, S. (2007). Assessment 
of endothelial function in alzheimer's disease: Is alzheimer's disease a vascular 
disease? Journal of the American Geriatrics Society, 55(10), 1613-1617. doi: 
10.1111/j.1532-5415.2007.01378.x 
Devore, E. E., Kang, J. H., Breteler, M. M. B., & Grodstein, F. (2012). Dietary intakes of 
berries and flavonoids in relation to cognitive decline. Annals of Neurology, 
72(1), 135-143. doi: 10.1002/ana.23594 
Dingemanse, J., Berlin, I., Payan, C., Thiede, H. M., & Puech, A. J. (1992). 
Comparative investigation of the effect of moclobemide and toloxatone on 
monoamine oxidase activity and psychometric performance in healthy subjects. 
Psychopharmacology, 106(1), S68-S70. doi: 10.1007/bf02246239 
Dingemanse, J., Wood, N., Jorga, K., & Kettler, R. (1997). Pharmacokinetics and 
pharmacodynamics of single and multiple doses of the mao-b inhibitor 
lazabemide in healthy subjects. British Journal of Clinical Pharmacology, 43(1), 
41-47.  
Donnelly, C. H., & Murphy, D. L. (1977). Substrate- and inhibitor-related characteristics 
of human platelet monoamine oxidase. Biochemical Pharmacology, 26(9), 853-
858. doi: http://dx.doi.org/10.1016/0006-2952(77)90398-7 
Donohoe, R. T., & Benton, D. (2000). Glucose tolerance predicts performance on tests 
of memory and cognition. Physiology & Behavior, 71(3–4), 395-401. doi: 
http://dx.doi.org/10.1016/S0031-9384(00)00359-0 
Dreiseitel, A., Schreier, P., Oehme, A., Locher, S., Rogler, G., Piberger, H., Hajak, G., 
& Sand, P. G. (2008). Inhibition of proteasome activity by anthocyanins and 
anthocyanidins. Biochemical and Biophysical Research Communications, 
372(1), 57-61. doi: 10.1016/j.bbrc.2008.04.140 
 
 
228 
 
Dreiseitel, A., Korte, G., Schreier, P., Oehme, A., Locher, S., Domani, M., Hajak, G., & 
Sand, P. (2009a). Berry anthocyanins and their aglycons inhibit monoamine 
oxidases a and b. Pharmacological Research, 59(5), 306-311.  
Dreiseitel, A., Oosterhuis, B., Vukman, K., Schreier, P., Oehme, A., Locher, S., Hajak, 
G., & Sand, P. (2009b). Berry anthocyanins and anthocyanidins exhibit distinct 
affinities for the efflux transporters bcrp and mdr1. British Journal of 
Pharmacology, 158(8), 1942-1950. doi: 10.1111/j.1476-5381.2009.00495.x 
Drummond, S. P. A., Brown, G. G., Stricker, J. L., Buxton, R. B., Wong, E. C., & Gillin, 
J. C. (1999). Sleep deprivation-induced reduction in cortical functional response 
to serial subtraction. NeuroReport, 10(18), 3745-3748.  
Eisler, T., Teravainen, H., Nelson, R., Krebs, H., Weise, V., Lake, C. R., Ebert, M. H., 
Whetzel, N., Murphy, D. L., Kopin, I. J., & Calne, D. B. (1981). Deprenyl in 
parkinson disease. Neurology, 31(1), 19. doi: 10.1212/wnl.31.1.19 
Engler, M. B., Engler, M. M., Chen, C. Y., Malloy, M. J., Browne, A., Chiu, E. Y., Kwak, 
H. K., Milbury, P., Paul, S. M., Blumberg, J., & Mietus-Synder, M. L. (2004). 
Flavonoid-rich dark chocolate improves endothelial function and increases 
plasma epicatechin concentrations in healthy adults. Journal of the American 
College of Nutrition, 23(3), 197-204.  
Erlund, I., Koli, R., Alfthan, G., Marniemi, J., Puukka, P., Mustonen, P., Mattila, P., & 
Jula, A. (2008). Favorable effects of berry consumption on platelet function, 
blood pressure, and hdl cholesterol. The American Journal of Clinical Nutrition, 
87(2), 323-331.  
Faridi, Z., Njike, V. Y., Dutta, S., Ali, A., & Katz, D. L. (2008a). Acute dark chocolate 
and cocoa ingestion and endothelial function: A randomized controlled 
crossover trial. The American Journal of Clinical Nutrition, 88(1), 58-63.  
Faridi, Z., Njike, V. Y., Dutta, S., Ali, A., & Katz, D. L. (2008b). Acute dark chocolate 
and cocoa ingestion and endothelial function: A randomized controlled 
crossover trial. American Journal of Clinical Nutrition, 88(1), 58-63.  
Field, D. T., Williams, C. M., & Butler, L. T. (2011). Consumption of cocoa flavanols 
results in an acute improvement in visual and cognitive functions. Physiology & 
Behavior, 103(3–4), 255-260. doi: 
http://dx.doi.org/10.1016/j.physbeh.2011.02.013 
Fisher, N. D., Hughes, M., Gerhard-Herman, M., & Hollenberg, N. K. (2003). Flavanol-
rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. 
Journal of Hypertension, 21(12), 2281-2286.  
Fisher, N. D., & Hollenberg, N. K. (2006). Aging and vascular responses to flavanol-rich 
cocoa. Journal of Hypertension, 24(8), 1575-1580 
1510.1097/1501.hjh.0000239293.0000240507.0000239292a.  
Fitzgerald, P., & Dinan, T. G. (2008). Prolactin and dopamine: What is the connection? 
A review article. Journal of Psychopharmacology, 22(2 suppl), 12-19. doi: 
10.1177/0269216307087148 
Floyd, R. A., & Hensley, K. (2002). Oxidative stress in brain aging: Implications for 
therapeutics of neurodegenerative diseases. Neurobiology of Aging, 23(5), 795-
807. doi: http://dx.doi.org/10.1016/S0197-4580(02)00019-2 
Fowler, J. S., Volkow, N. D., Wang, G. J., Logan, J., Pappas, N., Shea, C., & 
MacGregor, R. (1997). Age-related increases in brain monoamine oxidase b in 
 
 
229 
 
living healthy human subjects. Neurobiology of Aging, 18(4), 431-435. doi: 
http://dx.doi.org/10.1016/S0197-4580(97)00037-7 
Francis, S. T., Head, K., Morris, P. G., & Macdonald, I. A. (2006). The effect of flavanol-
rich cocoa on the fmri response to a cognitive task in healthy young people. 
Journal of Cardiovascular Pharmacology, 47, S215-S220.  
Galli, R. L., Bielinski, D. F., Szprengiel, A., Shukitt-Hale, B., & Joseph, J. A. (2006). 
Blueberry supplemented diet reverses age-related decline in hippocampal 
hsp70 neuroprotection. Neurobiology of Aging, 27(2), 344-350.  
Gao, L., & Mazza, G. (1994). Quantitation and distribution of simple and acylated 
anthocyanins and other phenolics in blueberries. Journal of Food Science, 
59(5), 1057-1059. doi: 10.1111/j.1365-2621.1994.tb08189.x 
Gareri, P., Falconi, U., De Fazio, P., & De Sarro, G. (2000). Conventional and new 
antidepressant drugs in the elderly. Progress in Neurobiology, 61(4), 353-396. 
doi: http://dx.doi.org/10.1016/S0301-0082(99)00050-7 
Girouard, H., & Iadecola, C. (2006). Neurovascular coupling in the normal brain and in 
hypertension, stroke, and alzheimer disease. Journal of Applied Physiology, 
100(1), 328-335. doi: 10.1152/japplphysiol.00966.2005 
Goyarzu, P., Malin, D. H., Lau, F. C., Taglialatela, G., Moon, W. D., Jennings, R., Moy, 
E., Moy, D., Lippold, S., Shukitt-Hale, B., & Joseph, J. A. (2004). Blueberry 
supplemented diet: Effects on object recognition memory and nuclear factor-
kappa b levels in aged rats. Nutritional Neuroscience, 7(2), 75-83. doi: 
10.1080/10284150410001710410 
Grassi, D., Lippi, C., Necozione, S., Desideri, G., & Ferri, C. (2005a). Short-term 
administration of dark chocolate is followed by a significant increase in insulin 
sensitivity and a decrease in blood pressure in healthy persons. The American 
Journal of Clinical Nutrition, 81(3), 611-614.  
Grassi, D., Necozione, S., Lippi, C., Croce, G., Valeri, L., Pasqualetti, P., Desideri, G., 
Blumberg, J., & Ferri, C. (2005b). Cocoa reduces blood pressure and insulin 
resistance and improves endothelium-dependent vasodilation in hypertensives. 
Hypertension, 46(2), 398-405. doi: 10.1161/01.hyp.0000174990.46027.70 
Grassi, D., Desideri, G., Necozione, S., Lippi, C., Casale, R., Properzi, G., Blumberg, 
J., & Ferri, C. (2008). Blood pressure is reduced and insulin sensitivity 
increased in glucose-intolerant, hypertensive subjects after 15 days of 
consuming high-polyphenol dark chocolate. The Journal of nutrition, 138(9), 
1671-1676.  
Greenwood, C. E., Kaplan, R. J., Hebblethwaite, S., & Jenkins, D. J. A. (2003). 
Carbohydrate-induced memory impairment in adults with type 2 diabetes. 
Diabetes Care, 26(7), 1961-1966. doi: 10.2337/diacare.26.7.1961 
Gu, L., Kelm, M. A., Hammerstone, J. F., Beecher, G., Holden, J., Haytowitz, D., 
Gebhardt, S., & Prior, R. L. (2004). Concentrations of proanthocyanidins in 
common foods and estimations of normal consumption. The Journal of nutrition, 
134(3), 613-617.  
Hägg, M., Ylikoski, S., & Kumpulainen, J. (1995). Vitamin c content in fruits and berries 
consumed in finland. Journal of Food Composition and Analysis, 8(1), 12-20. 
doi: http://dx.doi.org/10.1006/jfca.1995.1003 
 
 
230 
 
Halliwell, B. (2008). Are polyphenols antioxidants or pro-oxidants? What do we learn 
from cell culture and in vivo studies? Archives of Biochemistry and Biophysics, 
476(2), 107-112.  
Hammerstone, J. F., Lazarus, S. A., & Schmitz, H. H. (2000). Procyanidin content and 
variation in some commonly consumed foods. The Journal of nutrition, 130(8), 
2086S-2092S.  
Hanagasi, H. A., Gurvit, H., Unsalan, P., Horozoglu, H., Tuncer, N., Feyzioglu, A., 
Gunal, D. I., Yener, G. G., Cakmur, R., Sahin, H. A., & Emre, M. (2011). The 
effects of rasagiline on cognitive deficits in parkinson's disease patients without 
dementia: A randomized, double-blind, placebo-controlled, multicenter study. 
Movement Disorders, 26(10), 1851-1858. doi: 10.1002/mds.23738 
Harada, M., Sawa, T., Okuda, C., Matsuda, T., & Tanaka, Y. (1993). Effects of glucose 
load on brain extracellular lactate concentration in conscious rats using a 
microdialysis technique. Horm Metab Res, 25(11), 560-563. doi: 10.1055/s-
2007-1002177 
Harrison, F. E. (2012). A critical review of vitamin c for the prevention of age-related 
cognitive decline and alzheimer's disease. Journal of Alzheimer's Disease, 
29(4), 711-726. doi: 10.3233/jad-2012-111853 
Haskell, C. F., Kennedy, D. O., Wesnes, K. A., Milne, A. L., & Scholey, A. B. (2007). A 
double-blind, placebo-controlled, multi-dose evaluation of the acute behavioural 
effects of guarana in humans. J Psychopharmacol, 21(1), 65-70. doi: 
0269881106063815 [pii] 10.1177/0269881106063815 
Haskell, C. F., Kennedy, D. O., Milne, A. L., Wesnes, K. A., & Scholey, A. B. (2008). 
The effects of l-theanine, caffeine and their combination on cognition and mood. 
Biol Psychol, 77(2), 113-122. doi: S0301-0511(07)00157-3 [pii] 
10.1016/j.biopsycho.2007.09.008 
Haskell, C. F., Robertson, B., Jones, E., Forster, J., Jones, R., Wilde, A., Maggini, S., & 
Kennedy, D. O. (2010). Effects of a multi-vitamin/mineral supplement on 
cognitive function and fatigue during extended multi-tasking. Hum 
Psychopharmacol, 25(6), 448-461. doi: 10.1002/hup.1144 
He, F. J., Nowson, C. A., & MacGregor, G. A. (2006). Fruit and vegetable consumption 
and stroke: Meta-analysis of cohort studies. Lancet, 367(9507), 320-326.  
Heiss, C., Finis, D., Kleinbongard, P., Hoffmann, A., Schroeter, H., Kelm, M., & Sies, H. 
(2005). Repetitive flavanol intake leads to sustained improvement of endothelial 
function in humans. Free Radical Biology and Medicine, 39, S86-S86.  
Heiss, C., Finis, D., Kleinbongard, P., Hoffmann, A., Rassaf, T., Kelm, M., & Sies, H. 
(2007). Sustained increase in flow-mediated dilation after daily intake of high-
flavanol cocoa drink over 1 week. Journal of Cardiovascular Pharmacology, 
49(2), 74-80 10.1097/FJC.1090b1013e31802d30001.  
Hendrickson, S. J., & Mattes, R. D. (1998). No acute effects of grape juice on appetite, 
implicit memory, and mood. Food and Nutrition Research, 52. doi: DOI: 
10.3402/fnr.v52i0.1891 
Heneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Hanke, A., Dewachter, I., Kuiperi, 
C., O'Banion, K., Klockgether, T., Van Leuven, F., & Landreth, G. E. (2005). 
Acute treatment with the pparγ agonist pioglitazone and ibuprofen reduces glial 
inflammation and aβ1–42 levels in appv717i transgenic mice. Brain, 128(6), 
1442-1453. doi: 10.1093/brain/awh452 
 
 
231 
 
Herrmann, M. J., Walter, A., Ehlis, A. C., & Fallgatter, A. J. (2006). Cerebral 
oxygenation changes in the prefrontal cortex: Effects of age and gender. 
Neurobiology of Aging, 27(6), 888-894. doi: 
http://dx.doi.org/10.1016/j.neurobiolaging.2005.04.013 
Ho, K. Y., Smythe, G. A., & Lazarus, L. (1985). Studies on the central and peripheral 
dopaminergic control of prl secretion in man: Failure to demonstrate the 
existence of a dopamine-mediated prolactin-inhibiting factor. 
Neuroendocrinology, 40(6), 457-462.  
Hollands, W., Brett, G. M., Radreau, P., Saha, S., Teucher, B., Bennett, R. N., & Kroon, 
P. A. (2008). Processing blackcurrants dramatically reduces the content and 
does not enhance the urinary yield of anthocyanins in human subjects. Food 
Chemistry, 108(3), 869-878. doi: 
http://dx.doi.org/10.1016/j.foodchem.2007.11.052 
Holmin, S., & Mathiesen, T. (2000). Intracerebral administration of interleukin-1β and 
induction of inflammation, apoptosis, and vasogenic edema. Journal of 
Neurosurgery, 92(1), 108-120. doi: doi:10.3171/jns.2000.92.1.0108 
Hooper, L., Kay, C., Abdelhamid, A., Kroon, P. A., Cohn, J. S., Rimm, E. B., & Cassidy, 
A. (2012). Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular 
health: A systematic review and meta-analysis of randomized trials. The 
American Journal of Clinical Nutrition, 95(3), 740-751. doi: 
10.3945/ajcn.111.023457 
Hoshi, Y., & Tamura, M. (1993). Detection of dynamic changes in cerebral oxygenation 
coupled to neuronal function during mental work in man. Neuroscience Letters, 
150(1), 5-8. doi: http://dx.doi.org/10.1016/0304-3940(93)90094-2 
Hunot, S., & Hirsch, E. C. (2003). Neuroinflammatory processes in parkinson's disease. 
Annals of Neurology, 53(S3), S49-S60. doi: 10.1002/ana.10481 
Huppert, T. J., Hoge, R. D., Diamond, S. G., Franceschini, M. A., & Boas, D. A. (2006). 
A temporal comparison of bold, asl, and nirs hemodynamic responses to motor 
stimuli in adult humans. NeuroImage, 29(2), 368-382. doi: 
http://dx.doi.org/10.1016/j.neuroimage.2005.08.065 
Illi, A., Sundberg, S., Ojala-Karlsson, P., Scheinin, M., & Gordin, A. (1996). 
Simultaneous inhibition of catechol-o-methyltransferase and monoamine 
oxidase a: Effects on hemodynamics and catecholamine metabolism in healthy 
volunteers[ast]. Clin Pharmacol Ther, 59(4), 450-457.  
Jackson, P. A., Reay, J. L., Scholey, A. B., & Kennedy, D. O. (2012). Dha-rich oil 
modulates the cerebral haemodynamic response to cognitive tasks in healthy 
young adults: A near ir spectroscopy pilot study. British Journal of Nutrition, 
107(08), 1093-1098. doi: doi:10.1017/S0007114511004041 
Jackson, R. A., Peters, N., Advani, U., Perry, G., Rogers, J., Brough, W. H., & 
Pilkington, T. R. E. (1973). Forearm glucose uptake during the oral glucose 
tolerance test in normal subjects. Diabetes, 22(6), 442-458. doi: 
10.2337/diab.22.6.442 
Jaeggi, S. M., Buschkuehl, M., Perrig, W. J., & Meier, B. (2010). The concurrent validity 
of the n-back task as a working memory measure. Memory, 18(4), 394-412. doi: 
10.1080/09658211003702171 
Jahanshahi, M., Jones, C. R. G., Zijlmans, J., Katzenschlager, R., Lee, L., Quinn, N., 
Frith, C. D., & Lees, A. J. (2010). Dopaminergic modulation of striato-frontal 
 
 
232 
 
connectivity during motor timing in parkinson’s disease. Brain, 133(3), 727-745. 
doi: 10.1093/brain/awq012 
Jin, Y., Alimbetov, D., George, T., Gordon, M. H., & Lovegrove, J. A. (2011). A 
randomised trial to investigate the effects of acute consumption of a 
blackcurrant juice drink on markers of vascular reactivity and bioavailability of 
anthocyanins in human subjects. Eur J Clin Nutr, 65(7), 849-856.  
Johnston, J. P. (1968). Some observations upon a new inhibitor of monoamine oxidase 
in brain tissue. Biochemical Pharmacology, 17(7), 1285-1297. doi: 
10.1016/0006-2952(68)90066-x 
Johnston, K. L., Clifford, M. N., & Morgan, L. M. (2002). Possible role for apple juice 
phenolic compounds in the acute modification of glucose tolerance and 
gastrointestinal hormone secretion in humans. Journal of the Science of Food 
and Agriculture, 82(15), 1800-1805. doi: 10.1002/jsfa.1264 
Joseph, J. A., Shukitt-Hale, B., Denisova, N. A., Bielinski, D., Martin, A., McEwen, J. J., 
& Bickford, P. C. (1999). Reversals of age-related declines in neuronal signal 
transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or 
strawberry dietary supplementation. The Journal of Neuroscience, 19(18), 
8114.  
Joseph, J. A., Arendash, G., Gordon, M., Diamond, D., Shukitt-Hale, B., Morgan, D., & 
Denisova, N. A. (2003). Blueberry supplementation enhances signaling and 
prevents behavioral deficits in an alzheimer disease model. Nutritional 
Neuroscience, 6(3), 153-162. doi: 10.1080/1028415031000111282 
Kähkönen, M. P., Hopia, A. I., & Heinonen, M. (2001). Berry phenolics and their 
antioxidant activity. Journal of agricultural and food chemistry, 49(8), 4076-
4082. doi: 10.1021/jf010152t 
Kanaya, A., Barrett-Connor, E., Gildengorin, G., & Yaffe, K. (2004). Change in 
cognitive function by glucose tolerance status in older adults: A 4-year 
prospective study of the rancho bernardo study cohort. Archives of Internal 
Medicine, 164(12), 1327-1333. doi: 10.1001/archinte.164.12.1327 
Kaplan, R. J., Greenwood, C. E., Winocur, G., & Wolever, T. M. (2000). Cognitive 
performance is associated with glucose regulation in healthy elderly persons 
and can be enhanced with glucose and dietary carbohydrates. The American 
Journal of Clinical Nutrition, 72(3), 825-836.  
Kay, C. D., Mazza, G., Holub, B. J., & Wang, J. (2004). Anthocyanin metabolites in 
human urine and serum. British Journal of Nutrition, 91(06), 933-942. doi: 
doi:10.1079/BJN20041126 
Kazui, H., Kitagaki, H., & Mori, E. (2000). Cortical activation during retrieval of 
arithmetical facts and actual calculation: A functional magnetic resonance 
imaging study. Psychiatry and Clinical Neurosciences, 54(4), 479-485. doi: 
10.1046/j.1440-1819.2000.00739.x 
Kennedy, D. O., & Scholey, A. B. (2000). Glucose administration, heart rate and 
cognitive performance: Effects of increasing mental effort. 
Psychopharmacology, 149(1), 63-71. doi: 10.1007/s002139900335 
Kennedy, D. O., Scholey, A. B., & Wesnes, K. A. (2000). The dose-dependent 
cognitive effects of acute administration of ginkgo biloba to healthy young 
volunteers. Psychopharmacology, 151(4), 416-423. doi: 
10.1007/s002130000501 
 
 
233 
 
Kennedy, D. O., & Scholey, A. B. (2004). A glucose-caffeine ‘energy drink’ ameliorates 
subjective and performance deficits during prolonged cognitive demand. 
Appetite, 42(3), 331-333. doi: http://dx.doi.org/10.1016/j.appet.2004.03.001 
Kennedy, D. O., Pace, S., Haskell, C., Okello, E. J., Milne, A., & Scholey, A. B. (2006). 
Effects of cholinesterase inhibiting sage (salvia officinalis) on mood, anxiety and 
performance on a psychological stressor battery. Neuropsychopharmacology, 
31(4), 845-852. doi: 1300907 [pii] 10.1038/sj.npp.1300907 
Kennedy, D. O., Jackson, P. A., Haskell, C. F., & Scholey, A. B. (2007). Modulation of 
cognitive performance following single doses of 120 mg ginkgo biloba extract 
administered to healthy young volunteers. Hum Psychopharmacol, 22(8), 559-
566. doi: 10.1002/hup.885 
Kennedy, D. O., Wightman, E. L., Reay, J. L., Lietz, G., Okello, E. J., Wilde, A., & 
Haskell, C. F. (2010). Effects of resveratrol on cerebral blood flow variables and 
cognitive performance in humans: A double-blind, placebo-controlled, crossover 
investigation. Am J Clin Nutr, 91(6), 1590-1597. doi: ajcn.2009.28641 [pii] 
10.3945/ajcn.2009.28641 
Kennedy, D. O., & Haskell, C. F. (2011). Cerebral blood flow and behavioural effects of 
caffeine in habitual and non-habitual consumers of caffeine: A near infrared 
spectroscopy study. Biological Psychology, 86(3), 298-306. doi: 
http://dx.doi.org/10.1016/j.biopsycho.2010.12.010 
Kennedy, D. O., & Wightman, E. L. (2011). Herbal extracts and phytochemicals: Plant 
secondary metabolites and the enhancement of human brain function. 
Advances in Nutrition: An International Review Journal, 2(1), 32-50. doi: 
10.3945/an.110.000117 
Keppler, K., & Humpf, H.-U. (2005). Metabolism of anthocyanins and their phenolic 
degradation products by the intestinal microflora. Bioorganic & Medicinal 
Chemistry, 13(17), 5195-5205. doi: http://dx.doi.org/10.1016/j.bmc.2005.05.003 
Kesse-Guyot, E., Fezeu, L., Andreeva, V. A., Touvier, M., Scalbert, A., Hercberg, S., & 
Galan, P. (2012). Total and specific polyphenol intakes in midlife are associated 
with cognitive function measured 13 years later. The Journal of nutrition, 142(1), 
76-83. doi: 10.3945/jn.111.144428 
Kim, D.-H., Jung, E.-A., Sohng, I.-S., Han, J.-A., Kim, T.-H., & Han, M. (1998). 
Intestinal bacterial metabolism of flavonoids and its relation to some biological 
activities. Archives of Pharmacal Research, 21(1), 17-23. doi: 
10.1007/bf03216747 
Kim, J., Lee, H. J., & Lee, K. W. (2010). Naturally occurring phytochemicals for the 
prevention of alzheimer’s disease. Journal of Neurochemistry, 112(6), 1415-
1430. doi: 10.1111/j.1471-4159.2009.06562.x 
Kish, S. J., Shannak, K., Rajput, A., Deck, J. H. N., & Hornykiewicz, O. (1992). Aging 
produces a specific pattern of striatal dopamine loss: Implications for the 
etiology of idiopathic parkinson's disease. Journal of Neurochemistry, 58(2), 
642-648. doi: 10.1111/j.1471-4159.1992.tb09766.x 
Kitaura, H., Uozumi, N., Tohmi, M., Yamazaki, M., Sakimura, K., Kudoh, M., Shimizu, 
T., & Shibuki, K. (2007). Roles of nitric oxide as a vasodilator in neurovascular 
coupling of mouse somatosensory cortex. Neuroscience Research, 59(2), 160-
171. doi: http://dx.doi.org/10.1016/j.neures.2007.06.1469 
 
 
234 
 
Klemsdal, T. O., Andersson, T. L. G., Matz, J., Ferns, G. A. A., Gjesdal, K., & Änggård, 
E. E. (1994). Vitamin e restores endothelium dependent vasodilatation in 
cholesterol fed rabbits: In vivo measurements by photoplethysmography. 
Cardiovascular Research, 28(9), 1397-1402. doi: 10.1093/cvr/28.9.1397 
Koes, R. E., Quattrocchio, F., & Mol, J. N. M. (1994). The flavonoid biosynthetic 
pathway in plants: Function and evolution. BioEssays, 16(2), 123-132. doi: 
10.1002/bies.950160209 
Kohmura, K., Iwamoto, K., Aleksic, B., Sasada, K., Kawano, N., Katayama, H., Noda, 
Y., Noda, A., Iidaka, T., & Ozaki, N. (2013). Effects of sedative antidepressants 
on prefrontal cortex activity during verbal fluency task in healthy subjects: A 
near-infrared spectroscopy study. Psychopharmacology, 226(1), 75-81. doi: 
10.1007/s00213-012-2885-8 
Kong, J.-M., Chia, L.-S., Goh, N.-K., Chia, T.-F., & Brouillard, R. (2003). Analysis and 
biological activities of anthocyanins. Phytochemistry, 64(5), 923-933. doi: 
http://dx.doi.org/10.1016/S0031-9422(03)00438-2 
Kootstra, A. (1994). Protection from uv-b-induced DNA damage by flavonoids. Plant 
Molecular Biology, 26(2), 771-774. doi: 10.1007/bf00013762 
Kopin, I. J. (1985). Catecholamine metabolism: Basic aspects and clinical significance. 
Pharmacological Reviews, 37(4), 333-364.  
Korczyn, A. D., Brunt, E. R., Larsen, J. P., Nagy, Z., Poewe, W. H., Ruggieri, S., & 
Group, f. t. S. (1999). A 3-year randomized trial of ropinirole and bromocriptine 
in early parkinson’s disease. Neurology, 53(2), 364. doi: 10.1212/wnl.53.2.364 
Koulu, M., Scheinin, M., Kaarttinen, A., Kallio, J., Pyykko, K., Vuorinen, J., & Zimmer, 
R. H. (1989). Inhibition of monoamine oxidase by moclobemide: Effects on 
monoamine metabolism and secretion of anterior pituitary hormones and 
cortisol in healthy volunteers. British Journal of Clinical Pharmacology, 27(2), 
243-255. doi: 10.1111/j.1365-2125.1989.tb05357.x 
Krikorian, R., Nash, T. A., Shidler, M. D., Shukitt-Hale, B., & Joseph, J. A. (2010a). 
Concord grape juice supplementation improves memory function in older adults 
with mild cognitive impairment. British Journal of Nutrition, 103(05), 730-734. 
doi: doi:10.1017/S0007114509992364 
Krikorian, R., Shidler, M. D., Nash, T. A., Kalt, W., Vinqvist-Tymchuk, M. R., Shukitt-
Hale, B., & Joseph, J. A. (2010b). Blueberry supplementation improves memory 
in older adults. Journal of agricultural and food chemistry, 58(7), 3996-4000. 
doi: 10.1021/jf9029332 
Krikorian, R., Boespflug, E. L., Fleck, D. E., Stein, A. L., Wightman, J. D., Shidler, M. 
D., & Sadat-Hossieny, S. (2012). Concord grape juice supplementation and 
neurocognitive function in human aging. Journal of agricultural and food 
chemistry, 60(23), 5736-5742. doi: 10.1021/jf300277g 
Krimer, L. S., Muly, E. C., Williams, G. V., & Goldman-Rakic, P. S. (1998). 
Dopaminergic regulation of cerebral cortical microcirculation. Nat Neurosci, 
1(4), 286-289.  
LaHoste, G. J., Swanson, J. M., Wigal, S. B., Glabe, C., Wigal, T., King, N., & 
Kennedy, J. L. (1996). Dopamine d4 receptor gene polymorphism is associated 
with attention deficit hyperactivity disorder. Molecular psychiatry, 1(2), 121-124.  
 
 
 
235 
 
Lamport, D. J., Hoyle, E., Lawton, C. L., Mansfield, M. W., & Dye, L. (2011). Evidence for a 
second meal cognitive effect: Glycaemic responses to high and low glycaemic index 
evening meals are associated with cognition the following morning. Nutritional 
Neuroscience, 14(2), 66-71. doi: 10.1179/1476830511y.0000000002 
Larrabee, M. G. (1995). Lactate metabolism and its effects on glucose metabolism in 
an excised neural tissue. Journal of Neurochemistry, 64(4), 1734-1741. doi: 
10.1046/j.1471-4159.1995.64041734.x 
Lau, F. C., Bielinski, D. F., & Joseph, J. A. (2007). Inhibitory effects of blueberry extract 
on the production of inflammatory mediators in lipopolysaccharide-activated bv2 
microglia. Journal of Neuroscience Research, 85(5), 1010-1017. doi: 
10.1002/jnr.21205 
Laurienti, P. J., Field, A. S., Burdette, J. H., Maldjian, J. A., Yen, Y.-F., & Moody, D. M. 
(2003). Relationship between caffeine-induced changes in resting cerebral 
perfusion and blood oxygenation level-dependent signal. American Journal of 
Neuroradiology, 24(8), 1607-1611.  
Leenders, K. L., Wolfson, l., Gibbs, J. M., Wise, R. J. S., Causon, R., Jones, T., & 
Legg, N. J. (1985). The effects of l-dopa on regional cerebral blood flow and 
oxygen metabolism in patients with parkinson's disease. Brain, 108(1), 171-191. 
doi: 10.1093/brain/108.1.171 
Leenders, K. L., Perani, D., Lammertsma, A. A., Heather, J. D., Buckingham, P., 
Jones, T., Healy, M. J. R., Gibbs, J. M., Wise, R. J. S., Hatazawa, J., Herold, S., 
Beany, R. P., Brooks, D. J., Spinks, T., Rhodes, C., & Fracowiak, R. S. J. 
(1990). Cerebral blood flow, blood volume and oxygen utilization: Normal 
values and effect of age. Brain, 113(1), 27-47. doi: 10.1093/brain/113.1.27 
Letenneur, L., Proust-Lima, C., Le Gouge, A., Dartigues, J., & Barberger-Gateau, P. 
(2007). Flavonoid intake and cognitive decline over a 10-year period. American 
Journal of Epidemiology, 165(12), 1364-1371. doi: 10.1093/aje/kwm036 
Levy, G., Jacobs, D. M., Tang, M.-X., Côté, L. J., Louis, E. D., Alfaro, B., Mejia, H., 
Stern, Y., & Marder, K. (2002). Memory and executive function impairment 
predict dementia in parkinson's disease. Movement Disorders, 17(6), 1221-
1226. doi: 10.1002/mds.10280 
Luciana, M., Collins, P. F., & Depue, R. A. (1998). Opposing roles for dopamine and 
serotonin in the modulation of human spatial working memory functions. 
Cerebral Cortex, 8(3), 218-226. doi: 10.1093/cercor/8.3.218 
Manach, C., Williamson, G., Morand, C., Scalbert, A., & Remesy, C. (2005). 
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 
bioavailability studies. American Journal of Clinical Nutrition, 81(1), 230S.  
Manzano, S., & Williamson, G. (2010). Polyphenols and phenolic acids from strawberry 
and apple decrease glucose uptake and transport by human intestinal caco-2 
cells. Molecular Nutrition & Food Research, 54(12), 1773-1780. doi: 
10.1002/mnfr.201000019 
Marciani, L., Pfeiffer, J. C., Hort, J., Head, K., Bush, D., Taylor, A. J., Spiller, R. C., 
Francis, S., & Gowland, P. A. (2006). Improved methods for fmri studies of 
combined taste and aroma stimuli. Journal of Neuroscience Methods, 158(2), 
186-194. doi: 10.1016/j.jneumeth.2006.05.035 
Marcus, J. S., Karackattu, S. L., Fleegal, M. A., & Sumners, C. (2003). Cytokine-
stimulated inducible nitric oxide synthase expression in astroglia: Role of erk 
 
 
236 
 
mitogen-activated protein kinase and nf-κb. Glia, 41(2), 152-160. doi: 
10.1002/glia.10168 
Marrow, L., Overton, p., & Clark, D. (1993). Disruption of conditioned reaction time 
performance by dopamine receptor antagonists in the rat. Behavioural 
Pharmacology, 4(1), 15-28.  
Matsumoto, H., Inaba, H., Kishi, M., Tominaga, S., Hirayama, M., & Tsuda, T. (2001). 
Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are 
directly absorbed in rats and humans and appear in the blood as the intact 
forms. J. Agric. Food Chem, 49(3), 1546-1551.  
Matsumoto, H., Ito, K., Yonekura, K., & Ichihashi, M. (2005a). Improvement of shade 
ring under the eyes by blackcurrant polyphenol intake. Skin Research, 4(5), 5.  
Matsumoto, H., Takenami, E., Iwasaki-Kurashige, K., Osada, T., Katsumura, T., & 
Hamaoka, T. (2005b). Effects of blackcurrant anthocyanin intake on peripheral 
muscle circulation during typing work in humans. European journal of applied 
physiology, 94(1), 36-45.  
Mattila, P., Hellström, J., & Törrönen, R. (2006). Phenolic acids in berries, fruits, and 
beverages. Journal of agricultural and food chemistry, 54(19), 7193-7199. doi: 
10.1021/jf0615247 
Mazza, G., Kay, C. D., Cottrell, T., & Holub, B. J. (2002). Absorption of anthocyanins 
from blueberries and serum antioxidant status in human subjects. Journal of 
agricultural and food chemistry, 50(26), 7731-7737. doi: 10.1021/jf020690l 
McKim, W. A. (2003). Drugs and behavior: An introduction to behavioral pharmacology 
(5th ed. Vol. 1): Pearson Education. 
McNaught, A. D., Wilkinson, A., & IUPAC. (1997). Compendium of chemical 
terminology The gold book (2 ed., Vol. 2, pp. 571): Blackwell Scientific 
Publications. 
Meneilly, G. S., Cheung, E., Tessier, D., Yakura, C., & Tuokko, H. (1993). The effect of 
improved glycemic control on cognitive functions in the elderly patient with 
diabetes. Journal of Gerontology, 48(4), M117-M121. doi: 
10.1093/geronj/48.4.M117 
Messier, C. (1998). The absence of effect of glucose on memory is associated with low 
susceptibility to the amnestic effects of scopolamine in a strain of mice. 
Behavioural Brain Research, 96(1–2), 47-57. doi: 
http://dx.doi.org/10.1016/S0166-4328(97)00196-4 
Messier, C., Tsiakas, M., Gagnon, M., Desrochers, A., & Awad, N. (2003). Effect of age 
and glucoregulation on cognitive performance. Neurobiology of Aging, 24(7), 
985-1003. doi: http://dx.doi.org/10.1016/S0197-4580(03)00004-6 
Messier, C. (2004). Glucose improvement of memory: A review. European Journal of 
Pharmacology, 490(1-3), 33-57. doi: DOI: 10.1016/j.ejphar.2004.02.043 
Middleton, E., Kandaswami, C., & Theoharides, T. C. (2000). The effects of plant 
flavonoids on mammalian cells:Implications for inflammation, heart disease, and 
cancer. Pharmacological Reviews, 52(4), 673-751.  
Miner, B. (1971). Interhemispheric differences in the localization of psychological 
processes in man. British Medical Bulletin, 27(3), 272-277.  
 
 
237 
 
Moss, M., & Oliver, L. (2012). Plasma 1,8-cineole correlates with cognitive performance 
following exposure to rosemary essential oil aroma. Therapeutic Advances in 
Psychopharmacology. doi: 10.1177/2045125312436573 
Moss, M. C., Scholey, A. B., & Wesnes, K. (1998). Oxygen administration selectively 
enhances cognitive performance in healthy young adults: A placebo-controlled 
double-blind crossover study. Psychopharmacology, 138(1), 27-33. doi: 
10.1007/s002130050641 
Murphy, D. L., Moya, P. R., Fox, M. A., Rubenstein, L. M., Wendland, J. R., & Timpano, 
K. R. (2013). Anxiety and affective disorder comorbidity related to serotonin and 
other neurotransmitter systems: Obsessive–compulsive disorder as an example 
of overlapping clinical and genetic heterogeneity. Philosophical Transactions of 
the Royal Society B: Biological Sciences, 368(1615). doi: 
10.1098/rstb.2012.0435 
Nakazawa, F. (1922). Influence of phloridzin on intestinal absorption. Tohokv J Exp 
Med, 3, 288-294.  
Naruszewicz, M., Łaniewska, I., Millo, B., & Dłużniewski, M. (2007). Combination 
therapy of statin with flavonoids rich extract from chokeberry fruits enhanced 
reduction in cardiovascular risk markers in patients after myocardial infraction 
(mi). Atherosclerosis, 194(2), e179-e184.  
Netzel, M., Strass, G., Janssen, M., Bitsch, I., & Bitsch, R. (2001). Bioactive 
anthocyanins detected in human urine after ingestion of blackcurrant juice. 
20(2), 7.  
Nielsen, I., Dragsted, L., Ravn-Haren, G., Freese, R., & Rasmussen, S. (2003). 
Absorption and excretion of black currant anthocyanins in humans and 
watanabe heritable hyperlipidemic rabbits. J. Agric. Food Chem, 51(9), 2813-
2820.  
Nieoullon, A. (2002). Dopamine and the regulation of cognition and attention. Progress 
in Neurobiology, 67(1), 53-83. doi: 10.1016/s0301-0082(02)00011-4 
Nizamutdinova, I. T., Kim, Y. M., Chung, J. I., Shin, S. C., Jeong, Y.-K., Seo, H. G., 
Lee, J. H., Chang, K. C., & Kim, H. J. (2009). Anthocyanins from black soybean 
seed coats stimulate wound healing in fibroblasts and keratinocytes and 
prevent inflammation in endothelial cells. Food and Chemical Toxicology, 
47(11), 2806-2812. doi: http://dx.doi.org/10.1016/j.fct.2009.08.016 
Njike, V. Y., Faridi, Z., Shuval, K., Dutta, S., Kay, C. D., West, S. G., Kris-Etherton, P. 
M., & Katz, D. L. (2011). Effects of sugar-sweetened and sugar-free cocoa on 
endothelial function in overweight adults. International Journal of Cardiology, 
149(1), 83-88. doi: 10.1016/j.ijcard.2009.12.010 
Nurk, E., Refsum, H., Drevon, C. A., Tell, G. S., Nygaard, H. A., Engedal, K., & Smith, 
A. D. (2009). Intake of flavonoid-rich wine, tea, and chocolate by elderly men 
and women is associated with better cognitive test performance. The Journal of 
nutrition, 139(1), 120-127. doi: 10.3945/jn.108.095182 
O’Sullivan, S. S., Wu, K., Politis, M., Lawrence, A. D., Evans, A. H., Bose, S. K., 
Djamshidian, A., Lees, A. J., & Piccini, P. (2011). Cue-induced striatal 
dopamine release in parkinson's disease-associated impulsive-compulsive 
behaviours. Brain, 134(4), 969-978. doi: 10.1093/brain/awr003 
 
 
238 
 
Obrig, H., & Villringer, A. (2003). Beyond the visible--imaging the human brain with 
light. Journal of cerebral blood flow and metabolism : official journal of the 
International Society of Cerebral Blood Flow and Metabolism, 23(1), 1-18.  
Owen, A. M., McMillan, K. M., Laird, A. R., & Bullmore, E. (2005). N-back working 
memory paradigm: A meta-analysis of normative functional neuroimaging 
studies. Human Brain Mapping, 25(1), 46-59. doi: 10.1002/hbm.20131 
Pedersen, C. B., Kyle, J., Jenkinson, A. M., Gardner, P. T., McPhail, D. B., & Duthie, G. 
G. (2000). Effects of blueberry and cranberry juice consumption on the plasma 
antioxidant capacity of healthy female volunteers. European Journal of Clinical 
Nutrition, 54(5), 405-408. doi: http://dx.doi.org/10.1038/sj.ejcn.1600972 
Pergola, C., Rossi, A., Dugo, P., Cuzzocrea, S., & Sautebin, L. (2006). Inhibition of 
nitric oxide biosynthesis by anthocyanin fraction of blackberry extract. Nitric 
Oxide, 15(1), 30-39. doi: http://dx.doi.org/10.1016/j.niox.2005.10.003 
Peterson, E. C., Wang, Z., & Britz, G. (2011). Regulation of cerebral blood flow. 
International Journal of Vascular Medicine, 2011. doi: 10.1155/2011/823525 
Pfizer.Inc. (2007). Nardil (phenelzine sulfate)  tablet, film coated  usp.   Retrieved 
04/03/2013, 2013, from 
http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=5440 
Pipingas, A., Silberstein, R. B., Vitetta, L., Rooy, C. V., Harris, E. V., Young, J. M., 
Frampton, C. M., Sali, A., & Nastasi, J. (2008). Improved cognitive performance 
after dietary supplementation with a pinus radiata bark extract formulation. 
Phytotherapy Research, 22(9), 1168-1174. doi: 10.1002/ptr.2388 
Pizzinat, N., Copin, N., Vindis, C., Parini, A., & Cambon, C. (1999). Reactive oxygen 
species production by monoamine oxidases in intact cells. Naunyn-
Schmiedeberg's Archives of Pharmacology, 359(5), 428-431. doi: 
10.1007/pl00005371 
Pombo, S., Levy, P., Bicho, M., Ismail, F., & Cardoso, J. M. N. (2008). 
Neuropsychological function and platelet monoamine oxidase activity levels in 
type i alcoholic patients. Alcohol Alcohol., 43(4), 423-430. doi: 
10.1093/alcalc/agn021 
Ramirez, M. R., Izquierdo, I., Raseira, M. d. C. B., Zuanazzi, J. Â., Barros, D., & 
Henriques, A. T. (2005). Effect of lyophilised vaccinium berries on memory, 
anxiety and locomotion in adult rats. Pharmacological Research, 52(6), 457-
462. doi: 10.1016/j.phrs.2005.07.003 
Rendeiro, C., Vauzour, D., Rattray, M., Waffo-Téguo, P., Mérillon, J. M., Butler, L. T., 
Williams, C. M., & Spencer, J. P. E. (2013). Dietary levels of pure flavonoids 
improve spatial memory performance and increase hippocampal brain-derived 
neurotrophic factor. PLoS ONE, 8(5), e63535. doi: 
10.1371/journal.pone.0063535 
Riby, L. M., Meikle, A., & Glover, C. (2004). The effects of age, glucose ingestion and 
gluco-regulatory control on episodic memory. Age and Ageing, 33(5), 483-487. 
doi: 10.1093/ageing/afh173 
Riederer, P., & Youdim, M. B. H. (1986). Monoamine oxidase activity and monoamine 
metabolism in brains of parkinsonian patients treated with l-deprenyl. Journal of 
Neurochemistry, 46(5), 1359-1365. doi: 10.1111/j.1471-4159.1986.tb01747.x 
 
 
239 
 
Rigney, U., Kimber, S., & Hindmarch, I. (1999). The effects of acute doses of 
standardized ginkgo biloba extract on memory and psychomotor performance in 
volunteers. Phytother Res, 13(1), 7.  
Robinson, M. J., & Cobb, M. H. (1997). Mitogen-activated protein kinase pathways. 
Current Opinion in Cell Biology, 9(2), 180-186. doi: 
http://dx.doi.org/10.1016/S0955-0674(97)80061-0 
Rodriguez-Mateos, A., Cifuentes-Gomez, T., George, T. W., & Spencer, J. P. E. 
(2013). Impact of cooking, proving, and baking on the (poly)phenol content of 
wild blueberry. Journal of agricultural and food chemistry. doi: 
10.1021/jf403366q 
Ryan, J., Croft, K., Mori, T., Wesnes, K., Spong, J., Downey, L., Kure, C., Lloyd, J., & 
Stough, C. (2008). An examination of the effects of the antioxidant pycnogenol® 
on cognitive performance, serum lipid profile, endocrinological and oxidative 
stress biomarkers in an elderly population. Journal of Psychopharmacology, 
22(5), 553-562. doi: 10.1177/0269881108091584 
Safonova, L. P., Michalos, A., Wolf, U., Wolf, M., Hueber, D. M., Choi, J. H., Gupta, R., 
Polzonetti, C., Mantulin, W. W., & Gratton, E. (2004). Age-correlated changes in 
cerebral hemodynamics assessed by near-infrared spectroscopy. Archives of 
Gerontology and Geriatrics, 39(3), 207-225. doi: 
http://dx.doi.org/10.1016/j.archger.2004.03.007 
Salthouse, T. A. (1991). Mediation of adult age differences in cognition by reductions in 
working memory and speed of processing. Psychological Science, 2(3), 179-
183. doi: 10.1111/j.1467-9280.1991.tb00127.x 
Salthouse, T. A. (1992). What do adult age differences in the digit symbol substitution 
test reflect? Journal of Gerontology, 47(3), P121-P128. doi: 
10.1093/geronj/47.3.P121 
Salthouse, T. A. (2009). When does age-related cognitive decline begin? Neurobiology 
of Aging, 30(4), 507-514.  
Santizo, R., Baughman, V. L., & Pelligrino, D. A. (2000). Relative contributions from 
neuronal and endothelial nitric oxide synthases to regional cerebral blood flow 
changes during forebrain ischemia in rats. NeuroReport, 11(7), 1549-1553.  
Saura Marti, J., Kettler, R., Prada, M., & Richards, J. G. (1990). Molecular 
neuroanatomy of mao-a and mao-b. In P. Riederer & M. H. Youdim (Eds.), 
Amine oxidases and their impact on neurobiology (Vol. 32, pp. 49-53): Springer 
Vienna. 
Scheinin, M., Karhuvaara, S., Ojala-Karlsson, P., Kallio, A., & Koulu, M. (1991). Plasma 
3, 4-dihydroxyphenylglycol (dhpg) and 3-methoxy-4- hydroxyphenylglycol 
(mhpg) are insensitive indicators of α2-adrenoceptor mediated regulation of 
norepinephrine release in healthy human volunteers. Life Sciences, 49(1), 75-
84. doi: http://dx.doi.org/10.1016/0024-3205(91)90581-U 
Scholey. A. B, Harper, S., & Kennedy, D. O. (2001). Cognitive demand and blood 
glucose. Physiology & Behavior, 73(4), 585-592. doi: 
http://dx.doi.org/10.1016/S0031-9384(01)00476-0 
Scholey, & Kennedy, D. (2004). Cognitive and physiological effects of an “energy 
drink”: An evaluation of the whole drink and of glucose, caffeine and herbal 
flavouring fractions. Psychopharmacology, 176(3-4), 320-330. doi: 
10.1007/s00213-004-1935-2 
 
 
240 
 
Scholey, A., Downey, L. A., Ciorciari, J., Pipingas, A., Nolidin, K., Finn, M., Wines, M., 
Catchlove, S., Terrens, A., Barlow, E., Gordon, L., & Stough, C. (2012). Acute 
neurocognitive effects of epigallocatechin gallate (egcg). Appetite, 58(2), 767-
770. doi: http://dx.doi.org/10.1016/j.appet.2011.11.016 
Scholey, A. B., French, S. J., Morris, P. J., Kennedy, D. O., Milne, A. L., & Haskell, C. 
F. (2010). Consumption of cocoa flavanols results in acute improvements in 
mood and cognitive performance during sustained mental effort. J 
Psychopharmacol, 24(10), 1505-1514. doi: 0269881109106923 [pii] 
10.1177/0269881109106923 
Schrage, B., Stevenson, D., Wells, R. W., Lyall, K., Holmes, S., Deng, D., & Hurst, R. 
D. (2010). Evaluating the health benefits of fruits for physical fitness: A research 
platform. Journal of Berry Research, 1(1), 35-44. doi: 10.3233/br-2010-004 
Sheline, Y. I., Mintun, M., Moerlein, S. M., & Snyder, A. Z. (2002). Greater loss of 5-
ht2a receptors in midlife than in late life. American Journal of Psychiatry, 
159(3), 7.  
Shukitt-Hale, B., Carey, A., Simon, L., Mark, D. A., & Joseph, J. A. (2006). Effects of 
concord grape juice on cognitive and motor deficits in aging. Nutrition, 22(3), 
295-302. doi: http://dx.doi.org/10.1016/j.nut.2005.07.016 
Shukitt-Hale, B., Cheng, V., & Joseph, J. A. (2009a). Effects of blackberries on motor 
and cognitive function in aged rats. Nutr Neurosci, 12(3), 135-140. doi: 
10.1179/147683009X423292 
Shukitt-Hale, B., Kalt, W., Carey, A. N., Vinqvist-Tymchuk, M., McDonald, J., & Joseph, 
J. A. (2009b). Plum juice, but not dried plum powder, is effective in mitigating 
cognitive deficits in aged rats. Nutrition, 25(5), 567-573. doi: 
http://dx.doi.org/10.1016/j.nut.2008.10.018 
Silberstein, R. B., Schier, M. A., Pipingas, A., Ciorciari, J., Wood, S. R., & Simpson, D. 
G. (1990). Steady-state visually evoked potential topography associated with a 
visual vigilance task. Brain Topography, 3(2), 337-347. doi: 
10.1007/bf01135443 
Singh, B., Song, H., Liu, X.-D., Hardy, M., Liu, G.-Z., Vinjamury, S. P., & der 
Martirosian, C. (2004). Dangshen (codonopsis pilosula) and bai guo (gingko 
biloba) enhance learning and memory. Alternative Therapies in Health & 
Medicine, 10(4), 6.  
Skrede, G., Wrolstad, R. E., & Durst, R. W. (2000). Changes in anthocyanins and 
polyphenolics during juice processing of highbush blueberries (vaccinium 
corymbosum l.). Journal of Food Science, 65(2), 357-364. doi: 10.1111/j.1365-
2621.2000.tb16007.x 
Slimestad, R., & Solheim, H. (2002). Anthocyanins from black currants (ribes nigrum l.). 
Journal of agricultural and food chemistry, 50(11), 3228-3231. doi: 
10.1021/jf011581u 
Smit, H., Gaffan, E., & Rogers, P. (2004). Methylxanthines are the psycho-
pharmacologically active constituents of chocolate. Psychopharmacology, 
176(3-4), 412-419. doi: 10.1007/s00213-004-1898-3 
Smith, A. P., Clark, R. E., Nutt, D. J., Haller, S. G., Hayward, S. G., & Perry, K. (1999). 
Vitamin c, mood and cognitive functioning in the elderly. Nutritional 
Neuroscience, 2(1), 249-256.  
 
 
241 
 
Smith, Y., & Kieval, J. Z. (2000). Anatomy of the dopamine system in the basal ganglia. 
Trends in Neurosciences, 23, Supplement 1(0), S28-S33. doi: 
http://dx.doi.org/10.1016/S1471-1931(00)00023-9 
Smits, M., Peeters, R. R., van Hecke, P., & Sunaert, S. (2007). A 3 t event-related 
functional magnetic resonance imaging (fmri) study of primary and secondary 
gustatory cortex localization using natural tastants. Neuroradiology, 49(1), 61-
71. doi: 10.1007/s00234-006-0160-6 
Snell, L., Glanz, J., & Tabakoff, B. (2002). Relationships between effects of smoking, 
gender, and alcohol dependence on platelet monoamine oxidase b: Activity, 
affinity labeling, and protein measurements. Alcoholism: Clinical and 
Experimental Research, 26(7), 1105-1113.  
Sorond, F. A., Lipsitz, L. A., Hollenberg, N. K., & Fisher, N. D. (2008). Cerebral blood 
flow response to flavanol-rich cocoa in healthy elderly humans. 
Neuropsychiatric disease and treatment, 4(2), 433-440.  
Sparks D, Woeltz, V. M. Markesbery, W. R. (1991). Alterations in brain monoamine 
oxidase activity in aging, alzheimers disease, and picks disease. Archives of 
Neurology, 48(7), 718-721. doi: 10.1001/archneur.1991.00530190064017 
Spencer, J. P. E., Vauzour, D., & Rendeiro, C. (2009). Flavonoids and cognition: The 
molecular mechanisms underlying their behavioural effects. Archives of 
Biochemistry and Biophysics, 492(1-2), 1-9. doi: DOI: 
10.1016/j.abb.2009.10.003 
Spielberger CD, G. R., Lushene RE (1970). Manual for the state-trait anxiety inventory. 
Consulting Psychologists Press, Palo Alto, CA:.  
Stein, J. H., Keevil, J. G., Wiebe, D. A., Aeschlimann, S., & Folts, J. D. (1999). Purple 
grape juice improves endothelial function and reduces the susceptibility of ldl 
cholesterol to oxidation in patients with coronary artery disease. Circulation, 
100(10), 1050-1055. doi: 10.1161/01.cir.100.10.1050 
Steinbrink, J., Villringer, A., Kempf, F., Haux, D., Boden, S., & Obrig, H. (2006). 
Illuminating the bold signal: Combined fmri–fnirs studies. Magnetic Resonance 
Imaging, 24(4), 495-505. doi: http://dx.doi.org/10.1016/j.mri.2005.12.034 
Stonehouse, W., Conlon, C. A., Podd, J., Hill, S. R., Minihane, A. M., Haskell, C., & 
Kennedy, D. (2013). Dha supplementation improved both memory and reaction 
time in healthy young adults: A randomized controlled trial. The American 
Journal of Clinical Nutrition, 97(5), 1134-1143. doi: 10.3945/ajcn.112.053371 
Sturza, A., Leisegang, M. S., Babelova, A., Schröder, K., Benkhoff, S., Loot, A. E., 
Fleming, I., Schulz, R., Muntean, D. M., & Brandes, R. P. (2013). Monoamine 
oxidases are mediators of endothelial dysfunction in the mouse aorta. 
Hypertension, 62(1), 140-146. doi: 10.1161/hypertensionaha.113.01314 
Sumner, M. D., Elliott-Eller, M., Weidner, G., Daubenmier, J. J., Chew, M. H., Marlin, 
R., Raisin, C. J., & Ornish, D. (2005). Effects of pomegranate juice consumption 
on myocardial perfusion in patients with coronary heart disease. The American 
journal of cardiology, 96(6), 810-814.  
Sun, H. N., Kim, S. U., Lee, M. S., Kim, S. K., Kim, J. M., Yim, M., Yu, D. Y., & Lee, D. 
S. (2008). Nicotinamide adenine dinucleotide phosphate (nadph) oxidase-
dependent activation of phosphoinositide 3-kinase and p38 mitogen-activated 
protein kinase signal pathways is required for lipopolysaccharide-induced 
 
 
242 
 
microglial phagocytosis. Biological and Pharmaceutical Bulletin, 31(9), 1711-
1715.  
Sünram-Lea, S. I., Owen, L., Finnegan, Y., & Hu, H. (2011). Dose–response 
investigation into glucose facilitation of memory performance and mood in 
healthy young adults. Journal of Psychopharmacology, 25(8), 1076-1087. doi: 
10.1177/0269881110367725 
Sweeney, M. I., Kalt, W., MacKinnon, S. L., Ashby, J., & Gottschall-Pass, K. T. (2002). 
Feeding rats diets enriched in lowbush blueberries for six weeks decreases 
ischemia-induced brain damage. Nutritional Neuroscience, 5(6), 427-431. doi: 
10.1080/1028415021000055970 
Takazawa, K., Tanaka, N., Fujita, M., Matsuoka, O., Saiki, T., Aikawa, M., Tamura, S., 
& Ibukiyama, C. (1998). Assessment of vasoactive agents and vascular aging 
by the second derivative of photoplethysmogram waveform. Hypertension, 
32(2), 365-370. doi: 10.1161/01.hyp.32.2.365 
Tansey, M. J., & Schlechte, J. A. (2001). Pituitary production of prolactin and prolactin-
suppressing drugs. Lupus, 10(10), 660-664. doi: 
10.1191/096120301717164886 
Targonski, P. V., Bonetti, P. O., Pumper, G. M., Higano, S. T., Holmes, D. R., & 
Lerman, A. (2003). Coronary endothelial dysfunction is associated with an 
increased risk of cerebrovascular events. Circulation, 107(22), 2805-2809. doi: 
10.1161/01.cir.0000072765.93106.ee 
Thaipong, K., Boonprakob, U., Crosby, K., Cisneros-Zevallos, L., & Hawkins Byrne, D. 
(2006). Comparison of abts, dpph, frap, and orac assays for estimating 
antioxidant activity from guava fruit extracts. Journal of Food Composition and 
Analysis, 19(6–7), 669-675. doi: http://dx.doi.org/10.1016/j.jfca.2006.01.003 
Törrönen, R., Sarkkinen, E., Niskanen, T., Tapola, N., Kilpi, K., & Niskanen, L. (2012). 
Postprandial glucose, insulin and glucagon-like peptide 1 responses to sucrose 
ingested with berries in healthy subjects. British Journal of Nutrition, 107(10), 
1445-1451. doi: doi:10.1017/S0007114511004557 
Tsai, S. K., Hung, L. M., Fu, Y. T., Cheng, H., Nien, M. W., Liu, H. Y., Zhang, F. B., & 
Huang, S. S. (2007). Resveratrol neuroprotective effects during focal cerebral 
ischemia injury via nitric oxide mechanism in rats. Journal of vascular surgery, 
46(2), 346-353.  
Tully, T., Bourtchouladze, R., Scott, R., & Tallman, J. (2003). Targeting the creb 
pathway for memory enhancers. Nat Rev Drug Discov, 2(4), 267-277.  
Tuomilehto, J., Lindstrom, J., Keinanen-Kiukaanniemie, S., Hiltunen, L., Kivela, S. L., 
Gallus, G., Garancini, M. P., Schranz, A., Bouter, L. M., Dekker, J. M., Heine, R. 
J., Nijpels, G., Pajak, A., Castell, C., Lloveras, G., Tresserras, R., Pablos-
Velasco, P. L., Martinez-Martin, F. J., Rodriguez-Perez, F., Gabriel, R., 
Serrano-Rios, M., Pladevall, M., Muniz, J., Eliasson, M., Stegmayr, B., 
Lundberg, V., Unwin, N., George, K., Alberti, M. M., Hayes, L., Borch-Johnsen, 
K., Eriksson, J., Qiao, Q., Hu, G., & Balkau, B. (2003). Age- and sex-specific 
prevalences of diabetes and impaired glucose regulation in 13 european 
cohorts. Diabetes Care, 26(1), 61-69.  
Vafeiadou, K., Vauzour, D., Lee, H. Y., Rodriguez-Mateos, A., Williams, R. J., & 
Spencer, J. P. E. (2009). The citrus flavanone naringenin inhibits inflammatory 
signalling in glial cells and protects against neuroinflammatory injury. Archives 
 
 
243 
 
of Biochemistry and Biophysics, 484(1), 100-109. doi: 
http://dx.doi.org/10.1016/j.abb.2009.01.016 
van Praag, H., Lucero, M. J., Yeo, G. W., Stecker, K., Heivand, N., Zhao, C., Yip, E., 
Afanador, M., Schroeter, H., Hammerstone, J., & Gage, F. H. (2007). Plant-
derived flavanol (−)epicatechin enhances angiogenesis and retention of spatial 
memory in mice. The Journal of Neuroscience, 27(22), 5869-5878. doi: 
10.1523/jneurosci.0914-07.2007 
Viallet, F., Trouche, E., Beaubaton, D., Nieoullon, A., & Legallet, E. (1983). Motor 
impairment after unilateral electrolytic lesions of the substantia nigra in 
baboons: Behavioral data with quantitative and kinematic analysis of a pointing 
movement. Brain Research, 279(1–2), 193-206. doi: 
http://dx.doi.org/10.1016/0006-8993(83)90178-6 
Vlachopoulos, C., Alexopoulos, N., & Stefanadis, C. (2006). Effect of dark chocolate on 
arterial function in healthy individuals: Cocoa instead of ambrosia? Current 
Hypertension Reports, 8(3), 205-211. doi: 10.1007/s11906-006-0052-5 
Volkow, N. D., Gur, R. C., Wang, G.-J., Fowler, J. S., Moberg, P. J., Ding, Y.-S., 
Hitzemann, R., Smith, G., & Logan, J. (1998). Association between decline in 
brain dopamine activity with age and cognitive and motor impairment in healthy 
individuals. American Journal of Psychiatry, 155(3), 344-349.  
Volkow, N. D., Logan, J., Fowler, J. S., Wang, G.-J., Gur, R. C., Wong, C., Felder, C., 
Gatley, S. J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (2000). Association 
between age-related decline in brain dopamine activity and impairment in 
frontal and cingulate metabolism. American Journal of Psychiatry, 157(1), 75-
80. doi: 10.1176/appi.ajp.157.10.1709 
Walpole, S., Prieto-Merino, D., Edwards, P., Cleland, J., Stevens, G., & Roberts, I. 
(2012). The weight of nations: An estimation of adult human biomass. BMC 
Public Health, 12(1), 439.  
Wang, Y., Wang, L., Wu, J., & Cai, J. (2006). The in vivo synaptic plasticity mechanism 
of egb 761-induced enhancement of spatial learning and memory in aged rats. 
British Journal of Pharmacology, 148(2), 147-153. doi: 10.1038/sj.bjp.0706720 
Watanabe, A., Kato, N., & Kato, T. (2002). Effects of creatine on mental fatigue and 
cerebral hemoglobin oxygenation. Neuroscience Research, 42(4), 279-285. doi: 
http://dx.doi.org/10.1016/S0168-0102(02)00007-X 
Watanabe, Y., Tanaka, H., Dan, I., Sakurai, K., Kimoto, K., Takashima, R., & Hirata, K. 
(2011). Monitoring cortical hemodynamic changes after sumatriptan injection 
during migraine attack by near-infrared spectroscopy. Neuroscience Research, 
69(1), 60-66. doi: http://dx.doi.org/10.1016/j.neures.2010.09.003 
Weber, P., Lütschg, J., & Fahnenstich, H. (2007). Methylphenidate-induced changes in 
cerebral hemodynamics measured by functional near-infrared spectroscopy. 
Journal of Child Neurology, 22(7), 812-817. doi: 10.1177/0883073807304197 
Whyte, A. R., & Williams, C. M. (2012). The cognitive effects of acute blueberry 
anthocyanin interventions on 7–9 year old children. Appetite, 59(2), 637. doi: 
http://dx.doi.org/10.1016/j.appet.2012.05.108 
Wightman, E. L., Haskell, C. F., Forster, J. S., Veasey, R. C., & Kennedy, D. O. (2012). 
Epigallocatechin gallate, cerebral blood flow parameters, cognitive performance 
and mood in healthy humans: A double-blind, placebo-controlled, crossover 
 
 
244 
 
investigation. Human Psychopharmacology: Clinical and Experimental, 27(2), 
177-186. doi: 10.1002/hup.1263 
Williams, C. M., El Mohsen, M. A., Vauzour, D., Rendeiro, C., Butler, L. T., Ellis, J. A., 
Whiteman, M., & Spencer, J. P. E. (2008). Blueberry-induced changes in spatial 
working memory correlate with changes in hippocampal creb phosphorylation 
and brain-derived neurotrophic factor (bdnf) levels. Free Radical Biology and 
Medicine, 45(3), 295-305. doi: 10.1016/j.freeradbiomed.2008.04.008 
Williams, E. (1949). Experimental designs balanced for the estimation of residual 
effects of treatments. Australian Journal of Chemistry, 2(2), 149-168. doi: 
http://dx.doi.org/10.1071/CH9490149 
Willis, L. M., Shukitt-Hale, B., Cheng, V., & Joseph, J. A. (2009). Dose-dependent 
effects of walnuts on motor and cognitive function in aged rats. British Journal 
of Nutrition, 101(08), 1140-1144. doi: doi:10.1017/S0007114508059369 
Wilson, T., Singh J, P., Vorsa, N., Goettlc, D., Kittleson, K., M, Roe, C., M, Kastello, G., 
M, & Ragsdale. F, R. (2008a). Human glycemic response and phenolic content 
of unsweetened cranberry juice. Journal of Medicinal Food, 1(11), 12.  
Wilson, T., Meyers, S. L., Singh, A. P., Limburg, P. J., & Vorsa, N. (2008b). Favorable 
glycemic response of type 2 diabetics to low-calorie cranberry juice. Journal of 
Food Science, 73(9), H241-H245. doi: 10.1111/j.1750-3841.2008.00964.x 
Wink, M. (2003). Evolution of secondary metabolites from an ecological and molecular 
phylogenetic perspective. Phytochemistry, 64(1), 3-19. doi: 
http://dx.doi.org/10.1016/S0031-9422(03)00300-5 
Witt, S. T., Laird, A. R., & Meyerand, M. E. (2008). Functional neuroimaging correlates 
of finger-tapping task variations: An ale meta-analysis. NeuroImage, 42(1), 343-
356. doi: http://dx.doi.org/10.1016/j.neuroimage.2008.04.025 
Yamada, M., & Yasuhara, H. (2004). Clinical pharmacology of mao inhibitors: Safety 
and future. NeuroToxicology, 25(1-2), 215-221.  
Youdim, K. A., Martin, A., & Joseph, J. A. (2000). Incorporation of the elderberry 
anthocyanins by endothelial cells increases protection against oxidative stress. 
Free Radical Biology and Medicine, 29(1), 51-60. doi: 
http://dx.doi.org/10.1016/S0891-5849(00)00329-4 
Youdim, M. B. H., Finberg, J. P. M., & Tipton, K. F. (1988). Catecholamine ii. Handbook 
of experimental pharmacology (pp. 127-199). 
Youdim, M. B. H., & Bakhle, Y. S. (2006). Monoamine oxidase: Isoforms and inhibitors 
in parkinson's disease and depressive illness. British Journal of Pharmacology, 
147(S1), S287-S296. doi: 10.1038/sj.bjp.0706464 
Zhang, W., & Liu, H. T. (2002). Mapk signal pathways in the regulation of cell 
proliferation in mammalian cells. Cell Res, 12(1), 9-18.  
Zheng, Z., Lee, J. E., & Yenari, M. A. (2003). Stroke: Molecular mechanisms and 
potential targets for treatment. Current Molecular Medicine, 3(4), 361-372. doi: 
10.2174/1566524033479717 
Zimmer, R. (1990). Relationship between tyramine potentiation and monoamine 
oxidase (mao) inhibition: Comparison between moclobemide and other mao 
inhibitors. Acta Psychiatrica Scandinavica, 82(S360), 81-83. doi: 
10.1111/j.1600-0447.1990.tb05342.x 
 
 
245 
 
APPENDICES 
 
Appendix I  Example screening questionnaire 
Appendix II  Example Case Report form 
Appendix III  Amplex red MAO-B assay 
Appendix IV  Mental fatigue & Bond-Lader Alert 
Appendix VI  FRAP assay 
Appendix VII  Blood lactate 
Appendix VIII  Change from baseline post-dose glucose levels 
Appendix IX   NIRS resting baseline scores 
Appendix X  Raw Mean pre-dose baseline, post dose scores and 
standard deviations for all outcomes 
   
 
 
246 
 
Appendix I - Example screening questionnaire 
      
 
 
General Exclusion Criteria 
 
Our research focuses on the interaction between nutrition and behaviour. Below is a 
list of criteria relating to how the brain works, how your body deals with ingested 
substances (food or otherwise), and some general health criteria. If any apply to you, 
you will not be eligible to take part in the research study. If you are unsure or wish to 
discuss any of these points with the researcher then you are welcome to do so. 
 
1. You have learning difficulties, dyslexia or colour blindness 
2. You have visual impairment that cannot be corrected with glasses or contact 
lenses 
3. You have a history of neurological or psychiatric illness (excluding depressive 
illness and anxiety) 
4. You have a current diagnosis of depression and/or anxiety 
5. You have a history or current diagnosis of drug/alcohol abuse 
6. You have frequent migraines that require medication. 
7. You have any disorders of the blood 
8. You have a heart disorder or history of vascular illness  
9. You have diabetes 
10. You have any medical condition that affects absorption of food components 
11. You have a history of kidney or liver disease  
12. You have an over- or underactive thyroid gland 
13. You are pregnant or trying to become pregnant. 
14. You are lactating 
15. You have any food intolerances/sensitivities 
16. You have any known active infections 
17. You are HIV antibody positive or you think that you may be HIV positive 
18. You currently have, have ever had, or think you may be at risk of  hepatitis 
19. You have ever had breast cancer and/or a mastectomy 
20.  You have haemophilia or any similar clotting disorder 
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Appendix II - Example Case Report form 
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Appendix III - Amplex red MAO-B assay 
 
Stock Solution Preparation 
1.1 Prepare a ~20 mM stock solution of the Amplex Red reagent by allowing one vial of 
the Amplex Red reagent (Component A) and the DMSO (Component B) to warm to 
room temperature. Just prior to use, dissolve the contents of one vial of Amplex Red 
reagent (1mg) in 200μl DMSO. Each vial of Amplex Red reagent provides sufficient 
material for approximately 100 assays of 200μl each. This stock solution should be 
stored frozen at ≤–20°C, protected from light. 
1.2 Prepare a 1X working solution of Reaction Buffer by adding 5ml of 5X Reaction 
Buffer stock solution (Component E) to 20ml of deionized water (dH2O). This 25ml 
volume of 1X Reaction Buffer is sufficient for approximately 100 assays of 200μl each, 
with a 5ml excess for making stock solutions and dilutions. 
1.3 Prepare a 200U/ml stock solution of horseradish per oxidase (HRP) by dissolving 
the entire vial of HRP (Component C) in 1.0ml of 1X Reaction Buffer. After use, the 
remaining solution should be divided into small aliquots and stored frozen at ≤–20°C. 
1.4 Prepare a 20mM H2O2 working solution by diluting the ~3% H2O2 stock solution 
(Component D) into the appropriate volume of 1X Reaction Buffer. The actual H2O2 
concentration is indicated on the components label. For instance, a 20 mm H2O2 
working solution can be prepared from a 3.0% H2O2 stock solution by diluting 23μl of 
3.0% H2O2 into 977μl of 1X Reaction Buffer. Please note that although the ~3% H2O2 
stock solution has been stabilized to slow degradation, the 20 mm H2O2 working 
solution will be less stable and should be used promptly. 
1ml of 20mM H2O2 solution = 20.6 µl of H2O2 + 979.4 µl of buffer.  
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Below is a table of dilutions for standards. 
  Dilution Stock Buffer 
A 10µm 5µm   9.995ml 
B 7.5µm 750.2µm of A 249.8ml 
C 5µm 500µm of A 500ml 
D 2.5µm 500µm of C 500ml 
E 1000nm 100µm of A 900ml 
F 100nm 100µm of E 900ml 
G 10nm 100µm of F 900ml 
 
1.5 Prepare 100mm stock solutions of the two amine oxidase substrates (benzylamine 
and tyramine, Components F and G) by adding 1.2ml dH2O directly to the individual 
substrate vials. Substrate stock solutions should be stored at ≤–20°C.  
1.6 Prepare 0.5 mm stock solutions of each of the MAO inhibitors (clorgyline and 
pargyline, Components H and I) by adding 1.0 ml dH2O directly to the individual vials. 
Inhibitor stock solutions should be stored at ≤–20°C. 
1:10 dilution for 1.e 10 µl 1µl clorgyline to 9 µl of dH2O. 
1.7 If desired, prepare a 2 mm stock solution of resorufin by adding 1ml dH2O directly 
to the vial of resorufin solid (Component J). This solution can be used to prepare a 
standard curve to determine the moles of product produced in the Amplex Red 
reaction. This stock solution should be stored frozen at ≤–20°C,protected from light. 
 
Amine Oxidase Assay 
 
 
2.1 Dilute the blood platelets in 1X Reaction Buffer. A volume of 50μl will be used for 
each reaction. One of the MAO inhibitors (at a concentration of 1μm) can be included, if 
desired, by adding the equivalent of 0.2μl of the 0.5 mm inhibitor stock solution 
(prepared in step 1.6) to each 100μl volume of diluted sample and pre-incubating the 
sample (e.g. 30 minutes at room temperature). Please note that amine oxidase and 
inhibitor concentrations will be twofold lower in the final reaction volume. 
 
 
269 
 
2.2 Prepare a positive control by diluting the 20 mm H2O2 working solution to 10μm in 
1X Reaction Buffer. Use 1X Reaction Buffer without H2O2 as a negative control.  
2.3 Pipette 100μl of the diluted amine oxidase samples and controls into separate wells 
of a microplate. 
2.4 Prepare a working solution of 400μm Amplex Red reagent containing 2 U/ml HRP 
and 2 mm substrate by adding 200μl of Amplex Red reagent stock solution (prepared 
in step 1.1), 100μl of the HRP stock solution (prepared in step 1.3) and 200μl of 
substrate stock solution (prepared in 1.5) to 9.5 ml 1X Reaction Buffer. This 10ml 
volume is sufficient for ~100 assays. Note that final concentrations of each component 
will be twofold lower in the final reaction volume. 
For 10 ml of solution:  
200µl Amplex red 
100µl HRP 
200µl Substrate 
9.5ml buffer 
2.5 Begin the reactions by adding 100μl of the Amplex Red reagent/HRP/substrate 
working solution to each micro plate well containing the amine oxidase samples and 
controls. 
2.6 Incubate the reactions for 30 minutes or longer at room temperature, protected 
from light. Because the assay is continuous (not terminated), fluorescence may be 
measured at multiple time points to follow the kinetics of the reactions. 
2.7 If desired, prepare a resorufin standard curve: Dilute the appropriate amount of 2 
mm resorufin stock solution in 1X Reaction Buffer to yield resorufin solution ranging 
from 0 to 20μm resorufin. Pipette 200μl of each resorufin standard into individual 
(empty) wells of a microplate at any time prior to measuring fluorescence. 
2.8 Measure the fluorescence in a fluorescence micro plate reader using excitation in 
the range of 530–560 nm and emission detection at ~590 nm (see Figure 1). 
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2.9 For each point, correct for background fluorescence by subtracting the values 
derived from the no–amine oxidase control. 
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Appendix IV- Mental fatigue & Bond-Lader alert 
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Appendix VI- FRAP assay 
Sodium acetate trihydrate and iron (III) chloride hexahydrate (ferric chloride) were 
obtained from Sigma-Aldrich, Poole, Dorset, U.K. Glacial acetic acid was obtained from 
BDH Laboratory Supplies. 2,4,6-Tripyridyl-s-triazine (TPTZ) was obtained from Fluka 
Chemicals, Switzerland. Hydrochloric acid (HCl) was obtained from Merck, Darmstadt, 
Germany.  
A Cecil Instruments 1000 series (Cambridge, England) UV/Visible spectrophotometer 
was used to measure the absorbance readings. The spectrophotometer was set to 
read at 593nm absorbency and a 3.0ml sample of FRAP was used as a blank to zero 
the equipment. 
Acetate buffer (300 mM) was prepared from 1.55g sodium acetate trihydrate mixed 
with 8ml glacial acetic acid and made up to 500ml with distilled water; 10mM TPTZ 
solution was prepared in 40mM HCl; Ferric chloride was dissolved in deionised water 
to generate a 20 mM solution. These solutions were mixed in the ratio 10:1:1 to give 
the working FRAP reagent. FRAP reagent was prepared fresh daily. 
100µl of plasma or standard was added to 3.0ml of FRAP solution.. The cuvette was 
vortexed and a reading was taken. The sample was then incubated at 37ºC. At 4 
minutes, the sample was removed from the incubator and a second reading was taken. 
FRAP values were obtained by comparing the absorbance at 593nm of the sample and 
the blank reagent (Benzie & Strain, 1999). 
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Appendix VII- change from baseline post-dose lactate levels 
 
Mean change from baseline post-dose lactate levels indicating no effects of treatment following consumption of the 
Blackadder blackcurrant extract and control intervention drinks. (t=p<0.1). 
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Appendix VIII change from baseline post-dose glucose levels 
 
 
 
 
Mean change from baseline post-dose glucose levels indicating no effects of treatment after a glucose load 200 minutes 
post supplementation (chapter six) 
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Appendix IX- NIRS resting baseline scores 
8.1 Mean scores (mmol/L) and, standard deviations (SD) for left hemisphere (LH), right hemisphere (RH) and 
hemispheres combined (combined) for NIRS outcomes total-HB Oxy-HB and deoxy-HB during the resting baseline 
measurement 
Measure 
N Treatment 
Resting Baseline 
Mean SD 
Combined OxyHb 20 
Control -1.545 3.542 
Juice -1.249 2.688 
OxyHb LH 20 
Control -1.489 3.360 
Juice -1.035 2.948 
OxyHb RH 20 
Control -1.601 4.186 
Juice -1.463 3.097 
Combined DeoxyHb 20 
Control 0.081 1.045 
Juice 0.091 1.179 
DeoxyHb LH 20 
Control 0.296 1.165 
Juice 0.021 1.487 
DeoxyHb RH 20 
Control -0.132 1.248 
Juice 0.162 1.153 
Combined TotalHb 20 
Control -1.627 3.689 
Juice -1.340 3.024 
TotalHb LH 20 
Control -1.785 3.416 
Juice -1.056 3.488 
TotalHb RH 20 
Control -1.469 4.313 
Juice -1.625 3.008 
Data presented In this table is arbitrary and, therefore ,does not represent actual levels of haemoglobin at baseline.   
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Appendix X – Raw Mean pre-dose baseline, post dose scores and 
standard deviations for all outcomes 
 
Chapter 2 
 
Table 9.1 Mean pre-dose baseline, post dose scores and standard deviations for Bond-Lader mood scales following 
supplementation of the control, Delcyan
TM
 and Blackadder juice drinks. 
Measure N Treatment 
Baseline Repetition 1 Repetition 2 
Mean SD Mean SD Mean SD 
Bond-Lader 
calm 
33 
Control 58.71 15.05 58.06 11.02 63.23 20.13 
Delcyan
TM
 61.06 16.35 57.83 11.31 63.51 14.53 
Juice 60.11 15.08 62.35 14.32 64.55 18.43 
Bond-Lader 
content 
33 
Control 69.33 10.2 67.4 10.08 58.95 13.78 
Delcyan
TM
 70.16 11.41 69.76 5.58 63.74 10.13 
Juice 69.01 11.09 69.09 5.79 62.76 12.99 
Bond-Lader 
alert 
33 
Control 61.31 12.6 59.5 10.83 38.82 15.95 
Delcyan
TM
 62.99 15.32 62.37 6.51 48.83 13.99 
Juice 62.83 13.15 62.07 11.45 44.46 18.54 
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Table 9.2 Mean pre-dose baseline, post dose scores and standard deviations for each cognitive condition following supplementation of the control, Delcyan
TM
 and Blackadder juice drinks. 
Measure N Treatment 
Baseline Repetition 1 Repetition 2 Repetition 3 Repetition 4 Repetition 5 Repetition 6 Repetition 7 
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Digit vigilance accuracy (%) 33 
Control 97.03 4.3 95.97 3.24 93.85 7.73 92.16 10.26 89.96 7.48 89.54 9.41 88.27 9.88 90.01 8.74 
Delcyan
TM
 97.5 3.22 95.51 6.26 92.99 8.68 91.28 13.51 91.69 9.56 91.67 8.64 92.05 7.92 90.59 10.23 
Juice 96.45 3.83 95.04 8.46 93.56 7.04 91.16 10.69 89.82 10.87 91.05 7.62 88.24 12.77 91.74 7.92 
Digit vigilance false alarms 
(Number) 
33 
Control 0.91 1.34 1.40 1.22 1.43 1.82 1.89 1.51 2.60 2.25 2.57 1.85 2.83 2.24 2.43 2.02 
Delcyan
TM
 0.8 0.8 1.03 1.12 1.51 1.62 1.80 1.95 1.80 1.91 2.37 1.90 1.86 1.56 2.06 2.10 
Juice 0.86 1.14 1.14 1.53 1.78 1.77 2.28 2.48 2.42 2.17 2.28 1.85 2.69 2.57 2.28 2.25 
Digit vigilance reaction time 
(msec) 
33 
Control 414.1 29.28 434.2 32.39 442.2 32.30 444.4 32.43 457.6 34.41 450.9 32.29 458.7 32.22 457.1 32.21 
Delcyan
TM
 413.5 28.64 427.8 29.01 431.5 29.55 448.8 35.02 445.1 33.87 448.3 31.81 445.8 29.95 452.1 29.48 
Juice 422.1 31.03 427.9 28.13 440.9 33.97 448.3 34.08 447.7 30.29 450.6 31.97 455.5 30.13 451.0 32.80 
RVIP accuracy (%) 32 
Control 65.86 15.26 64.61 11.47 59.14 11.84 62.27 12.76 58.28 12.32 57.27 16.82 57.73 11.55 55.23 14.84 
Delcyan
TM
 64.53 17.59 64.30 9.38 62.97 10.04 66.48 10.79 62.81 11.80 62.81 10.73 62.97 10.79 62.50 16.08 
Juice 70.47 14.6 65.16 12.08 63.91 12.84 62.89 14.11 59.77 13.17 59.92 13.81 60.63 13.51 61.64 14.31 
RVIP false alarms 32 
Control 4 4.7 2.97 3.76 3.06 3.43 2.72 3.21 3.75 3.56 3.25 4.13 3.03 3.36 3.28 3.39 
Delcyan
TM
 2.88 4.88 2.63 3.41 2.69 3.76 2.63 4.44 2.50 4.29 2.91 3.95 2.63 4.54 3.16 5.29 
Juice 2.81 3.35 1.93 2.55 2.40 2.87 3.19 2.09 3.47 3.74 2.68 2.78 2.09 3.20 2.56 2.86 
RVIP reaction time (msec) 32 
Control 484.4 43.93 483.53 29.83 491.6 31.80 497.1 31.23 493.8 32.70 495.3 35.65 493.2 40.32 504.1 44.98 
Delcyan
TM
 479.8 35.2 487.51 34.25 494.2 37.04 488.2 31.31 490.5 35.15 494.1 37.62 484.3 37.58 492.3 35.15 
Juice 484.6 40.58 483.22 26.74 500.5 32.19 495.7 34.31 499.0 40.99 496.6 35.43 492.1 35.99 494.9 43.18 
Stroop accuracy (%) 35 
Control 98.88 2.14 98.72 2.28 99.02 1.61 99.03 2.43 98.15 2.86 98.21 2.73 98.37 2.53 98.59 2.29 
Delcyan
TM
 99.14 1.61 98.83 1.91 98.83 2.05 99.21 1.90 99.18 1.59 98.72 1.83 99.23 1.69 98.42 2.27 
Juice 98.9 2.77 98.33 2.97 98.64 2.11 98.93 2.06 98.90 2.49 98.63 2.51 98.62 2.29 98.40 3.01 
Stroop reaction time (msec) 35 
Control 797.4 105.9 788.37 51.78 793.2 49.64 786.1 54.52 812.3 60.77 807.9 59.67 851.2 174.70 816.0 64.57 
Delcyan
TM
 801.5 124.4 785.64 49.59 799.2 57.42 827.9 157.30 799.9 57.53 790.1 120.66 807.5 60.99 798.2 72.49 
Juice 788.5 115.1 772.81 70.97 780.6 81.20 793.8 102.10 813.5 121.70 786.1 70.25 808.2 95.64 796.3 79.30 
VAS fatigue 
33 
Control 35.06 19.23 38.61 13.13 45.09 17.41 47.79 16.19 50.45 18.22 55.64 19.31 57.00 17.08 58.39 18.22 
(mm) Delcyan
TM
 34.42 19.97 37.57 10.48 41.45 12.57 42.72 12.93 45.06 13.55 48.81 14.88 49.45 15.68 49.72 16.53 
 
Juice 32.61 17.69 37.79 15.47 40.13 15.99 46.64 17.30 47.52 17.48 51.52 15.99 51.58 16.70 53.58 16.54 
VAS difficulty 
33 
Control 48.97 15.48 51.91 14.29 59.94 20.25 66.21 14.14 69.73 18.76 74.00 17.67 74.52 18.86 78.21 17.73 
(mm) Delcyan
TM
 40.12 18.97 45.03 10.85 53.00 14.57 55.12 12.78 57.73 14.83 61.36 15.25 62.57 15.95 63.24 16.04 
 
Juice 39.85 20.63 47.55 18.05 55.52 21.86 57.64 18.51 60.43 17.26 64.67 19.43 66.58 21.01 67.33 20.04 
Logical reasoning reaction 
time 
33 
Control 3977 1330 3,840.30 797.5 
 
Delcyan
TM
 3834 1132 3,725.10 964.1 
Juice 3963 1266 3,705.30 750.1 
Logical reasoning accuracy 
(%) 
33 
Control 86.48 15.88 87.87 22.97 
 
Delcyan
TM
 86.48 15.85 86.66 8.34 
Juice 86.3 16.93 87.82 11.25 
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Table 9.3 Mean pre-dose baseline, post dose scores and standard deviations for  each physiological parameter following 
supplementation of the control, Delcyan
TM
 and Blackadder juice drinks. 
Measure N Treatment 
Baseline Repetition 1 Repetition 2 
Mean SD Mean SD Mean SD 
Heart rate (BPM) 35 
Control 69.60 11.76 67.34 10.88 62.14 9.91 
Delcyan
TM
 72.14 12.07 67.94 12.16 64.00 12.00 
Juice 72.46 11.89 68.37 10.02 62.26 9.31 
Diastolic blood pressure 
(mmHg) 
35 
Control 76.83 7.64 74.66 7.96 77.54 8.66 
Delcyan
TM
 76.89 8.31 74.97 8.22 76.77 7.82 
Juice 74.63 7.32 75.17 7.19 74.63 9.37 
Systolic blood pressure 
(mmHg) 
35 
Control 121.30 12.62 118.23 10.51 121.03 11.41 
Delcyan
TM
 122.70 13.65 120.54 12.07 122.14 13.73 
Juice 122.90 11.74 121.03 13.91 119.37 13.89 
Glucose (mmoL) 35 
Control 4.95 0.53 4.75 0.77 5.29 0.78 
Delcyan
TM
 4.93 0.39 4.95 0.68 4.54 0.36 
Juice 4.96 0.48 4.52 0.46 4.74 0.61 
Prolactin (IU/L) 
8 Control 271.60 70.52 169.29 50.36 
 
7 Delcyan
TM
 315.40 135.90 194.14 94.37 
5 Juice 353.40 105.30 146.00 48.53 
MAO-B 
8 
Control 258.00 112.30 269.33 106.76 
(nmol H
2
O
2
) Delcyan
TM
 220.60 131.20 142.55 105.24 
 
Juice 273.10 114.10 5.68 6.75 
Total anthocyanins (nM/L) 17 
Control 0 0 0.23 0.05 
Delcyan
TM
 0 0 22.19 5.57 
Juice 0 0 15.20 3.89 
Phenylethylamine (ng/ml) 17 
Control 0.05 0.18 0.05 0.20 
Delcyan
TM
 0.04 0.14 0.05 0.18 
Juice 0.09 0.35 0.09 0.35 
Dopamine 
17 
Control 0.02 0.02 0.02 0.02 
(ng/ml) Delcyan
TM
 0.02 0.01 0.02 0.01 
 
Juice 0.02 0.01 0.02 0.01 
Serotonin 
17 
Control 1.9 1.34 1.82 1.57 
(ng/ml) Delcyan
TM
 2.37 2.06 2.01 1.83 
 
Juice 2.23 2.3 1.91 1.83 
Normetanephrine (ng/ml) 17 
Control 0.05 0.02 0.06 0.03 
Delcyan
TM
 0.06 0.03 0.07 0.03 
Juice 0.05 0.02 0.07 0.03 
Noradrenaline (ng/ml) 17 
Control 0.3 0.1 0.38 0.18 
Delcyan
TM
 0.35 0.1 0.41 0.16 
Juice 0.33 0.11 0.37 0.15 
Adrenaline 
17 
Control 0.02 0.02 0.03 0.03 
(ng/ml) Delcyan
TM
 0.02 0.03 0.02 0.03 
 
Juice 0.02 0.02 0.02 0.02 
DHPG 
17 
Control 1.61 0.36 1.71 0.47 
(ng/ml) Delcyan
TM
 1.6 0.34 1.70 0.45 
 
Juice 1.63 0.37 1.34 0.44 
Homovanillic acid (ng/ml) 17 
Control 21.42 12.21 19.42 12.02 
Delcyan
TM
 27.45 16.7 23.62 14.62 
Juice 17.12 8.01 14.47 7.18 
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Chapter three 
 
Table 9.4  Mean pre-dose baseline, post dose scores and standard deviations for each mood parameter over both measured assessments 
Measure N Treatment 
Baseline Session 1 (60 minutes) Session 2 (150 minutes) 
 
Repetition 1 Repetition 2 Repetition 3 Repetition 4 Repetition 1 Repetition 2 Repetition 3 Repetition 4 
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
VAS mentally 
energised 
32 
Control 45.06 11.93 45.88 13.54 41.97 12.25 39.88 16.22 37.56 16.64 46.44 15.16 42.84 17.95 39.47 16.45 41.66 16.44 
125mg 46.91 11.47 47.38 13.60 42.47 16.51 43.03 16.61 40.56 16.64 47.53 14.60 44.56 16.73 46.28 16.81 47.47 17.92 
250mg 46.13 15.55 46.50 16.09 44.69 14.44 43.91 18.31 40.84 17.67 44.72 17.68 42.97 19.81 42.44 17.73 40.06 18.34 
500mg 44.63 12.47 47.38 13.60 42.47 16.51 43.03 16.61 40.56 16.64 47.53 14.60 44.56 16.73 46.28 16.81 47.47 17.92 
VAS motivation 32 
Control 47.88 14.66 44.41 13.34 41.22 11.64 37.81 13.91 37.88 13.95 46.03 11.85 42.06 14.74 41.31 15.26 40.88 15.89 
125mg 49.78 10.25 47.28 14.92 42.41 17.46 40.06 16.55 40.38 16.72 47.94 15.86 42.22 18.80 42.66 18.13 44.25 18.27 
250mg 47.56 15.96 48.66 17.23 43.84 18.88 40.09 18.46 38.75 18.62 44.50 16.86 40.16 19.88 37.50 18.14 38.56 19.18 
500mg 49.5 12.56 47.28 14.92 42.41 17.46 40.06 16.55 40.38 16.72 47.94 15.86 42.22 18.80 42.66 18.13 44.25 18.27 
VAS physically 
energised 
32 
Control 48.97 13.05 46.38 12.31 42.50 13.80 39.88 18.11 40.00 16.15 49.09 11.37 43.06 16.38 43.25 16.19 41.66 16.39 
125mg 49.31 11.03 48.44 13.15 41.28 18.30 42.84 17.99 38.97 17.04 49.03 13.66 45.50 17.80 46.69 15.69 45.56 17.17 
250mg 45.47 13.35 48.88 16.78 43.28 19.18 43.09 18.87 42.53 19.44 46.59 14.20 41.88 18.47 42.16 18.36 41.41 17.19 
500mg 46.81 11.8 48.44 13.15 41.28 18.30 42.84 17.99 38.97 17.04 49.03 13.66 45.50 17.80 46.69 15.69 45.56 17.17 
STA-I 32 
Control 31.31 1.32 30.48 7.18 
    
33.72 8.51 31.20 8.05 
    
32.65 8.61 
125mg 32.1 1.23 32.00 8.12 
    
33.63 8.40 32.03 8.48 
    
32.91 8.03 
250mg 31.53 1.13 31.19 7.06 
    
33.41 8.61 31.38 7.57 
    
33.41 8.67 
500mg 31.31 1.32 31.00 7.12 
    
33.19 7.64 31.53 7.41 
    
32.63 8.08 
Bond-Lader calm 32 
Control 62.84 11.71 58.34 12.60 
    
61.34 12.32 59.48 12.14 
    
61.34 11.42 
125mg 62.97 11.44 61.50 13.17 
    
62.42 10.39 61.48 12.26 
    
59.58 10.10 
250mg 64.23 10.8 61.95 10.21 
    
62.67 11.58 61.73 12.19 
    
60.33 11.34 
500mg 63.34 11.69 57.89 9.19 
    
58.94 10.38 59.98 8.94 
    
58.59 9.89 
Bond-Lader content 32 
Control 61.99 13.51 61.56 13.24 
    
60.50 13.45 61.71 12.85 
    
61.18 13.33 
125mg 62.41 12.73 62.61 12.29 
    
60.66 13.36 63.49 12.56 
    
63.52 11.94 
250mg 63.54 12.73 64.24 13.00 
    
61.67 10.89 63.98 10.28 
    
62.37 12.16 
500mg 63.15 11.37 61.26 12.84 
    
58.13 13.36 61.96 11.62 
    
61.15 14.15 
Bond-Lader alert 32 
Control 52.89 13.57 54.64 13.99 
    
46.56 14.22 52.24 13.64 
    
44.91 15.44 
125mg 55.73 12.32 57.36 10.57 
    
47.79 12.19 55.67 13.26 
    
52.57 13.45 
250mg 53.53 14.71 52.66 13.27 
    
44.71 13.52 52.48 10.97 
    
50.06 12.04 
500mg 51.63 11.24 54.62 12.26 
    
45.97 12.61 53.39 11.02 
    
48.36 13.18 
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Table 9.5 Mean pre-dose baseline, post dose scores and standard deviations for each physiological parameter over both 
measured epochs 
Measure N Treatment 
Baseline Post Dose 
Mean SD Mean SD 
Platelet MAO-B 8 
Control 2517 1556 2517 856.1 
125mg 2391 1600 2391 1219 
250mg 2366 1897 2366 905.4 
500mg 2276 1319 2276 1053 
FRAP 10 
Control 859.9 110.7 935.4 286.7 
125mg 917.7 113.1 873.5 166.2 
250mg 843.5 124.9 877.0 165.1 
500mg 873.2 105.7 875.0 95.85 
Prolactin 9 
Control 340.4 187.1 216.7 64.13 
125mg 367.4 158.7 187.6 54.66 
250mg 325.9 124.2 178.0 54.19 
500mg 357.1 116.3 159.3 34.69 
 
Chapter 4 
Table 9.6 Mean pre-dose baseline, post dose scores and standard deviations for all behavioural outcomes 
Measure N Treatment 
Baseline Repetition 1 Repetition 2 Repetition 3 
Mean SD Mean SD Mean SD Mean SD 
Serial 3 incorrect responses 20 
Control 1.95 12.27 2.25 3.34 2.70 3.53 3.40 4.11 
Juice 2.8 17.39 2.05 3.02 3.55 3.38 4.10 3.60 
Serial 3 correct responses 20 
Control 44.2 51.11 44.65 11.82 45.50 11.96 44.90 10.40 
Juice 42.85 76.74 44.05 16.72 43.75 15.70 42.05 13.92 
Serial 3 number of responses 20 
Control 46.15 54.74 46.90 11.79 48.20 12.36 48.30 10.39 
Juice 45.65 69.13 46.10 14.99 47.30 15.07 46.15 13.79 
Serial 7 incorrect responses 20 
Control 2.95 12.09 2.95 3.05 3.85 3.00 2.74 3.44 
Juice 2.8 12.78 2.75 3.30 2.75 2.65 2.94 2.75 
Serial 7 correct responses 20 
Control 24.25 49.01 27.05 27.05 26.80 10.81 10.79 10.89 
Juice 25.25 54.02 28.00 28.30 28.00 11.91 10.88 11.74 
Serial 7 number of responses 20 
Control 27.2 45.06 30.00 30.10 30.65 9.30 9.59 9.50 
Juice 28.05 48.87 30.75 31.60 30.75 10.92 9.76 10.65 
RVIP correct responses 20 
Control 53.5 62.59 53.25 52.00 53.63 23.55 21.97 25.91 
Juice 55.79 57.76 56.25 51.63 52.63 22.75 23.89 23.01 
RVIP false alarms 20 
Control 0.85 26.59 0.70 1.15 1.00 0.92 1.50 1.41 
Juice 0.84 35.04 1.10 0.65 1.35 1.25 1.18 1.46 
RVIP reaction time 20 
Control 482.88 54.45 483.24 478.14 477.06 57.99 49.35 64.43 
Juice 482.53 55.75 479.83 497.88 447.42 51.76 88.73 115.29 
Fatigue 20 
Control 28.6 77.9 44.60 26.88 50.70 29.98 54.40 31.30 
Juice 23.75 90.3 34.90 21.75 43.00 22.95 47.10 27.04 
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Chapter Five 
Table 9.7 Mean pre-dose baseline, post dose scores and standard deviations for all haemodynamic parameters 
Measure Treatment N 
Baseline 15 minutes 30 minutes 45 minutes 1 hour 1.5 hours 2 hours 2.4 hours 3 hours 4 hours 
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Heart rate Control 
8 
60.50 11.22 61.38 11.73 65.25 20.89 65.50 10.04 65.50 13.03 62.88 11.32 61.00 14.40 56.00 13.54 58.13 14.86 58.63 9.44 
(BPM) Juice 63.63 8.52 63.63 8.52 60.50 7.15 62.63 12.99 64.25 5.80 65.38 8.62 63.75 10.71 57.88 12.37 59.25 9.13 56.13 8.64 
DVP - SI 
Control 
8 
5.71 1.08 6.34 6.34 6.34 6.34 6.34 6.34 6.51 1.06 6.07 1.20 6.20 1.18 6.16 1.24 6.15 1.24 5.94 1.20 
Juice 6.63 0.97 6.79 0.97 6.37 0.95 6.93 1.74 6.57 1.10 6.55 1.20 6.53 1.38 6.24 1.02 6.46 1.16 6.17 1.10 
DVP - RI 
Control 
8 
61.88 16.34 69.00 19.14 62.00 16.38 65.63 18.69 67.63 16.62 56.00 10.46 61.13 12.84 67.00 12.65 67.38 8.23 60.13 9.95 
Juice 69.13 12.98 69.13 12.98 68.13 14.86 61.75 10.69 64.75 5.70 64.25 10.82 63.25 21.09 66.25 14.47 67.50 18.16 64.63 16.06 
Glucose Control 
8 
4.25 0.47 5.91 1.64 5.70 1.61 4.12 1.27 3.56 0.88 3.65 0.59 3.92 0.29 3.98 0.40 4.17 0.15 4.15 0.17 
(mmol/L) Juice 4.23 0.44 5.02 1.06 5.33 1.01 4.71 1.38 3.83 1.11 3.66 0.65 3.90 0.34 4.03 0.34 4.21 0.45 4.07 0.17 
Lactate Control 
8 
0.72 0.24 1.12 0.61 1.52 0.51 1.39 0.46 1.21 0.35 0.80 0.33 0.68 0.19 0.69 0.20 0.78 0.18 0.69 0.24 
(mmol/L) Juice 0.93 0.37 0.98 0.38 1.25 0.48 1.52 0.54 1.46 0.32 0.98 0.22 0.88 0.21 0.69 0.34 0.79 0.17 0.62 0.44 
MAO-B Control 
8 
1074 376.6 2367 3305 1013 277.5 956.1 367.0 1050 253.3 1259 573.6 1434 637.5 1458 686.7 1504 545.7 3563 5785 
(nmol H
2
O
2
) Juice 1526 1095 52.31 420.3 0.00 197.3 0.00 125.10 0.00 221.8 0.00 179.4 0.00 139.5 36.85 186.3 0.68 198.5 215.9 205.38 
Prolactin Control 
8 
285.3 81.90 239.2 53.58 220.8 54.68 207.0 58.71 201.70 68.72 216.3 78.22 236.4 62.69 177.9 71.69 185.0 86.57 188.5 90.99 
(mIU/L) Juice 285.8 63.10 246.7 64.22 208.3 63.20 189.6 59.63 164.67 51.80 130.7 36.30 109.6 38.27 121.0 46.66 127.3 57.46 150.6 95.00 
Table 9.8 Mean pre-dose baseline, post dose scores and, standard deviations for 
 MAO-B, prolactin glucose, lactate and DVP 24 hour parameters 
Measure Treatment N 
24h 
Mean SD 
MAO-B Control 
6 
1739 681.0 
(nmol H
2
O
2
) Juice 1417 542.2 
Prolactin Control 
6 
294.5 72.35 
(mIU/L) Juice 286.1 127.1 
Glucose Control 
8 
4.50 0.35 
(mmol/L) Juice 4.34 0.60 
Lactate Control 
8 
1.01 0.44 
(mmol/L) Juice 0.66 0.30 
Heart Rate Control 
8 
63.50 12.75 
(BPM) Juice 57.63 12.78 
DVP -SI 
Control 
8 
6.31 0.98 
juice 6.44 1.22 
DVP -RI 
Control 
8 
55.75 7.44 
Juice 65.00 6.09 
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Chapter six 
Table 9.9 Mean pre-dose baseline, post dose scores and standard deviations for all behavioural parameters 
Measure N Treatment 
Baseline Repetition 1 Repetition 2 Repetition 3 Repetition 4 
Mean SD Mean SD Mean SD Mean SD Mean SD 
Finger tap 
number of 
taps 
34 
Control 500.4 63.1 495.1 57.97 490.0 107.6 476.9 54.19 484.7 60.59 
Delcyan
TM
 508.8 51.19 490.11 61.51 501.9 128.1 478.4 55.03 496.9 59.68 
Juice 523.1 101.9 501.0 92.60 502.9 95.58 484.5 52.91 488.2 74.84 
Immediate 
word recall 
correct 
34 
Control 6.03 0.61 5.37 1.57 5.69 1.60 5.51 1.36 5.40 1.59 
Delcyan
TM
 6.09 0.51 5.40 1.33 5.29 1.43 4.91 1.84 5.20 1.73 
Juice 6.31 0.53 5.49 1.87 5.37 1.61 5.29 1.76 5.31 1.78 
Immediate 
word recall 
incorrect 
34 
Control 0.71 0.3 0.63 0.69 0.43 0.74 0.74 1.15 0.77 0.91 
Delcyan
TM
 0.77 0.35 0.57 0.88 0.83 0.89 1.06 1.45 1.00 1.35 
Juice 0.49 0.25 0.86 1.00 1.14 1.26 0.74 1.04 0.74 1.01 
DSST correct 34 
Control 57.77 4.05 60.29 12.43 60.31 11.48 61.46 11.70 60.37 11.46 
Delcyan
TM
 54.91 2.69 59.14 8.96 61.26 9.92 60.46 9.11 61.20 10.43 
Juice 55.91 3.81 59.63 11.68 59.40 11.82 61.49 11.67 62.86 12.02 
DSST 
incorrect 
34 
Control 0.14 0.11 0.06 0.24 0.11 0.32 0.11 0.32 0.06 0.24 
Delcyan
TM
 0.11 0.1 0.11 0.32 0.11 0.40 0.00 0.00 0.09 0.28 
Juice 0.11 0.13 0.11 0.32 0.14 0.43 0.11 0.53 0.06 0.24 
Numeric 
working 
memory % 
correct 
34 
Control 96.36 3.9 95.93 3.50 96.60 3.50 95.99 3.58 95.56 4.50 
Delcyan
TM
 95.99 3.26 96.30 2.48 96.26 2.44 95.83 3.60 95.96 3.46 
Juice 96.13 3.48 96.57 3.65 96.23 3.44 95.99 4.03 96.10 4.87 
Numeric 
working 
memory RT 
(msec) 
34 
Control 860.5 210 835.7 222.7 841.9 226.9 836.1 230.9 834.6 234.6 
Delcyan
TM
 834.3 231 822.9 237.9 802.5 179.2 854.8 385.9 824.1 199.4 
Juice 867.8 255 810.6 208.0 820.6 205.5 825.1 223.8 778.7 207.2 
Corsi blocks 
RT (msec) 
34 
Control 6424 1775 5.87 0.94 5.74 0.84 5.86 0.82 5.77 0.77 
Delcyan
TM
 6273 1468 5.89 0.74 5.92 0.91 5.87 0.84 5.57 0.94 
Juice 6360 1384 5.87 0.95 6.03 0.73 5.66 1.33 5.81 0.99 
Corsi blocks 
span 
34 
Control 5.87 0.93 6070 1640 5842 1482 6283 1622 5814 1466 
Delcyan
TM
 5.89 0.73 6729 1583 6198 1279 6148 1606 5823 1599 
Juice 5.87 0.94 6239 1744 6061 1375 6085 1561 5984 1467 
Peg and ball 
thinking time 
34 
Control 3129 1824 2811 1160 2773 1115 2618 1201 2675 1032 
Delcyan
TM
 2939 1214 2857 1086 2851 1154 2700 934 2763 1046 
Juice 2934 1029 2796 1083 2801 894 2704 817 2666 759 
Peg and ball 
working time 
(msec) 
34 
Control 9623 2660 9043 2420 8806 2084 8773 2281 8798 2157 
Delcyan
TM
 9467 2091 8903 1644 8763 2088 8724 1764 8737 1941 
Juice 9232 1952 8795 1708 8851 1188 8516 1236 8419 1473 
Peg and ball 
errors 
34 
Control 3.88 4.29 4.00 2.91 2.97 3.11 3.68 3.55 3.97 4.58 
Delcyan
TM
 4.35 3.89 3.09 3.58 2.71 2.47 4.06 3.98 3.32 3.21 
Juice 3.18 3.2 3.00 2.83 3.79 3.84 2.97 3.39 3.38 1.84 
Digit vigilance 
% correct 
34 
Control 95.29 4.7 92.76 9.51 93.33 10.47 90.69 10.44 93.79 8.34 
DelcyanTM 93.33 16.1 94.25 7.91 94.83 5.75 89.42 16.62 93.56 8.50 
Juice 95.75 5.37 94.02 9.61 93.79 10.46 93.33 8.40 95.52 7.42 
Digit vigilance 
RT (msec) 
34 
Control 453.1 41.6 459.13 51.97 469.67 55.76 473.37 50.91 470.03 54.75 
Delcyan
TM
 448.7 51.7 471.35 55.36 471.30 52.76 473.04 54.94 471.77 50.23 
Juice 448.1 41.2 460.58 56.38 462.71 53.12 471.22 60.44 471.89 48.98 
Digit vigilance 
false alarms 
(number) 
29 
Control 0.07 0.23 0.310 0.541 0.172 0.384 0.241 0.511 0.172 0.468 
Delcyan
TM
 0.31 1.04 0.310 0.541 0.172 0.468 0.345 0.614 0.207 0.491 
Juice 0.14 0.32 0.103 0.310 0.379 1.015 0.310 0.541 0.241 0.830 
Stroop 
accuracy (%) 
29 
Control 98.38 -2.35 98.24 2.24 98.77 1.66 97.84 2.61 98.19 2.44 
Delcyan
TM
 98.38 -1.99 98.73 1.48 98.77 1.66 98.38 1.99 98.38 1.61 
Juice 98.48 -1.62 98.43 1.92 98.38 2.58 98.33 2.17 98.14 2.31 
Stroop 
reaction time 
(msec) 
29 
Control 810 -177 791.2 170.1 791.3 161.2 781.8 142.8 777.0 162.7 
Delcyan
TM
 788.2 -131 758.8 115.3 770.1 129.5 787.1 247.3 799.7 270.2 
Juice 799.4 -137 763.8 129.6 764.9 125.4 785.3 151.3 736.2 116.5 
RVIP 
accuracy (%) 
29 
Control 55.39 19.2 58.44 20.88 57.34 20.91 56.80 21.91 56.80 19.75 
Delcyan
TM
 53.67 17.7 57.58 20.92 56.33 17.61 56.09 21.50 57.42 21.34 
Juice 58.91 20.9 59.06 20.34 59.84 21.19 57.42 21.49 58.36 22.98 
RVIP false 
alarms 
(number) 
29 
Control 1.31 1.2 1.656 1.619 1.563 1.645 1.344 1.537 1.125 1.212 
Delcyan
TM
 1.13 1.2 1.469 1.565 1.188 1.091 1.156 1.081 0.938 1.105 
Juice 1.59 1.8 1.594 1.757 1.000 1.164 1.438 1.458 1.375 1.519 
RVIP reaction 
time (msec) 
29 
Control 501.5 49.9 505.2 56.9 506.8 60.7 497.9 57.8 504.8 53.8 
Delcyan
TM
 507.2 46.8 507.3 50.5 511.9 53.6 506.9 55.3 512.7 67.0 
Juice 513.3 50.8 504.7 57.4 505.8 52.7 506.9 51.2 494.1 54.5 
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Delayed word 
recall % 
correct 
(number) 
35 
Control 3.83 0.68 2.057 1.909 2.086 1.721 1.943 1.939 1.886 1.676 
Delcyan
TM
 4.03 0.51 1.971 1.543 1.771 1.816 1.943 1.862 2.371 1.848 
Juice 3.57 0.53 2.257 2.005 2.143 2.060 1.743 1.502 2.114 1.952 
Delayed word 
recall 
incorrect 
(number) 
35 
Control 1.17 0.37 1.343 1.413 1.171 1.505 1.429 1.989 1.000 1.237 
Delcyan
TM
 1.06 0.37 1.143 1.458 1.600 1.866 1.000 1.534 1.743 2.254 
Juice 0.54 0.61 1.457 1.597 1.657 1.814 1.486 1.755 1.257 1.837 
Word 
recognition 
RT (msec) 
35 
Control 972.9 218 1012.3 229.4 969.2 224.3 1006.7 298.4 955.7 239.2 
Delcyan
TM
 933.3 189 980.3 228.3 967.6 208.2 962.3 252.4 963.2 254.4 
Juice 992.1 245 974.5 227.4 969.0 209.1 945.1 212.2 905.4 168.0 
Word 
recognition % 
correct 
35 
Control 75.81 9.51 72.19 8.85 73.05 9.48 69.14 8.64 73.24 10.95 
Delcyan
TM
 77.71 8.61 73.14 9.11 68.38 10.71 70.48 8.86 70.76 9.50 
Juice 77.24 9.03 72.95 10.38 72.57 9.67 70.86 11.12 70.57 12.38 
Picture 
recognition 
RT (msec) 
35 
Control 872.9 155 882.5 156.2 914.7 216.1 921.5 215.7 887.4 209.7 
Delcyan
TM
 830.9 120 857.4 132.3 878.4 169.6 914.3 188.4 872.6 155.0 
Juice 857.7 221 898.4 180.4 849.3 148.9 872.8 174.9 866.8 168.1 
Picture 
recognition % 
correct 
35 
Control 94.95 6.39 94.57 5.25 93.05 5.01 93.05 5.85 92.19 5.88 
Delcyan
TM
 95.43 5.11 94.48 5.42 94.57 6.16 92.28 6.56 91.71 7.20 
Juice 95.43 4.37 92.95 7.04 94.57 6.11 93.62 6.69 92.00 8.37 
Bond-Lader 
alert (mm) 
35 
Control 65.83 13.8 62.09 14.47 59.97 16.29 56.87 18.58 58.38 15.95 
Delcyan
TM
 65.34 13.3 65.96 13.80 65.77 13.13 64.81 13.77 64.51 13.59 
Juice 66.47 14.6 64.00 14.50 60.74 16.09 57.84 16.96 60.07 17.01 
Bond-Lader 
content (mm) 
35 
Control 71.03 13.7 71.69 11.88 71.32 13.28 72.64 12.94 72.14 11.97 
Delcyan
TM
 71.77 10.9 71.03 12.56 70.71 11.56 70.41 12.79 72.19 11.49 
Juice 73.08 11.5 72.69 9.84 72.55 11.34 73.30 10.97 73.86 10.74 
Bond-Lader 
calm (mm) 
35 
Control 61.81 14.2 64.44 14.44 63.49 14.26 67.83 14.19 65.70 13.72 
Delcyan
TM
 63.1 15.1 60.63 14.62 57.46 14.48 56.42 15.40 59.78 14.69 
Juice 63.39 13.6 63.69 13.90 66.36 12.66 67.17 13.49 64.61 12.14 
VAS fatigue 
(mm) 
35 
Control 37.23 18.2 42.46 16.09 44.57 18.19 52.23 19.43 47.51 16.93 
Delcyan
TM
 39.69 16.4 42.57 18.73 48.03 16.46 50.06 17.12 49.49 17.20 
Juice 34.46 17.1 38.74 15.67 43.40 21.19 50.49 20.70 46.83 18.52 
VAS mentally 
energised 
(mm) 
35 
Control 56.91 15.3 54.51 13.92 52.34 16.08 47.60 18.94 49.69 15.93 
Delcyan
TM
 54.63 16.7 50.83 18.70 47.57 18.15 46.97 16.44 51.89 17.45 
Juice 58.23 18.9 51.14 19.55 47.34 16.85 46.37 20.86 46.40 18.16 
VAS 
physically 
energised 
(mm) 
35 
Control 58.46 15.2 52.86 15.35 50.94 17.23 47.80 18.08 48.03 16.00 
Delcyan
TM
 56.89 15.9 49.91 18.48 48.51 15.50 46.83 16.56 50.63 16.85 
Juice 57.03 17.8 55.20 17.79 50.83 18.94 48.94 19.75 48.23 17.96 
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Table 9.10 Mean pre-dose baseline, post dose scores and standard deviations for all blood parameters 
Measure N Treatment 
Baseline 60 Minutes 140 minutes 180 minutes 200 minutes 230 minutes 350 minutes 
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Blood glucose 
(mmol/L) 
35 
Control 4.79 0.08 5.088 0.806 4.272 0.398 4.388 0.651 5.489 0.957 7.704 1.001 5.582 0.642 
Delcyan
TM
 4.8 0.09 5.324 1.110 4.313 0.656 4.436 0.779 5.615 1.049 7.701 1.206 5.551 0.826 
Juice 4.78 0.12 5.579 0.891 4.143 0.484 4.241 0.390 5.272 1.151 7.634 1.257 5.540 0.900 
Blood lactate 
(mmol/L) 
35 
Control 1.47 0.13 2.025 0.729 1.334 0.647 1.136 0.540 1.544 0.568 1.814 0.671 1.247 0.512 
Delcyan
TM
 1.35 0.15 1.851 0.511 1.297 0.553 1.136 0.492 1.477 0.510 1.648 0.397 1.298 0.516 
Juice 1.36 0.12 2.149 0.815 1.329 0.526 1.118 0.462 1.583 0.643 1.909 0.647 1.239 0.558 
MAO- activity 
(nmol H
2
O
2
) 
5 
Control 1192 446 1119 922.8 
 
Delcyan
TM
 1090 328 811.5 352.4 
Juice 906 394 1135 937.4 
Prolactin 
(mIU/L) 
11 
Control 270.2 30.9 333.1 42.6 
 
Delcyan
TM
 287.2 55.5 293.2 58.1 
Juice 232.4 17.4 270.1 22.9 
